/artkey/inf-990000-0100_about-the-journal.php weekly 0.3 /artkey/inf-990000-1400_Redakcni-rada.php weekly 0.3 /artkey/inf-990000-1300_editorial-board.php weekly 0.3 /artkey/inf-990000-1000_Kontakt.php weekly 0.3 /artkey/inf-990000-0900_Contact.php weekly 0.3 /artkey/inf-990000-0600_Pokyny-pro-autory.php weekly 0.3 /artkey/inf-990000-0500_author-guidelines.php weekly 0.3 /artkey/inf-990000-0200_O-casopisu.php weekly 0.3 /artkey/inf-990000-1700_Objednavka-casopisu.php weekly 0.3 /rolrequest.php weekly 0.3 /current_issue.php daily 0.7 /archive.php daily 0.7 /magno/csf/2026/mn1.php daily 0.7 /en/magno/csf/2026/mn1.php daily 0.7 /artkey/csf-202601-0002_pharmacokinetic-changes-and-approach-to-drug-dosing-in-patients-with-obesity-and-after-bariatric-surgery.php daily 0.7 /en/artkey/csf-202601-0002_pharmacokinetic-changes-and-approach-to-drug-dosing-in-patients-with-obesity-and-after-bariatric-surgery.php daily 0.7 /artkey/csf-202601-0010_jiz-155-let-pomahame-rozvijet-farmacii.php daily 0.7 /en/artkey/csf-202601-0010_jiz-155-let-pomahame-rozvijet-farmacii.php daily 0.7 /artkey/csf-202601-0001_idiopathic-interstitial-lung-diseases-treatment-options.php daily 0.7 /en/artkey/csf-202601-0001_idiopathic-interstitial-lung-diseases-treatment-options.php daily 0.7 /artkey/csf-202601-0003_artificial-intelligence-in-pharmacy-services-practical-applications.php daily 0.7 /en/artkey/csf-202601-0003_artificial-intelligence-in-pharmacy-services-practical-applications.php daily 0.7 /artkey/csf-202601-0004_effective-communication-in-the-pharmacy.php daily 0.7 /en/artkey/csf-202601-0004_effective-communication-in-the-pharmacy.php daily 0.7 /artkey/csf-202601-0005_pelargonium-sidoides-dc-vs-pelargonium-reniforme-andrews-curtis-active-constituents-and-medicinal-effects.php daily 0.7 /en/artkey/csf-202601-0005_pelargonium-sidoides-dc-vs-pelargonium-reniforme-andrews-curtis-active-constituents-and-medicinal-effects.php daily 0.7 /artkey/csf-202601-0006_sinusitis-self-treatment.php daily 0.7 /en/artkey/csf-202601-0006_sinusitis-self-treatment.php daily 0.7 /artkey/csf-202601-0007_ocular-manifestations-of-allergies-options-for-self-treatment.php daily 0.7 /en/artkey/csf-202601-0007_ocular-manifestations-of-allergies-options-for-self-treatment.php daily 0.7 /artkey/csf-202601-0008_stripky-z-xxvii-sympozia-klinicke-farmacie-rene-macha.php daily 0.7 /en/artkey/csf-202601-0008_stripky-z-xxvii-sympozia-klinicke-farmacie-rene-macha.php daily 0.7 /artkey/csf-202601-0013_drug-unavailability-increases-off-label-prescribing-in-the-pediatric-population-in-slovakia.php daily 0.7 /en/artkey/csf-202601-0013_drug-unavailability-increases-off-label-prescribing-in-the-pediatric-population-in-slovakia.php daily 0.7 /artkey/csf-202601-0014_synteza-a-antimikrobialni-vlastnosti-derivatu-2-7-ethyl-3-methylxanthin-8-yl-sulfanyl-acetohydrazidu.php daily 0.7 /en/artkey/csf-202601-0014_synteza-a-antimikrobialni-vlastnosti-derivatu-2-7-ethyl-3-methylxanthin-8-yl-sulfanyl-acetohydrazidu.php daily 0.7 /artkey/csf-202601-0009_fixni-kombinace-antihypertenziv-adherence-a-rizika-zameny-v-klinicke-praxi.php daily 0.7 /en/artkey/csf-202601-0009_fixni-kombinace-antihypertenziv-adherence-a-rizika-zameny-v-klinicke-praxi.php daily 0.7 /artkey/csf-202601-0011_where-did-history-of-the-pharmacy-go.php daily 0.7 /en/artkey/csf-202601-0011_where-did-history-of-the-pharmacy-go.php daily 0.7 /artkey/csf-202601-0012_skin-hydration-how-to-increase-the-water-content-in-the-skin-with-dermocosmetics.php daily 0.7 /en/artkey/csf-202601-0012_skin-hydration-how-to-increase-the-water-content-in-the-skin-with-dermocosmetics.php daily 0.7 /magno/csf/2025/mn1.php weekly 0.7 /en/magno/csf/2025/mn1.php weekly 0.7 /flashbook/csf/2025/1.php monthly 0.2 /artkey/csf-202501-0008_doktorske-studium-na-faf-mu-v-brne.php weekly 0.7 /en/artkey/csf-202501-0008_doktorske-studium-na-faf-mu-v-brne.php weekly 0.7 /artkey/csf-202501-0009_management-of-gastrointestinal-adverse-effects-of-cancer-treatment-part-2-nausea-vomiting-immune-related-ga.php weekly 0.7 /en/artkey/csf-202501-0009_management-of-gastrointestinal-adverse-effects-of-cancer-treatment-part-2-nausea-vomiting-immune-related-ga.php weekly 0.7 /artkey/csf-202501-0001_possibilities-of-mixing-powder-mixtures-for-capsules-using-three-dimensional-mixer-devices-in-pharmacy-practice.php weekly 0.7 /en/artkey/csf-202501-0001_possibilities-of-mixing-powder-mixtures-for-capsules-using-three-dimensional-mixer-devices-in-pharmacy-practice.php weekly 0.7 /artkey/csf-202501-0002_self-treatment-of-acute-cough-in-adults-and-adolescents-older-than-12-years.php weekly 0.7 /en/artkey/csf-202501-0002_self-treatment-of-acute-cough-in-adults-and-adolescents-older-than-12-years.php weekly 0.7 /artkey/csf-202501-0003_a-patient-with-allergy-symptoms-and-options-of-self-medication.php weekly 0.7 /en/artkey/csf-202501-0003_a-patient-with-allergy-symptoms-and-options-of-self-medication.php weekly 0.7 /artkey/csf-202501-0004_acute-diarrhoea-self-treatment-options.php weekly 0.7 /en/artkey/csf-202501-0004_acute-diarrhoea-self-treatment-options.php weekly 0.7 /artkey/csf-202501-0005_chronic-venous-disease-what-to-advice-at-the-pharmacy.php weekly 0.7 /en/artkey/csf-202501-0005_chronic-venous-disease-what-to-advice-at-the-pharmacy.php weekly 0.7 /artkey/csf-202501-0006_stripky-z-xxvi-sympozia-klinicke-farmacie-rene-macha.php weekly 0.7 /en/artkey/csf-202501-0006_stripky-z-xxvi-sympozia-klinicke-farmacie-rene-macha.php weekly 0.7 /artkey/csf-202501-0010_adherence-to-the-pharmacist-8217-s-8239-protocol-of-sore-throat-symptomatic-treatment-in-ukraine-and-problems.php weekly 0.7 /en/artkey/csf-202501-0010_adherence-to-the-pharmacist-8217-s-8239-protocol-of-sore-throat-symptomatic-treatment-in-ukraine-and-problems.php weekly 0.7 /artkey/csf-202501-0011_covalent-drugs.php weekly 0.7 /en/artkey/csf-202501-0011_covalent-drugs.php weekly 0.7 /artkey/csf-202501-0007_zaznelo-na-webinari-trochu-jiny-pohled-na-respiracni-infekce-aneb-rozpustit-hlen-nestaci.php weekly 0.7 /en/artkey/csf-202501-0007_zaznelo-na-webinari-trochu-jiny-pohled-na-respiracni-infekce-aneb-rozpustit-hlen-nestaci.php weekly 0.7 /magno/csf/2025/mn2.php weekly 0.7 /en/magno/csf/2025/mn2.php weekly 0.7 /artkey/csf-202502-0003_proposal-of-limit-values-for-surface-contamination-by-cytotoxic-drugs-in-pharmacies-and-hospitals.php weekly 0.7 /en/artkey/csf-202502-0003_proposal-of-limit-values-for-surface-contamination-by-cytotoxic-drugs-in-pharmacies-and-hospitals.php weekly 0.7 /artkey/csf-202502-0011_doktorske-studium-na-farmaceuticke-fakulte-uk-v-8239-hradci-kralove-cesta-k-8239-vede-ktera-ma-smysl.php weekly 0.7 /en/artkey/csf-202502-0011_doktorske-studium-na-farmaceuticke-fakulte-uk-v-8239-hradci-kralove-cesta-k-8239-vede-ktera-ma-smysl.php weekly 0.7 /artkey/csf-202502-0001_current-trends-in-insulin-therapy.php weekly 0.7 /en/artkey/csf-202502-0001_current-trends-in-insulin-therapy.php weekly 0.7 /artkey/csf-202502-0002_current-pharmacotheraupeutical-options-of-lower-urinary-tract-symptoms.php weekly 0.7 /en/artkey/csf-202502-0002_current-pharmacotheraupeutical-options-of-lower-urinary-tract-symptoms.php weekly 0.7 /artkey/csf-202502-0006_good-storage-practices-for-medical-devices-and-in-vitro-diagnostic-medical-devices-by-healthcare-providers.php weekly 0.7 /en/artkey/csf-202502-0006_good-storage-practices-for-medical-devices-and-in-vitro-diagnostic-medical-devices-by-healthcare-providers.php weekly 0.7 /artkey/csf-202502-0007_self-treatment-options-for-gynecological-issues.php weekly 0.7 /en/artkey/csf-202502-0007_self-treatment-options-for-gynecological-issues.php weekly 0.7 /artkey/csf-202502-0008_repellents-and-protection-against-insects-and-ticks.php weekly 0.7 /en/artkey/csf-202502-0008_repellents-and-protection-against-insects-and-ticks.php weekly 0.7 /artkey/csf-202502-0009_photoprotection.php weekly 0.7 /en/artkey/csf-202502-0009_photoprotection.php weekly 0.7 /artkey/csf-202502-0012_anticonvulsant-biotargets-of-digoxin-in-silico-study-and-in-vivo-verification.php weekly 0.7 /en/artkey/csf-202502-0012_anticonvulsant-biotargets-of-digoxin-in-silico-study-and-in-vivo-verification.php weekly 0.7 /artkey/csf-202502-0013_the-management-of-vulvovaginal-candidiasis-the-results-of-survey-in-lviv-ukraine.php weekly 0.7 /en/artkey/csf-202502-0013_the-management-of-vulvovaginal-candidiasis-the-results-of-survey-in-lviv-ukraine.php weekly 0.7 /artkey/csf-202502-0005_resources-and-drug-information-on-pharmacotherapy-in-pregnancy.php weekly 0.7 /en/artkey/csf-202502-0005_resources-and-drug-information-on-pharmacotherapy-in-pregnancy.php weekly 0.7 /artkey/csf-202502-0010_cestovatelsky-prujem-priciny-lecba-a-prevence.php weekly 0.7 /en/artkey/csf-202502-0010_cestovatelsky-prujem-priciny-lecba-a-prevence.php weekly 0.7 /artkey/csf-202502-0004_car-t-therapy-the-role-of-the-pharmacist.php weekly 0.7 /en/artkey/csf-202502-0004_car-t-therapy-the-role-of-the-pharmacist.php weekly 0.7 /magno/csf/2025/mn3.php weekly 0.7 /en/magno/csf/2025/mn3.php weekly 0.7 /artkey/csf-202503-0009_specializacni-vzdelavani-farmaceutu-v-8239-gesci-katedry-lekarenstvi-klic-k-8239-profesnimu-rustu-a-8239-kv.php weekly 0.7 /en/artkey/csf-202503-0009_specializacni-vzdelavani-farmaceutu-v-8239-gesci-katedry-lekarenstvi-klic-k-8239-profesnimu-rustu-a-8239-kv.php weekly 0.7 /artkey/csf-202503-0001_medications-with-dependence-potential-pharmacological-aspects-and-clinical-practise.php weekly 0.7 /en/artkey/csf-202503-0001_medications-with-dependence-potential-pharmacological-aspects-and-clinical-practise.php weekly 0.7 /artkey/csf-202503-0002_current-trends-in-the-teatment-of-multiple-sclerosis.php weekly 0.7 /en/artkey/csf-202503-0002_current-trends-in-the-teatment-of-multiple-sclerosis.php weekly 0.7 /artkey/csf-202503-0003_individually-prepared-medicinal-products-in-palliative-care.php weekly 0.7 /en/artkey/csf-202503-0003_individually-prepared-medicinal-products-in-palliative-care.php weekly 0.7 /artkey/csf-202503-0006_interesting-pharmacological-effects-of-phenolic-acids-found-in-plants.php weekly 0.7 /en/artkey/csf-202503-0006_interesting-pharmacological-effects-of-phenolic-acids-found-in-plants.php weekly 0.7 /artkey/csf-202503-0007_periodontitis-pharmacist-s-options-in-its-prevention-and-treatment.php weekly 0.7 /en/artkey/csf-202503-0007_periodontitis-pharmacist-s-options-in-its-prevention-and-treatment.php weekly 0.7 /artkey/csf-202503-0008_self-treatment-for-dry-eye-syndrome.php weekly 0.7 /en/artkey/csf-202503-0008_self-treatment-for-dry-eye-syndrome.php weekly 0.7 /artkey/csf-202503-0011_adme-profile-calculation-and-drug-similarity-study-of-new-1-2-4-triazole-derivatives-containing-2-bromo-5-metho.php weekly 0.7 /en/artkey/csf-202503-0011_adme-profile-calculation-and-drug-similarity-study-of-new-1-2-4-triazole-derivatives-containing-2-bromo-5-metho.php weekly 0.7 /artkey/csf-202503-0004_resources-and-drug-information-on-pharmacotherapy-in-breastfeeding.php weekly 0.7 /en/artkey/csf-202503-0004_resources-and-drug-information-on-pharmacotherapy-in-breastfeeding.php weekly 0.7 /artkey/csf-202503-0005_case-reports-from-individual-consultations-provided-to-patients-in-the-pharmacy.php weekly 0.7 /en/artkey/csf-202503-0005_case-reports-from-individual-consultations-provided-to-patients-in-the-pharmacy.php weekly 0.7 /artkey/csf-202503-0010_mezinarodni-sympozium-efmc-o-8239-pokrocich-v-8239-synteticke-a-8239-medicinalni-chemii.php weekly 0.7 /en/artkey/csf-202503-0010_mezinarodni-sympozium-efmc-o-8239-pokrocich-v-8239-synteticke-a-8239-medicinalni-chemii.php weekly 0.7 /artkey/csf-202503-0012_oral-ulceration-and-stomatitis-induced-by-mycophenolate-mofetil-in-a-8239-4-year-old-boy-after-kidney-transpla.php weekly 0.7 /en/artkey/csf-202503-0012_oral-ulceration-and-stomatitis-induced-by-mycophenolate-mofetil-in-a-8239-4-year-old-boy-after-kidney-transpla.php weekly 0.7 /artkey/csf-202503-0013_hearing-aids-and-hearing-protection.php weekly 0.7 /en/artkey/csf-202503-0013_hearing-aids-and-hearing-protection.php weekly 0.7 /magno/csf/2025/mn4.php weekly 0.7 /en/magno/csf/2025/mn4.php weekly 0.7 /artkey/csf-202504-0002_the-role-of-the-pharmacist-in-the-management-of-anticoagulant-therapy-with-warfarin-literature-review.php weekly 0.7 /en/artkey/csf-202504-0002_the-role-of-the-pharmacist-in-the-management-of-anticoagulant-therapy-with-warfarin-literature-review.php weekly 0.7 /artkey/csf-202504-0009_role-subkatedry-klinicke-farmacie-v-8239-systemu-specializacniho-vzdelavani-farmaceutu-v-8239-ceske-republi.php weekly 0.7 /en/artkey/csf-202504-0009_role-subkatedry-klinicke-farmacie-v-8239-systemu-specializacniho-vzdelavani-farmaceutu-v-8239-ceske-republi.php weekly 0.7 /artkey/csf-202504-0001_treatment-of-arterial-hypertension-in-children-and-adolescents.php weekly 0.7 /en/artkey/csf-202504-0001_treatment-of-arterial-hypertension-in-children-and-adolescents.php weekly 0.7 /artkey/csf-202504-0003_radiopharmaceutical-68ga-psma-11-for-prostate-cancer-diagnostics.php weekly 0.7 /en/artkey/csf-202504-0003_radiopharmaceutical-68ga-psma-11-for-prostate-cancer-diagnostics.php weekly 0.7 /artkey/csf-202504-0007_self-treatment-of-cough-in-respiratory-infections.php weekly 0.7 /en/artkey/csf-202504-0007_self-treatment-of-cough-in-respiratory-infections.php weekly 0.7 /artkey/csf-202504-0008_topical-application-of-vitamin-c-and-its-derivatives-in-dermatology-and-cosmetics.php weekly 0.7 /en/artkey/csf-202504-0008_topical-application-of-vitamin-c-and-its-derivatives-in-dermatology-and-cosmetics.php weekly 0.7 /artkey/csf-202504-0011_efficacy-of-quercetin-and-the-role-of-endothelial-protection-in-the-treatment-of-patients-with-arterial-hyperte.php weekly 0.7 /en/artkey/csf-202504-0011_efficacy-of-quercetin-and-the-role-of-endothelial-protection-in-the-treatment-of-patients-with-arterial-hyperte.php weekly 0.7 /artkey/csf-202504-0012_organizational-challenges-and-benefits-of-electronic-prescriptions-in-physicians-8217-daily-practice-sur.php weekly 0.7 /en/artkey/csf-202504-0012_organizational-challenges-and-benefits-of-electronic-prescriptions-in-physicians-8217-daily-practice-sur.php weekly 0.7 /artkey/csf-202504-0004_choosing-wisely-in-practice-how-sick-day-rules-help-prevent-medication-related-complications.php weekly 0.7 /en/artkey/csf-202504-0004_choosing-wisely-in-practice-how-sick-day-rules-help-prevent-medication-related-complications.php weekly 0.7 /artkey/csf-202504-0010_i-8222-kosmeticka-8220-zmena-v-8239-terapii-arterialni-hypertenze-muze-prinest-velky-a-8239-ne-vzdy-ch.php weekly 0.7 /en/artkey/csf-202504-0010_i-8222-kosmeticka-8220-zmena-v-8239-terapii-arterialni-hypertenze-muze-prinest-velky-a-8239-ne-vzdy-ch.php weekly 0.7 /artkey/csf-202504-0013_the-feminization-of-czech-pharmacy-in-the-20th-century.php weekly 0.7 /en/artkey/csf-202504-0013_the-feminization-of-czech-pharmacy-in-the-20th-century.php weekly 0.7 /artkey/csf-202504-0005_selected-case-reports-from-the-practice-of-a-clinical-pharmacist-in-the-field-of-pneumology.php weekly 0.7 /en/artkey/csf-202504-0005_selected-case-reports-from-the-practice-of-a-clinical-pharmacist-in-the-field-of-pneumology.php weekly 0.7 /artkey/csf-202504-0006_bioactive-compounds-with-adjuvant-therapeutic-potential-in-neurodegenerative-diseases-and-peripheral-neuropathy.php weekly 0.7 /en/artkey/csf-202504-0006_bioactive-compounds-with-adjuvant-therapeutic-potential-in-neurodegenerative-diseases-and-peripheral-neuropathy.php weekly 0.7 /magno/csf/2024/mn1.php weekly 0.7 /en/magno/csf/2024/mn1.php weekly 0.7 /flashbook/csf/2024/1.php monthly 0.2 /artkey/csf-202401-0004_direct-oral-anticoagulants-from-the-perspective-of-czech-pharmacists-opinions-attitudes-confidence-and-pat.php weekly 0.7 /en/artkey/csf-202401-0004_direct-oral-anticoagulants-from-the-perspective-of-czech-pharmacists-opinions-attitudes-confidence-and-pat.php weekly 0.7 /artkey/csf-202401-0005_safety-of-injectable-dosage-forms-during-their-preparation-and-administration-by-nurses-in-hospitals-a-literat.php weekly 0.7 /en/artkey/csf-202401-0005_safety-of-injectable-dosage-forms-during-their-preparation-and-administration-by-nurses-in-hospitals-a-literat.php weekly 0.7 /artkey/csf-202401-0011_ceska-a-slovenska-farmacie-casopis-pro-vsechny-farmaceuty.php weekly 0.7 /en/artkey/csf-202401-0011_ceska-a-slovenska-farmacie-casopis-pro-vsechny-farmaceuty.php weekly 0.7 /artkey/csf-202401-0001_obsolete-for-many-years-but-still-in-use-consumption-of-phenobarbital-in-compounding-pharmacies.php weekly 0.7 /en/artkey/csf-202401-0001_obsolete-for-many-years-but-still-in-use-consumption-of-phenobarbital-in-compounding-pharmacies.php weekly 0.7 /artkey/csf-202401-0002_chronic-spontaneous-urticaria-treatment-with-antihistamines.php weekly 0.7 /en/artkey/csf-202401-0002_chronic-spontaneous-urticaria-treatment-with-antihistamines.php weekly 0.7 /artkey/csf-202401-0003_pharmacological-profile-of-erdosteine-known-molecule-new-effects.php weekly 0.7 /en/artkey/csf-202401-0003_pharmacological-profile-of-erdosteine-known-molecule-new-effects.php weekly 0.7 /artkey/csf-202401-0006_oral-supplementation-of-sodium-potassium-and-phosphate-ions-in-extemporaneous-preparation.php weekly 0.7 /en/artkey/csf-202401-0006_oral-supplementation-of-sodium-potassium-and-phosphate-ions-in-extemporaneous-preparation.php weekly 0.7 /artkey/csf-202401-0007_new-edition-of-the-czech-pharmacopoeia-2023-and-what-preceded-it.php weekly 0.7 /en/artkey/csf-202401-0007_new-edition-of-the-czech-pharmacopoeia-2023-and-what-preceded-it.php weekly 0.7 /artkey/csf-202401-0008_rosemary-its-biologically-active-compounds-and-their-pharmacological-effects.php weekly 0.7 /en/artkey/csf-202401-0008_rosemary-its-biologically-active-compounds-and-their-pharmacological-effects.php weekly 0.7 /artkey/csf-202401-0009_pharmaceutical-care-in-the-self-treatment-of-common-urological-problems.php weekly 0.7 /en/artkey/csf-202401-0009_pharmaceutical-care-in-the-self-treatment-of-common-urological-problems.php weekly 0.7 /artkey/csf-202401-0010_rhinitis-and-allergic-rhinitis-self-medication-options.php weekly 0.7 /en/artkey/csf-202401-0010_rhinitis-and-allergic-rhinitis-self-medication-options.php weekly 0.7 /artkey/csf-202401-0012_odborne-akce-poradane-ceskou-farmaceutickou-spolecnosti-ceske-lekarske-spolecnosti-j-e-purkyne-z-s-v-roce.php weekly 0.7 /en/artkey/csf-202401-0012_odborne-akce-poradane-ceskou-farmaceutickou-spolecnosti-ceske-lekarske-spolecnosti-j-e-purkyne-z-s-v-roce.php weekly 0.7 /magno/csf/2024/mn2.php weekly 0.7 /en/magno/csf/2024/mn2.php weekly 0.7 /flashbook/csf/2024/2.php monthly 0.2 /artkey/csf-202402-0003_drug-related-hospitalizations-insights-from-the-czech-republic.php weekly 0.7 /en/artkey/csf-202402-0003_drug-related-hospitalizations-insights-from-the-czech-republic.php weekly 0.7 /artkey/csf-202402-0002_what-should-we-know-about-the-skin-as-an-application-site-for-not-only-dermo-cosmetic-products.php weekly 0.7 /en/artkey/csf-202402-0002_what-should-we-know-about-the-skin-as-an-application-site-for-not-only-dermo-cosmetic-products.php weekly 0.7 /artkey/csf-202402-0010_vyvoj-novych-modelov-cenotvorby-a-systemov-uhrad-pre-nakladovo-efektivne-a-cenovo-dostupne-zdravotnicke-inovaci.php weekly 0.7 /en/artkey/csf-202402-0010_vyvoj-novych-modelov-cenotvorby-a-systemov-uhrad-pre-nakladovo-efektivne-a-cenovo-dostupne-zdravotnicke-inovaci.php weekly 0.7 /artkey/csf-202402-0001_the-importance-of-neurotropic-vitamins-in-the-prevention-and-adjuvant-therapy-of-peripheral-neuropathy-a-phar.php weekly 0.7 /en/artkey/csf-202402-0001_the-importance-of-neurotropic-vitamins-in-the-prevention-and-adjuvant-therapy-of-peripheral-neuropathy-a-phar.php weekly 0.7 /artkey/csf-202402-0004_comprehensive-therapy-of-upper-functional-dyspepsia-the-potential-of-herbal-medicines.php weekly 0.7 /en/artkey/csf-202402-0004_comprehensive-therapy-of-upper-functional-dyspepsia-the-potential-of-herbal-medicines.php weekly 0.7 /artkey/csf-202402-0006_travellers-diarrhoea-what-to-advise-at-a-pharmacy-currently.php weekly 0.7 /en/artkey/csf-202402-0006_travellers-diarrhoea-what-to-advise-at-a-pharmacy-currently.php weekly 0.7 /artkey/csf-202402-0007_comprehensive-and-rational-approach-to-photoprotection.php weekly 0.7 /en/artkey/csf-202402-0007_comprehensive-and-rational-approach-to-photoprotection.php weekly 0.7 /artkey/csf-202402-0005_daprodustat-a-new-approach-to-the-treatment-of-anemia-in-chronic-kidney-disease.php weekly 0.7 /en/artkey/csf-202402-0005_daprodustat-a-new-approach-to-the-treatment-of-anemia-in-chronic-kidney-disease.php weekly 0.7 /artkey/csf-202402-0008_paratext-in-antidotarium-cassoviense-1732.php weekly 0.7 /en/artkey/csf-202402-0008_paratext-in-antidotarium-cassoviense-1732.php weekly 0.7 /artkey/csf-202402-0009_chronicke-zilni-onemocneni-co-vse-muzeme-udelat-pro-pacienta-v-lekarne-8211-zaznelo-na-18-kongresu-prakti.php weekly 0.7 /en/artkey/csf-202402-0009_chronicke-zilni-onemocneni-co-vse-muzeme-udelat-pro-pacienta-v-lekarne-8211-zaznelo-na-18-kongresu-prakti.php weekly 0.7 /artkey/csf-202402-0012_pharmaceutical-care-of-patients-with-metabolic-syndrome-in-slovakia-questionnaire.php weekly 0.7 /en/artkey/csf-202402-0012_pharmaceutical-care-of-patients-with-metabolic-syndrome-in-slovakia-questionnaire.php weekly 0.7 /artkey/csf-202402-0013_the-use-of-certain-elements-of-the-marketing-communications-system-by-ukrainian-pharmacies-in-emergencies.php weekly 0.7 /en/artkey/csf-202402-0013_the-use-of-certain-elements-of-the-marketing-communications-system-by-ukrainian-pharmacies-in-emergencies.php weekly 0.7 /artkey/csf-202402-0011_auxiliary-drugs-benzodiazepines-opioid-analgesics-presynaptic-945-2-adrenergic-receptor-agonists-peripher.php weekly 0.7 /en/artkey/csf-202402-0011_auxiliary-drugs-benzodiazepines-opioid-analgesics-presynaptic-945-2-adrenergic-receptor-agonists-peripher.php weekly 0.7 /magno/csf/2024/mn3.php weekly 0.7 /en/magno/csf/2024/mn3.php weekly 0.7 /flashbook/csf/2024/3.php monthly 0.2 /artkey/csf-202403-0003_omega-3-fatty-acids-in-nutrition-and-supplementation.php weekly 0.7 /en/artkey/csf-202403-0003_omega-3-fatty-acids-in-nutrition-and-supplementation.php weekly 0.7 /artkey/csf-202403-0010_30-let-lekoveho-informacniho-centra-faf-uk.php weekly 0.7 /en/artkey/csf-202403-0010_30-let-lekoveho-informacniho-centra-faf-uk.php weekly 0.7 /artkey/csf-202403-0001_pharmaceutical-care-for-patients-with-acne.php weekly 0.7 /en/artkey/csf-202403-0001_pharmaceutical-care-for-patients-with-acne.php weekly 0.7 /artkey/csf-202403-0002_current-pharmacotherapy-of-rosacea.php weekly 0.7 /en/artkey/csf-202403-0002_current-pharmacotherapy-of-rosacea.php weekly 0.7 /artkey/csf-202403-0004_new-approaches-to-the-issue-of-pyrogens-in-parenteral-preparations.php weekly 0.7 /en/artkey/csf-202403-0004_new-approaches-to-the-issue-of-pyrogens-in-parenteral-preparations.php weekly 0.7 /artkey/csf-202403-0006_1-8-cineole-eucalyptol-in-a-therapy-of-respiratory-diseases.php weekly 0.7 /en/artkey/csf-202403-0006_1-8-cineole-eucalyptol-in-a-therapy-of-respiratory-diseases.php weekly 0.7 /artkey/csf-202403-0007_pain-and-possibilities-of-its-self-treatment-what-can-be-recommended-in-a-pharmacy.php weekly 0.7 /en/artkey/csf-202403-0007_pain-and-possibilities-of-its-self-treatment-what-can-be-recommended-in-a-pharmacy.php weekly 0.7 /artkey/csf-202403-0014_pharmaceutical-company-norgine-in-usti-nad-labem-aussig.php weekly 0.7 /en/artkey/csf-202403-0014_pharmaceutical-company-norgine-in-usti-nad-labem-aussig.php weekly 0.7 /artkey/csf-202403-0011_evaluation-of-polycystic-ovary-syndrome-pharmacotherapy.php weekly 0.7 /en/artkey/csf-202403-0011_evaluation-of-polycystic-ovary-syndrome-pharmacotherapy.php weekly 0.7 /artkey/csf-202403-0012_novel-pyrazole-bearing-heterocyclic-hybrids-as-promising-biologically-active-compounds.php weekly 0.7 /en/artkey/csf-202403-0012_novel-pyrazole-bearing-heterocyclic-hybrids-as-promising-biologically-active-compounds.php weekly 0.7 /artkey/csf-202403-0013_enhancing-pharmacovigilance-practices-insights-from-audits-and-ethical-connotations.php weekly 0.7 /en/artkey/csf-202403-0013_enhancing-pharmacovigilance-practices-insights-from-audits-and-ethical-connotations.php weekly 0.7 /artkey/csf-202403-0005_acute-intoxications-with-medications-in-children-and-the-role-of-pharmacist-in-the-national-toxicological-infor.php weekly 0.7 /en/artkey/csf-202403-0005_acute-intoxications-with-medications-in-children-and-the-role-of-pharmacist-in-the-national-toxicological-infor.php weekly 0.7 /artkey/csf-202403-0008_available-diagnostic-tests-in-the-pharmacy-and-the-role-of-the-pharmacist.php weekly 0.7 /en/artkey/csf-202403-0008_available-diagnostic-tests-in-the-pharmacy-and-the-role-of-the-pharmacist.php weekly 0.7 /artkey/csf-202403-0009_pridani-extraktu-egb-761-ke-kognitivum-je-ucinnejsi-nez-monoterapie.php weekly 0.7 /en/artkey/csf-202403-0009_pridani-extraktu-egb-761-ke-kognitivum-je-ucinnejsi-nez-monoterapie.php weekly 0.7 /magno/csf/2024/mn4.php weekly 0.7 /en/magno/csf/2024/mn4.php weekly 0.7 /flashbook/csf/2024/4.php monthly 0.2 /artkey/csf-202404-0004_evaluation-tools-used-for-assessing-inhalation-technique-in-patients-with-chronic-obstructive-lung-disease-a.php weekly 0.7 /en/artkey/csf-202404-0004_evaluation-tools-used-for-assessing-inhalation-technique-in-patients-with-chronic-obstructive-lung-disease-a.php weekly 0.7 /artkey/csf-202404-0010_k-55-vyroci-zalozeni-farmaceuticke-fakulty-uk-v-hradci-kralove.php weekly 0.7 /en/artkey/csf-202404-0010_k-55-vyroci-zalozeni-farmaceuticke-fakulty-uk-v-hradci-kralove.php weekly 0.7 /artkey/csf-202404-0001_pharmacotherapy-of-chronic-heart-failure-essential-summary-for-pharmacists.php weekly 0.7 /en/artkey/csf-202404-0001_pharmacotherapy-of-chronic-heart-failure-essential-summary-for-pharmacists.php weekly 0.7 /artkey/csf-202404-0002_management-of-gastrointestinal-side-effects-of-cancer-pharmacotherapy-part-1-diarrhoea-constipation-mucosi.php weekly 0.7 /en/artkey/csf-202404-0002_management-of-gastrointestinal-side-effects-of-cancer-pharmacotherapy-part-1-diarrhoea-constipation-mucosi.php weekly 0.7 /artkey/csf-202404-0003_contamination-of-drugs-with-nitrosamines-a-restored-problem.php weekly 0.7 /en/artkey/csf-202404-0003_contamination-of-drugs-with-nitrosamines-a-restored-problem.php weekly 0.7 /artkey/csf-202404-0006_pharmaceutical-care-for-patients-with-sore-throat-not-requiring-medical-attention.php weekly 0.7 /en/artkey/csf-202404-0006_pharmaceutical-care-for-patients-with-sore-throat-not-requiring-medical-attention.php weekly 0.7 /artkey/csf-202404-0011_xxviii-mezinarodni-sympozium-o-medicinalni-chemii-se-letos-konalo-v-rime-52-mezinarodni-konference-synteza.php weekly 0.7 /en/artkey/csf-202404-0011_xxviii-mezinarodni-sympozium-o-medicinalni-chemii-se-letos-konalo-v-rime-52-mezinarodni-konference-synteza.php weekly 0.7 /artkey/csf-202404-0012_rising-consumption-of-anticoagulants-in-central-and-eastern-european-countries-in-the-period-2007-8211-2019.php weekly 0.7 /en/artkey/csf-202404-0012_rising-consumption-of-anticoagulants-in-central-and-eastern-european-countries-in-the-period-2007-8211-2019.php weekly 0.7 /artkey/csf-202404-0013_evaluation-tools-used-for-assessing-inhalation-technique-in-patients-with-chronic-obstructive-lung-disease-a.php weekly 0.7 /en/artkey/csf-202404-0013_evaluation-tools-used-for-assessing-inhalation-technique-in-patients-with-chronic-obstructive-lung-disease-a.php weekly 0.7 /artkey/csf-202404-0005_adjunctive-treatment-of-behavioral-disorders-in-patients-with-cognitive-deficit.php weekly 0.7 /en/artkey/csf-202404-0005_adjunctive-treatment-of-behavioral-disorders-in-patients-with-cognitive-deficit.php weekly 0.7 /artkey/csf-202404-0007_medical-devices-in-wound-healing-v-special-types-of-wound-plasters-ii.php weekly 0.7 /en/artkey/csf-202404-0007_medical-devices-in-wound-healing-v-special-types-of-wound-plasters-ii.php weekly 0.7 /artkey/csf-202404-0008_objev-novych-ucinnych-latek-v-extraktech-z-ginkgo-biloba.php weekly 0.7 /en/artkey/csf-202404-0008_objev-novych-ucinnych-latek-v-extraktech-z-ginkgo-biloba.php weekly 0.7 /artkey/csf-202404-0009_vyznam-vitaminu-c-v-prevenci-poruch-nervoveho-a-imunitniho-systemu.php weekly 0.7 /en/artkey/csf-202404-0009_vyznam-vitaminu-c-v-prevenci-poruch-nervoveho-a-imunitniho-systemu.php weekly 0.7 /artkey/csf-202404-0014_pharmaceutical-literature-in-the-broumov-benedictine-convent-library-in-the-year-1801.php weekly 0.7 /en/artkey/csf-202404-0014_pharmaceutical-literature-in-the-broumov-benedictine-convent-library-in-the-year-1801.php weekly 0.7 /magno/csf/2023/mn1.php weekly 0.7 /en/magno/csf/2023/mn1.php weekly 0.7 /artkey/csf-202301-0004_new-trends-in-advanced-parkinson-disease-stage-therapy.php weekly 0.7 /en/artkey/csf-202301-0004_new-trends-in-advanced-parkinson-disease-stage-therapy.php weekly 0.7 /artkey/csf-202301-0005_are-some-covid-19-vaccines-better-than-others-regarding-the-short-term-side-effects.php weekly 0.7 /en/artkey/csf-202301-0005_are-some-covid-19-vaccines-better-than-others-regarding-the-short-term-side-effects.php weekly 0.7 /artkey/csf-202301-0001_contribution-to-the-concept-of-polypharmacy-ii-prescription-and-use-of-medicines.php weekly 0.7 /en/artkey/csf-202301-0001_contribution-to-the-concept-of-polypharmacy-ii-prescription-and-use-of-medicines.php weekly 0.7 /artkey/csf-202301-0002_entry-and-competition-of-retail-pharmacies-a-case-study-of-otc-drugs-sales-and-ownership-deregulation.php weekly 0.7 /en/artkey/csf-202301-0002_entry-and-competition-of-retail-pharmacies-a-case-study-of-otc-drugs-sales-and-ownership-deregulation.php weekly 0.7 /artkey/csf-202301-0003_childhood-obesity-causes-consequences-and-prevention.php weekly 0.7 /en/artkey/csf-202301-0003_childhood-obesity-causes-consequences-and-prevention.php weekly 0.7 /magno/csf/2023/mn2.php weekly 0.7 /en/magno/csf/2023/mn2.php weekly 0.7 /artkey/csf-202302-0004_marketing-research-of-combined-drugs-for-treatment-of-cardiovascular-diseases.php weekly 0.7 /en/artkey/csf-202302-0004_marketing-research-of-combined-drugs-for-treatment-of-cardiovascular-diseases.php weekly 0.7 /artkey/csf-202302-0005_antimicrobial-properties-of-the-new-combined-dental-gel.php weekly 0.7 /en/artkey/csf-202302-0005_antimicrobial-properties-of-the-new-combined-dental-gel.php weekly 0.7 /artkey/csf-202302-0001_colour-and-content-of-some-metals-in-honey.php weekly 0.7 /en/artkey/csf-202302-0001_colour-and-content-of-some-metals-in-honey.php weekly 0.7 /artkey/csf-202302-0002_selective-inhibitors-of-cyclooxygenase-2-their-past-present-and-future.php weekly 0.7 /en/artkey/csf-202302-0002_selective-inhibitors-of-cyclooxygenase-2-their-past-present-and-future.php weekly 0.7 /artkey/csf-202302-0003_role-of-pharmaceutical-care-in-therapeutic-regimens-within-the-community-pharmacy.php weekly 0.7 /en/artkey/csf-202302-0003_role-of-pharmaceutical-care-in-therapeutic-regimens-within-the-community-pharmacy.php weekly 0.7 /artkey/csf-202302-0007_nove-knihy.php weekly 0.7 /en/artkey/csf-202302-0007_nove-knihy.php weekly 0.7 /artkey/csf-202302-0006_mezinarodni-spoluprace-tri-uznavanych-farmaceutickych-fakult-sdileni-vyzkumnych-zkusenosti-a-vzdelavacich-tec.php weekly 0.7 /en/artkey/csf-202302-0006_mezinarodni-spoluprace-tri-uznavanych-farmaceutickych-fakult-sdileni-vyzkumnych-zkusenosti-a-vzdelavacich-tec.php weekly 0.7 /magno/csf/2023/mn3.php weekly 0.7 /en/magno/csf/2023/mn3.php weekly 0.7 /artkey/csf-202303-0001_high-vs-low-dose-leucovorin-in-regimens-with-fluorouracil-in-colorectal-cancer-therapy.php weekly 0.7 /en/artkey/csf-202303-0001_high-vs-low-dose-leucovorin-in-regimens-with-fluorouracil-in-colorectal-cancer-therapy.php weekly 0.7 /artkey/csf-202303-0002_a-study-of-hypoglycemic-activity-of-acids-and-salts-containing-1-2-4-triazole.php weekly 0.7 /en/artkey/csf-202303-0002_a-study-of-hypoglycemic-activity-of-acids-and-salts-containing-1-2-4-triazole.php weekly 0.7 /artkey/csf-202303-0003_comparison-of-the-preparation-of-the-radiopharmaceutical-68ga-psma-11-at-two-czech-worksites.php weekly 0.7 /en/artkey/csf-202303-0003_comparison-of-the-preparation-of-the-radiopharmaceutical-68ga-psma-11-at-two-czech-worksites.php weekly 0.7 /artkey/csf-202303-0004_optimization-of-spray-dried-porous-microparticles-preparation-for-pulmonary-delivery.php weekly 0.7 /en/artkey/csf-202303-0004_optimization-of-spray-dried-porous-microparticles-preparation-for-pulmonary-delivery.php weekly 0.7 /artkey/csf-202303-0005_friedrich-jakub-fuker-and-his-universal-preventive-tincture.php weekly 0.7 /en/artkey/csf-202303-0005_friedrich-jakub-fuker-and-his-universal-preventive-tincture.php weekly 0.7 /artkey/csf-202303-0006_terapeuticke-monitorovanie-lieciv-2023.php weekly 0.7 /en/artkey/csf-202303-0006_terapeuticke-monitorovanie-lieciv-2023.php weekly 0.7 /magno/csf/2023/mn4.php weekly 0.7 /en/magno/csf/2023/mn4.php weekly 0.7 /artkey/csf-202304-0003_effect-of-digoxin-sodium-valproate-and-celecoxib-on-the-cerebral-cyclooxygenase-pathway-and-neuron-specific-e.php weekly 0.7 /en/artkey/csf-202304-0003_effect-of-digoxin-sodium-valproate-and-celecoxib-on-the-cerebral-cyclooxygenase-pathway-and-neuron-specific-e.php weekly 0.7 /artkey/csf-202304-0004_study-of-the-anti-inflammatory-properties-of-a-thick-extract-of-tribulus-terrestris-l.php weekly 0.7 /en/artkey/csf-202304-0004_study-of-the-anti-inflammatory-properties-of-a-thick-extract-of-tribulus-terrestris-l.php weekly 0.7 /artkey/csf-202304-0005_synthesis-characterization-molecular-docking-studies-of-new-alkyl-derivatives-of-5-2-bromo-4-fluorophenyl-4.php weekly 0.7 /en/artkey/csf-202304-0005_synthesis-characterization-molecular-docking-studies-of-new-alkyl-derivatives-of-5-2-bromo-4-fluorophenyl-4.php weekly 0.7 /artkey/csf-202304-0001_general-intravenous-anesthetics-pharmacodynamics-pharmacokinetics-and-chiral-properties.php weekly 0.7 /en/artkey/csf-202304-0001_general-intravenous-anesthetics-pharmacodynamics-pharmacokinetics-and-chiral-properties.php weekly 0.7 /artkey/csf-202304-0002_diazotization-titrations-in-pharmacopoeial-quality-control-of-medicines-and-proposals-for-their-revision-in-the.php weekly 0.7 /en/artkey/csf-202304-0002_diazotization-titrations-in-pharmacopoeial-quality-control-of-medicines-and-proposals-for-their-revision-in-the.php weekly 0.7 /magno/csf/2023/mn5.php weekly 0.7 /en/magno/csf/2023/mn5.php weekly 0.7 /artkey/csf-202305-0002_preparation-and-evaluation-of-spray-dried-inhalable-microparticles-from-carrier-mixtures.php weekly 0.7 /en/artkey/csf-202305-0002_preparation-and-evaluation-of-spray-dried-inhalable-microparticles-from-carrier-mixtures.php weekly 0.7 /artkey/csf-202305-0003_hyperferritinemia-as-a-factor-associated-with-poor-prognosis-in-covid-19-patients.php weekly 0.7 /en/artkey/csf-202305-0003_hyperferritinemia-as-a-factor-associated-with-poor-prognosis-in-covid-19-patients.php weekly 0.7 /artkey/csf-202305-0004_two-lactobacilli-strains-as-adjuvant-therapy-in-the-management-of-irritable-bowel-syndrome-a-randomized-contro.php weekly 0.7 /en/artkey/csf-202305-0004_two-lactobacilli-strains-as-adjuvant-therapy-in-the-management-of-irritable-bowel-syndrome-a-randomized-contro.php weekly 0.7 /artkey/csf-202305-0001_therapeutic-monitoring-of-antipsychotics-with-a-focus-on-lurasidone-and-its-dosing.php weekly 0.7 /en/artkey/csf-202305-0001_therapeutic-monitoring-of-antipsychotics-with-a-focus-on-lurasidone-and-its-dosing.php weekly 0.7 /artkey/csf-202305-0005_xlivrd-work-days-of-the-pharmacological-section-of-the-czech-nuclear-medicine-society-faf-uk-hradec-kralove.php weekly 0.7 /en/artkey/csf-202305-0005_xlivrd-work-days-of-the-pharmacological-section-of-the-czech-nuclear-medicine-society-faf-uk-hradec-kralove.php weekly 0.7 /artkey/csf-202305-0006_instructions-to-the-authors.php weekly 0.7 /en/artkey/csf-202305-0006_instructions-to-the-authors.php weekly 0.7 /magno/csf/2023/mn6.php weekly 0.7 /en/magno/csf/2023/mn6.php weekly 0.7 /artkey/csf-202306-0003_potential-impact-on-mental-health-in-patients-with-treatment-resistant-schizophrenia-clozapine-augmentation-w.php weekly 0.7 /en/artkey/csf-202306-0003_potential-impact-on-mental-health-in-patients-with-treatment-resistant-schizophrenia-clozapine-augmentation-w.php weekly 0.7 /artkey/csf-202306-0004_prospects-of-x441-omplex-pharmaceutical-composition-application-for-pharmacological-correction-of-metabolic-s.php weekly 0.7 /en/artkey/csf-202306-0004_prospects-of-x441-omplex-pharmaceutical-composition-application-for-pharmacological-correction-of-metabolic-s.php weekly 0.7 /artkey/csf-202306-0005_increasing-the-efficiency-of-hypolipidemic-therapy-with-the-combined-use-of-quercetin-in-patients-with-non-alco.php weekly 0.7 /en/artkey/csf-202306-0005_increasing-the-efficiency-of-hypolipidemic-therapy-with-the-combined-use-of-quercetin-in-patients-with-non-alco.php weekly 0.7 /artkey/csf-202306-0006_analysis-of-medication-administration-in-relation-to-food-and-beverages-in-inpatients.php weekly 0.7 /en/artkey/csf-202306-0006_analysis-of-medication-administration-in-relation-to-food-and-beverages-in-inpatients.php weekly 0.7 /artkey/csf-202306-0001_ethical-aspects-of-conducting-clinical-trials-of-human-medicinal-products.php weekly 0.7 /en/artkey/csf-202306-0001_ethical-aspects-of-conducting-clinical-trials-of-human-medicinal-products.php weekly 0.7 /artkey/csf-202306-0002_brief-insight-into-the-in-silico-properties-structure-activity-relationships-and-biotransformation-of-fruquint.php weekly 0.7 /en/artkey/csf-202306-0002_brief-insight-into-the-in-silico-properties-structure-activity-relationships-and-biotransformation-of-fruquint.php weekly 0.7 /artkey/csf-202306-0007_on-the-history-and-development-of-some-changes-in-pharmacy-practice-work-safety-in-pharmacies.php weekly 0.7 /en/artkey/csf-202306-0007_on-the-history-and-development-of-some-changes-in-pharmacy-practice-work-safety-in-pharmacies.php weekly 0.7 /artkey/csf-202306-0008_beauty-in-books-pharmaceutical-bookplates-in-the-territory-of-the-present-czech-republic.php weekly 0.7 /en/artkey/csf-202306-0008_beauty-in-books-pharmaceutical-bookplates-in-the-territory-of-the-present-czech-republic.php weekly 0.7 /magno/csf/2022/mn1.php weekly 0.7 /en/magno/csf/2022/mn1.php weekly 0.7 /artkey/csf-202201-0004_surviving-of-production-probiotic-strains-in-a-selected-application-form.php weekly 0.7 /en/artkey/csf-202201-0004_surviving-of-production-probiotic-strains-in-a-selected-application-form.php weekly 0.7 /artkey/csf-202201-0005_cerebroprotective-properties-of-recombinant-interleukin-1-receptor-an-experimental-study.php weekly 0.7 /en/artkey/csf-202201-0005_cerebroprotective-properties-of-recombinant-interleukin-1-receptor-an-experimental-study.php weekly 0.7 /artkey/csf-202201-0001_ethical-and-legal-requirements-for-vaccination-against-covid-19.php weekly 0.7 /en/artkey/csf-202201-0001_ethical-and-legal-requirements-for-vaccination-against-covid-19.php weekly 0.7 /artkey/csf-202201-0002_the-role-of-individuals-receiving-health-care-terminological-notes.php weekly 0.7 /en/artkey/csf-202201-0002_the-role-of-individuals-receiving-health-care-terminological-notes.php weekly 0.7 /artkey/csf-202201-0003_colour-and-antioxidant-activity-of-honey.php weekly 0.7 /en/artkey/csf-202201-0003_colour-and-antioxidant-activity-of-honey.php weekly 0.7 /magno/csf/2022/mn2.php weekly 0.7 /en/magno/csf/2022/mn2.php weekly 0.7 /artkey/csf-202202-0001_community-pharmacists-and-proper-administration-of-inhaled-medications.php weekly 0.7 /en/artkey/csf-202202-0001_community-pharmacists-and-proper-administration-of-inhaled-medications.php weekly 0.7 /artkey/csf-202202-0002_beliefs-and-knowledge-related-to-nutritional-supplements-among-pharmacy-students.php weekly 0.7 /en/artkey/csf-202202-0002_beliefs-and-knowledge-related-to-nutritional-supplements-among-pharmacy-students.php weekly 0.7 /artkey/csf-202202-0003_capillary-zone-electrophoresis-in-combination-with-uv-detection-for-simultaneous-determination-of-tramadol-and.php weekly 0.7 /en/artkey/csf-202202-0003_capillary-zone-electrophoresis-in-combination-with-uv-detection-for-simultaneous-determination-of-tramadol-and.php weekly 0.7 /artkey/csf-202202-0004_digoxin-at-sub-cardiotonic-dose-modulates-the-anticonvulsive-potential-of-valproate-levetiracetam-and-topirama.php weekly 0.7 /en/artkey/csf-202202-0004_digoxin-at-sub-cardiotonic-dose-modulates-the-anticonvulsive-potential-of-valproate-levetiracetam-and-topirama.php weekly 0.7 /magno/csf/2022/mn3.php weekly 0.7 /en/magno/csf/2022/mn3.php weekly 0.7 /artkey/csf-202203-0002_the-effect-of-aronia-melanocarpa-extract-on-the-phospholipid-composition-of-the-rat-myocardium-during-stress.php weekly 0.7 /en/artkey/csf-202203-0002_the-effect-of-aronia-melanocarpa-extract-on-the-phospholipid-composition-of-the-rat-myocardium-during-stress.php weekly 0.7 /artkey/csf-202203-0003_pulsed-electric-field-energy-calculation-to-damage-red-galangal-alpinia-purpurata-k-scumm-rhizome-slices-an.php weekly 0.7 /en/artkey/csf-202203-0003_pulsed-electric-field-energy-calculation-to-damage-red-galangal-alpinia-purpurata-k-scumm-rhizome-slices-an.php weekly 0.7 /artkey/csf-202203-0004_study-of-possible-sex-features-of-ramipril-and-candesartan-treatment-under-experimental-arterial-hypertension-i.php weekly 0.7 /en/artkey/csf-202203-0004_study-of-possible-sex-features-of-ramipril-and-candesartan-treatment-under-experimental-arterial-hypertension-i.php weekly 0.7 /artkey/csf-202203-0001_metronomic-therapy-in-the-treatment-of-cancer.php weekly 0.7 /en/artkey/csf-202203-0001_metronomic-therapy-in-the-treatment-of-cancer.php weekly 0.7 /artkey/csf-202203-0005_rndr-phmr-ernest-alt-in-memoriam.php weekly 0.7 /en/artkey/csf-202203-0005_rndr-phmr-ernest-alt-in-memoriam.php weekly 0.7 /artkey/csf-202203-0006_za-prof-ing-petrom-kovacsom-drsc-in-memoriam.php weekly 0.7 /en/artkey/csf-202203-0006_za-prof-ing-petrom-kovacsom-drsc-in-memoriam.php weekly 0.7 /magno/csf/2022/mn4.php weekly 0.7 /en/magno/csf/2022/mn4.php weekly 0.7 /artkey/csf-202204-0004_investigation-of-the-antimicrobial-and-antifungal-activities-of-some-1-2-4-triazole-derivatives.php weekly 0.7 /en/artkey/csf-202204-0004_investigation-of-the-antimicrobial-and-antifungal-activities-of-some-1-2-4-triazole-derivatives.php weekly 0.7 /artkey/csf-202204-0001_colour-and-content-of-some-biologically-active-substances-in-honey.php weekly 0.7 /en/artkey/csf-202204-0001_colour-and-content-of-some-biologically-active-substances-in-honey.php weekly 0.7 /artkey/csf-202204-0002_selected-polyphenolic-compounds-and-their-use-as-a-supportive-therapy-in-metabolic-syndrome.php weekly 0.7 /en/artkey/csf-202204-0002_selected-polyphenolic-compounds-and-their-use-as-a-supportive-therapy-in-metabolic-syndrome.php weekly 0.7 /artkey/csf-202204-0003_neuroactive-steroids-new-possibilities-in-the-treatment-of-postpartum-depression.php weekly 0.7 /en/artkey/csf-202204-0003_neuroactive-steroids-new-possibilities-in-the-treatment-of-postpartum-depression.php weekly 0.7 /artkey/csf-202204-0007_prof-rndr-jan-subert-csc-osemdesiatrocny.php weekly 0.7 /en/artkey/csf-202204-0007_prof-rndr-jan-subert-csc-osemdesiatrocny.php weekly 0.7 /artkey/csf-202204-0008_vystava-zahrada-vuni-aneb-rostliny-v-parfemech.php weekly 0.7 /en/artkey/csf-202204-0008_vystava-zahrada-vuni-aneb-rostliny-v-parfemech.php weekly 0.7 /artkey/csf-202204-0005_vasen-pro-krasu-lekarnika-mojmira-helceleta.php weekly 0.7 /en/artkey/csf-202204-0005_vasen-pro-krasu-lekarnika-mojmira-helceleta.php weekly 0.7 /artkey/csf-202204-0006_xliii-pracovni-dny-radiofarmaceuticke-sekce-csnm-hotel-straznice-18-az-20-kvetna-2022.php weekly 0.7 /en/artkey/csf-202204-0006_xliii-pracovni-dny-radiofarmaceuticke-sekce-csnm-hotel-straznice-18-az-20-kvetna-2022.php weekly 0.7 /magno/csf/2022/mn5.php weekly 0.7 /en/magno/csf/2022/mn5.php weekly 0.7 /artkey/csf-202205-0001_safety-of-drug-administration-from-the-perspective-of-hospitalized-patients-in-selected-hospitals-of-the-south.php weekly 0.7 /en/artkey/csf-202205-0001_safety-of-drug-administration-from-the-perspective-of-hospitalized-patients-in-selected-hospitals-of-the-south.php weekly 0.7 /artkey/csf-202205-0002_formulation-and-evaluation-of-novel-collagen-carboxymethylcellulose-blend-film-wound-dressing.php weekly 0.7 /en/artkey/csf-202205-0002_formulation-and-evaluation-of-novel-collagen-carboxymethylcellulose-blend-film-wound-dressing.php weekly 0.7 /artkey/csf-202205-0003_characteristics-of-development-and-dissemination-of-environmental-management-systems-in-the-area-of-production.php weekly 0.7 /en/artkey/csf-202205-0003_characteristics-of-development-and-dissemination-of-environmental-management-systems-in-the-area-of-production.php weekly 0.7 /artkey/csf-202205-0004_the-effect-of-non-steroidal-anti-inflammatory-drugs-with-different-mechanisms-of-action-on-the-body-temperature.php weekly 0.7 /en/artkey/csf-202205-0004_the-effect-of-non-steroidal-anti-inflammatory-drugs-with-different-mechanisms-of-action-on-the-body-temperature.php weekly 0.7 /artkey/csf-202205-0005_promising-anticonvulsant-n-2-4-dichlorophenyl-methyl-2-2-4-dioxo-1h-quinazolin-3-yl-acetamide-dose-depen.php weekly 0.7 /en/artkey/csf-202205-0005_promising-anticonvulsant-n-2-4-dichlorophenyl-methyl-2-2-4-dioxo-1h-quinazolin-3-yl-acetamide-dose-depen.php weekly 0.7 /artkey/csf-202205-0006_vystava-vchazeni-do-krajinomalby-a-krajinarske-fotografie.php weekly 0.7 /en/artkey/csf-202205-0006_vystava-vchazeni-do-krajinomalby-a-krajinarske-fotografie.php weekly 0.7 /magno/csf/2022/mn6.php weekly 0.7 /en/magno/csf/2022/mn6.php weekly 0.7 /artkey/csf-202206-0004_medicinal-mushrooms-ophiocordyceps-sinensis-and-cordyceps-militaris.php weekly 0.7 /en/artkey/csf-202206-0004_medicinal-mushrooms-ophiocordyceps-sinensis-and-cordyceps-militaris.php weekly 0.7 /artkey/csf-202206-0001_the-efficacy-of-triazavirin-riamilovir-based-treatment-for-coronavirus-disease-2019-covid-19-in-clinical-tr.php weekly 0.7 /en/artkey/csf-202206-0001_the-efficacy-of-triazavirin-riamilovir-based-treatment-for-coronavirus-disease-2019-covid-19-in-clinical-tr.php weekly 0.7 /artkey/csf-202206-0002_contribution-to-the-concept-of-polypharmacy-i-etymological-notes-and-characteristics.php weekly 0.7 /en/artkey/csf-202206-0002_contribution-to-the-concept-of-polypharmacy-i-etymological-notes-and-characteristics.php weekly 0.7 /artkey/csf-202206-0003_dose-dumping-of-modified-release-solid-oral-dosage-forms.php weekly 0.7 /en/artkey/csf-202206-0003_dose-dumping-of-modified-release-solid-oral-dosage-forms.php weekly 0.7 /magno/csf/2021/mn1.php weekly 0.7 /en/magno/csf/2021/mn1.php weekly 0.7 /artkey/csf-202101-0004_on-the-development-of-first-aid-kits-composition.php weekly 0.7 /en/artkey/csf-202101-0004_on-the-development-of-first-aid-kits-composition.php weekly 0.7 /artkey/csf-202101-0005_influence-of-emulsification-mode-stirring-speed-and-volume-on-ibuprofen-loaded-plga-microparticles.php weekly 0.7 /en/artkey/csf-202101-0005_influence-of-emulsification-mode-stirring-speed-and-volume-on-ibuprofen-loaded-plga-microparticles.php weekly 0.7 /artkey/csf-202101-0001_further-development-of-the-content-of-the-national-part-of-the-czech-pharmacopoeia-2017-in-its-supplements-from.php weekly 0.7 /en/artkey/csf-202101-0001_further-development-of-the-content-of-the-national-part-of-the-czech-pharmacopoeia-2017-in-its-supplements-from.php weekly 0.7 /artkey/csf-202101-0002_general-inhalational-anesthetics-pharmacodynamics-pharmacokinetics-and-chiral-properties.php weekly 0.7 /en/artkey/csf-202101-0002_general-inhalational-anesthetics-pharmacodynamics-pharmacokinetics-and-chiral-properties.php weekly 0.7 /artkey/csf-202101-0003_triazavirin-might-be-the-new-hope-to-fight-severe-acute-respiratory-syndrome-coronavirus-2-sars-cov-2.php weekly 0.7 /en/artkey/csf-202101-0003_triazavirin-might-be-the-new-hope-to-fight-severe-acute-respiratory-syndrome-coronavirus-2-sars-cov-2.php weekly 0.7 /magno/csf/2021/mn2.php weekly 0.7 /en/magno/csf/2021/mn2.php weekly 0.7 /artkey/csf-202102-0001_causes-and-interventions-of-medication-errors-in-healthcare-facilities.php weekly 0.7 /en/artkey/csf-202102-0001_causes-and-interventions-of-medication-errors-in-healthcare-facilities.php weekly 0.7 /artkey/csf-202102-0002_synthesis-and-hplc-enantioseparation-of-novel-derivatives-of-3-alkoxy-4-hydroxyphenylalkanones-of-a-potential.php weekly 0.7 /en/artkey/csf-202102-0002_synthesis-and-hplc-enantioseparation-of-novel-derivatives-of-3-alkoxy-4-hydroxyphenylalkanones-of-a-potential.php weekly 0.7 /artkey/csf-202102-0003_investigation-of-the-anabolic-activity-of-dry-extracts-of-iris-hungarica-leaves-and-rhizomes-on-the-model-of-hy.php weekly 0.7 /en/artkey/csf-202102-0003_investigation-of-the-anabolic-activity-of-dry-extracts-of-iris-hungarica-leaves-and-rhizomes-on-the-model-of-hy.php weekly 0.7 /artkey/csf-202102-0004_formulation-development-of-anti-stress-compressed-lozenges-using-a-fractional-factorial-latin-cube-design-and-a.php weekly 0.7 /en/artkey/csf-202102-0004_formulation-development-of-anti-stress-compressed-lozenges-using-a-fractional-factorial-latin-cube-design-and-a.php weekly 0.7 /magno/csf/2021/mn3.php weekly 0.7 /en/magno/csf/2021/mn3.php weekly 0.7 /artkey/csf-202103-0002_investigation-of-the-effect-of-a-modified-fragment-of-neuropeptide-y-on-memory-phases-and-extrapolation-escape.php weekly 0.7 /en/artkey/csf-202103-0002_investigation-of-the-effect-of-a-modified-fragment-of-neuropeptide-y-on-memory-phases-and-extrapolation-escape.php weekly 0.7 /artkey/csf-202103-0003_antioxidant-and-anticytolytic-action-as-the-basis-of-the-pancreo-plant-reg-hepatoprotective-effect-in-acute-li.php weekly 0.7 /en/artkey/csf-202103-0003_antioxidant-and-anticytolytic-action-as-the-basis-of-the-pancreo-plant-reg-hepatoprotective-effect-in-acute-li.php weekly 0.7 /artkey/csf-202103-0004_friction-cost-approach-methodology-in-pharmacoeconomic-analyses.php weekly 0.7 /en/artkey/csf-202103-0004_friction-cost-approach-methodology-in-pharmacoeconomic-analyses.php weekly 0.7 /artkey/csf-202103-0001_colour-and-content-of-some-biologically-active-substances-in-natural-products-and-products-of-natural-origin.php weekly 0.7 /en/artkey/csf-202103-0001_colour-and-content-of-some-biologically-active-substances-in-natural-products-and-products-of-natural-origin.php weekly 0.7 /artkey/csf-202103-0005_phenolic-acids-and-antioxidant-potential-of-caragana-frutex-shoots.php weekly 0.7 /en/artkey/csf-202103-0005_phenolic-acids-and-antioxidant-potential-of-caragana-frutex-shoots.php weekly 0.7 /magno/csf/2021/mn4.php weekly 0.7 /en/magno/csf/2021/mn4.php weekly 0.7 /artkey/csf-202104-0003_68ga-dotatoc.php weekly 0.7 /en/artkey/csf-202104-0003_68ga-dotatoc.php weekly 0.7 /artkey/csf-202104-0001_specific-nature-of-medicines-and-value-of-medicines.php weekly 0.7 /en/artkey/csf-202104-0001_specific-nature-of-medicines-and-value-of-medicines.php weekly 0.7 /artkey/csf-202104-0002_the-role-of-vitamin-d-in-primary-and-secondary-prevention-in-orthopaedic-patients.php weekly 0.7 /en/artkey/csf-202104-0002_the-role-of-vitamin-d-in-primary-and-secondary-prevention-in-orthopaedic-patients.php weekly 0.7 /artkey/csf-202104-0005_ceska-farmacie-150-let-pod-kridly-odborne-spolecnosti.php weekly 0.7 /en/artkey/csf-202104-0005_ceska-farmacie-150-let-pod-kridly-odborne-spolecnosti.php weekly 0.7 /artkey/csf-202104-0004_pharmaceutical-art-and-peculiarities-in-the-latin-dissertation-de-phthisi-on-tuberculosis-from-1679-by-slovak.php weekly 0.7 /en/artkey/csf-202104-0004_pharmaceutical-art-and-peculiarities-in-the-latin-dissertation-de-phthisi-on-tuberculosis-from-1679-by-slovak.php weekly 0.7 /magno/csf/2021/mn5.php weekly 0.7 /en/magno/csf/2021/mn5.php weekly 0.7 /artkey/csf-202105-0003_antiadhesive-antibiofilm-and-dispersion-activity-of-biosurfactants-isolated-from-bacillus-amyloliquefaciens-3.php weekly 0.7 /en/artkey/csf-202105-0003_antiadhesive-antibiofilm-and-dispersion-activity-of-biosurfactants-isolated-from-bacillus-amyloliquefaciens-3.php weekly 0.7 /artkey/csf-202105-0004_the-effect-of-meloxicam-and-cryopreserved-placenta-extract-on-initial-inflammatory-response-an-experimental-s.php weekly 0.7 /en/artkey/csf-202105-0004_the-effect-of-meloxicam-and-cryopreserved-placenta-extract-on-initial-inflammatory-response-an-experimental-s.php weekly 0.7 /artkey/csf-202105-0005_films-from-poly-gamma-glutamic-acid-and-poly-epsilon-lysine-as-the-potential-wound-dressings-formulation.php weekly 0.7 /en/artkey/csf-202105-0005_films-from-poly-gamma-glutamic-acid-and-poly-epsilon-lysine-as-the-potential-wound-dressings-formulation.php weekly 0.7 /artkey/csf-202105-0001_use-of-droplet-based-microfluidic-techniques-in-the-preparation-of-microparticles.php weekly 0.7 /en/artkey/csf-202105-0001_use-of-droplet-based-microfluidic-techniques-in-the-preparation-of-microparticles.php weekly 0.7 /artkey/csf-202105-0002_telacebec-q203-is-there-a-novel-effective-and-safe-anti-tuberculosis-drug-on-the-horizon.php weekly 0.7 /en/artkey/csf-202105-0002_telacebec-q203-is-there-a-novel-effective-and-safe-anti-tuberculosis-drug-on-the-horizon.php weekly 0.7 /artkey/csf-202105-0006_laudatio-rndr-roman-smiesko-70-rokov.php weekly 0.7 /en/artkey/csf-202105-0006_laudatio-rndr-roman-smiesko-70-rokov.php weekly 0.7 /magno/csf/2021/mn6.php weekly 0.7 /en/magno/csf/2021/mn6.php weekly 0.7 /artkey/csf-202106-0001_antibiotics-and-the-quality-indicators-for-outpatient-antibiotic-use-in-slovakia.php weekly 0.7 /en/artkey/csf-202106-0001_antibiotics-and-the-quality-indicators-for-outpatient-antibiotic-use-in-slovakia.php weekly 0.7 /artkey/csf-202106-0002_phenylpropanoids-and-flavonoid-from-helichrysum-petiolare-hilliard-amp-b-l-burtt.php weekly 0.7 /en/artkey/csf-202106-0002_phenylpropanoids-and-flavonoid-from-helichrysum-petiolare-hilliard-amp-b-l-burtt.php weekly 0.7 /artkey/csf-202106-0003_preformulation-design-of-plga-particulate-system-for-multi-day-drug-delivery-of-the-antidepressant-mirtazapine.php weekly 0.7 /en/artkey/csf-202106-0003_preformulation-design-of-plga-particulate-system-for-multi-day-drug-delivery-of-the-antidepressant-mirtazapine.php weekly 0.7 /artkey/csf-202106-0006_spomienka-na-osobnosti-farmakognozie.php weekly 0.7 /en/artkey/csf-202106-0006_spomienka-na-osobnosti-farmakognozie.php weekly 0.7 /artkey/csf-202106-0004_supply-of-medicines-in-the-terezin-ghetto.php weekly 0.7 /en/artkey/csf-202106-0004_supply-of-medicines-in-the-terezin-ghetto.php weekly 0.7 /artkey/csf-202106-0005_xlii-pracovni-den-radiofarmaceuticke-sekce-csnm.php weekly 0.7 /en/artkey/csf-202106-0005_xlii-pracovni-den-radiofarmaceuticke-sekce-csnm.php weekly 0.7 /magno/csf/2020/mn1.php weekly 0.7 /en/magno/csf/2020/mn1.php weekly 0.7 /artkey/csf-202001-0003_double-coated-pellets-with-semipermeable-ethylcellulose-coating-for-detection-of-cholinesterase-inhibitors.php weekly 0.7 /en/artkey/csf-202001-0003_double-coated-pellets-with-semipermeable-ethylcellulose-coating-for-detection-of-cholinesterase-inhibitors.php weekly 0.7 /artkey/csf-202001-0004_development-and-uniformity-evaluation-of-low-dose-medicated-chewing-gums-prepared-by-compression-method.php weekly 0.7 /en/artkey/csf-202001-0004_development-and-uniformity-evaluation-of-low-dose-medicated-chewing-gums-prepared-by-compression-method.php weekly 0.7 /artkey/csf-202001-0005_investigation-of-thioctic-acid-magnesium-stearate-and-pyridoxine-hydrochloride-compatibility.php weekly 0.7 /en/artkey/csf-202001-0005_investigation-of-thioctic-acid-magnesium-stearate-and-pyridoxine-hydrochloride-compatibility.php weekly 0.7 /artkey/csf-202001-0001_metal-complexes-in-medicine-and-pharmacy-the-past-and-the-present-ii.php weekly 0.7 /en/artkey/csf-202001-0001_metal-complexes-in-medicine-and-pharmacy-the-past-and-the-present-ii.php weekly 0.7 /artkey/csf-202001-0002_pharmacokinetic-aspects-of-beta-lactam-antibiotic-therapy-in-intensive-care-unit-patients-a-one-center-experie.php weekly 0.7 /en/artkey/csf-202001-0002_pharmacokinetic-aspects-of-beta-lactam-antibiotic-therapy-in-intensive-care-unit-patients-a-one-center-experie.php weekly 0.7 /artkey/csf-202001-0007_k-zivotnemu-jubileu-pani-doc-rndr-zuzany-vitkovej-csc.php weekly 0.7 /en/artkey/csf-202001-0007_k-zivotnemu-jubileu-pani-doc-rndr-zuzany-vitkovej-csc.php weekly 0.7 /artkey/csf-202001-0008_zivotne-jubileum-prof-rndr-daniela-grancaia-csc.php weekly 0.7 /en/artkey/csf-202001-0008_zivotne-jubileum-prof-rndr-daniela-grancaia-csc.php weekly 0.7 /artkey/csf-202001-0009_zomrel-alois-borovansky.php weekly 0.7 /en/artkey/csf-202001-0009_zomrel-alois-borovansky.php weekly 0.7 /artkey/csf-202001-0006_the-amino-acid-and-carbohydrate-composition-of-the-herb-and-roots-of-smallanthus-sonchifolius.php weekly 0.7 /en/artkey/csf-202001-0006_the-amino-acid-and-carbohydrate-composition-of-the-herb-and-roots-of-smallanthus-sonchifolius.php weekly 0.7 /magno/csf/2020/mn2.php weekly 0.7 /en/magno/csf/2020/mn2.php weekly 0.7 /artkey/csf-202002-0002_evaluation-of-adherence-to-treatment-in-patients-suffering-from-diabetes-mellitus.php weekly 0.7 /en/artkey/csf-202002-0002_evaluation-of-adherence-to-treatment-in-patients-suffering-from-diabetes-mellitus.php weekly 0.7 /artkey/csf-202002-0003_the-influence-of-laquo-saprogel-raquo-in-the-wound-healing-process-on-rats-with-a-full-thickness-wound-model.php weekly 0.7 /en/artkey/csf-202002-0003_the-influence-of-laquo-saprogel-raquo-in-the-wound-healing-process-on-rats-with-a-full-thickness-wound-model.php weekly 0.7 /artkey/csf-202002-0004_a-cost-minimization-analysis-of-alpha-2b-interferon-supplementation-in-complex-pharmacotherapy-of-rotavirus-in.php weekly 0.7 /en/artkey/csf-202002-0004_a-cost-minimization-analysis-of-alpha-2b-interferon-supplementation-in-complex-pharmacotherapy-of-rotavirus-in.php weekly 0.7 /artkey/csf-202002-0005_formulation-and-technology-development-of-vaginal-pessaries-with-probiotic-activity.php weekly 0.7 /en/artkey/csf-202002-0005_formulation-and-technology-development-of-vaginal-pessaries-with-probiotic-activity.php weekly 0.7 /artkey/csf-202002-0001_advances-in-the-use-of-instrumental-measurement-of-colour-in-the-development-production-and-quality-control-of.php weekly 0.7 /en/artkey/csf-202002-0001_advances-in-the-use-of-instrumental-measurement-of-colour-in-the-development-production-and-quality-control-of.php weekly 0.7 /artkey/csf-202002-0007_nove-knihy.php weekly 0.7 /en/artkey/csf-202002-0007_nove-knihy.php weekly 0.7 /artkey/csf-202002-0006_rosuvastatin-induced-rhabdomyolysis-due-to-medication-errors.php weekly 0.7 /en/artkey/csf-202002-0006_rosuvastatin-induced-rhabdomyolysis-due-to-medication-errors.php weekly 0.7 /magno/csf/2020/mn3.php weekly 0.7 /en/magno/csf/2020/mn3.php weekly 0.7 /artkey/csf-202003-0004_anti-inflammatory-potential-of-composites-of-yeast-glucan-particles-and-geranylated-flavonoid-diplacone.php weekly 0.7 /en/artkey/csf-202003-0004_anti-inflammatory-potential-of-composites-of-yeast-glucan-particles-and-geranylated-flavonoid-diplacone.php weekly 0.7 /artkey/csf-202003-0005_the-study-of-hypoglycemic-and-hypolipidemic-activity-of-camelina-sativa-l-crantz-extracts-in-rats-under-cond.php weekly 0.7 /en/artkey/csf-202003-0005_the-study-of-hypoglycemic-and-hypolipidemic-activity-of-camelina-sativa-l-crantz-extracts-in-rats-under-cond.php weekly 0.7 /artkey/csf-202003-0006_a-pharmacodynamic-study-of-a-new-gel-containing-an-extract-of-aloe-vera-and-an-extract-of-oak-bark-for-potentia.php weekly 0.7 /en/artkey/csf-202003-0006_a-pharmacodynamic-study-of-a-new-gel-containing-an-extract-of-aloe-vera-and-an-extract-of-oak-bark-for-potentia.php weekly 0.7 /artkey/csf-202003-0001_ingavirin-might-be-a-promising-agent-to-combat-severe-acute-respiratory-coronavirus-2-sars-cov-2.php weekly 0.7 /en/artkey/csf-202003-0001_ingavirin-might-be-a-promising-agent-to-combat-severe-acute-respiratory-coronavirus-2-sars-cov-2.php weekly 0.7 /artkey/csf-202003-0002_medicinal-products-with-controlled-drug-release-for-local-therapy-of-inflammatory-bowel-diseases-from-perspecti.php weekly 0.7 /en/artkey/csf-202003-0002_medicinal-products-with-controlled-drug-release-for-local-therapy-of-inflammatory-bowel-diseases-from-perspecti.php weekly 0.7 /artkey/csf-202003-0003_metal-complexes-in-medicine-and-pharmacy-the-past-and-the-present-iii.php weekly 0.7 /en/artkey/csf-202003-0003_metal-complexes-in-medicine-and-pharmacy-the-past-and-the-present-iii.php weekly 0.7 /magno/csf/2020/mn4.php weekly 0.7 /en/magno/csf/2020/mn4.php weekly 0.7 /artkey/csf-202004-0002_collagen-in-combination-with-the-acid-form-of-carboxymethylcellulose-in-the-form-of-a-nonwoven-textile-as-a-mod.php weekly 0.7 /en/artkey/csf-202004-0002_collagen-in-combination-with-the-acid-form-of-carboxymethylcellulose-in-the-form-of-a-nonwoven-textile-as-a-mod.php weekly 0.7 /artkey/csf-202004-0003_application-of-inhaled-drugs-from-the-pharmacist-s-point-of-view.php weekly 0.7 /en/artkey/csf-202004-0003_application-of-inhaled-drugs-from-the-pharmacist-s-point-of-view.php weekly 0.7 /artkey/csf-202004-0004_simultaneous-determination-of-amoxicillin-and-potassium-clavulanate-in-combined-medicinal-forms-procedure-tran.php weekly 0.7 /en/artkey/csf-202004-0004_simultaneous-determination-of-amoxicillin-and-potassium-clavulanate-in-combined-medicinal-forms-procedure-tran.php weekly 0.7 /artkey/csf-202004-0001_vaccines-from-the-perspective-of-a-pharmacist.php weekly 0.7 /en/artkey/csf-202004-0001_vaccines-from-the-perspective-of-a-pharmacist.php weekly 0.7 /artkey/csf-202004-0005_composition-of-fatty-acids-in-centaurea-cyanus-l.php weekly 0.7 /en/artkey/csf-202004-0005_composition-of-fatty-acids-in-centaurea-cyanus-l.php weekly 0.7 /magno/csf/2020/mn5.php weekly 0.7 /en/magno/csf/2020/mn5.php weekly 0.7 /artkey/csf-202005-0002_development-and-validation-of-a-hplc-method-for-quantifica-tion-of-degradation-impurities-of-salbutamol-sulfate.php weekly 0.7 /en/artkey/csf-202005-0002_development-and-validation-of-a-hplc-method-for-quantifica-tion-of-degradation-impurities-of-salbutamol-sulfate.php weekly 0.7 /artkey/csf-202005-0003_automated-preparation-of-radiopharmaceuticals-as-a-tool-of-radiation-protection-optimisation-of-staff.php weekly 0.7 /en/artkey/csf-202005-0003_automated-preparation-of-radiopharmaceuticals-as-a-tool-of-radiation-protection-optimisation-of-staff.php weekly 0.7 /artkey/csf-202005-0004_the-hepatoprotective-effect-of-the-combination-of-glucosamine-derivatives-with-quercetin-against-methotrexate-i.php weekly 0.7 /en/artkey/csf-202005-0004_the-hepatoprotective-effect-of-the-combination-of-glucosamine-derivatives-with-quercetin-against-methotrexate-i.php weekly 0.7 /artkey/csf-202005-0005_meropenem-serum-concentrations-in-intensive-care-patients-a-retrospective-analysis.php weekly 0.7 /en/artkey/csf-202005-0005_meropenem-serum-concentrations-in-intensive-care-patients-a-retrospective-analysis.php weekly 0.7 /artkey/csf-202005-0006_determination-of-thiamine-and-pyridoxine-in-food-supplements-and-beverages-by-the-simple-capillary-zone-electro.php weekly 0.7 /en/artkey/csf-202005-0006_determination-of-thiamine-and-pyridoxine-in-food-supplements-and-beverages-by-the-simple-capillary-zone-electro.php weekly 0.7 /artkey/csf-202005-0001_focus-on-perchlozone-an-anti-tuberculosis-drug-from-the-russian-federation.php weekly 0.7 /en/artkey/csf-202005-0001_focus-on-perchlozone-an-anti-tuberculosis-drug-from-the-russian-federation.php weekly 0.7 /artkey/csf-202005-0007_k-zivotnimu-jubileu-prof-rndr-jozefa-cs-lleiho-csc.php weekly 0.7 /en/artkey/csf-202005-0007_k-zivotnimu-jubileu-prof-rndr-jozefa-cs-lleiho-csc.php weekly 0.7 /magno/csf/2019/mn1.php weekly 0.7 /en/magno/csf/2019/mn1.php weekly 0.7 /artkey/csf-201901-0003_film-wound-dressing-containing-dexpanthenol-preparation-and-evaluation.php weekly 0.7 /en/artkey/csf-201901-0003_film-wound-dressing-containing-dexpanthenol-preparation-and-evaluation.php weekly 0.7 /artkey/csf-201901-0001_plant-derived-drugs-and-their-applicaction-in-the-anticancer-therapy.php weekly 0.7 /en/artkey/csf-201901-0001_plant-derived-drugs-and-their-applicaction-in-the-anticancer-therapy.php weekly 0.7 /artkey/csf-201901-0002_microneedles-as-a-perspective-for-transdermal-therapeutic-systems.php weekly 0.7 /en/artkey/csf-201901-0002_microneedles-as-a-perspective-for-transdermal-therapeutic-systems.php weekly 0.7 /artkey/csf-201901-0005_zivotne-jubileum-jana-svetlika.php weekly 0.7 /en/artkey/csf-201901-0005_zivotne-jubileum-jana-svetlika.php weekly 0.7 /artkey/csf-201901-0006_65-rokov-slovenskej-farmaceutickej-spolocnosti.php weekly 0.7 /en/artkey/csf-201901-0006_65-rokov-slovenskej-farmaceutickej-spolocnosti.php weekly 0.7 /artkey/csf-201901-0004_theory-and-practice-of-pharmacopoeial-control-of-quality-of-drugs-and-excipients-viii-end-point-indication-and.php weekly 0.7 /en/artkey/csf-201901-0004_theory-and-practice-of-pharmacopoeial-control-of-quality-of-drugs-and-excipients-viii-end-point-indication-and.php weekly 0.7 /magno/csf/2019/mn2.php weekly 0.7 /en/magno/csf/2019/mn2.php weekly 0.7 /artkey/csf-201902-0003_influence-of-formulation-and-process-parameters-on-the-properties-of-cu2-alginate-particles-prepared-by-extern.php weekly 0.7 /en/artkey/csf-201902-0003_influence-of-formulation-and-process-parameters-on-the-properties-of-cu2-alginate-particles-prepared-by-extern.php weekly 0.7 /artkey/csf-201902-0004_otc-market-comparing-czech-republic-and-greece.php weekly 0.7 /en/artkey/csf-201902-0004_otc-market-comparing-czech-republic-and-greece.php weekly 0.7 /artkey/csf-201902-0001_bevacizumab-treatment-in-metastatic-colorectal-carcinoma-an-economic-perspective.php weekly 0.7 /en/artkey/csf-201902-0001_bevacizumab-treatment-in-metastatic-colorectal-carcinoma-an-economic-perspective.php weekly 0.7 /artkey/csf-201902-0002_prenylated-phenols-with-cytotoxic-and-antiproliferative-activity-isolated-from-morus-alba.php weekly 0.7 /en/artkey/csf-201902-0002_prenylated-phenols-with-cytotoxic-and-antiproliferative-activity-isolated-from-morus-alba.php weekly 0.7 /magno/csf/2019/mn3.php weekly 0.7 /en/magno/csf/2019/mn3.php weekly 0.7 /artkey/csf-201903-0003_selection-of-technological-parameters-for-the-preparation-of-the-combined-oral-solution-maglycimet-trade.php weekly 0.7 /en/artkey/csf-201903-0003_selection-of-technological-parameters-for-the-preparation-of-the-combined-oral-solution-maglycimet-trade.php weekly 0.7 /artkey/csf-201903-0001_theory-and-practice-of-pharmacopoeial-control-of-quality-of-drugs-and-excipients-ix-the-problem-of-tolerance-l.php weekly 0.7 /en/artkey/csf-201903-0001_theory-and-practice-of-pharmacopoeial-control-of-quality-of-drugs-and-excipients-ix-the-problem-of-tolerance-l.php weekly 0.7 /artkey/csf-201903-0002_schisandra-chinensis-and-its-phytotherapeutical-applications.php weekly 0.7 /en/artkey/csf-201903-0002_schisandra-chinensis-and-its-phytotherapeutical-applications.php weekly 0.7 /artkey/csf-201903-0005_zemrel-pan-docent-rndr-pavel-komarek-phd-dagger-8-cervence-2019.php weekly 0.7 /en/artkey/csf-201903-0005_zemrel-pan-docent-rndr-pavel-komarek-phd-dagger-8-cervence-2019.php weekly 0.7 /artkey/csf-201903-0004_xli-pracovni-dny-radiofarmaceuticke-sekce-ceske-spolecnosti-nuklearni-mediciny-cls-jep.php weekly 0.7 /en/artkey/csf-201903-0004_xli-pracovni-dny-radiofarmaceuticke-sekce-ceske-spolecnosti-nuklearni-mediciny-cls-jep.php weekly 0.7 /magno/csf/2019/mn4.php weekly 0.7 /en/magno/csf/2019/mn4.php weekly 0.7 /artkey/csf-201904-0004_study-of-biocompatibility-of-peritoneal-dialysis-solutions-measured-as-in-vitro-cells-viability.php weekly 0.7 /en/artkey/csf-201904-0004_study-of-biocompatibility-of-peritoneal-dialysis-solutions-measured-as-in-vitro-cells-viability.php weekly 0.7 /artkey/csf-201904-0005_nephroprotective-effect-of-n-acetylglucosamine-in-rats-with-acute-kidney-injury.php weekly 0.7 /en/artkey/csf-201904-0005_nephroprotective-effect-of-n-acetylglucosamine-in-rats-with-acute-kidney-injury.php weekly 0.7 /artkey/csf-201904-0001_new-approach-for-detoxification-of-patients-dependent-on-benzodiazepines-and-z-drugs-for-reduction-of-psychogen.php weekly 0.7 /en/artkey/csf-201904-0001_new-approach-for-detoxification-of-patients-dependent-on-benzodiazepines-and-z-drugs-for-reduction-of-psychogen.php weekly 0.7 /artkey/csf-201904-0002_plant-alpha-amylase-inhibitors-and-their-effect-on-the-utilization-of-polysaccharides-contained-in-the-diet.php weekly 0.7 /en/artkey/csf-201904-0002_plant-alpha-amylase-inhibitors-and-their-effect-on-the-utilization-of-polysaccharides-contained-in-the-diet.php weekly 0.7 /artkey/csf-201904-0003_theory-and-practice-of-pharmacopoeial-control-of-quality-of-drugs-and-excipients-x-number-of-parallel-determin.php weekly 0.7 /en/artkey/csf-201904-0003_theory-and-practice-of-pharmacopoeial-control-of-quality-of-drugs-and-excipients-x-number-of-parallel-determin.php weekly 0.7 /magno/csf/2019/mn5.php weekly 0.7 /en/magno/csf/2019/mn5.php weekly 0.7 /artkey/csf-201905-0002_pulse-check-as-a-tool-to-raise-awareness-of-atrial-fibrillation-in-pharmacies-in-the-czech-republic-a-pilot-p.php weekly 0.7 /en/artkey/csf-201905-0002_pulse-check-as-a-tool-to-raise-awareness-of-atrial-fibrillation-in-pharmacies-in-the-czech-republic-a-pilot-p.php weekly 0.7 /artkey/csf-201905-0001_meth-acrylate-copolymers-of-eudragit-reg-type-in-oral-tablet-technology.php weekly 0.7 /en/artkey/csf-201905-0001_meth-acrylate-copolymers-of-eudragit-reg-type-in-oral-tablet-technology.php weekly 0.7 /artkey/csf-201905-0006_nove-knihy.php weekly 0.7 /en/artkey/csf-201905-0006_nove-knihy.php weekly 0.7 /artkey/csf-201905-0003_honoring-the-80th-anniversary-of-the-world-war-ii-outbrake.php weekly 0.7 /en/artkey/csf-201905-0003_honoring-the-80th-anniversary-of-the-world-war-ii-outbrake.php weekly 0.7 /artkey/csf-201905-0005_x-zjazd-slovenskej-farmaceutickej-spolocnosti.php weekly 0.7 /en/artkey/csf-201905-0005_x-zjazd-slovenskej-farmaceutickej-spolocnosti.php weekly 0.7 /artkey/csf-201905-0004_pokroky-ve-farmaceuticke-technologii-pracovni-den-sekce-technologie-leku.php weekly 0.7 /en/artkey/csf-201905-0004_pokroky-ve-farmaceuticke-technologii-pracovni-den-sekce-technologie-leku.php weekly 0.7 /magno/csf/2019/mn6.php weekly 0.7 /en/magno/csf/2019/mn6.php weekly 0.7 /artkey/csf-201906-0002_preparation-and-evaluation-of-bilayer-films-based-on-collagen-and-carboxymethylcellulose-for-wound-therapy.php weekly 0.7 /en/artkey/csf-201906-0002_preparation-and-evaluation-of-bilayer-films-based-on-collagen-and-carboxymethylcellulose-for-wound-therapy.php weekly 0.7 /artkey/csf-201906-0001_lipid-profile-and-risks-of-cardiovascular-diseases-in-conditions-of-rheumatoid-arthritis.php weekly 0.7 /en/artkey/csf-201906-0001_lipid-profile-and-risks-of-cardiovascular-diseases-in-conditions-of-rheumatoid-arthritis.php weekly 0.7 /artkey/csf-201906-0008_nove-knihy.php weekly 0.7 /en/artkey/csf-201906-0008_nove-knihy.php weekly 0.7 /artkey/csf-201906-0003_henisch-s-translation-of-pharmaceutical-works.php weekly 0.7 /en/artkey/csf-201906-0003_henisch-s-translation-of-pharmaceutical-works.php weekly 0.7 /artkey/csf-201906-0004_pharmacists-among-members-of-the-czech-moravian-capuchin-province.php weekly 0.7 /en/artkey/csf-201906-0004_pharmacists-among-members-of-the-czech-moravian-capuchin-province.php weekly 0.7 /artkey/csf-201906-0007_x-zjazd-slovenskej-farmaceutickej-spolocnosti-bratislava-5-a-6-septembra-2019.php weekly 0.7 /en/artkey/csf-201906-0007_x-zjazd-slovenskej-farmaceutickej-spolocnosti-bratislava-5-a-6-septembra-2019.php weekly 0.7 /artkey/csf-201906-0005_sympozia-sekce-dejin-farmacie-cfs-v-roce-2019.php weekly 0.7 /en/artkey/csf-201906-0005_sympozia-sekce-dejin-farmacie-cfs-v-roce-2019.php weekly 0.7 /artkey/csf-201906-0006_lxvi-sympozium-z-historie-farmacie-a-otvirani-muzea-2019-kuks-18-kvetna-2019.php weekly 0.7 /en/artkey/csf-201906-0006_lxvi-sympozium-z-historie-farmacie-a-otvirani-muzea-2019-kuks-18-kvetna-2019.php weekly 0.7 /magno/csf/2018/mn1.php weekly 0.7 /en/magno/csf/2018/mn1.php weekly 0.7 /artkey/csf-201801-0003_the-immunomodulatory-activity-of-the-extracts-and-complexes-of-biologically-active-compounds-of-galium-verum-l.php weekly 0.7 /en/artkey/csf-201801-0003_the-immunomodulatory-activity-of-the-extracts-and-complexes-of-biologically-active-compounds-of-galium-verum-l.php weekly 0.7 /artkey/csf-201801-0001_genistein-a-promising-molecule-modulating-tumour-growth-and-wound-healing.php weekly 0.7 /en/artkey/csf-201801-0001_genistein-a-promising-molecule-modulating-tumour-growth-and-wound-healing.php weekly 0.7 /artkey/csf-201801-0002_liberalization-and-integration-of-drug-distribution-in-the-eu-28-and-norway.php weekly 0.7 /en/artkey/csf-201801-0002_liberalization-and-integration-of-drug-distribution-in-the-eu-28-and-norway.php weekly 0.7 /artkey/csf-201801-0006_nove-knihy.php weekly 0.7 /en/artkey/csf-201801-0006_nove-knihy.php weekly 0.7 /artkey/csf-201801-0005_pharmacy-and-johann-wolfgang-von-goethe-pharmacists-as-goethe-s-chemistry-teaches.php weekly 0.7 /en/artkey/csf-201801-0005_pharmacy-and-johann-wolfgang-von-goethe-pharmacists-as-goethe-s-chemistry-teaches.php weekly 0.7 /artkey/csf-201801-0004_theory-and-practice-of-pharmacopoeial-control-of-the-quality-of-drugs-and-excipients-vii-the-colour-reference.php weekly 0.7 /en/artkey/csf-201801-0004_theory-and-practice-of-pharmacopoeial-control-of-the-quality-of-drugs-and-excipients-vii-the-colour-reference.php weekly 0.7 /magno/csf/2018/mn2.php weekly 0.7 /en/magno/csf/2018/mn2.php weekly 0.7 /artkey/csf-201802-0005_on-the-content-of-the-national-part-of-the-czech-pharmacopoeia-2017.php weekly 0.7 /en/artkey/csf-201802-0005_on-the-content-of-the-national-part-of-the-czech-pharmacopoeia-2017.php weekly 0.7 /artkey/csf-201802-0001_melatonin-as-a-structural-template-in-the-development-of-novel-drugs-for-neurodegenerative-disorders.php weekly 0.7 /en/artkey/csf-201802-0001_melatonin-as-a-structural-template-in-the-development-of-novel-drugs-for-neurodegenerative-disorders.php weekly 0.7 /artkey/csf-201802-0002_superdisintegrants-used-in-pharmaceutical-technology.php weekly 0.7 /en/artkey/csf-201802-0002_superdisintegrants-used-in-pharmaceutical-technology.php weekly 0.7 /artkey/csf-201802-0003_selenium-in-the-prevention-and-subsidiary-therapy-of-cancer-of-soft-tissues.php weekly 0.7 /en/artkey/csf-201802-0003_selenium-in-the-prevention-and-subsidiary-therapy-of-cancer-of-soft-tissues.php weekly 0.7 /artkey/csf-201802-0004_microbiome-in-connection-with-metabolic-syndrome-and-the-therapeutic-potential-of-its-influencing.php weekly 0.7 /en/artkey/csf-201802-0004_microbiome-in-connection-with-metabolic-syndrome-and-the-therapeutic-potential-of-its-influencing.php weekly 0.7 /artkey/csf-201802-0006_enchiridion-medicinae-by-georg-henisch-1549-1618.php weekly 0.7 /en/artkey/csf-201802-0006_enchiridion-medicinae-by-georg-henisch-1549-1618.php weekly 0.7 /magno/csf/2018/mn3.php weekly 0.7 /en/magno/csf/2018/mn3.php weekly 0.7 /artkey/csf-201803-0002_the-immunomodulatory-activity-of-ethanolic-extracts-from-galium-verum-l-herb.php weekly 0.7 /en/artkey/csf-201803-0002_the-immunomodulatory-activity-of-ethanolic-extracts-from-galium-verum-l-herb.php weekly 0.7 /artkey/csf-201803-0003_biosurfactants-and-their-role-in-the-inhibition-of-the-biofilmforming-pathogens.php weekly 0.7 /en/artkey/csf-201803-0003_biosurfactants-and-their-role-in-the-inhibition-of-the-biofilmforming-pathogens.php weekly 0.7 /artkey/csf-201803-0001_inflammatory-bowel-disease-factors-involved-in-pathogenesis.php weekly 0.7 /en/artkey/csf-201803-0001_inflammatory-bowel-disease-factors-involved-in-pathogenesis.php weekly 0.7 /artkey/csf-201803-0008_remko-m-zapisky-chemika-bratislava-remedika-2018-368-s-isbn-978-80-972954-0-0.php weekly 0.7 /en/artkey/csf-201803-0008_remko-m-zapisky-chemika-bratislava-remedika-2018-368-s-isbn-978-80-972954-0-0.php weekly 0.7 /artkey/csf-201803-0007_vystava-lecivych-rostlin-v-brne.php weekly 0.7 /en/artkey/csf-201803-0007_vystava-lecivych-rostlin-v-brne.php weekly 0.7 /artkey/csf-201803-0005_pharmacy-pharmacists-and-drugs-in-the-terezin-ghetto.php weekly 0.7 /en/artkey/csf-201803-0005_pharmacy-pharmacists-and-drugs-in-the-terezin-ghetto.php weekly 0.7 /artkey/csf-201803-0006_xliv-lekarnicke-dni-lekarnickej-sekcie-sfs-o-z-sls-donovaly-21-az-23-juna-2018.php weekly 0.7 /en/artkey/csf-201803-0006_xliv-lekarnicke-dni-lekarnickej-sekcie-sfs-o-z-sls-donovaly-21-az-23-juna-2018.php weekly 0.7 /artkey/csf-201803-0004_research-in-the-chemical-composition-of-the-bark-of-sorbus-aucuparia.php weekly 0.7 /en/artkey/csf-201803-0004_research-in-the-chemical-composition-of-the-bark-of-sorbus-aucuparia.php weekly 0.7 /magno/csf/2018/mn4.php weekly 0.7 /en/magno/csf/2018/mn4.php weekly 0.7 /artkey/csf-201804-0002_study-of-influence-of-1-3-oxazole-4-yl-phosphonic-acid-derivative-on-nitric-oxide-system-indicators-in-rats-wit.php weekly 0.7 /en/artkey/csf-201804-0002_study-of-influence-of-1-3-oxazole-4-yl-phosphonic-acid-derivative-on-nitric-oxide-system-indicators-in-rats-wit.php weekly 0.7 /artkey/csf-201804-0001_biological-role-of-copper-as-an-essential-trace-element-in-the-human-organism.php weekly 0.7 /en/artkey/csf-201804-0001_biological-role-of-copper-as-an-essential-trace-element-in-the-human-organism.php weekly 0.7 /artkey/csf-201804-0003_gas-chromatography-mass-spectrometry-study-of-the-root-and-herb-of-smallanthus-sonchifolius.php weekly 0.7 /en/artkey/csf-201804-0003_gas-chromatography-mass-spectrometry-study-of-the-root-and-herb-of-smallanthus-sonchifolius.php weekly 0.7 /artkey/csf-201804-0004_pracovni-den-sekce-technologie-leku-s-nazvem-pokroky-ve-farmaceuticke-technologii.php weekly 0.7 /en/artkey/csf-201804-0004_pracovni-den-sekce-technologie-leku-s-nazvem-pokroky-ve-farmaceuticke-technologii.php weekly 0.7 /magno/csf/2018/mn5.php weekly 0.7 /en/magno/csf/2018/mn5.php weekly 0.7 /artkey/csf-201805-0003_wastage-of-medicines-and-its-financial-impact-on-the-healthcare-system-in-the-czech-republic.php weekly 0.7 /en/artkey/csf-201805-0003_wastage-of-medicines-and-its-financial-impact-on-the-healthcare-system-in-the-czech-republic.php weekly 0.7 /artkey/csf-201805-0004_nmr-and-ir-analysis-of-natural-substances-isolated-from-cordyceps-medicinal-mushrooms.php weekly 0.7 /en/artkey/csf-201805-0004_nmr-and-ir-analysis-of-natural-substances-isolated-from-cordyceps-medicinal-mushrooms.php weekly 0.7 /artkey/csf-201805-0001_co-processed-excipients-for-direct-compression-of-tablets.php weekly 0.7 /en/artkey/csf-201805-0001_co-processed-excipients-for-direct-compression-of-tablets.php weekly 0.7 /artkey/csf-201805-0002_metal-complexes-in-medicine-and-pharmacy-the-past-and-the-present-i.php weekly 0.7 /en/artkey/csf-201805-0002_metal-complexes-in-medicine-and-pharmacy-the-past-and-the-present-i.php weekly 0.7 /artkey/csf-201805-0010_nove-knihy.php weekly 0.7 /en/artkey/csf-201805-0010_nove-knihy.php weekly 0.7 /artkey/csf-201805-0005_clinical-pharmacist-involvement-in-fall-management-in-a-polymorbid-geriatric-patient-with-a-history-of-recurren.php weekly 0.7 /en/artkey/csf-201805-0005_clinical-pharmacist-involvement-in-fall-management-in-a-polymorbid-geriatric-patient-with-a-history-of-recurren.php weekly 0.7 /artkey/csf-201805-0008_emeritni-dekan-a-byvaly-predseda-cfs-profesor-ludek-jahodar-slavi-sedmdesatku.php weekly 0.7 /en/artkey/csf-201805-0008_emeritni-dekan-a-byvaly-predseda-cfs-profesor-ludek-jahodar-slavi-sedmdesatku.php weekly 0.7 /artkey/csf-201805-0009_zivotne-jubileum-marie-kohutovej.php weekly 0.7 /en/artkey/csf-201805-0009_zivotne-jubileum-marie-kohutovej.php weekly 0.7 /artkey/csf-201805-0007_the-beginnings-of-health-libraries-of-the-czech-brothers-hospitallers-in-the-18th-century.php weekly 0.7 /en/artkey/csf-201805-0007_the-beginnings-of-health-libraries-of-the-czech-brothers-hospitallers-in-the-18th-century.php weekly 0.7 /artkey/csf-201805-0006_beer-with-reduced-carbohydrates-and-alcohol-content-suitable-for-diabetics.php weekly 0.7 /en/artkey/csf-201805-0006_beer-with-reduced-carbohydrates-and-alcohol-content-suitable-for-diabetics.php weekly 0.7 /artkey/csf-201805-0011_autorsky-rejstrik.php weekly 0.7 /en/artkey/csf-201805-0011_autorsky-rejstrik.php weekly 0.7 /magno/csf/2017/mn1.php weekly 0.7 /en/magno/csf/2017/mn1.php weekly 0.7 /artkey/csf-201701-0001_medical-and-non-medical-costs-of-parkinson-disease-comparison-of-europe-usa-asia-an-australia.php weekly 0.7 /en/artkey/csf-201701-0001_medical-and-non-medical-costs-of-parkinson-disease-comparison-of-europe-usa-asia-an-australia.php weekly 0.7 /artkey/csf-201701-0002_gas-chromatography-mass-spectrometry-studies-of-the-component-composition-of-carboxylic-acids-of-the-rhizomes.php weekly 0.7 /en/artkey/csf-201701-0002_gas-chromatography-mass-spectrometry-studies-of-the-component-composition-of-carboxylic-acids-of-the-rhizomes.php weekly 0.7 /artkey/csf-201701-0003_cytotoxic-anti-cancer-and-anti-microbial-effects-of-different-extracts-obtained-from-artemisia-rupestris.php weekly 0.7 /en/artkey/csf-201701-0003_cytotoxic-anti-cancer-and-anti-microbial-effects-of-different-extracts-obtained-from-artemisia-rupestris.php weekly 0.7 /artkey/csf-201701-0004_self-emulsifying-drug-delivery-system-sedds-of-ibuprofen-formulation-in-vitro-and-in-vivo-evaluation.php weekly 0.7 /en/artkey/csf-201701-0004_self-emulsifying-drug-delivery-system-sedds-of-ibuprofen-formulation-in-vitro-and-in-vivo-evaluation.php weekly 0.7 /artkey/csf-201701-0005_the-fate-of-jewish-pharmacists-from-the-czech-lands-during-the-holocaust.php weekly 0.7 /en/artkey/csf-201701-0005_the-fate-of-jewish-pharmacists-from-the-czech-lands-during-the-holocaust.php weekly 0.7 /artkey/csf-201701-0006_sympozia-sekce-dejin-farmacie-cfs-v-roce-2016.php weekly 0.7 /en/artkey/csf-201701-0006_sympozia-sekce-dejin-farmacie-cfs-v-roce-2016.php weekly 0.7 /magno/csf/2017/mn2.php weekly 0.7 /en/magno/csf/2017/mn2.php weekly 0.7 /artkey/csf-201702-0001_mobile-applications-as-good-intervention-tools-for-individuals-with-depression.php weekly 0.7 /en/artkey/csf-201702-0001_mobile-applications-as-good-intervention-tools-for-individuals-with-depression.php weekly 0.7 /artkey/csf-201702-0002_separation-of-phenylalanine-and-methionine-enantiomers-by-hplc-method-a-comparison-of-stationary-phase-types.php weekly 0.7 /en/artkey/csf-201702-0002_separation-of-phenylalanine-and-methionine-enantiomers-by-hplc-method-a-comparison-of-stationary-phase-types.php weekly 0.7 /artkey/csf-201702-0003_identifying-the-interprofessional-agreement-between-community-pharmacist-s-and-general-practitioner-s-views-on.php weekly 0.7 /en/artkey/csf-201702-0003_identifying-the-interprofessional-agreement-between-community-pharmacist-s-and-general-practitioner-s-views-on.php weekly 0.7 /artkey/csf-201702-0004_targeted-drug-delivery-system-potential-application-to-resveratrol.php weekly 0.7 /en/artkey/csf-201702-0004_targeted-drug-delivery-system-potential-application-to-resveratrol.php weekly 0.7 /artkey/csf-201702-0008_nove-knihy.php weekly 0.7 /en/artkey/csf-201702-0008_nove-knihy.php weekly 0.7 /artkey/csf-201702-0006_alois-borovansky-95-rocny.php weekly 0.7 /en/artkey/csf-201702-0006_alois-borovansky-95-rocny.php weekly 0.7 /artkey/csf-201702-0007_vzpominka-na-doc-rndr-phmr-veru-spurnou-drsc.php weekly 0.7 /en/artkey/csf-201702-0007_vzpominka-na-doc-rndr-phmr-veru-spurnou-drsc.php weekly 0.7 /artkey/csf-201702-0005_the-image-of-a-good-pharmacist-in-the-works-of-saladin-di-ascoli-and-valerius-cordus.php weekly 0.7 /en/artkey/csf-201702-0005_the-image-of-a-good-pharmacist-in-the-works-of-saladin-di-ascoli-and-valerius-cordus.php weekly 0.7 /magno/csf/2017/mn3.php weekly 0.7 /en/magno/csf/2017/mn3.php weekly 0.7 /artkey/csf-201703-0003_the-extent-of-the-burnout-syndrome-among-pharmacists-partial-study.php weekly 0.7 /en/artkey/csf-201703-0003_the-extent-of-the-burnout-syndrome-among-pharmacists-partial-study.php weekly 0.7 /artkey/csf-201703-0004_the-role-of-a-hospital-pharmacist-in-the-management-of-asthma-in-great-britain.php weekly 0.7 /en/artkey/csf-201703-0004_the-role-of-a-hospital-pharmacist-in-the-management-of-asthma-in-great-britain.php weekly 0.7 /artkey/csf-201703-0005_effect-of-the-vaginal-pessaries-melanizol-reg-and-klimedeks-reg-on-the-glycogen-level-in-the-vaginal-tissue-o.php weekly 0.7 /en/artkey/csf-201703-0005_effect-of-the-vaginal-pessaries-melanizol-reg-and-klimedeks-reg-on-the-glycogen-level-in-the-vaginal-tissue-o.php weekly 0.7 /artkey/csf-201703-0001_herpes-simplex-virus-infection-an-overview-of-the-problem-pharmacologic-therapy-and-dietary-measures.php weekly 0.7 /en/artkey/csf-201703-0001_herpes-simplex-virus-infection-an-overview-of-the-problem-pharmacologic-therapy-and-dietary-measures.php weekly 0.7 /artkey/csf-201703-0002_drugs-and-dosage-forms-as-risk-factors-for-dental-caries.php weekly 0.7 /en/artkey/csf-201703-0002_drugs-and-dosage-forms-as-risk-factors-for-dental-caries.php weekly 0.7 /artkey/csf-201703-0007_nove-knihy.php weekly 0.7 /en/artkey/csf-201703-0007_nove-knihy.php weekly 0.7 /artkey/csf-201703-0006_xxxix-pracovni-dny-radiofarmaceuticke-sekce-ceske-spolecnosti-nuklearni-mediciny-cls-jep.php weekly 0.7 /en/artkey/csf-201703-0006_xxxix-pracovni-dny-radiofarmaceuticke-sekce-ceske-spolecnosti-nuklearni-mediciny-cls-jep.php weekly 0.7 /magno/csf/2017/mn4.php weekly 0.7 /en/magno/csf/2017/mn4.php weekly 0.7 /artkey/csf-201704-0004_synergistic-effect-of-azole-antimycotics-clotrimazole-and-fluconazole-and-natural-substances.php weekly 0.7 /en/artkey/csf-201704-0004_synergistic-effect-of-azole-antimycotics-clotrimazole-and-fluconazole-and-natural-substances.php weekly 0.7 /artkey/csf-201704-0001_cholinesterase-activity-assays-and-their-use-in-the-diagnosis-of-various-pathological-states-including-poisonin.php weekly 0.7 /en/artkey/csf-201704-0001_cholinesterase-activity-assays-and-their-use-in-the-diagnosis-of-various-pathological-states-including-poisonin.php weekly 0.7 /artkey/csf-201704-0002_possibilities-of-using-sodium-hyaluronate-in-pharmaceutical-and-medical-fields.php weekly 0.7 /en/artkey/csf-201704-0002_possibilities-of-using-sodium-hyaluronate-in-pharmaceutical-and-medical-fields.php weekly 0.7 /artkey/csf-201704-0003_specifics-of-some-calcium-salts-in-intravenous-therapy-of-hypocalcemia-and-their-further-use.php weekly 0.7 /en/artkey/csf-201704-0003_specifics-of-some-calcium-salts-in-intravenous-therapy-of-hypocalcemia-and-their-further-use.php weekly 0.7 /artkey/csf-201704-0008_nove-knihy.php weekly 0.7 /en/artkey/csf-201704-0008_nove-knihy.php weekly 0.7 /artkey/csf-201704-0007_brnenske-vystavy-herbaru.php weekly 0.7 /en/artkey/csf-201704-0007_brnenske-vystavy-herbaru.php weekly 0.7 /artkey/csf-201704-0005_simplicia-and-medical-containers-from-the-jesuit-pharmacy-in-telc.php weekly 0.7 /en/artkey/csf-201704-0005_simplicia-and-medical-containers-from-the-jesuit-pharmacy-in-telc.php weekly 0.7 /artkey/csf-201704-0006_xliii-lekarnicke-dni-lekarnickej-sekcie-slovenskej-farmaceutickej-spolocnosti-venovane-65-vyrociu-vzniku-far.php weekly 0.7 /en/artkey/csf-201704-0006_xliii-lekarnicke-dni-lekarnickej-sekcie-slovenskej-farmaceutickej-spolocnosti-venovane-65-vyrociu-vzniku-far.php weekly 0.7 /magno/csf/2017/mn5.php weekly 0.7 /en/magno/csf/2017/mn5.php weekly 0.7 /artkey/csf-201705-0003_fatty-acid-composition-of-lipids-of-iris-sibirica.php weekly 0.7 /en/artkey/csf-201705-0003_fatty-acid-composition-of-lipids-of-iris-sibirica.php weekly 0.7 /artkey/csf-201705-0004_development-of-the-composition-of-intramammary-combined-preparation-based-on-silver-citrate-for-veterinary-use.php weekly 0.7 /en/artkey/csf-201705-0004_development-of-the-composition-of-intramammary-combined-preparation-based-on-silver-citrate-for-veterinary-use.php weekly 0.7 /artkey/csf-201705-0001_active-substances-from-marine-organisms-in-clinical-trials-and-practice.php weekly 0.7 /en/artkey/csf-201705-0001_active-substances-from-marine-organisms-in-clinical-trials-and-practice.php weekly 0.7 /artkey/csf-201705-0002_herbs-for-increasing-breast-milk-production.php weekly 0.7 /en/artkey/csf-201705-0002_herbs-for-increasing-breast-milk-production.php weekly 0.7 /artkey/csf-201705-0005_idiopathic-thrombocytopenia-refractery-to-therapy-of-cyclosporine-a-in-clinical-practice-case-report.php weekly 0.7 /en/artkey/csf-201705-0005_idiopathic-thrombocytopenia-refractery-to-therapy-of-cyclosporine-a-in-clinical-practice-case-report.php weekly 0.7 /artkey/csf-201705-0008_60-rokov-katedry-farmaceutickej-chemie-faf-uk-v-bratislave.php weekly 0.7 /en/artkey/csf-201705-0008_60-rokov-katedry-farmaceutickej-chemie-faf-uk-v-bratislave.php weekly 0.7 /artkey/csf-201705-0006_pokroky-ve-farmaceuticke-technologii-brno-5-zari-2017.php weekly 0.7 /en/artkey/csf-201705-0006_pokroky-ve-farmaceuticke-technologii-brno-5-zari-2017.php weekly 0.7 /artkey/csf-201705-0007_36-technologicke-dni-nove-trendy-v-oblasti-vyskumu-a-vyvoja-liekov-inovacie-v-oblasti-zdravotnickych-pom-cok.php weekly 0.7 /en/artkey/csf-201705-0007_36-technologicke-dni-nove-trendy-v-oblasti-vyskumu-a-vyvoja-liekov-inovacie-v-oblasti-zdravotnickych-pom-cok.php weekly 0.7 /magno/csf/2017/mn6.php weekly 0.7 /en/magno/csf/2017/mn6.php weekly 0.7 /artkey/csf-201706-0002_the-size-reduced-eudragit-reg-rs-microparticles-prepared-by-solvent-evaporation-method-monitoring-the-effect.php weekly 0.7 /en/artkey/csf-201706-0002_the-size-reduced-eudragit-reg-rs-microparticles-prepared-by-solvent-evaporation-method-monitoring-the-effect.php weekly 0.7 /artkey/csf-201706-0003_development-of-dissolution-method-for-warfarin-sodium-tablets.php weekly 0.7 /en/artkey/csf-201706-0003_development-of-dissolution-method-for-warfarin-sodium-tablets.php weekly 0.7 /artkey/csf-201706-0001_gut-microbiota-its-development-and-relation-to-certain-diseases.php weekly 0.7 /en/artkey/csf-201706-0001_gut-microbiota-its-development-and-relation-to-certain-diseases.php weekly 0.7 /artkey/csf-201706-0006_zprava-z-mezinarodniho-setkani-historiku-farmacie-ve-varsave.php weekly 0.7 /en/artkey/csf-201706-0006_zprava-z-mezinarodniho-setkani-historiku-farmacie-ve-varsave.php weekly 0.7 /artkey/csf-201706-0004_carboxylic-acids-from-brown-algae-fucus-vesiculosus-and-padina-pavonica.php weekly 0.7 /en/artkey/csf-201706-0004_carboxylic-acids-from-brown-algae-fucus-vesiculosus-and-padina-pavonica.php weekly 0.7 /artkey/csf-201706-0005_sympozia-sekce-dejin-farmacie-cfs-v-roce-2017.php weekly 0.7 /en/artkey/csf-201706-0005_sympozia-sekce-dejin-farmacie-cfs-v-roce-2017.php weekly 0.7 /artkey/csf-201706-0007_autorsky-rejstrik.php weekly 0.7 /en/artkey/csf-201706-0007_autorsky-rejstrik.php weekly 0.7 /magno/csf/2016/mn1.php weekly 0.7 /en/magno/csf/2016/mn1.php weekly 0.7 /artkey/csf-201601-0004_influence-of-the-mesh-of-extrusion-dies-on-the-properties-of-cores-intended-for-the-preparation-of-pellets-with.php weekly 0.7 /en/artkey/csf-201601-0004_influence-of-the-mesh-of-extrusion-dies-on-the-properties-of-cores-intended-for-the-preparation-of-pellets-with.php weekly 0.7 /artkey/csf-201601-0001_the-relationship-of-lipid-imbalance-and-chronic-inflammation-mediated-by-ppar.php weekly 0.7 /en/artkey/csf-201601-0001_the-relationship-of-lipid-imbalance-and-chronic-inflammation-mediated-by-ppar.php weekly 0.7 /artkey/csf-201601-0002_antimicrobial-antiparasitic-and-anticancer-properties-of-hibiscus-sabdariffa-l-and-its-phytochemicals-in-v.php weekly 0.7 /en/artkey/csf-201601-0002_antimicrobial-antiparasitic-and-anticancer-properties-of-hibiscus-sabdariffa-l-and-its-phytochemicals-in-v.php weekly 0.7 /artkey/csf-201601-0003_oral-films-as-perspective-dosage-form.php weekly 0.7 /en/artkey/csf-201601-0003_oral-films-as-perspective-dosage-form.php weekly 0.7 /artkey/csf-201601-0009_farmakognozia-biologicky-aktivne-rastlinne-metabolity-a-ich-zdroje.php weekly 0.7 /en/artkey/csf-201601-0009_farmakognozia-biologicky-aktivne-rastlinne-metabolity-a-ich-zdroje.php weekly 0.7 /artkey/csf-201601-0008_35-technologicke-dni-a-pohlad-do-historie-tohto-podujatia.php weekly 0.7 /en/artkey/csf-201601-0008_35-technologicke-dni-a-pohlad-do-historie-tohto-podujatia.php weekly 0.7 /artkey/csf-201601-0005_potential-anticancer-agent-hypericin-and-its-model-compound-emodin-interaction-with-dna.php weekly 0.7 /en/artkey/csf-201601-0005_potential-anticancer-agent-hypericin-and-its-model-compound-emodin-interaction-with-dna.php weekly 0.7 /artkey/csf-201601-0006_development-of-a-spectrophotometric-method-for-carmoisine-determination-in-quality-control-of-equipment-cleanin.php weekly 0.7 /en/artkey/csf-201601-0006_development-of-a-spectrophotometric-method-for-carmoisine-determination-in-quality-control-of-equipment-cleanin.php weekly 0.7 /artkey/csf-201601-0007_thin-layer-chromatography-application-for-the-standardization-of-sophora-flowers.php weekly 0.7 /en/artkey/csf-201601-0007_thin-layer-chromatography-application-for-the-standardization-of-sophora-flowers.php weekly 0.7 /magno/csf/2016/mn2.php weekly 0.7 /en/magno/csf/2016/mn2.php weekly 0.7 /artkey/csf-201602-0005_the-evaluation-of-the-prevalence-of-constipation-at-the-centre-of-clinical-gerontology.php weekly 0.7 /en/artkey/csf-201602-0005_the-evaluation-of-the-prevalence-of-constipation-at-the-centre-of-clinical-gerontology.php weekly 0.7 /artkey/csf-201602-0001_potential-immunomodulatory-and-antiinflammatory-mechanisms-of-probiotics.php weekly 0.7 /en/artkey/csf-201602-0001_potential-immunomodulatory-and-antiinflammatory-mechanisms-of-probiotics.php weekly 0.7 /artkey/csf-201602-0002_mice-lacking-individual-molecular-forms-of-cholinesterases.php weekly 0.7 /en/artkey/csf-201602-0002_mice-lacking-individual-molecular-forms-of-cholinesterases.php weekly 0.7 /artkey/csf-201602-0003_oral-adverse-drug-reactions-in-various-medications.php weekly 0.7 /en/artkey/csf-201602-0003_oral-adverse-drug-reactions-in-various-medications.php weekly 0.7 /artkey/csf-201602-0004_phenolic-compounds-of-the-genus-iris-plants-iridaceae.php weekly 0.7 /en/artkey/csf-201602-0004_phenolic-compounds-of-the-genus-iris-plants-iridaceae.php weekly 0.7 /artkey/csf-201602-0008_bartunek-a-dejiny-slovenskeho-lekarnictva-i-10-storocie-az-1918.php weekly 0.7 /en/artkey/csf-201602-0008_bartunek-a-dejiny-slovenskeho-lekarnictva-i-10-storocie-az-1918.php weekly 0.7 /artkey/csf-201602-0007_zemrel-doc-rndr-phmr-vaclav-rusek-csc-25-unora-1928-30-ledna-2016.php weekly 0.7 /en/artkey/csf-201602-0007_zemrel-doc-rndr-phmr-vaclav-rusek-csc-25-unora-1928-30-ledna-2016.php weekly 0.7 /artkey/csf-201602-0006_vybor-slovenskej-farmaceutickej-spolocnosti-na-roky-2016-2020.php weekly 0.7 /en/artkey/csf-201602-0006_vybor-slovenskej-farmaceutickej-spolocnosti-na-roky-2016-2020.php weekly 0.7 /magno/csf/2016/mn3.php weekly 0.7 /en/magno/csf/2016/mn3.php weekly 0.7 /artkey/csf-201603-0002_the-influence-of-hyaluronan-addition-on-thickness-weight-uniformity-of-mass-and-water-content-of-mucoadhesive.php weekly 0.7 /en/artkey/csf-201603-0002_the-influence-of-hyaluronan-addition-on-thickness-weight-uniformity-of-mass-and-water-content-of-mucoadhesive.php weekly 0.7 /artkey/csf-201603-0003_ageing-and-alzheimer-disease-system-dynamics-model-prediction.php weekly 0.7 /en/artkey/csf-201603-0003_ageing-and-alzheimer-disease-system-dynamics-model-prediction.php weekly 0.7 /artkey/csf-201603-0004_preparation-and-evaluation-of-indomethacin-loaded-alginate-microspheres.php weekly 0.7 /en/artkey/csf-201603-0004_preparation-and-evaluation-of-indomethacin-loaded-alginate-microspheres.php weekly 0.7 /artkey/csf-201603-0001_rhodiola-rosea-and-its-neuropsychotropic-effects.php weekly 0.7 /en/artkey/csf-201603-0001_rhodiola-rosea-and-its-neuropsychotropic-effects.php weekly 0.7 /artkey/csf-201603-0009_nove-knihy.php weekly 0.7 /en/artkey/csf-201603-0009_nove-knihy.php weekly 0.7 /artkey/csf-201603-0007_prof-rndr-dusan-mlynarcik-drsc-75-rocny.php weekly 0.7 /en/artkey/csf-201603-0007_prof-rndr-dusan-mlynarcik-drsc-75-rocny.php weekly 0.7 /artkey/csf-201603-0008_in-memoriam-rndr-vera-tomaskova-csc.php weekly 0.7 /en/artkey/csf-201603-0008_in-memoriam-rndr-vera-tomaskova-csc.php weekly 0.7 /artkey/csf-201603-0005_xxxviii-pracovni-dny-radiofarmaceuticke-sekce-ceske-spolecnosti-nuklearni-mediciny-cls-jep.php weekly 0.7 /en/artkey/csf-201603-0005_xxxviii-pracovni-dny-radiofarmaceuticke-sekce-ceske-spolecnosti-nuklearni-mediciny-cls-jep.php weekly 0.7 /artkey/csf-201603-0006_antiproliferative-effect-of-1-methoxybrassinin.php weekly 0.7 /en/artkey/csf-201603-0006_antiproliferative-effect-of-1-methoxybrassinin.php weekly 0.7 /magno/csf/2016/mn4.php weekly 0.7 /en/magno/csf/2016/mn4.php weekly 0.7 /artkey/csf-201604-0005_phenolic-compounds-in-leaves-insertions-of-mentha-villosa-huds-cv-snezna.php weekly 0.7 /en/artkey/csf-201604-0005_phenolic-compounds-in-leaves-insertions-of-mentha-villosa-huds-cv-snezna.php weekly 0.7 /artkey/csf-201604-0002_constituents-of-the-leaves-of-cornus-officinalis-sieb-et-zucc.php weekly 0.7 /en/artkey/csf-201604-0002_constituents-of-the-leaves-of-cornus-officinalis-sieb-et-zucc.php weekly 0.7 /artkey/csf-201604-0003_cellular-and-molecular-mechanisms-of-action-of-bitter-compounds-recent-knowledge-and-perspective.php weekly 0.7 /en/artkey/csf-201604-0003_cellular-and-molecular-mechanisms-of-action-of-bitter-compounds-recent-knowledge-and-perspective.php weekly 0.7 /artkey/csf-201604-0004_use-of-plant-extracts-as-an-efficient-alternative-therapy-of-respiratory-tract-infections.php weekly 0.7 /en/artkey/csf-201604-0004_use-of-plant-extracts-as-an-efficient-alternative-therapy-of-respiratory-tract-infections.php weekly 0.7 /artkey/csf-201604-0006_in-memoriam-doc-rndr-phmr-jarmila-vlckova-csc.php weekly 0.7 /en/artkey/csf-201604-0006_in-memoriam-doc-rndr-phmr-jarmila-vlckova-csc.php weekly 0.7 /artkey/csf-201604-0001_zivotne-jubileum-dr-h-c-prof-rndr-vaclava-sucheho-drsc.php weekly 0.7 /en/artkey/csf-201604-0001_zivotne-jubileum-dr-h-c-prof-rndr-vaclava-sucheho-drsc.php weekly 0.7 /magno/csf/2016/mn5.php weekly 0.7 /en/magno/csf/2016/mn5.php weekly 0.7 /artkey/csf-201605-0001_the-optical-method-of-measurement-of-sizes-and-the-refractive-index-of-nanoparticles-ag-fe3o4.php weekly 0.7 /en/artkey/csf-201605-0001_the-optical-method-of-measurement-of-sizes-and-the-refractive-index-of-nanoparticles-ag-fe3o4.php weekly 0.7 /artkey/csf-201605-0002_the-conscientious-objection-among-pharmacists-in-the-slovak-republic.php weekly 0.7 /en/artkey/csf-201605-0002_the-conscientious-objection-among-pharmacists-in-the-slovak-republic.php weekly 0.7 /artkey/csf-201605-0008_nove-knihy.php weekly 0.7 /en/artkey/csf-201605-0008_nove-knihy.php weekly 0.7 /artkey/csf-201605-0005_vystava-lecive-rostliny-a-jejich-dvojnici.php weekly 0.7 /en/artkey/csf-201605-0005_vystava-lecive-rostliny-a-jejich-dvojnici.php weekly 0.7 /artkey/csf-201605-0006_prof-rndr-viliam-foltan-csc-jubiluje.php weekly 0.7 /en/artkey/csf-201605-0006_prof-rndr-viliam-foltan-csc-jubiluje.php weekly 0.7 /artkey/csf-201605-0007_prof-rndr-ludek-benes-drsc-in-memoriam.php weekly 0.7 /en/artkey/csf-201605-0007_prof-rndr-ludek-benes-drsc-in-memoriam.php weekly 0.7 /artkey/csf-201605-0003_jews-in-european-pharmacy-from-the-seventh-to-the-early-twentieth-centuries.php weekly 0.7 /en/artkey/csf-201605-0003_jews-in-european-pharmacy-from-the-seventh-to-the-early-twentieth-centuries.php weekly 0.7 /artkey/csf-201605-0004_pracovni-den-sekce-technologie-leku-pokroky-v-lekovych-formach.php weekly 0.7 /en/artkey/csf-201605-0004_pracovni-den-sekce-technologie-leku-pokroky-v-lekovych-formach.php weekly 0.7 /magno/csf/2016/mn6.php weekly 0.7 /en/magno/csf/2016/mn6.php weekly 0.7 /artkey/csf-201606-0001_influence-of-drug-concentration-and-blending-technology-on-the-content-uniformity-of-mixture-for-low-dose-warfa.php weekly 0.7 /en/artkey/csf-201606-0001_influence-of-drug-concentration-and-blending-technology-on-the-content-uniformity-of-mixture-for-low-dose-warfa.php weekly 0.7 /artkey/csf-201606-0002_level-of-understanding-of-medical-terms-among-italian-students.php weekly 0.7 /en/artkey/csf-201606-0002_level-of-understanding-of-medical-terms-among-italian-students.php weekly 0.7 /artkey/csf-201606-0003_fractal-aspects-of-the-flow-and-shear-behaviour-of-free-flowable-particle-size-fractions-of-pharmaceutical-dire.php weekly 0.7 /en/artkey/csf-201606-0003_fractal-aspects-of-the-flow-and-shear-behaviour-of-free-flowable-particle-size-fractions-of-pharmaceutical-dire.php weekly 0.7 /artkey/csf-201606-0004_effect-of-eudragit-reg-rs-on-the-release-behaviour-of-theophylline-solid-dispersions.php weekly 0.7 /en/artkey/csf-201606-0004_effect-of-eudragit-reg-rs-on-the-release-behaviour-of-theophylline-solid-dispersions.php weekly 0.7 /artkey/csf-201606-0005_42-lekarnicke-dni-lekarnickej-sekcie-sfs.php weekly 0.7 /en/artkey/csf-201606-0005_42-lekarnicke-dni-lekarnickej-sekcie-sfs.php weekly 0.7 /artkey/csf-201606-0006_autorsky-rejstrik.php weekly 0.7 /en/artkey/csf-201606-0006_autorsky-rejstrik.php weekly 0.7 /artkey/inf-990000-1600.php weekly 0.7 /magno/csf/2015/mn1.php weekly 0.7 /en/magno/csf/2015/mn1.php weekly 0.7 /artkey/csf-201501-0003_the-effect-of-the-size-of-a-conical-hopper-aperture-on-the-parameters-of-the-flow-equation-of-sorbitol-and-its.php weekly 0.7 /en/artkey/csf-201501-0003_the-effect-of-the-size-of-a-conical-hopper-aperture-on-the-parameters-of-the-flow-equation-of-sorbitol-and-its.php weekly 0.7 /artkey/csf-201501-0004_synthesis-and-anti-infective-evaluation-of-5-amino-n-phenylpyrazine-2-carboxamides.php weekly 0.7 /en/artkey/csf-201501-0004_synthesis-and-anti-infective-evaluation-of-5-amino-n-phenylpyrazine-2-carboxamides.php weekly 0.7 /artkey/csf-201501-0005_alzheimer-s-disease-cost-cuts-call-for-novel-drugs-development-and-national-strategy.php weekly 0.7 /en/artkey/csf-201501-0005_alzheimer-s-disease-cost-cuts-call-for-novel-drugs-development-and-national-strategy.php weekly 0.7 /artkey/csf-201501-0006_use-of-selected-otc-drugs-comparing-greece-and-the-czech-republic.php weekly 0.7 /en/artkey/csf-201501-0006_use-of-selected-otc-drugs-comparing-greece-and-the-czech-republic.php weekly 0.7 /artkey/csf-201501-0001_effectiveness-of-phytotherapy-in-supportive-treatment-of-type-2-diabetes-mellitus-billberry-vaccinium-myrtillu.php weekly 0.7 /en/artkey/csf-201501-0001_effectiveness-of-phytotherapy-in-supportive-treatment-of-type-2-diabetes-mellitus-billberry-vaccinium-myrtillu.php weekly 0.7 /artkey/csf-201501-0002_bioavailability-and-factors-influencing-its-rate.php weekly 0.7 /en/artkey/csf-201501-0002_bioavailability-and-factors-influencing-its-rate.php weekly 0.7 /artkey/csf-201501-0014_zdravotnicke-pom-cky-legislativa-a-regulacia.php weekly 0.7 /en/artkey/csf-201501-0014_zdravotnicke-pom-cky-legislativa-a-regulacia.php weekly 0.7 /artkey/csf-201501-0015_alois-borovansky-farmaceuticky-chemik-par-excellence.php weekly 0.7 /en/artkey/csf-201501-0015_alois-borovansky-farmaceuticky-chemik-par-excellence.php weekly 0.7 /artkey/csf-201501-0016_jedova-stopa.php weekly 0.7 /en/artkey/csf-201501-0016_jedova-stopa.php weekly 0.7 /artkey/csf-201501-0017_antitrombotika-v-klinickej-praxi.php weekly 0.7 /en/artkey/csf-201501-0017_antitrombotika-v-klinickej-praxi.php weekly 0.7 /artkey/csf-201501-0011_k-zivotnemu-jubileu-pani-doc-rndr-zuzany-vitkovej-phd.php weekly 0.7 /en/artkey/csf-201501-0011_k-zivotnemu-jubileu-pani-doc-rndr-zuzany-vitkovej-phd.php weekly 0.7 /artkey/csf-201501-0012_podpora-aktivni-ucasti-jednoho-clena-ceske-farmaceuticke-spolecnosti-na-kongresu-fip-v-d-sseldorfu.php weekly 0.7 /en/artkey/csf-201501-0012_podpora-aktivni-ucasti-jednoho-clena-ceske-farmaceuticke-spolecnosti-na-kongresu-fip-v-d-sseldorfu.php weekly 0.7 /artkey/csf-201501-0013_vyskum-a-vyvoj-liekovych-foriem-v-sucasnosti.php weekly 0.7 /en/artkey/csf-201501-0013_vyskum-a-vyvoj-liekovych-foriem-v-sucasnosti.php weekly 0.7 /artkey/csf-201501-0007_5-postgradual-and-3-postdoctoral-conference-faculty-of-pharmacy-uk.php weekly 0.7 /en/artkey/csf-201501-0007_5-postgradual-and-3-postdoctoral-conference-faculty-of-pharmacy-uk.php weekly 0.7 /artkey/csf-201501-0008_jewish-pharmacists-in-pharmacies-of-interwar-czechoslovakia-and-their-lives-during-world-war-ii.php weekly 0.7 /en/artkey/csf-201501-0008_jewish-pharmacists-in-pharmacies-of-interwar-czechoslovakia-and-their-lives-during-world-war-ii.php weekly 0.7 /artkey/csf-201501-0009_computational-approach-to-search-for-novel-antituberculostics.php weekly 0.7 /en/artkey/csf-201501-0009_computational-approach-to-search-for-novel-antituberculostics.php weekly 0.7 /artkey/csf-201501-0010_alkaloids-from-hydrastidis-canadensis-and-their-cholinesterase-and-prolyl-oligopeptidase-inhibitory.php weekly 0.7 /en/artkey/csf-201501-0010_alkaloids-from-hydrastidis-canadensis-and-their-cholinesterase-and-prolyl-oligopeptidase-inhibitory.php weekly 0.7 /magno/csf/2015/mn3.php weekly 0.7 /en/magno/csf/2015/mn3.php weekly 0.7 /artkey/csf-201503-0003_the-quality-of-life-of-patients-suffering-from-the-osteoporosis.php weekly 0.7 /en/artkey/csf-201503-0003_the-quality-of-life-of-patients-suffering-from-the-osteoporosis.php weekly 0.7 /artkey/csf-201503-0001_enhancing-of-drug-bioavailability-using-liquisolid-system-formulation.php weekly 0.7 /en/artkey/csf-201503-0001_enhancing-of-drug-bioavailability-using-liquisolid-system-formulation.php weekly 0.7 /artkey/csf-201503-0002_effectiveness-of-phytotherapy-in-supportive-treatment-of-type-2-diabetes-mellitus-ii-fenugreek-trigonella-fo.php weekly 0.7 /en/artkey/csf-201503-0002_effectiveness-of-phytotherapy-in-supportive-treatment-of-type-2-diabetes-mellitus-ii-fenugreek-trigonella-fo.php weekly 0.7 /artkey/csf-201503-0008_zlyhanie-farmakoterapie-moznosti-prevencie.php weekly 0.7 /en/artkey/csf-201503-0008_zlyhanie-farmakoterapie-moznosti-prevencie.php weekly 0.7 /artkey/csf-201503-0009_analyticka-chemia.php weekly 0.7 /en/artkey/csf-201503-0009_analyticka-chemia.php weekly 0.7 /artkey/csf-201503-0007_milan-lehky-dev-tdesiatnikom.php weekly 0.7 /en/artkey/csf-201503-0007_milan-lehky-dev-tdesiatnikom.php weekly 0.7 /artkey/csf-201503-0004_pharmaceutical-history-of-the-capuchin-monastery-in-prague-hradcany-part-i-monastic-pharmacy.php weekly 0.7 /en/artkey/csf-201503-0004_pharmaceutical-history-of-the-capuchin-monastery-in-prague-hradcany-part-i-monastic-pharmacy.php weekly 0.7 /artkey/csf-201503-0005_pharmaceutical-history-of-capuchin-monastery-in-prague-hradcan-part-ii-capuchin-balsam-balsamum-capucinorum.php weekly 0.7 /en/artkey/csf-201503-0005_pharmaceutical-history-of-capuchin-monastery-in-prague-hradcan-part-ii-capuchin-balsam-balsamum-capucinorum.php weekly 0.7 /artkey/csf-201503-0006_xxxvii-pracovni-dny-radiofarmaceuticke-sekce-ceske-spolecnosti-nuklearni-mediciny-cls-jep.php weekly 0.7 /en/artkey/csf-201503-0006_xxxvii-pracovni-dny-radiofarmaceuticke-sekce-ceske-spolecnosti-nuklearni-mediciny-cls-jep.php weekly 0.7 /magno/csf/2015/mn4.php weekly 0.7 /en/magno/csf/2015/mn4.php weekly 0.7 /artkey/csf-201504-0004_influence-of-ganoderma-lucidum-curt-fr-p-karst-on-t-cell-mediated-immunity-in-normal-and-immunosuppresse.php weekly 0.7 /en/artkey/csf-201504-0004_influence-of-ganoderma-lucidum-curt-fr-p-karst-on-t-cell-mediated-immunity-in-normal-and-immunosuppresse.php weekly 0.7 /artkey/csf-201504-0005_study-of-local-anaesthetics-part-206-micellization-of-selected-of-quaternary-ammonium-salt-derived-from-hepta.php weekly 0.7 /en/artkey/csf-201504-0005_study-of-local-anaesthetics-part-206-micellization-of-selected-of-quaternary-ammonium-salt-derived-from-hepta.php weekly 0.7 /artkey/csf-201504-0006_medicinal-products-for-human-use-in-veterinary-prescription.php weekly 0.7 /en/artkey/csf-201504-0006_medicinal-products-for-human-use-in-veterinary-prescription.php weekly 0.7 /artkey/csf-201504-0001_determination-of-flavonoids-in-natural-materials-with-hplc.php weekly 0.7 /en/artkey/csf-201504-0001_determination-of-flavonoids-in-natural-materials-with-hplc.php weekly 0.7 /artkey/csf-201504-0002_effectiveness-of-phytotherapy-in-supportive-treatment-of-type-2-diabetes-mellitus-iii-momordica-momordica-ch.php weekly 0.7 /en/artkey/csf-201504-0002_effectiveness-of-phytotherapy-in-supportive-treatment-of-type-2-diabetes-mellitus-iii-momordica-momordica-ch.php weekly 0.7 /artkey/csf-201504-0003_legislative-aspects-of-the-development-of-medical-devices.php weekly 0.7 /en/artkey/csf-201504-0003_legislative-aspects-of-the-development-of-medical-devices.php weekly 0.7 /artkey/csf-201504-0007_uvod-do-vseobecnej-a-klinicky-aplikovanej-biochemie.php weekly 0.7 /en/artkey/csf-201504-0007_uvod-do-vseobecnej-a-klinicky-aplikovanej-biochemie.php weekly 0.7 /artkey/csf-201504-0008_prakticka-apiterapia.php weekly 0.7 /en/artkey/csf-201504-0008_prakticka-apiterapia.php weekly 0.7 /magno/csf/2015/mn5.php weekly 0.7 /en/magno/csf/2015/mn5.php weekly 0.7 /artkey/csf-201505-0002_drugs-and-health-care-expenditure-on-the-aging-population.php weekly 0.7 /en/artkey/csf-201505-0002_drugs-and-health-care-expenditure-on-the-aging-population.php weekly 0.7 /artkey/csf-201505-0003_level-and-factors-influencing-the-patients-satisfaction-with-the-pharmaceutical-care-in-slovakia.php weekly 0.7 /en/artkey/csf-201505-0003_level-and-factors-influencing-the-patients-satisfaction-with-the-pharmaceutical-care-in-slovakia.php weekly 0.7 /artkey/csf-201505-0001_methods-used-in-pharmaceutical-technology-to-increase-bioavailability-of-poorly-soluble-drugs-after-oral-admini.php weekly 0.7 /en/artkey/csf-201505-0001_methods-used-in-pharmaceutical-technology-to-increase-bioavailability-of-poorly-soluble-drugs-after-oral-admini.php weekly 0.7 /artkey/csf-201505-0023_farmakochemie.php weekly 0.7 /en/artkey/csf-201505-0023_farmakochemie.php weekly 0.7 /artkey/csf-201505-0005_drug-bioavailability-increasing-by-formulation-of-liquisolid-systems.php weekly 0.7 /en/artkey/csf-201505-0005_drug-bioavailability-increasing-by-formulation-of-liquisolid-systems.php weekly 0.7 /artkey/csf-201505-0006_hodnoceni-sypnych-a-konsolidacnich-vlastnosti-prasku-ve-farmaceuticke-technologii.php weekly 0.7 /en/artkey/csf-201505-0006_hodnoceni-sypnych-a-konsolidacnich-vlastnosti-prasku-ve-farmaceuticke-technologii.php weekly 0.7 /artkey/csf-201505-0007_evaluation-of-compressibility-of-tableting-mixtures-using-the-compaction-equation.php weekly 0.7 /en/artkey/csf-201505-0007_evaluation-of-compressibility-of-tableting-mixtures-using-the-compaction-equation.php weekly 0.7 /artkey/csf-201505-0008_branched-polyesters-as-mucoadhesive-carriers-of-drugs.php weekly 0.7 /en/artkey/csf-201505-0008_branched-polyesters-as-mucoadhesive-carriers-of-drugs.php weekly 0.7 /artkey/csf-201505-0009_formulacni-aspekty-orodispergovatelnych-tablet.php weekly 0.7 /en/artkey/csf-201505-0009_formulacni-aspekty-orodispergovatelnych-tablet.php weekly 0.7 /artkey/csf-201505-0010_evaluation-of-water-absorption-rate-of-tablets-by-using-an-enslin-neff-device.php weekly 0.7 /en/artkey/csf-201505-0010_evaluation-of-water-absorption-rate-of-tablets-by-using-an-enslin-neff-device.php weekly 0.7 /artkey/csf-201505-0011_evaluation-of-the-influence-of-lubricants-on-the-viscoelastic-properties-of-tablets-using-the-stress-relaxation.php weekly 0.7 /en/artkey/csf-201505-0011_evaluation-of-the-influence-of-lubricants-on-the-viscoelastic-properties-of-tablets-using-the-stress-relaxation.php weekly 0.7 /artkey/csf-201505-0022_prof-rndr-jaroslav-kvetina-drsc-dr-h-c-fcma-85lety.php weekly 0.7 /en/artkey/csf-201505-0022_prof-rndr-jaroslav-kvetina-drsc-dr-h-c-fcma-85lety.php weekly 0.7 /artkey/csf-201505-0004_pracovni-den-sekce-technologie-leku-ceske-farmaceuticke-spolecnosti-cls-jep-pokroky-v-lekovych-formach.php weekly 0.7 /en/artkey/csf-201505-0004_pracovni-den-sekce-technologie-leku-ceske-farmaceuticke-spolecnosti-cls-jep-pokroky-v-lekovych-formach.php weekly 0.7 /artkey/csf-201505-0012_44th-conference-drug-synthesis-and-analysis-part-1-brno-2nd-to-4th-september-2015.php weekly 0.7 /en/artkey/csf-201505-0012_44th-conference-drug-synthesis-and-analysis-part-1-brno-2nd-to-4th-september-2015.php weekly 0.7 /artkey/csf-201505-0013_determination-of-biologically-active-compounds-in-the-fungi-of-the-genus-cordyceps-sinensis-by-hplc-and-nmr.php weekly 0.7 /en/artkey/csf-201505-0013_determination-of-biologically-active-compounds-in-the-fungi-of-the-genus-cordyceps-sinensis-by-hplc-and-nmr.php weekly 0.7 /artkey/csf-201505-0014_determination-of-cmc-of-cationic-tenside-in-aqueous-and-mixed-water-alcohol-solutions.php weekly 0.7 /en/artkey/csf-201505-0014_determination-of-cmc-of-cationic-tenside-in-aqueous-and-mixed-water-alcohol-solutions.php weekly 0.7 /artkey/csf-201505-0015_a-comparison-of-sio2-cu-and-ni-supported-au-nanoparticles-for-selective-glycerol-oxidation-to-acetic-acid.php weekly 0.7 /en/artkey/csf-201505-0015_a-comparison-of-sio2-cu-and-ni-supported-au-nanoparticles-for-selective-glycerol-oxidation-to-acetic-acid.php weekly 0.7 /artkey/csf-201505-0016_determination-of-acid-base-dissociation-constants-of-newly-synthesized-arylethanolamine-derivatives-using-capil.php weekly 0.7 /en/artkey/csf-201505-0016_determination-of-acid-base-dissociation-constants-of-newly-synthesized-arylethanolamine-derivatives-using-capil.php weekly 0.7 /artkey/csf-201505-0017_hplc-method-for-stability-evaluation-of-pharmaceutical-preparations-containing-sodium-picosulfate.php weekly 0.7 /en/artkey/csf-201505-0017_hplc-method-for-stability-evaluation-of-pharmaceutical-preparations-containing-sodium-picosulfate.php weekly 0.7 /artkey/csf-201505-0018_the-use-of-2-6-dichloroquinone-4-chlorimide-for-quantitative-determination-of-phenylephrine-hydrochloride-in-co.php weekly 0.7 /en/artkey/csf-201505-0018_the-use-of-2-6-dichloroquinone-4-chlorimide-for-quantitative-determination-of-phenylephrine-hydrochloride-in-co.php weekly 0.7 /artkey/csf-201505-0019_the-utilization-of-radionuclide-x-ray-spectrometry-in-the-determination-of-elements-in-medicinal-plants-and-med.php weekly 0.7 /en/artkey/csf-201505-0019_the-utilization-of-radionuclide-x-ray-spectrometry-in-the-determination-of-elements-in-medicinal-plants-and-med.php weekly 0.7 /artkey/csf-201505-0020_on-line-hyphenated-capillary-electrophoresis-and-tandem-mass-spectrometry-used-for-the-analysis-of-selected-bio.php weekly 0.7 /en/artkey/csf-201505-0020_on-line-hyphenated-capillary-electrophoresis-and-tandem-mass-spectrometry-used-for-the-analysis-of-selected-bio.php weekly 0.7 /artkey/csf-201505-0021_validation-of-spectrophotometric-methods-of-assaying-metronidazole-in-capsules.php weekly 0.7 /en/artkey/csf-201505-0021_validation-of-spectrophotometric-methods-of-assaying-metronidazole-in-capsules.php weekly 0.7 /magno/csf/2015/mn6.php weekly 0.7 /en/magno/csf/2015/mn6.php weekly 0.7 /artkey/csf-201506-0005_body-surface-area-and-body-weight-of-czech-adult-cancer-population.php weekly 0.7 /en/artkey/csf-201506-0005_body-surface-area-and-body-weight-of-czech-adult-cancer-population.php weekly 0.7 /artkey/csf-201506-0001_antibacterial-activity-of-natural-compounds-essential-oils.php weekly 0.7 /en/artkey/csf-201506-0001_antibacterial-activity-of-natural-compounds-essential-oils.php weekly 0.7 /artkey/csf-201506-0003_cholinergic-system-of-the-heart.php weekly 0.7 /en/artkey/csf-201506-0003_cholinergic-system-of-the-heart.php weekly 0.7 /artkey/csf-201506-0002_organicka-synteza-laboratorny-manual.php weekly 0.7 /en/artkey/csf-201506-0002_organicka-synteza-laboratorny-manual.php weekly 0.7 /artkey/csf-201506-0004_probehl-42-mezinarodni-kongres-k-dejinam-farmacie.php weekly 0.7 /en/artkey/csf-201506-0004_probehl-42-mezinarodni-kongres-k-dejinam-farmacie.php weekly 0.7 /artkey/csf-201506-0021_sympozia-sekce-dejin-farmacie-cfs-v-roce-2015.php weekly 0.7 /en/artkey/csf-201506-0021_sympozia-sekce-dejin-farmacie-cfs-v-roce-2015.php weekly 0.7 /artkey/csf-201506-0006_stable-gold-nanoparticles-synthesis-bioconjugation-and-application.php weekly 0.7 /en/artkey/csf-201506-0006_stable-gold-nanoparticles-synthesis-bioconjugation-and-application.php weekly 0.7 /artkey/csf-201506-0007_determination-of-antigripal-drugs-pheniramine-phenylephrine-in-biological-samples-by-on-line-citp-cze-couple.php weekly 0.7 /en/artkey/csf-201506-0007_determination-of-antigripal-drugs-pheniramine-phenylephrine-in-biological-samples-by-on-line-citp-cze-couple.php weekly 0.7 /artkey/csf-201506-0008_development-of-the-hydrocortisone-butyrate-qualitative-determination-method.php weekly 0.7 /en/artkey/csf-201506-0008_development-of-the-hydrocortisone-butyrate-qualitative-determination-method.php weekly 0.7 /artkey/csf-201506-0009_estimation-of-lipohydrophilic-properties-of-molecules-with-potential-beta-3-agonistic-activity.php weekly 0.7 /en/artkey/csf-201506-0009_estimation-of-lipohydrophilic-properties-of-molecules-with-potential-beta-3-agonistic-activity.php weekly 0.7 /artkey/csf-201506-0010_determination-of-the-colorants-in-vitamin-e-by-hplc-with-photodiode-array-detection.php weekly 0.7 /en/artkey/csf-201506-0010_determination-of-the-colorants-in-vitamin-e-by-hplc-with-photodiode-array-detection.php weekly 0.7 /artkey/csf-201506-0011_analysis-of-flavonoids-in-grape-leaves-by-hplc-dad-ms-ms.php weekly 0.7 /en/artkey/csf-201506-0011_analysis-of-flavonoids-in-grape-leaves-by-hplc-dad-ms-ms.php weekly 0.7 /artkey/csf-201506-0012_antioxidative-protection-of-inactivated-rabies-vaccine-with-squalene-adjuvant-by-beta-carotene.php weekly 0.7 /en/artkey/csf-201506-0012_antioxidative-protection-of-inactivated-rabies-vaccine-with-squalene-adjuvant-by-beta-carotene.php weekly 0.7 /artkey/csf-201506-0013_from-an-old-drug-to-a-new-one-synthesis-of-valproate-from-5-5-dipropylbarbituric-acid.php weekly 0.7 /en/artkey/csf-201506-0013_from-an-old-drug-to-a-new-one-synthesis-of-valproate-from-5-5-dipropylbarbituric-acid.php weekly 0.7 /artkey/csf-201506-0014_synthesis-and-antimicrobial-activity-of-novel-sulfonamide-derivatives.php weekly 0.7 /en/artkey/csf-201506-0014_synthesis-and-antimicrobial-activity-of-novel-sulfonamide-derivatives.php weekly 0.7 /artkey/csf-201506-0015_synthesis-and-antioxidant-activity-of-phenylcarbamic-acid-derivatives-acting-on-the-cardiovascular-system.php weekly 0.7 /en/artkey/csf-201506-0015_synthesis-and-antioxidant-activity-of-phenylcarbamic-acid-derivatives-acting-on-the-cardiovascular-system.php weekly 0.7 /artkey/csf-201506-0016_synthesis-and-biological-activity-of-selected-cinnamic-acid-derivatives.php weekly 0.7 /en/artkey/csf-201506-0016_synthesis-and-biological-activity-of-selected-cinnamic-acid-derivatives.php weekly 0.7 /artkey/csf-201506-0017_synthesis-and-biological-properties-of-chosen-symmetrical-amides-and-thioamides-of-terephthalic-acid.php weekly 0.7 /en/artkey/csf-201506-0017_synthesis-and-biological-properties-of-chosen-symmetrical-amides-and-thioamides-of-terephthalic-acid.php weekly 0.7 /artkey/csf-201506-0018_synthesis-of-quinoline-derivatives-using-a-nano-pd-cu-catalyst-in-the-search-of-new-fluorophores.php weekly 0.7 /en/artkey/csf-201506-0018_synthesis-of-quinoline-derivatives-using-a-nano-pd-cu-catalyst-in-the-search-of-new-fluorophores.php weekly 0.7 /artkey/csf-201506-0019_synthesis-of-triclosan-derivatives-and-their-antimycobacterial-effect.php weekly 0.7 /en/artkey/csf-201506-0019_synthesis-of-triclosan-derivatives-and-their-antimycobacterial-effect.php weekly 0.7 /artkey/csf-201506-0020_the-development-of-a-dental-drug-in-the-form-of-medicated-chewing-gum.php weekly 0.7 /en/artkey/csf-201506-0020_the-development-of-a-dental-drug-in-the-form-of-medicated-chewing-gum.php weekly 0.7 /artkey/csf-201506-0022_autorsky-rejstrik.php weekly 0.7 /en/artkey/csf-201506-0022_autorsky-rejstrik.php weekly 0.7 /magno/csf/2014/mn1.php weekly 0.7 /en/magno/csf/2014/mn1.php weekly 0.7 /artkey/csf-201401-0004_production-of-flavonoids-and-isoflavonoids-in-jasmonic-acid-induced-red-clover-suspension-cultures.php weekly 0.7 /en/artkey/csf-201401-0004_production-of-flavonoids-and-isoflavonoids-in-jasmonic-acid-induced-red-clover-suspension-cultures.php weekly 0.7 /artkey/csf-201401-0005_study-of-local-anaesthetics-part-204-determination-of-critical-micelle-concentrations-of-selected-derivatives.php weekly 0.7 /en/artkey/csf-201401-0005_study-of-local-anaesthetics-part-204-determination-of-critical-micelle-concentrations-of-selected-derivatives.php weekly 0.7 /artkey/csf-201401-0006_inhibition-of-12-15-lipoxygenase-by-curcumin-and-an-extract-from-curcuma-longa-l.php weekly 0.7 /en/artkey/csf-201401-0006_inhibition-of-12-15-lipoxygenase-by-curcumin-and-an-extract-from-curcuma-longa-l.php weekly 0.7 /artkey/csf-201401-0007_identifying-and-solving-drug-related-problems-in-terms-of-the-community-pharmacist.php weekly 0.7 /en/artkey/csf-201401-0007_identifying-and-solving-drug-related-problems-in-terms-of-the-community-pharmacist.php weekly 0.7 /artkey/csf-201401-0008_globalization-and-its-impact-on-pharmacy-services-in-the-slovak-republic.php weekly 0.7 /en/artkey/csf-201401-0008_globalization-and-its-impact-on-pharmacy-services-in-the-slovak-republic.php weekly 0.7 /artkey/csf-201401-0002_separation-of-amino-acid-enantiomers-by-high-performance-liquid-chromatography.php weekly 0.7 /en/artkey/csf-201401-0002_separation-of-amino-acid-enantiomers-by-high-performance-liquid-chromatography.php weekly 0.7 /artkey/csf-201401-0003_where-does-the-development-of-new-antituberculotics-go-part-2-in-vitro-evaluation.php weekly 0.7 /en/artkey/csf-201401-0003_where-does-the-development-of-new-antituberculotics-go-part-2-in-vitro-evaluation.php weekly 0.7 /artkey/csf-201401-0011_nove-knihy.php weekly 0.7 /en/artkey/csf-201401-0011_nove-knihy.php weekly 0.7 /artkey/csf-201401-0009_docent-rndr-pavel-komarek-phd-jubiluje.php weekly 0.7 /en/artkey/csf-201401-0009_docent-rndr-pavel-komarek-phd-jubiluje.php weekly 0.7 /artkey/csf-201401-0010_42-konference-synteza-a-analyza-leciv-byla-opet-uspesna.php weekly 0.7 /en/artkey/csf-201401-0010_42-konference-synteza-a-analyza-leciv-byla-opet-uspesna.php weekly 0.7 /artkey/csf-201401-0001_casopis-ceska-a-slovenska-farmacie-vstupuje-do-roku-2014.php weekly 0.7 /en/artkey/csf-201401-0001_casopis-ceska-a-slovenska-farmacie-vstupuje-do-roku-2014.php weekly 0.7 /magno/csf/2014/mn2.php weekly 0.7 /en/magno/csf/2014/mn2.php weekly 0.7 /artkey/csf-201402-0004_possibilities-of-influencing-the-drug-content-and-encapsulation-efficiency-of-chitosan-microspheres-prepared-by.php weekly 0.7 /en/artkey/csf-201402-0004_possibilities-of-influencing-the-drug-content-and-encapsulation-efficiency-of-chitosan-microspheres-prepared-by.php weekly 0.7 /artkey/csf-201402-0005_medical-and-entrepreneurial-character-of-the-community-pharmacy.php weekly 0.7 /en/artkey/csf-201402-0005_medical-and-entrepreneurial-character-of-the-community-pharmacy.php weekly 0.7 /artkey/csf-201402-0001_selected-natural-phenolic-compounds-potential-treatment-for-peripheral-neuropathy.php weekly 0.7 /en/artkey/csf-201402-0001_selected-natural-phenolic-compounds-potential-treatment-for-peripheral-neuropathy.php weekly 0.7 /artkey/csf-201402-0002_active-pharmaceutical-ingredients-available-as-substances-for-extemporaneous-preparation-in-veterinary-medicine.php weekly 0.7 /en/artkey/csf-201402-0002_active-pharmaceutical-ingredients-available-as-substances-for-extemporaneous-preparation-in-veterinary-medicine.php weekly 0.7 /artkey/csf-201402-0003_41-mezinarodni-kongres-pro-dejiny-farmacie-v-parizi.php weekly 0.7 /en/artkey/csf-201402-0003_41-mezinarodni-kongres-pro-dejiny-farmacie-v-parizi.php weekly 0.7 /artkey/csf-201402-0008_doc-mgr-fils-andriamainty-phd-oceneny-sfs.php weekly 0.7 /en/artkey/csf-201402-0008_doc-mgr-fils-andriamainty-phd-oceneny-sfs.php weekly 0.7 /artkey/csf-201402-0006_history-of-the-development-and-production-of-drugs-in-the-firm-lachema-in-brno.php weekly 0.7 /en/artkey/csf-201402-0006_history-of-the-development-and-production-of-drugs-in-the-firm-lachema-in-brno.php weekly 0.7 /artkey/csf-201402-0007_pracovni-den-sekce-technologie-leku-ceske-farmaceuticke-spolecnosti-cls-jep-pokroky-v-lekovych-formach.php weekly 0.7 /en/artkey/csf-201402-0007_pracovni-den-sekce-technologie-leku-ceske-farmaceuticke-spolecnosti-cls-jep-pokroky-v-lekovych-formach.php weekly 0.7 /magno/csf/2014/mn3.php weekly 0.7 /en/magno/csf/2014/mn3.php weekly 0.7 /artkey/csf-201403-0002_preparation-and-evalution-of-the-oral-gel-containing-the-essential-oil-from-siberian-fir-abies-sibirica-ledeb.php weekly 0.7 /en/artkey/csf-201403-0002_preparation-and-evalution-of-the-oral-gel-containing-the-essential-oil-from-siberian-fir-abies-sibirica-ledeb.php weekly 0.7 /artkey/csf-201403-0004_flavonoids-main-constituents-of-the-leaves-of-philadelphus-tenuifolius-rupr-et-maxim.php weekly 0.7 /en/artkey/csf-201403-0004_flavonoids-main-constituents-of-the-leaves-of-philadelphus-tenuifolius-rupr-et-maxim.php weekly 0.7 /artkey/csf-201403-0005_formulation-of-benzethonium-chloride-into-gels.php weekly 0.7 /en/artkey/csf-201403-0005_formulation-of-benzethonium-chloride-into-gels.php weekly 0.7 /artkey/csf-201403-0007_impact-of-formulation-and-process-parameters-on-the-properties-of-chitosan-based-microspheres-prepared-by-exter.php weekly 0.7 /en/artkey/csf-201403-0007_impact-of-formulation-and-process-parameters-on-the-properties-of-chitosan-based-microspheres-prepared-by-exter.php weekly 0.7 /artkey/csf-201403-0001_advances-in-the-use-of-instrumental-measurement-of-colour-in-the-development-production-and-quality-control-of.php weekly 0.7 /en/artkey/csf-201403-0001_advances-in-the-use-of-instrumental-measurement-of-colour-in-the-development-production-and-quality-control-of.php weekly 0.7 /artkey/csf-201403-0008_lekarne-a-lekarnici-v-okrese-zilina-pred-rokom-1990.php weekly 0.7 /en/artkey/csf-201403-0008_lekarne-a-lekarnici-v-okrese-zilina-pred-rokom-1990.php weekly 0.7 /artkey/csf-201403-0003_hradec-kralove-hostil-mlade-farmaceuticke-chemiky-z-cele-evropy.php weekly 0.7 /en/artkey/csf-201403-0003_hradec-kralove-hostil-mlade-farmaceuticke-chemiky-z-cele-evropy.php weekly 0.7 /artkey/csf-201403-0006_9th-world-meeting-on-pharmaceutics-biopharmaceutics-and-pharmaceutical-technology-pbp-meeting.php weekly 0.7 /en/artkey/csf-201403-0006_9th-world-meeting-on-pharmaceutics-biopharmaceutics-and-pharmaceutical-technology-pbp-meeting.php weekly 0.7 /artkey/csf-201403-0009_alois-jandous-s-czech-pharmacopoeial-terminology-of-1864.php weekly 0.7 /en/artkey/csf-201403-0009_alois-jandous-s-czech-pharmacopoeial-terminology-of-1864.php weekly 0.7 /artkey/csf-201403-0010_rationalization-in-20th-century-czechoslovak-pharmacy-practice-commission-for-rationalization-and-standardiza.php weekly 0.7 /en/artkey/csf-201403-0010_rationalization-in-20th-century-czechoslovak-pharmacy-practice-commission-for-rationalization-and-standardiza.php weekly 0.7 /magno/csf/2014/mn4.php weekly 0.7 /en/magno/csf/2014/mn4.php weekly 0.7 /artkey/csf-201404-0003_studies-of-local-anaesthetics-part-205-studies-of-stability-of-heptacainium-chloride-and-carbisocainium-chlor.php weekly 0.7 /en/artkey/csf-201404-0003_studies-of-local-anaesthetics-part-205-studies-of-stability-of-heptacainium-chloride-and-carbisocainium-chlor.php weekly 0.7 /artkey/csf-201404-0004_in-vivo-testing-of-new-ultrashort-acting-beta-blockers-with-the-effect-on-systolic-blood-pressure-and-heart-r.php weekly 0.7 /en/artkey/csf-201404-0004_in-vivo-testing-of-new-ultrashort-acting-beta-blockers-with-the-effect-on-systolic-blood-pressure-and-heart-r.php weekly 0.7 /artkey/csf-201404-0005_prick-of-conscience-in-the-pharmaceutical-profession.php weekly 0.7 /en/artkey/csf-201404-0005_prick-of-conscience-in-the-pharmaceutical-profession.php weekly 0.7 /artkey/csf-201404-0002_metabolic-syndrome-dysregulation-of-adipose-tissue-endocrine-function.php weekly 0.7 /en/artkey/csf-201404-0002_metabolic-syndrome-dysregulation-of-adipose-tissue-endocrine-function.php weekly 0.7 /artkey/csf-201404-0008_intoxikacie-hubami-rastlinami-a-zivocisnymi-toxinmi-extrakcne-metody-vo-farmaceutickej-technologii.php weekly 0.7 /en/artkey/csf-201404-0008_intoxikacie-hubami-rastlinami-a-zivocisnymi-toxinmi-extrakcne-metody-vo-farmaceutickej-technologii.php weekly 0.7 /artkey/csf-201404-0006_rationalization-in-20th-century-czechoslovak-pharmacy-practice-commission-for-rationalization-and-standardiza.php weekly 0.7 /en/artkey/csf-201404-0006_rationalization-in-20th-century-czechoslovak-pharmacy-practice-commission-for-rationalization-and-standardiza.php weekly 0.7 /artkey/csf-201404-0001_zmeny-v-redakci-casopisu-ceska-a-slovenska-farmacie.php weekly 0.7 /en/artkey/csf-201404-0001_zmeny-v-redakci-casopisu-ceska-a-slovenska-farmacie.php weekly 0.7 /artkey/csf-201404-0007_xxxvi-pracovni-dny-radiofarmaceuticke-sekce-ceske-spolecnosti-nuklearni-mediciny-cls-jep.php weekly 0.7 /en/artkey/csf-201404-0007_xxxvi-pracovni-dny-radiofarmaceuticke-sekce-ceske-spolecnosti-nuklearni-mediciny-cls-jep.php weekly 0.7 /magno/csf/2014/mn5.php weekly 0.7 /en/magno/csf/2014/mn5.php weekly 0.7 /artkey/csf-201405-0002_formulation-of-cores-for-the-controlled-release-of-glucose-for-prevention-of-hypoglycemia-in-diabetes-patients.php weekly 0.7 /en/artkey/csf-201405-0002_formulation-of-cores-for-the-controlled-release-of-glucose-for-prevention-of-hypoglycemia-in-diabetes-patients.php weekly 0.7 /artkey/csf-201405-0003_preparation-of-feed-premix-for-veterinary-purposes.php weekly 0.7 /en/artkey/csf-201405-0003_preparation-of-feed-premix-for-veterinary-purposes.php weekly 0.7 /artkey/csf-201405-0004_optimization-of-technological-processes-for-the-preparation-of-tablets-with-a-low-content-of-warfarin-by-direct.php weekly 0.7 /en/artkey/csf-201405-0004_optimization-of-technological-processes-for-the-preparation-of-tablets-with-a-low-content-of-warfarin-by-direct.php weekly 0.7 /artkey/csf-201405-0005_continuing-life-long-education-of-pharmacists-in-the-czech-republic-4th-cycle-2008-2011.php weekly 0.7 /en/artkey/csf-201405-0005_continuing-life-long-education-of-pharmacists-in-the-czech-republic-4th-cycle-2008-2011.php weekly 0.7 /artkey/csf-201405-0001_lyophilisation-of-protein-based-drugs.php weekly 0.7 /en/artkey/csf-201405-0001_lyophilisation-of-protein-based-drugs.php weekly 0.7 /artkey/csf-201405-0007_zomrel-doc-ing-ivan-lacko.php weekly 0.7 /en/artkey/csf-201405-0007_zomrel-doc-ing-ivan-lacko.php weekly 0.7 /artkey/csf-201405-0008_ix-zjazd-slovenskej-farmaceutickej-spolocnosti.php weekly 0.7 /en/artkey/csf-201405-0008_ix-zjazd-slovenskej-farmaceutickej-spolocnosti.php weekly 0.7 /artkey/csf-201405-0006_history-of-diabetes-treatment-in-czechoslovakia-prior-to-1989.php weekly 0.7 /en/artkey/csf-201405-0006_history-of-diabetes-treatment-in-czechoslovakia-prior-to-1989.php weekly 0.7 /magno/csf/2014/mn6.php weekly 0.7 /en/magno/csf/2014/mn6.php weekly 0.7 /artkey/csf-201406-0003_clinical-trials-in-the-european-union-and-the-czech-republic-in-the-years-2006-2009-and-2012.php weekly 0.7 /en/artkey/csf-201406-0003_clinical-trials-in-the-european-union-and-the-czech-republic-in-the-years-2006-2009-and-2012.php weekly 0.7 /artkey/csf-201406-0004_examples-of-off-label-use-of-human-medicinal-preparations-in-veterinary-medicine.php weekly 0.7 /en/artkey/csf-201406-0004_examples-of-off-label-use-of-human-medicinal-preparations-in-veterinary-medicine.php weekly 0.7 /artkey/csf-201406-0005_influence-of-excipients-on-caffeine-permeation-from-gels.php weekly 0.7 /en/artkey/csf-201406-0005_influence-of-excipients-on-caffeine-permeation-from-gels.php weekly 0.7 /artkey/csf-201406-0001_nanoparticulates-with-drug-release-based-on-temperature-change.php weekly 0.7 /en/artkey/csf-201406-0001_nanoparticulates-with-drug-release-based-on-temperature-change.php weekly 0.7 /artkey/csf-201406-0002_an-overview-of-urease-and-its-relation-to-the-ureolytic-bacteria-and-the-search-for-new-urease-inhibitors.php weekly 0.7 /en/artkey/csf-201406-0002_an-overview-of-urease-and-its-relation-to-the-ureolytic-bacteria-and-the-search-for-new-urease-inhibitors.php weekly 0.7 /artkey/csf-201406-0007_doc-rndr-milan-rehula-csc-4-ledna-1950-dagger-27-listopadu-2014.php weekly 0.7 /en/artkey/csf-201406-0007_doc-rndr-milan-rehula-csc-4-ledna-1950-dagger-27-listopadu-2014.php weekly 0.7 /artkey/csf-201406-0006_vysledky-voleb-do-vyboru-a-sekci-ceske-farmaceuticke-spolecnosti-cls-jep-pro-obdobi-2015-2018.php weekly 0.7 /en/artkey/csf-201406-0006_vysledky-voleb-do-vyboru-a-sekci-ceske-farmaceuticke-spolecnosti-cls-jep-pro-obdobi-2015-2018.php weekly 0.7 /artkey/csf-201406-0008_autorsky-rejstrik.php weekly 0.7 /en/artkey/csf-201406-0008_autorsky-rejstrik.php weekly 0.7 /artkey/csf-201406-0009_vecny-rejstrik.php weekly 0.7 /en/artkey/csf-201406-0009_vecny-rejstrik.php weekly 0.7 /magno/csf/2013/mn1.php weekly 0.7 /en/magno/csf/2013/mn1.php weekly 0.7 /artkey/csf-201301-0005_design-and-development-of-diltiazem-hydrochloride-transmucosal-drug-delivery-system.php weekly 0.7 /en/artkey/csf-201301-0005_design-and-development-of-diltiazem-hydrochloride-transmucosal-drug-delivery-system.php weekly 0.7 /artkey/csf-201301-0006_diclofenac-sodium-entrapment-and-release-from-halloysite-nanotubules.php weekly 0.7 /en/artkey/csf-201301-0006_diclofenac-sodium-entrapment-and-release-from-halloysite-nanotubules.php weekly 0.7 /artkey/csf-201301-0007_pediatric-oral-solutions-with-propranolol-hydrochloride-for-extemporaneous-compounding-the-formulation-and-sta.php weekly 0.7 /en/artkey/csf-201301-0007_pediatric-oral-solutions-with-propranolol-hydrochloride-for-extemporaneous-compounding-the-formulation-and-sta.php weekly 0.7 /artkey/csf-201301-0008_testing-of-the-potentially-probiotic-lactobacilli-for-use-in-food-supplements.php weekly 0.7 /en/artkey/csf-201301-0008_testing-of-the-potentially-probiotic-lactobacilli-for-use-in-food-supplements.php weekly 0.7 /artkey/csf-201301-0002_mucoadhesive-films-as-perspective-oral-dosage-form.php weekly 0.7 /en/artkey/csf-201301-0002_mucoadhesive-films-as-perspective-oral-dosage-form.php weekly 0.7 /artkey/csf-201301-0003_oral-mucosa-and-therapy-of-recurrent-aphthous-stomatitis.php weekly 0.7 /en/artkey/csf-201301-0003_oral-mucosa-and-therapy-of-recurrent-aphthous-stomatitis.php weekly 0.7 /artkey/csf-201301-0004_55-rokov-katedry-farmaceutickej-chemie-faf-uk-v-bratislave.php weekly 0.7 /en/artkey/csf-201301-0004_55-rokov-katedry-farmaceutickej-chemie-faf-uk-v-bratislave.php weekly 0.7 /artkey/csf-201301-0009_za-rndr-phmr-zdenkem-hanzlickem.php weekly 0.7 /en/artkey/csf-201301-0009_za-rndr-phmr-zdenkem-hanzlickem.php weekly 0.7 /artkey/csf-201301-0010_organization-and-management-of-nationalized-pharmaceutical-industry-in-slovakia-from-1945-to-1948.php weekly 0.7 /en/artkey/csf-201301-0010_organization-and-management-of-nationalized-pharmaceutical-industry-in-slovakia-from-1945-to-1948.php weekly 0.7 /artkey/csf-201301-0001_ceska-a-slovenska-farmacie-62-rocnik.php weekly 0.7 /en/artkey/csf-201301-0001_ceska-a-slovenska-farmacie-62-rocnik.php weekly 0.7 /artkey/csf-201301-0012_pracovni-den-sekce-technologie-leku-ceske-farmaceuticke-spolecnosti-cls-jep.php weekly 0.7 /en/artkey/csf-201301-0012_pracovni-den-sekce-technologie-leku-ceske-farmaceuticke-spolecnosti-cls-jep.php weekly 0.7 /artkey/csf-201301-0011_erratum.php weekly 0.7 /en/artkey/csf-201301-0011_erratum.php weekly 0.7 /magno/csf/2013/mn2.php weekly 0.7 /en/magno/csf/2013/mn2.php weekly 0.7 /artkey/csf-201302-0003_optimization-of-diclofenac-sodium-profile-from-halloysite-nanotubules.php weekly 0.7 /en/artkey/csf-201302-0003_optimization-of-diclofenac-sodium-profile-from-halloysite-nanotubules.php weekly 0.7 /artkey/csf-201302-0004_thiosemicarbazones-and-their-antimycobacterial-effects.php weekly 0.7 /en/artkey/csf-201302-0004_thiosemicarbazones-and-their-antimycobacterial-effects.php weekly 0.7 /artkey/csf-201302-0005_aminopyrazinoic-acid-esters-as-potential-antimycobacterial-drugs.php weekly 0.7 /en/artkey/csf-201302-0005_aminopyrazinoic-acid-esters-as-potential-antimycobacterial-drugs.php weekly 0.7 /artkey/csf-201302-0006_influence-of-the-degree-of-substitution-on-the-absorptivity-of-acidic-carboxymethyl-cellulose-in-the-form-of-no.php weekly 0.7 /en/artkey/csf-201302-0006_influence-of-the-degree-of-substitution-on-the-absorptivity-of-acidic-carboxymethyl-cellulose-in-the-form-of-no.php weekly 0.7 /artkey/csf-201302-0007_evaluation-of-the-influence-of-sterilization-method-on-the-stability-of-carboxymethyl-cellulose-wound-dressing.php weekly 0.7 /en/artkey/csf-201302-0007_evaluation-of-the-influence-of-sterilization-method-on-the-stability-of-carboxymethyl-cellulose-wound-dressing.php weekly 0.7 /artkey/csf-201302-0001_physiological-aspects-of-lipoxygenase-in-plant-signaling-systems-part-i-octadecanoid-pathway.php weekly 0.7 /en/artkey/csf-201302-0001_physiological-aspects-of-lipoxygenase-in-plant-signaling-systems-part-i-octadecanoid-pathway.php weekly 0.7 /artkey/csf-201302-0002_advances-in-the-use-of-instrumental-measurement-of-colour-in-the-development-production-and-quality-control-of.php weekly 0.7 /en/artkey/csf-201302-0002_advances-in-the-use-of-instrumental-measurement-of-colour-in-the-development-production-and-quality-control-of.php weekly 0.7 /artkey/csf-201302-0011_fytoterapia-v-sucasnej-medicine.php weekly 0.7 /en/artkey/csf-201302-0011_fytoterapia-v-sucasnej-medicine.php weekly 0.7 /artkey/csf-201302-0009_dr-h-c-prof-rndr-jozef-cizmarik-phd-sedemdesiatnik.php weekly 0.7 /en/artkey/csf-201302-0009_dr-h-c-prof-rndr-jozef-cizmarik-phd-sedemdesiatnik.php weekly 0.7 /artkey/csf-201302-0010_rndr-phmr-stefan-marecek-20-7-1920-dagger-28-1-2013.php weekly 0.7 /en/artkey/csf-201302-0010_rndr-phmr-stefan-marecek-20-7-1920-dagger-28-1-2013.php weekly 0.7 /artkey/csf-201302-0008_prolegomenon-of-the-czech-pharmacognosy-21st-century.php weekly 0.7 /en/artkey/csf-201302-0008_prolegomenon-of-the-czech-pharmacognosy-21st-century.php weekly 0.7 /magno/csf/2013/mn3.php weekly 0.7 /en/magno/csf/2013/mn3.php weekly 0.7 /artkey/csf-201303-0002_influence-of-formulation-and-process-parameters-on-the-characteristics-of-plga-based-microparticles-with-contro.php weekly 0.7 /en/artkey/csf-201303-0002_influence-of-formulation-and-process-parameters-on-the-characteristics-of-plga-based-microparticles-with-contro.php weekly 0.7 /artkey/csf-201303-0003_a-study-of-a-new-co-processed-dry-binder-based-on-spray-dried-lactose-and-microcrystalline-cellulose.php weekly 0.7 /en/artkey/csf-201303-0003_a-study-of-a-new-co-processed-dry-binder-based-on-spray-dried-lactose-and-microcrystalline-cellulose.php weekly 0.7 /artkey/csf-201303-0004_study-of-local-anaesthetics-part-201-determination-of-the-critical-micellar-concentration-of-pentacaine-hydro.php weekly 0.7 /en/artkey/csf-201303-0004_study-of-local-anaesthetics-part-201-determination-of-the-critical-micellar-concentration-of-pentacaine-hydro.php weekly 0.7 /artkey/csf-201303-0005_hplc-determination-of-saccharides-after-pre-column-derivatization-in-honey-samples.php weekly 0.7 /en/artkey/csf-201303-0005_hplc-determination-of-saccharides-after-pre-column-derivatization-in-honey-samples.php weekly 0.7 /artkey/csf-201303-0006_use-of-human-medicinal-preparations-in-veterinary-medicine.php weekly 0.7 /en/artkey/csf-201303-0006_use-of-human-medicinal-preparations-in-veterinary-medicine.php weekly 0.7 /artkey/csf-201303-0007_analysis-of-the-consumption-of-sedative-and-hypnotic-drugs-in-yemen-and-the-czech-republic.php weekly 0.7 /en/artkey/csf-201303-0007_analysis-of-the-consumption-of-sedative-and-hypnotic-drugs-in-yemen-and-the-czech-republic.php weekly 0.7 /artkey/csf-201303-0001_warfarin-its-synthesis-and-properties-in-a-twenty-year-retrospective.php weekly 0.7 /en/artkey/csf-201303-0001_warfarin-its-synthesis-and-properties-in-a-twenty-year-retrospective.php weekly 0.7 /artkey/csf-201303-0010_nove-knihy.php weekly 0.7 /en/artkey/csf-201303-0010_nove-knihy.php weekly 0.7 /artkey/csf-201303-0008_prof-rndr-milan-melnik-drsc-75-rocny.php weekly 0.7 /en/artkey/csf-201303-0008_prof-rndr-milan-melnik-drsc-75-rocny.php weekly 0.7 /artkey/csf-201303-0009_statne-vyznamenanie-dr-h-c-prof-rndr-jozefovi-cizmarikovi-phd.php weekly 0.7 /en/artkey/csf-201303-0009_statne-vyznamenanie-dr-h-c-prof-rndr-jozefovi-cizmarikovi-phd.php weekly 0.7 /magno/csf/2013/mn4.php weekly 0.7 /en/magno/csf/2013/mn4.php weekly 0.7 /artkey/csf-201304-0001_rare-diseases-in-italy-analysis-of-the-costs-and-pharmacotherapy.php weekly 0.7 /en/artkey/csf-201304-0001_rare-diseases-in-italy-analysis-of-the-costs-and-pharmacotherapy.php weekly 0.7 /artkey/csf-201304-0002_development-of-financial-participation-of-patients-in-the-costs-of-pharmacotherapy-in-the-years-2008-2012.php weekly 0.7 /en/artkey/csf-201304-0002_development-of-financial-participation-of-patients-in-the-costs-of-pharmacotherapy-in-the-years-2008-2012.php weekly 0.7 /artkey/csf-201304-0003_effect-of-abiotic-elicitation-on-the-sanguinarine-production-and-polyphenol-oxidase-activity-in-the-suspension.php weekly 0.7 /en/artkey/csf-201304-0003_effect-of-abiotic-elicitation-on-the-sanguinarine-production-and-polyphenol-oxidase-activity-in-the-suspension.php weekly 0.7 /artkey/csf-201304-0004_antioxidant-activity-of-extracts-and-hplc-analysis-of-flavonoids-from-capella-bursa-pastoris-l-medik.php weekly 0.7 /en/artkey/csf-201304-0004_antioxidant-activity-of-extracts-and-hplc-analysis-of-flavonoids-from-capella-bursa-pastoris-l-medik.php weekly 0.7 /artkey/csf-201304-0005_content-uniformity-of-warfarin-containing-mixtures-and-tablets.php weekly 0.7 /en/artkey/csf-201304-0005_content-uniformity-of-warfarin-containing-mixtures-and-tablets.php weekly 0.7 /artkey/csf-201304-0010_nove-knihy.php weekly 0.7 /en/artkey/csf-201304-0010_nove-knihy.php weekly 0.7 /artkey/csf-201304-0008_prof-rndr-udovit-krasnec-100-vyrocie-narodenia.php weekly 0.7 /en/artkey/csf-201304-0008_prof-rndr-udovit-krasnec-100-vyrocie-narodenia.php weekly 0.7 /artkey/csf-201304-0009_prof-ing-jozef-lehotay-drsc-sedemdesiatnik.php weekly 0.7 /en/artkey/csf-201304-0009_prof-ing-jozef-lehotay-drsc-sedemdesiatnik.php weekly 0.7 /artkey/csf-201304-0006_drugs-of-a-baroque-monastery-pharmacy.php weekly 0.7 /en/artkey/csf-201304-0006_drugs-of-a-baroque-monastery-pharmacy.php weekly 0.7 /artkey/csf-201304-0007_xxxv-pracovni-dny-radiofarmaceuticke-sekce-ceske-spolecnosti-nuklearni-mediciny-cls-jep.php weekly 0.7 /en/artkey/csf-201304-0007_xxxv-pracovni-dny-radiofarmaceuticke-sekce-ceske-spolecnosti-nuklearni-mediciny-cls-jep.php weekly 0.7 /magno/csf/2013/mn5.php weekly 0.7 /en/magno/csf/2013/mn5.php weekly 0.7 /artkey/csf-201305-0002_a-combination-of-grapefruit-seed-extract-and-concentrated-cranberry-juice-as-a-potential-antimicrobial-preserva.php weekly 0.7 /en/artkey/csf-201305-0002_a-combination-of-grapefruit-seed-extract-and-concentrated-cranberry-juice-as-a-potential-antimicrobial-preserva.php weekly 0.7 /artkey/csf-201305-0003_evaluation-of-liberation-of-caffeine-from-dermal-semisolids-drugs.php weekly 0.7 /en/artkey/csf-201305-0003_evaluation-of-liberation-of-caffeine-from-dermal-semisolids-drugs.php weekly 0.7 /artkey/csf-201305-0004_influence-of-temperature-and-concentration-of-a-surfactant-on-pharmaceutical-availability.php weekly 0.7 /en/artkey/csf-201305-0004_influence-of-temperature-and-concentration-of-a-surfactant-on-pharmaceutical-availability.php weekly 0.7 /artkey/csf-201305-0005_perception-of-body-weight-by-pharmacists-and-pharmaceutical-laboratory-assistants-in-slovakia-i.php weekly 0.7 /en/artkey/csf-201305-0005_perception-of-body-weight-by-pharmacists-and-pharmaceutical-laboratory-assistants-in-slovakia-i.php weekly 0.7 /artkey/csf-201305-0006_perception-of-body-weight-by-pharmacists-and-pharmaceutical-laboratory-assistants-in-slovakia-ii.php weekly 0.7 /en/artkey/csf-201305-0006_perception-of-body-weight-by-pharmacists-and-pharmaceutical-laboratory-assistants-in-slovakia-ii.php weekly 0.7 /artkey/csf-201305-0001_standard-prescriptions-for-extemporaneously-produced-medicinal-preparations-in-pharmacies-vi-collection-neues.php weekly 0.7 /en/artkey/csf-201305-0001_standard-prescriptions-for-extemporaneously-produced-medicinal-preparations-in-pharmacies-vi-collection-neues.php weekly 0.7 /artkey/csf-201305-0008_prof-ing-milan-remko-drsc-cchem-frsc-65-rocny.php weekly 0.7 /en/artkey/csf-201305-0008_prof-ing-milan-remko-drsc-cchem-frsc-65-rocny.php weekly 0.7 /artkey/csf-201305-0007_pracovni-den-u-prilezitosti-zivotniho-jubilea-prof-jana-solicha-a-doc-vaclava-ruska.php weekly 0.7 /en/artkey/csf-201305-0007_pracovni-den-u-prilezitosti-zivotniho-jubilea-prof-jana-solicha-a-doc-vaclava-ruska.php weekly 0.7 /magno/csf/2013/mn6.php weekly 0.7 /en/magno/csf/2013/mn6.php weekly 0.7 /artkey/csf-201306-0002_cationic-eudragit-reg-polymers-as-excipients-for-microparticles-prepared-by-solvent-evaporation-method.php weekly 0.7 /en/artkey/csf-201306-0002_cationic-eudragit-reg-polymers-as-excipients-for-microparticles-prepared-by-solvent-evaporation-method.php weekly 0.7 /artkey/csf-201306-0004_influence-of-quaternary-ammonium-salt-on-liberation-of-drug-with-antiseptic-effect.php weekly 0.7 /en/artkey/csf-201306-0004_influence-of-quaternary-ammonium-salt-on-liberation-of-drug-with-antiseptic-effect.php weekly 0.7 /artkey/csf-201306-0005_monitoring-of-formation-of-diclofenac-sodium-salt-hydrates-and-their-influence-on-the-drug-dissolution-from-pre.php weekly 0.7 /en/artkey/csf-201306-0005_monitoring-of-formation-of-diclofenac-sodium-salt-hydrates-and-their-influence-on-the-drug-dissolution-from-pre.php weekly 0.7 /artkey/csf-201306-0007_alkalimetric-titrations-of-salts-of-organic-bases-in-the-pharmacopoeia.php weekly 0.7 /en/artkey/csf-201306-0007_alkalimetric-titrations-of-salts-of-organic-bases-in-the-pharmacopoeia.php weekly 0.7 /artkey/csf-201306-0008_determination-of-varenicline-in-the-preparation-champix-reg-with-the-use-of-two-dimensional-capillary-electrop.php weekly 0.7 /en/artkey/csf-201306-0008_determination-of-varenicline-in-the-preparation-champix-reg-with-the-use-of-two-dimensional-capillary-electrop.php weekly 0.7 /artkey/csf-201306-0009_a-view-on-providing-care-in-the-field-of-medicines-in-slovakia-the-pharmacist-and-the-patient.php weekly 0.7 /en/artkey/csf-201306-0009_a-view-on-providing-care-in-the-field-of-medicines-in-slovakia-the-pharmacist-and-the-patient.php weekly 0.7 /artkey/csf-201306-0001_physiological-factors-with-impact-on-the-drug-behaviour-in-the-gastrointestinal-tract.php weekly 0.7 /en/artkey/csf-201306-0001_physiological-factors-with-impact-on-the-drug-behaviour-in-the-gastrointestinal-tract.php weekly 0.7 /artkey/csf-201306-0003_nove-knihy.php weekly 0.7 /en/artkey/csf-201306-0003_nove-knihy.php weekly 0.7 /artkey/csf-201306-0006_k-zivotnimu-jubileu-doc-rndr-phmr-milana-celadnika-csc.php weekly 0.7 /en/artkey/csf-201306-0006_k-zivotnimu-jubileu-doc-rndr-phmr-milana-celadnika-csc.php weekly 0.7 /artkey/csf-201306-0011_42-sympozium-klinicke-farmacie.php weekly 0.7 /en/artkey/csf-201306-0011_42-sympozium-klinicke-farmacie.php weekly 0.7 /artkey/csf-201306-0012_padesat-let-seminaru-a-sympozii-z-dejin-farmacie.php weekly 0.7 /en/artkey/csf-201306-0012_padesat-let-seminaru-a-sympozii-z-dejin-farmacie.php weekly 0.7 /artkey/csf-201306-0010_a-chapter-from-the-history-of-the-pharmacy-of-the-brothers-of-mercy-in-spisske-podhradi-in-the-19th-and-20th-ce.php weekly 0.7 /en/artkey/csf-201306-0010_a-chapter-from-the-history-of-the-pharmacy-of-the-brothers-of-mercy-in-spisske-podhradi-in-the-19th-and-20th-ce.php weekly 0.7 /artkey/csf-201306-0013_rejstriky.php weekly 0.7 /en/artkey/csf-201306-0013_rejstriky.php weekly 0.7 /magno/csf/2012/mn1.php weekly 0.7 /en/magno/csf/2012/mn1.php weekly 0.7 /artkey/csf-201201-0006_stability-testing-of-alginate-chitosan-films.php weekly 0.7 /en/artkey/csf-201201-0006_stability-testing-of-alginate-chitosan-films.php weekly 0.7 /artkey/csf-201201-0007_compatibility-of-phosphates-with-calcium-salts-in-parenteral-nutrition.php weekly 0.7 /en/artkey/csf-201201-0007_compatibility-of-phosphates-with-calcium-salts-in-parenteral-nutrition.php weekly 0.7 /artkey/csf-201201-0009_monitoring-of-effectiveness-of-some-preventive-measures-against-influenza.php weekly 0.7 /en/artkey/csf-201201-0009_monitoring-of-effectiveness-of-some-preventive-measures-against-influenza.php weekly 0.7 /artkey/csf-201201-0010_analytical-profile-of-mono-3-4-2-ethoxyethoxy-benzoyloxy-2-hydroxypropyl-tert-butylammonium-fumarate.php weekly 0.7 /en/artkey/csf-201201-0010_analytical-profile-of-mono-3-4-2-ethoxyethoxy-benzoyloxy-2-hydroxypropyl-tert-butylammonium-fumarate.php weekly 0.7 /artkey/csf-201201-0012_identification-of-lipoxygenase-expressing-omega-6-dioxygenase-activity-by-means-of-liquid-chromatography.php weekly 0.7 /en/artkey/csf-201201-0012_identification-of-lipoxygenase-expressing-omega-6-dioxygenase-activity-by-means-of-liquid-chromatography.php weekly 0.7 /artkey/csf-201201-0002_intended-pharmacotherapeutical-approaches-of-alzheimer-s-disease-therapy.php weekly 0.7 /en/artkey/csf-201201-0002_intended-pharmacotherapeutical-approaches-of-alzheimer-s-disease-therapy.php weekly 0.7 /artkey/csf-201201-0003_the-possibilities-of-innovation-of-extemporaneous-preparation-in-pharmacies-in-the-czech-republic.php weekly 0.7 /en/artkey/csf-201201-0003_the-possibilities-of-innovation-of-extemporaneous-preparation-in-pharmacies-in-the-czech-republic.php weekly 0.7 /artkey/csf-201201-0004_derivatives-of-phenylcarbamic-acid-as-potential-antituberculotics.php weekly 0.7 /en/artkey/csf-201201-0004_derivatives-of-phenylcarbamic-acid-as-potential-antituberculotics.php weekly 0.7 /artkey/csf-201201-0005_metabolomics-in-research-of-phytotherapeutics.php weekly 0.7 /en/artkey/csf-201201-0005_metabolomics-in-research-of-phytotherapeutics.php weekly 0.7 /artkey/csf-201201-0008_nove-knihy.php weekly 0.7 /en/artkey/csf-201201-0008_nove-knihy.php weekly 0.7 /artkey/csf-201201-0011_nove-knihy.php weekly 0.7 /en/artkey/csf-201201-0011_nove-knihy.php weekly 0.7 /artkey/csf-201201-0015_zpravy.php weekly 0.7 /en/artkey/csf-201201-0015_zpravy.php weekly 0.7 /artkey/csf-201201-0001_casopis-ceska-a-slovenska-farmacie-pri-vstupu-do-roku-2012.php weekly 0.7 /en/artkey/csf-201201-0001_casopis-ceska-a-slovenska-farmacie-pri-vstupu-do-roku-2012.php weekly 0.7 /artkey/csf-201201-0016_40-mezinarodni-kongres-pro-dejiny-farmacie.php weekly 0.7 /en/artkey/csf-201201-0016_40-mezinarodni-kongres-pro-dejiny-farmacie.php weekly 0.7 /artkey/csf-201201-0013_study-of-local-anaesthetics-part-196-formulation-of-the-local-anaesthetic-heptacaine-into-hydrogel-on-the-ba.php weekly 0.7 /en/artkey/csf-201201-0013_study-of-local-anaesthetics-part-196-formulation-of-the-local-anaesthetic-heptacaine-into-hydrogel-on-the-ba.php weekly 0.7 /artkey/csf-201201-0014_pracovni-den-sekce-technologie-leku-ceske-farmaceuticke-spolecnosti-cls-jep-pokroky-v-lekovych-formach.php weekly 0.7 /en/artkey/csf-201201-0014_pracovni-den-sekce-technologie-leku-ceske-farmaceuticke-spolecnosti-cls-jep-pokroky-v-lekovych-formach.php weekly 0.7 /magno/csf/2012/mn3.php weekly 0.7 /en/magno/csf/2012/mn3.php weekly 0.7 /artkey/csf-201203-0001_molecularly-imprinted-polymers.php weekly 0.7 /en/artkey/csf-201203-0001_molecularly-imprinted-polymers.php weekly 0.7 /artkey/csf-201203-0002_hot-melt-extrusion.php weekly 0.7 /en/artkey/csf-201203-0002_hot-melt-extrusion.php weekly 0.7 /artkey/csf-201203-0003_gamma-secretase-inhibitors-in-alzheimer-s-disease-therapy.php weekly 0.7 /en/artkey/csf-201203-0003_gamma-secretase-inhibitors-in-alzheimer-s-disease-therapy.php weekly 0.7 /artkey/csf-201203-0005_modulation-of-leukotriene-pathway-potential-targets.php weekly 0.7 /en/artkey/csf-201203-0005_modulation-of-leukotriene-pathway-potential-targets.php weekly 0.7 /artkey/csf-201203-0006_microbial-secondary-metabolites-as-inhibitors-of-pharmaceutically-important-transferases-and-oxidoreductases.php weekly 0.7 /en/artkey/csf-201203-0006_microbial-secondary-metabolites-as-inhibitors-of-pharmaceutically-important-transferases-and-oxidoreductases.php weekly 0.7 /artkey/csf-201203-0007_phenotyping-of-enzymes-participating-in-drug-metabolism.php weekly 0.7 /en/artkey/csf-201203-0007_phenotyping-of-enzymes-participating-in-drug-metabolism.php weekly 0.7 /artkey/csf-201203-0008_solutio-2011.php weekly 0.7 /en/artkey/csf-201203-0008_solutio-2011.php weekly 0.7 /artkey/csf-201203-0011_prof-rndr-j-cizmarik-phd-doctor-honoris-causa.php weekly 0.7 /en/artkey/csf-201203-0011_prof-rndr-j-cizmarik-phd-doctor-honoris-causa.php weekly 0.7 /artkey/csf-201203-0012_doc-rndr-ingrid-tumova-csc-jubiluje.php weekly 0.7 /en/artkey/csf-201203-0012_doc-rndr-ingrid-tumova-csc-jubiluje.php weekly 0.7 /artkey/csf-201203-0013_zivotne-jubileum-docenta-rndr-jozefa-sokolika-csc.php weekly 0.7 /en/artkey/csf-201203-0013_zivotne-jubileum-docenta-rndr-jozefa-sokolika-csc.php weekly 0.7 /artkey/csf-201203-0004_pod-ochranou-sv-dymphny-liv-sympozium-z-historie-farmacie-a-veterinarni-mediciny.php weekly 0.7 /en/artkey/csf-201203-0004_pod-ochranou-sv-dymphny-liv-sympozium-z-historie-farmacie-a-veterinarni-mediciny.php weekly 0.7 /artkey/csf-201203-0009_high-active-potential-antimycobacterial-agents-against-mycobacterium-avium.php weekly 0.7 /en/artkey/csf-201203-0009_high-active-potential-antimycobacterial-agents-against-mycobacterium-avium.php weekly 0.7 /artkey/csf-201203-0010_studies-of-local-anaesthetics-part-197-effect-of-xylitol-on-pharmaceutical-availability-of-lidocaine-and-flo.php weekly 0.7 /en/artkey/csf-201203-0010_studies-of-local-anaesthetics-part-197-effect-of-xylitol-on-pharmaceutical-availability-of-lidocaine-and-flo.php weekly 0.7 /magno/csf/2012/mn4.php weekly 0.7 /en/magno/csf/2012/mn4.php weekly 0.7 /artkey/csf-201204-0005_magistral-prepared-lidocaine-gel-for-topical-aplication-on-skin.php weekly 0.7 /en/artkey/csf-201204-0005_magistral-prepared-lidocaine-gel-for-topical-aplication-on-skin.php weekly 0.7 /artkey/csf-201204-0001_new-pharmaceutical-insights-related-to-the-pathways-of-pufas.php weekly 0.7 /en/artkey/csf-201204-0001_new-pharmaceutical-insights-related-to-the-pathways-of-pufas.php weekly 0.7 /artkey/csf-201204-0002_mitochondrial-enzyme-abad-and-its-role-in-the-development-and-treatment-of-alzheimer-s-disease.php weekly 0.7 /en/artkey/csf-201204-0002_mitochondrial-enzyme-abad-and-its-role-in-the-development-and-treatment-of-alzheimer-s-disease.php weekly 0.7 /artkey/csf-201204-0003_where-does-the-development-of-new-antituberculotics-aim-at.php weekly 0.7 /en/artkey/csf-201204-0003_where-does-the-development-of-new-antituberculotics-aim-at.php weekly 0.7 /artkey/csf-201204-0004_standard-prescriptions-for-the-formulation-of-medicinal-preparations-in-pharmacies-v-the-collection-dermatolog.php weekly 0.7 /en/artkey/csf-201204-0004_standard-prescriptions-for-the-formulation-of-medicinal-preparations-in-pharmacies-v-the-collection-dermatolog.php weekly 0.7 /artkey/csf-201204-0010_prof-rndr-bohumil-sikyta-drsc-jubiluje.php weekly 0.7 /en/artkey/csf-201204-0010_prof-rndr-bohumil-sikyta-drsc-jubiluje.php weekly 0.7 /artkey/csf-201204-0011_pharmdr-jozef-nemet-jubiluje.php weekly 0.7 /en/artkey/csf-201204-0011_pharmdr-jozef-nemet-jubiluje.php weekly 0.7 /artkey/csf-201204-0007_our-medicinal-preparations-in-the-mid-19th-century-part-i-introduction-and-chemical-preparations.php weekly 0.7 /en/artkey/csf-201204-0007_our-medicinal-preparations-in-the-mid-19th-century-part-i-introduction-and-chemical-preparations.php weekly 0.7 /artkey/csf-201204-0008_our-medicinal-preparations-in-the-mid-19th-century-part-ii-galenical-preparations.php weekly 0.7 /en/artkey/csf-201204-0008_our-medicinal-preparations-in-the-mid-19th-century-part-ii-galenical-preparations.php weekly 0.7 /artkey/csf-201204-0006_formulation-of-salvia-containing-gels.php weekly 0.7 /en/artkey/csf-201204-0006_formulation-of-salvia-containing-gels.php weekly 0.7 /artkey/csf-201204-0009_xxxiv-pracovni-dny-radiofarmaceuticke-sekce-ceske-spolecnosti-nuklearni-mediciny-cls-jep-mlada-boleslav-13.php weekly 0.7 /en/artkey/csf-201204-0009_xxxiv-pracovni-dny-radiofarmaceuticke-sekce-ceske-spolecnosti-nuklearni-mediciny-cls-jep-mlada-boleslav-13.php weekly 0.7 /magno/csf/2012/mn5.php weekly 0.7 /en/magno/csf/2012/mn5.php weekly 0.7 /artkey/csf-201205-0004_a-study-of-a-co-processed-dry-binder-composed-of-microcrystalline-cellulose-and-glycerol-monostearate.php weekly 0.7 /en/artkey/csf-201205-0004_a-study-of-a-co-processed-dry-binder-composed-of-microcrystalline-cellulose-and-glycerol-monostearate.php weekly 0.7 /artkey/csf-201205-0005_methods-of-pharmaceutical-technology-in-preparation-of-pellets-for-detection-of-acetylcholinesterase-inhibitors.php weekly 0.7 /en/artkey/csf-201205-0005_methods-of-pharmaceutical-technology-in-preparation-of-pellets-for-detection-of-acetylcholinesterase-inhibitors.php weekly 0.7 /artkey/csf-201205-0001_bergenia-genus-content-matters-and-biological-activity.php weekly 0.7 /en/artkey/csf-201205-0001_bergenia-genus-content-matters-and-biological-activity.php weekly 0.7 /artkey/csf-201205-0002_tacrine-and-its-derivatives-in-the-therapy-of-alzheimer-s-disease.php weekly 0.7 /en/artkey/csf-201205-0002_tacrine-and-its-derivatives-in-the-therapy-of-alzheimer-s-disease.php weekly 0.7 /artkey/csf-201205-0003_important-toxic-and-undesirable-effects-of-medicaments-in-animals-from-the-pharmacist-s-viewpoint.php weekly 0.7 /en/artkey/csf-201205-0003_important-toxic-and-undesirable-effects-of-medicaments-in-animals-from-the-pharmacist-s-viewpoint.php weekly 0.7 /artkey/csf-201205-0010_klimas-j-zostavovatel-60-rokov-farmaceutickej-fakulty-univerzity-komenskeho-v-bratislave-1952-2012-brati.php weekly 0.7 /en/artkey/csf-201205-0010_klimas-j-zostavovatel-60-rokov-farmaceutickej-fakulty-univerzity-komenskeho-v-bratislave-1952-2012-brati.php weekly 0.7 /artkey/csf-201205-0008_76th-prague-meeting-on-macromolecules.php weekly 0.7 /en/artkey/csf-201205-0008_76th-prague-meeting-on-macromolecules.php weekly 0.7 /artkey/csf-201205-0009_eufeps-a-9-stredoevropske-sympozium-farmaceuticke-technologie.php weekly 0.7 /en/artkey/csf-201205-0009_eufeps-a-9-stredoevropske-sympozium-farmaceuticke-technologie.php weekly 0.7 /artkey/csf-201205-0006_a-contribution-to-the-development-of-advertising-in-pharmacy-ii-historical-development-of-regulation-of-advert.php weekly 0.7 /en/artkey/csf-201205-0006_a-contribution-to-the-development-of-advertising-in-pharmacy-ii-historical-development-of-regulation-of-advert.php weekly 0.7 /artkey/csf-201205-0007_on-the-origin-of-the-czechoslovak-pharmacopoeia.php weekly 0.7 /en/artkey/csf-201205-0007_on-the-origin-of-the-czechoslovak-pharmacopoeia.php weekly 0.7 /magno/csf/2012/mn6.php weekly 0.7 /en/magno/csf/2012/mn6.php weekly 0.7 /artkey/csf-201206-0002_effects-of-zinc-and-cadmium-ions-on-cell-growth-and-production-of-coumarins-in-cell-suspension-cultures-of-ange.php weekly 0.7 /en/artkey/csf-201206-0002_effects-of-zinc-and-cadmium-ions-on-cell-growth-and-production-of-coumarins-in-cell-suspension-cultures-of-ange.php weekly 0.7 /artkey/csf-201206-0003_comparison-of-sanguinarine-production-in-suspension-cultures-of-the-papaveraceae-plants.php weekly 0.7 /en/artkey/csf-201206-0003_comparison-of-sanguinarine-production-in-suspension-cultures-of-the-papaveraceae-plants.php weekly 0.7 /artkey/csf-201206-0004_evaluation-of-content-uniformity-of-tablets-with-a-low-content-of-the-active-ingredient-with-a-narrow-therapeut.php weekly 0.7 /en/artkey/csf-201206-0004_evaluation-of-content-uniformity-of-tablets-with-a-low-content-of-the-active-ingredient-with-a-narrow-therapeut.php weekly 0.7 /artkey/csf-201206-0005_analysis-of-pharmaceutical-care-in-dispensing-of-over-the-counter-orlistat.php weekly 0.7 /en/artkey/csf-201206-0005_analysis-of-pharmaceutical-care-in-dispensing-of-over-the-counter-orlistat.php weekly 0.7 /artkey/csf-201206-0001_halloysite-interesting-nanotubular-carrier-for-drugs.php weekly 0.7 /en/artkey/csf-201206-0001_halloysite-interesting-nanotubular-carrier-for-drugs.php weekly 0.7 /artkey/csf-201206-0013_prirucka-vybratych-pojmov-v-analytickej-chemii.php weekly 0.7 /en/artkey/csf-201206-0013_prirucka-vybratych-pojmov-v-analytickej-chemii.php weekly 0.7 /artkey/csf-201206-0012_za-doc-drph-phmr-jozefom-hegerom.php weekly 0.7 /en/artkey/csf-201206-0012_za-doc-drph-phmr-jozefom-hegerom.php weekly 0.7 /artkey/csf-201206-0008_fip-oslavila-100-vyroci.php weekly 0.7 /en/artkey/csf-201206-0008_fip-oslavila-100-vyroci.php weekly 0.7 /artkey/csf-201206-0009_teaching-communication-skills-in-pharmacy-practise-to-know-and-to-do-are-two-different-things.php weekly 0.7 /en/artkey/csf-201206-0009_teaching-communication-skills-in-pharmacy-practise-to-know-and-to-do-are-two-different-things.php weekly 0.7 /artkey/csf-201206-0010_patient-counseling-in-pharmacy-practice-optimization-of-drug-therapy.php weekly 0.7 /en/artkey/csf-201206-0010_patient-counseling-in-pharmacy-practice-optimization-of-drug-therapy.php weekly 0.7 /artkey/csf-201206-0011_the-czech-pharmaceutical-society-1871-2012.php weekly 0.7 /en/artkey/csf-201206-0011_the-czech-pharmaceutical-society-1871-2012.php weekly 0.7 /artkey/csf-201206-0006_phenyl-salicylates-a-new-group-of-potential-antituberculotics.php weekly 0.7 /en/artkey/csf-201206-0006_phenyl-salicylates-a-new-group-of-potential-antituberculotics.php weekly 0.7 /artkey/csf-201206-0007_study-of-local-anaesthetics-part-200-choice-of-the-optimal-type-of-chitosan-for-the-formulation-of-local-ana.php weekly 0.7 /en/artkey/csf-201206-0007_study-of-local-anaesthetics-part-200-choice-of-the-optimal-type-of-chitosan-for-the-formulation-of-local-ana.php weekly 0.7 /artkey/csf-201206-0014_instructions-for-the-authors-submitting-papers-to-the-journal-czech-and-slovak-pharmacy.php weekly 0.7 /en/artkey/csf-201206-0014_instructions-for-the-authors-submitting-papers-to-the-journal-czech-and-slovak-pharmacy.php weekly 0.7 /artkey/csf-201206-0015_autorsky-rejstrik.php weekly 0.7 /en/artkey/csf-201206-0015_autorsky-rejstrik.php weekly 0.7 /artkey/csf-201206-0016_vecny-rejstrik.php weekly 0.7 /en/artkey/csf-201206-0016_vecny-rejstrik.php weekly 0.7 /magno/csf/2011/mn1.php weekly 0.7 /en/magno/csf/2011/mn1.php weekly 0.7 /artkey/csf-201101-0003_study-on-99mtc-mag3-and-99mtc-dmsa-renal-accumulation-using-in-vitro-cellular-model.php weekly 0.7 /en/artkey/csf-201101-0003_study-on-99mtc-mag3-and-99mtc-dmsa-renal-accumulation-using-in-vitro-cellular-model.php weekly 0.7 /artkey/csf-201101-0004_energy-evaluation-of-the-compaction-process-of-directly-compressible-isomalt.php weekly 0.7 /en/artkey/csf-201101-0004_energy-evaluation-of-the-compaction-process-of-directly-compressible-isomalt.php weekly 0.7 /artkey/csf-201101-0005_determination-of-nabumetone-and-6-methoxy-2-naphthylacetic-acid-in-plasma-using-hplc-with-uv-and-ms-detection.php weekly 0.7 /en/artkey/csf-201101-0005_determination-of-nabumetone-and-6-methoxy-2-naphthylacetic-acid-in-plasma-using-hplc-with-uv-and-ms-detection.php weekly 0.7 /artkey/csf-201101-0006_determination-of-airborne-and-surface-contamination-with-cyclophosphamide-at-the-masaryk-memorial-cancer-instit.php weekly 0.7 /en/artkey/csf-201101-0006_determination-of-airborne-and-surface-contamination-with-cyclophosphamide-at-the-masaryk-memorial-cancer-instit.php weekly 0.7 /artkey/csf-201101-0002_on-teaching-the-chemistry-of-pharmaceutical-auxiliary-substances-within-the-framework-of-pharmaceutical-educati.php weekly 0.7 /en/artkey/csf-201101-0002_on-teaching-the-chemistry-of-pharmaceutical-auxiliary-substances-within-the-framework-of-pharmaceutical-educati.php weekly 0.7 /artkey/csf-201101-0009_ocenenie-rndr-marii-svejnochovej.php weekly 0.7 /en/artkey/csf-201101-0009_ocenenie-rndr-marii-svejnochovej.php weekly 0.7 /artkey/csf-201101-0010_zivotni-jubileum-doc-pharmdr-miloslavy-rabiskove-csc.php weekly 0.7 /en/artkey/csf-201101-0010_zivotni-jubileum-doc-pharmdr-miloslavy-rabiskove-csc.php weekly 0.7 /artkey/csf-201101-0011_k-zivotnimu-jubileu-prof-rndr-karla-waissera-drsc.php weekly 0.7 /en/artkey/csf-201101-0011_k-zivotnimu-jubileu-prof-rndr-karla-waissera-drsc.php weekly 0.7 /artkey/csf-201101-0012_prof-ing-jan-mocak-drsc-nositel-weberovej-ceny-sfs.php weekly 0.7 /en/artkey/csf-201101-0012_prof-ing-jan-mocak-drsc-nositel-weberovej-ceny-sfs.php weekly 0.7 /artkey/csf-201101-0013_ocenenie-doc-rndr-josefovi-kucerovi-phd.php weekly 0.7 /en/artkey/csf-201101-0013_ocenenie-doc-rndr-josefovi-kucerovi-phd.php weekly 0.7 /artkey/csf-201101-0001_60-let-casopisu-ceska-a-slovenska-farmacie.php weekly 0.7 /en/artkey/csf-201101-0001_60-let-casopisu-ceska-a-slovenska-farmacie.php weekly 0.7 /artkey/csf-201101-0008_51-sympozium-z-dejin-farmacie-a-veterinarni-mediciny.php weekly 0.7 /en/artkey/csf-201101-0008_51-sympozium-z-dejin-farmacie-a-veterinarni-mediciny.php weekly 0.7 /artkey/csf-201101-0007_pracovni-den-sekce-technologie-leku-ceske-farmaceuticke-spolecnosti-cls-jep-pokroky-v-lekovych-formach.php weekly 0.7 /en/artkey/csf-201101-0007_pracovni-den-sekce-technologie-leku-ceske-farmaceuticke-spolecnosti-cls-jep-pokroky-v-lekovych-formach.php weekly 0.7 /magno/csf/2011/mn2.php weekly 0.7 /en/magno/csf/2011/mn2.php weekly 0.7 /artkey/csf-201102-0005_generic-substitution-replacement-and-substitution-of-drugs-contemporary-extent.php weekly 0.7 /en/artkey/csf-201102-0005_generic-substitution-replacement-and-substitution-of-drugs-contemporary-extent.php weekly 0.7 /artkey/csf-201102-0007_study-of-local-anaesthetics-part-194-evaluation-of-carbopol-hydrogels-with-lidocaine.php weekly 0.7 /en/artkey/csf-201102-0007_study-of-local-anaesthetics-part-194-evaluation-of-carbopol-hydrogels-with-lidocaine.php weekly 0.7 /artkey/csf-201102-0008_analytical-evaluation-of-mono-3-4-2-etoxyetoxy-benzoyloxy-2-hydroxypropyl-isopropyl-ammonium-fumarate.php weekly 0.7 /en/artkey/csf-201102-0008_analytical-evaluation-of-mono-3-4-2-etoxyetoxy-benzoyloxy-2-hydroxypropyl-isopropyl-ammonium-fumarate.php weekly 0.7 /artkey/csf-201102-0001_myasthenia-gravis-current-treatment-standards-and-emerging-drugs.php weekly 0.7 /en/artkey/csf-201102-0001_myasthenia-gravis-current-treatment-standards-and-emerging-drugs.php weekly 0.7 /artkey/csf-201102-0002_pelletization-of-melts-and-liquids.php weekly 0.7 /en/artkey/csf-201102-0002_pelletization-of-melts-and-liquids.php weekly 0.7 /artkey/csf-201102-0003_dyer-s-greenweed-genista-tinctoria-l-constituents-and-biological-activity.php weekly 0.7 /en/artkey/csf-201102-0003_dyer-s-greenweed-genista-tinctoria-l-constituents-and-biological-activity.php weekly 0.7 /artkey/csf-201102-0004_bacteriocins-produced-by-lactic-acid-bacteria.php weekly 0.7 /en/artkey/csf-201102-0004_bacteriocins-produced-by-lactic-acid-bacteria.php weekly 0.7 /artkey/csf-201102-0006_nove-knihy.php weekly 0.7 /en/artkey/csf-201102-0006_nove-knihy.php weekly 0.7 /artkey/csf-201102-0009_nove-knihy.php weekly 0.7 /en/artkey/csf-201102-0009_nove-knihy.php weekly 0.7 /artkey/csf-201102-0010_ocenenie-prace-pani-doc-rndr-ive-valaskovej-csc.php weekly 0.7 /en/artkey/csf-201102-0010_ocenenie-prace-pani-doc-rndr-ive-valaskovej-csc.php weekly 0.7 /artkey/csf-201102-0011_ocenenie-viere-jenikovej.php weekly 0.7 /en/artkey/csf-201102-0011_ocenenie-viere-jenikovej.php weekly 0.7 /magno/csf/2011/mn3.php weekly 0.7 /en/magno/csf/2011/mn3.php weekly 0.7 /artkey/csf-201103-0005_the-inhibition-activity-of-selected-carboline-alkaloids-on-enzymes-of-acetylcholinesterase-and-butyrylcholine.php weekly 0.7 /en/artkey/csf-201103-0005_the-inhibition-activity-of-selected-carboline-alkaloids-on-enzymes-of-acetylcholinesterase-and-butyrylcholine.php weekly 0.7 /artkey/csf-201103-0007_influence-of-membranes-on-alaptide-permeation-from-hydrogels.php weekly 0.7 /en/artkey/csf-201103-0007_influence-of-membranes-on-alaptide-permeation-from-hydrogels.php weekly 0.7 /artkey/csf-201103-0009_synthesis-and-basic-physicochemical-properties-of-1-3-y-alkoxyphenylcarbamoyloxy-2-hydroxypropyl-4-2-meth.php weekly 0.7 /en/artkey/csf-201103-0009_synthesis-and-basic-physicochemical-properties-of-1-3-y-alkoxyphenylcarbamoyloxy-2-hydroxypropyl-4-2-meth.php weekly 0.7 /artkey/csf-201103-0001_effects-of-health-service-reform-in-the-field-of-medicinal-drugs-i-analysis-from-the-standpoint-of-a-pharmacy.php weekly 0.7 /en/artkey/csf-201103-0001_effects-of-health-service-reform-in-the-field-of-medicinal-drugs-i-analysis-from-the-standpoint-of-a-pharmacy.php weekly 0.7 /artkey/csf-201103-0002_effects-of-health-service-reform-in-the-field-of-medicinal-drugs-ii-analysis-from-the-standpoint-of-financial.php weekly 0.7 /en/artkey/csf-201103-0002_effects-of-health-service-reform-in-the-field-of-medicinal-drugs-ii-analysis-from-the-standpoint-of-financial.php weekly 0.7 /artkey/csf-201103-0003_clinical-significance-of-cytochrome-p450-genetic-polymorphism-part-i-enzymatic-system-of-cytochrome-p450-and.php weekly 0.7 /en/artkey/csf-201103-0003_clinical-significance-of-cytochrome-p450-genetic-polymorphism-part-i-enzymatic-system-of-cytochrome-p450-and.php weekly 0.7 /artkey/csf-201103-0004_farmaceuticke-aspekty-zivocisnej-lipoxygenazy.php weekly 0.7 /en/artkey/csf-201103-0004_farmaceuticke-aspekty-zivocisnej-lipoxygenazy.php weekly 0.7 /artkey/csf-201103-0006_index-nominum-international-drug-directory-vol-1-a-vol-2-20th-edition.php weekly 0.7 /en/artkey/csf-201103-0006_index-nominum-international-drug-directory-vol-1-a-vol-2-20th-edition.php weekly 0.7 /artkey/csf-201103-0008_lacinova-uhrikova-d-biofyzika-nap-tovo-zavislych-ionovych-kanalov.php weekly 0.7 /en/artkey/csf-201103-0008_lacinova-uhrikova-d-biofyzika-nap-tovo-zavislych-ionovych-kanalov.php weekly 0.7 /artkey/csf-201103-0011_zpravy.php weekly 0.7 /en/artkey/csf-201103-0011_zpravy.php weekly 0.7 /artkey/csf-201103-0010_xxxiii-pracovni-dny-sekce-radiofarmacie-ceske-spolecnosti-nuklearni-mediciny-cls-jep-roznov-pod-radhostem-1.php weekly 0.7 /en/artkey/csf-201103-0010_xxxiii-pracovni-dny-sekce-radiofarmacie-ceske-spolecnosti-nuklearni-mediciny-cls-jep-roznov-pod-radhostem-1.php weekly 0.7 /magno/csf/2011/mn4.php weekly 0.7 /en/magno/csf/2011/mn4.php weekly 0.7 /artkey/csf-201104-0005_prosolv-reg-easytab-as-a-new-multifunctional-co-processed-dry-binder-a-study-of-the-properties-of-tablets-and.php weekly 0.7 /en/artkey/csf-201104-0005_prosolv-reg-easytab-as-a-new-multifunctional-co-processed-dry-binder-a-study-of-the-properties-of-tablets-and.php weekly 0.7 /artkey/csf-201104-0006_antiphlogistic-hydrogels-based-on-the-white-lily.php weekly 0.7 /en/artkey/csf-201104-0006_antiphlogistic-hydrogels-based-on-the-white-lily.php weekly 0.7 /artkey/csf-201104-0007_the-influence-of-pva-on-the-size-of-oligoester-nanoparticles-prepared-by-the-emulsion-solvent-distribution-meth.php weekly 0.7 /en/artkey/csf-201104-0007_the-influence-of-pva-on-the-size-of-oligoester-nanoparticles-prepared-by-the-emulsion-solvent-distribution-meth.php weekly 0.7 /artkey/csf-201104-0001_improving-the-quality-and-cost-effectiveness-of-depression-treatment.php weekly 0.7 /en/artkey/csf-201104-0001_improving-the-quality-and-cost-effectiveness-of-depression-treatment.php weekly 0.7 /artkey/csf-201104-0003_clinical-significance-of-cytochrome-p450-genetic-polymorphism-part-ii-cytochrome-p450-2c9.php weekly 0.7 /en/artkey/csf-201104-0003_clinical-significance-of-cytochrome-p450-genetic-polymorphism-part-ii-cytochrome-p450-2c9.php weekly 0.7 /artkey/csf-201104-0004_antagonists-of-angiotensin-at1-receptors.php weekly 0.7 /en/artkey/csf-201104-0004_antagonists-of-angiotensin-at1-receptors.php weekly 0.7 /artkey/csf-201104-0002_nove-knihy.php weekly 0.7 /en/artkey/csf-201104-0002_nove-knihy.php weekly 0.7 /artkey/csf-201104-0008_nove-knihy.php weekly 0.7 /en/artkey/csf-201104-0008_nove-knihy.php weekly 0.7 /artkey/csf-201104-0012_kniha.php weekly 0.7 /en/artkey/csf-201104-0012_kniha.php weekly 0.7 /artkey/csf-201104-0010_prohledavani-plnotextovych-zdroju-sciverse-sciencedirect-doplni-jiz-dostupnou-indexaci-a-abstrakta-vsech-period.php weekly 0.7 /en/artkey/csf-201104-0010_prohledavani-plnotextovych-zdroju-sciverse-sciencedirect-doplni-jiz-dostupnou-indexaci-a-abstrakta-vsech-period.php weekly 0.7 /artkey/csf-201104-0009_on-the-history-of-pharmaceutical-industry-in-the-czech-lands-interpharma.php weekly 0.7 /en/artkey/csf-201104-0009_on-the-history-of-pharmaceutical-industry-in-the-czech-lands-interpharma.php weekly 0.7 /artkey/csf-201104-0011_sympozium-z-historie-farmacie-a-veterinarni-mediciny.php weekly 0.7 /en/artkey/csf-201104-0011_sympozium-z-historie-farmacie-a-veterinarni-mediciny.php weekly 0.7 /magno/csf/2011/mn5.php weekly 0.7 /en/magno/csf/2011/mn5.php weekly 0.7 /artkey/csf-201105-0004_the-effect-of-three-different-elicitors-on-sanguinarine-production-in-suspension-cultures-of-a-low-morphine-var.php weekly 0.7 /en/artkey/csf-201105-0004_the-effect-of-three-different-elicitors-on-sanguinarine-production-in-suspension-cultures-of-a-low-morphine-var.php weekly 0.7 /artkey/csf-201105-0005_viscosity-and-consistence-measurements-following-ph-b-2009.php weekly 0.7 /en/artkey/csf-201105-0005_viscosity-and-consistence-measurements-following-ph-b-2009.php weekly 0.7 /artkey/csf-201105-0001_clinical-significance-of-cytochrome-p450-genetic-polymorphism-part-iii-cytochrome-p450-2c19.php weekly 0.7 /en/artkey/csf-201105-0001_clinical-significance-of-cytochrome-p450-genetic-polymorphism-part-iii-cytochrome-p450-2c19.php weekly 0.7 /artkey/csf-201105-0002_alzheimer-s-disease-aspects-of-contemporary-pharmacological-treatment.php weekly 0.7 /en/artkey/csf-201105-0002_alzheimer-s-disease-aspects-of-contemporary-pharmacological-treatment.php weekly 0.7 /artkey/csf-201105-0003_rhus-hirta-l-sudw-phytochemical-characteristics-of-the-most-widely-cultivated-representative-of-the-anaca.php weekly 0.7 /en/artkey/csf-201105-0003_rhus-hirta-l-sudw-phytochemical-characteristics-of-the-most-widely-cultivated-representative-of-the-anaca.php weekly 0.7 /artkey/csf-201105-0006_cena-ceske-farmaceuticke-spolecnosti.php weekly 0.7 /en/artkey/csf-201105-0006_cena-ceske-farmaceuticke-spolecnosti.php weekly 0.7 /artkey/csf-201105-0008_prof-rndr-viliam-foltan-csc-jubiluje.php weekly 0.7 /en/artkey/csf-201105-0008_prof-rndr-viliam-foltan-csc-jubiluje.php weekly 0.7 /artkey/csf-201105-0009_za-doc-drph-phmr-ladislavom-knazkom-csc.php weekly 0.7 /en/artkey/csf-201105-0009_za-doc-drph-phmr-ladislavom-knazkom-csc.php weekly 0.7 /artkey/csf-201105-0007_medicinal-preparations-in-this-country-at-the-end-of-the-18th-century-part-i-introduction-and-liquid-dosage.php weekly 0.7 /en/artkey/csf-201105-0007_medicinal-preparations-in-this-country-at-the-end-of-the-18th-century-part-i-introduction-and-liquid-dosage.php weekly 0.7 /artkey/csf-201105-0010_farmaceuti-rokovali-na-donovaloch.php weekly 0.7 /en/artkey/csf-201105-0010_farmaceuti-rokovali-na-donovaloch.php weekly 0.7 /magno/csf/2011/mn6.php weekly 0.7 /en/magno/csf/2011/mn6.php weekly 0.7 /artkey/csf-201106-0004_analytical-profile-of-1-3-3-propoxyphenylcarbamoyloxy-2-hydroxypropyl-4-3-tri-fluoromethylphenyl-piperazin.php weekly 0.7 /en/artkey/csf-201106-0004_analytical-profile-of-1-3-3-propoxyphenylcarbamoyloxy-2-hydroxypropyl-4-3-tri-fluoromethylphenyl-piperazin.php weekly 0.7 /artkey/csf-201106-0006_study-of-local-anesthetics-part-195-study-of-micellization-of-pentacainium-chloride-in-methanol-and-ethanol.php weekly 0.7 /en/artkey/csf-201106-0006_study-of-local-anesthetics-part-195-study-of-micellization-of-pentacainium-chloride-in-methanol-and-ethanol.php weekly 0.7 /artkey/csf-201106-0002_on-the-question-of-special-over-the-counter-drugs.php weekly 0.7 /en/artkey/csf-201106-0002_on-the-question-of-special-over-the-counter-drugs.php weekly 0.7 /artkey/csf-201106-0003_clinical-significance-of-cytochrome-p450-genetic-polymorphism-part-iv-cytochrome-p450-3a4-and-3a5.php weekly 0.7 /en/artkey/csf-201106-0003_clinical-significance-of-cytochrome-p450-genetic-polymorphism-part-iv-cytochrome-p450-3a4-and-3a5.php weekly 0.7 /artkey/csf-201106-0007_jesensky-m-alchymia-v-caplovicovej-kniznici.php weekly 0.7 /en/artkey/csf-201106-0007_jesensky-m-alchymia-v-caplovicovej-kniznici.php weekly 0.7 /artkey/csf-201106-0005_response-to-the-paper-viscosity-and-consistence-measurements-following-ph-b-2009-ces-slov-farm-2011-60.php weekly 0.7 /en/artkey/csf-201106-0005_response-to-the-paper-viscosity-and-consistence-measurements-following-ph-b-2009-ces-slov-farm-2011-60.php weekly 0.7 /artkey/csf-201106-0010_zpravy.php weekly 0.7 /en/artkey/csf-201106-0010_zpravy.php weekly 0.7 /artkey/csf-201106-0008_medicinal-preparations-in-this-country-at-the-end-of-the-18th-century-part-ii-semisolid-and-solid-dosage-for.php weekly 0.7 /en/artkey/csf-201106-0008_medicinal-preparations-in-this-country-at-the-end-of-the-18th-century-part-ii-semisolid-and-solid-dosage-for.php weekly 0.7 /artkey/csf-201106-0001_ceska-farmaceuticka-spolecnost-csl-jep-vzpomnela-140-vyroci-sveho-zalozeni.php weekly 0.7 /en/artkey/csf-201106-0001_ceska-farmaceuticka-spolecnost-csl-jep-vzpomnela-140-vyroci-sveho-zalozeni.php weekly 0.7 /artkey/csf-201106-0009_pracovny-den-technologickej-sekcie-slovenskej-farmaceutickej-spolocnosti-liekove-formy-sucasnosti-a-buducnost.php weekly 0.7 /en/artkey/csf-201106-0009_pracovny-den-technologickej-sekcie-slovenskej-farmaceutickej-spolocnosti-liekove-formy-sucasnosti-a-buducnost.php weekly 0.7 /artkey/csf-201106-0011_autorsky-rejstrik.php weekly 0.7 /en/artkey/csf-201106-0011_autorsky-rejstrik.php weekly 0.7 /artkey/csf-201106-0012_vecny-rejstrik.php weekly 0.7 /en/artkey/csf-201106-0012_vecny-rejstrik.php weekly 0.7 /magno/csf/2010/mn1.php weekly 0.7 /en/magno/csf/2010/mn1.php weekly 0.7 /artkey/csf-201001-0004_preparation-and-evaluation-of-hydrophilic-cream-with-propolis-extract.php weekly 0.7 /en/artkey/csf-201001-0004_preparation-and-evaluation-of-hydrophilic-cream-with-propolis-extract.php weekly 0.7 /artkey/csf-201001-0005_evaluation-of-the-reactivating-efficacy-of-selected-reactivators-of-paraoxon-inhibited-acetylcholinesterase-in.php weekly 0.7 /en/artkey/csf-201001-0005_evaluation-of-the-reactivating-efficacy-of-selected-reactivators-of-paraoxon-inhibited-acetylcholinesterase-in.php weekly 0.7 /artkey/csf-201001-0006_long-term-trends-in-the-utilization-of-beta-blocking-agents-in-the-czech-republic.php weekly 0.7 /en/artkey/csf-201001-0006_long-term-trends-in-the-utilization-of-beta-blocking-agents-in-the-czech-republic.php weekly 0.7 /artkey/csf-201001-0002_on-the-content-of-the-national-section-of-the-czech-pharmacopoeia-2009.php weekly 0.7 /en/artkey/csf-201001-0002_on-the-content-of-the-national-section-of-the-czech-pharmacopoeia-2009.php weekly 0.7 /artkey/csf-201001-0003_present-day-approaches-to-pharmacotherapy-pharmaceutical-care-or-drug-management.php weekly 0.7 /en/artkey/csf-201001-0003_present-day-approaches-to-pharmacotherapy-pharmaceutical-care-or-drug-management.php weekly 0.7 /artkey/csf-201001-0012_vybrane-kurzy-staze-a-seminare-ipvz-1-pololeti-roku-2010.php weekly 0.7 /en/artkey/csf-201001-0012_vybrane-kurzy-staze-a-seminare-ipvz-1-pololeti-roku-2010.php weekly 0.7 /artkey/csf-201001-0013_jak-se-hlasit-na-vzdelavaci-akce-ipzv.php weekly 0.7 /en/artkey/csf-201001-0013_jak-se-hlasit-na-vzdelavaci-akce-ipzv.php weekly 0.7 /artkey/csf-201001-0014_zivotne-jubileum-doc-rndr-lydie-bezakovej-ph-d.php weekly 0.7 /en/artkey/csf-201001-0014_zivotne-jubileum-doc-rndr-lydie-bezakovej-ph-d.php weekly 0.7 /artkey/csf-201001-0015_zivotne-jubileum-prof-rndr-daniela-grancaia-csc.php weekly 0.7 /en/artkey/csf-201001-0015_zivotne-jubileum-prof-rndr-daniela-grancaia-csc.php weekly 0.7 /artkey/csf-201001-0001_casopis-ceska-a-slovenska-farmacie-v-roce-2010.php weekly 0.7 /en/artkey/csf-201001-0001_casopis-ceska-a-slovenska-farmacie-v-roce-2010.php weekly 0.7 /artkey/csf-201001-0009_xlix-sympozium-z-historie-farmacie-a-veterinarni-mediciny.php weekly 0.7 /en/artkey/csf-201001-0009_xlix-sympozium-z-historie-farmacie-a-veterinarni-mediciny.php weekly 0.7 /artkey/csf-201001-0010_13-kongres-nemocnicnich-lekarniku.php weekly 0.7 /en/artkey/csf-201001-0010_13-kongres-nemocnicnich-lekarniku.php weekly 0.7 /artkey/csf-201001-0011_ze-zasedani-vyboru-ceske-farmaceuticke-spolecnosti.php weekly 0.7 /en/artkey/csf-201001-0011_ze-zasedani-vyboru-ceske-farmaceuticke-spolecnosti.php weekly 0.7 /artkey/csf-201001-0007_studies-on-local-anaesthetics-part-191-optimization-of-the-composition-of-hydrogels-from-the-standpoint-of-fl.php weekly 0.7 /en/artkey/csf-201001-0007_studies-on-local-anaesthetics-part-191-optimization-of-the-composition-of-hydrogels-from-the-standpoint-of-fl.php weekly 0.7 /artkey/csf-201001-0008_pracovni-den-sekce-technologie-leku-ceske-farmaceuticke-spolecnosti-cls-jep-pokroky-v-lekovych-formach.php weekly 0.7 /en/artkey/csf-201001-0008_pracovni-den-sekce-technologie-leku-ceske-farmaceuticke-spolecnosti-cls-jep-pokroky-v-lekovych-formach.php weekly 0.7 /magno/csf/2010/mn2.php weekly 0.7 /en/magno/csf/2010/mn2.php weekly 0.7 /artkey/csf-201002-0002_a-study-of-the-compaction-process-and-the-properties-of-tablets-from-two-types-of-directly-compressible-sorbito.php weekly 0.7 /en/artkey/csf-201002-0002_a-study-of-the-compaction-process-and-the-properties-of-tablets-from-two-types-of-directly-compressible-sorbito.php weekly 0.7 /artkey/csf-201002-0003_microparticles-on-the-oxycellulose-base-influence-of-processual-variables-on-encapsulation-efficiency.php weekly 0.7 /en/artkey/csf-201002-0003_microparticles-on-the-oxycellulose-base-influence-of-processual-variables-on-encapsulation-efficiency.php weekly 0.7 /artkey/csf-201002-0004_implementation-of-radio-frequency-identification-rfid-in-the-process-of-preparation-and-administration-of-dru.php weekly 0.7 /en/artkey/csf-201002-0004_implementation-of-radio-frequency-identification-rfid-in-the-process-of-preparation-and-administration-of-dru.php weekly 0.7 /artkey/csf-201002-0005_identification-and-susceptibility-evaluation-of-candida-yeasts-due-to-the-optimization-of-ciclopiroxolamine-rel.php weekly 0.7 /en/artkey/csf-201002-0005_identification-and-susceptibility-evaluation-of-candida-yeasts-due-to-the-optimization-of-ciclopiroxolamine-rel.php weekly 0.7 /artkey/csf-201002-0001_manufacture-of-granulates-containing-high-potency-drugs.php weekly 0.7 /en/artkey/csf-201002-0001_manufacture-of-granulates-containing-high-potency-drugs.php weekly 0.7 /artkey/csf-201002-0008_7-svetovy-kongres-farmaceuticke-technologie.php weekly 0.7 /en/artkey/csf-201002-0008_7-svetovy-kongres-farmaceuticke-technologie.php weekly 0.7 /artkey/csf-201002-0009_doc-rndr-otto-helia-csc-70-rocny.php weekly 0.7 /en/artkey/csf-201002-0009_doc-rndr-otto-helia-csc-70-rocny.php weekly 0.7 /artkey/csf-201002-0007_medicinal-preparations-in-czech-pharmacies-at-the-end-of-the-17th-century.php weekly 0.7 /en/artkey/csf-201002-0007_medicinal-preparations-in-czech-pharmacies-at-the-end-of-the-17th-century.php weekly 0.7 /artkey/csf-201002-0006_ze-zasedani-vyboru-ceske-farmaceuticke-spolecnosti.php weekly 0.7 /en/artkey/csf-201002-0006_ze-zasedani-vyboru-ceske-farmaceuticke-spolecnosti.php weekly 0.7 /magno/csf/2010/mn3.php weekly 0.7 /en/magno/csf/2010/mn3.php weekly 0.7 /artkey/csf-201003-0002_effects-of-aluminium-chloride-on-cell-growth-and-production-of-coumarins-in-cell-suspension-cultures-of-angelic.php weekly 0.7 /en/artkey/csf-201003-0002_effects-of-aluminium-chloride-on-cell-growth-and-production-of-coumarins-in-cell-suspension-cultures-of-angelic.php weekly 0.7 /artkey/csf-201003-0003_pyrazinecarboxylic-acid-derivatives-as-effective-abiotic-elicitors-of-isoflavonoids-production.php weekly 0.7 /en/artkey/csf-201003-0003_pyrazinecarboxylic-acid-derivatives-as-effective-abiotic-elicitors-of-isoflavonoids-production.php weekly 0.7 /artkey/csf-201003-0004_influence-of-the-kind-of-polymer-on-chlorhexidine-liberation-from-hydrogel.php weekly 0.7 /en/artkey/csf-201003-0004_influence-of-the-kind-of-polymer-on-chlorhexidine-liberation-from-hydrogel.php weekly 0.7 /artkey/csf-201003-0005_a-comparison-of-the-retardation-effects-of-natural-matrix-forming-polymers-and-the-synthetic-polymers-kollicoat.php weekly 0.7 /en/artkey/csf-201003-0005_a-comparison-of-the-retardation-effects-of-natural-matrix-forming-polymers-and-the-synthetic-polymers-kollicoat.php weekly 0.7 /artkey/csf-201003-0001_analytical-methods-for-the-determination-of-selected-psychopharmaceuticals.php weekly 0.7 /en/artkey/csf-201003-0001_analytical-methods-for-the-determination-of-selected-psychopharmaceuticals.php weekly 0.7 /artkey/csf-201003-0010_neue-arzneimittel-fakten-und-bewertungen-von-2005-bis-2007-zugelassenen-arzneimitteln-band-18.php weekly 0.7 /en/artkey/csf-201003-0010_neue-arzneimittel-fakten-und-bewertungen-von-2005-bis-2007-zugelassenen-arzneimitteln-band-18.php weekly 0.7 /artkey/csf-201003-0008_zivotne-jubileum-rndr-viery-hermanovej.php weekly 0.7 /en/artkey/csf-201003-0008_zivotne-jubileum-rndr-viery-hermanovej.php weekly 0.7 /artkey/csf-201003-0009_vybrane-kurzy-staze-a-seminare-ipvz-2-pololeti-roku-2010.php weekly 0.7 /en/artkey/csf-201003-0009_vybrane-kurzy-staze-a-seminare-ipvz-2-pololeti-roku-2010.php weekly 0.7 /artkey/csf-201003-0007_z-cinnosti-farmaceutickych-spolecnosti.php weekly 0.7 /en/artkey/csf-201003-0007_z-cinnosti-farmaceutickych-spolecnosti.php weekly 0.7 /artkey/csf-201003-0006_xxxii-pracovni-dny-sekce-radiofarmacie-ceske-spolecnosti-nuklearni-mediciny-cls-jep-zlin-9-11-cervna-2010.php weekly 0.7 /en/artkey/csf-201003-0006_xxxii-pracovni-dny-sekce-radiofarmacie-ceske-spolecnosti-nuklearni-mediciny-cls-jep-zlin-9-11-cervna-2010.php weekly 0.7 /magno/csf/2010/mn4.php weekly 0.7 /en/magno/csf/2010/mn4.php weekly 0.7 /artkey/csf-201004-0004_development-of-a-treatment-of-pregnant-women-suffering-from-epilepsy-in-the-region-of-ostrava-between-the-years.php weekly 0.7 /en/artkey/csf-201004-0004_development-of-a-treatment-of-pregnant-women-suffering-from-epilepsy-in-the-region-of-ostrava-between-the-years.php weekly 0.7 /artkey/csf-201004-0005_technology-of-controlled-release-tablets-containing-highly-soluble-active-ingredients.php weekly 0.7 /en/artkey/csf-201004-0005_technology-of-controlled-release-tablets-containing-highly-soluble-active-ingredients.php weekly 0.7 /artkey/csf-201004-0001_antimicrobial-substances-produced-by-lactic-acid-bacteria.php weekly 0.7 /en/artkey/csf-201004-0001_antimicrobial-substances-produced-by-lactic-acid-bacteria.php weekly 0.7 /artkey/csf-201004-0002_standard-formulations-for-medicinal-preparations-in-pharmacies-iv-the-usefulness-of-the-collection-formularium.php weekly 0.7 /en/artkey/csf-201004-0002_standard-formulations-for-medicinal-preparations-in-pharmacies-iv-the-usefulness-of-the-collection-formularium.php weekly 0.7 /artkey/csf-201004-0003_drug-controlled-release-from-dosage-forms-coated-with-aqueous-cellulose-and-acrylic-polymer-dispersions.php weekly 0.7 /en/artkey/csf-201004-0003_drug-controlled-release-from-dosage-forms-coated-with-aqueous-cellulose-and-acrylic-polymer-dispersions.php weekly 0.7 /artkey/csf-201004-0008_nove-knihy.php weekly 0.7 /en/artkey/csf-201004-0008_nove-knihy.php weekly 0.7 /artkey/csf-201004-0009_doc-rndr-marian-bukovsky-phd-jubiluje.php weekly 0.7 /en/artkey/csf-201004-0009_doc-rndr-marian-bukovsky-phd-jubiluje.php weekly 0.7 /artkey/csf-201004-0010_jaroslav-kvetina-osmdesatilety.php weekly 0.7 /en/artkey/csf-201004-0010_jaroslav-kvetina-osmdesatilety.php weekly 0.7 /artkey/csf-201004-0007_farmaceuti-rokovali-v-ruzomberku.php weekly 0.7 /en/artkey/csf-201004-0007_farmaceuti-rokovali-v-ruzomberku.php weekly 0.7 /artkey/csf-201004-0006_pracovni-den-sekce-prirodnich-leciv-ceske-farmaceuticke-spolecnosti-cls-jep-hradecky-den-lecivych-rostlin-hra.php weekly 0.7 /en/artkey/csf-201004-0006_pracovni-den-sekce-prirodnich-leciv-ceske-farmaceuticke-spolecnosti-cls-jep-hradecky-den-lecivych-rostlin-hra.php weekly 0.7 /magno/csf/2010/mn5.php weekly 0.7 /en/magno/csf/2010/mn5.php weekly 0.7 /artkey/csf-201005-0001_depression-relapse-and-antidepressants-consumption-in-the-quality-of-life-aspect.php weekly 0.7 /en/artkey/csf-201005-0001_depression-relapse-and-antidepressants-consumption-in-the-quality-of-life-aspect.php weekly 0.7 /artkey/csf-201005-0002_studies-of-local-anaesthetics-part-191-utilization-of-artificial-neural-networks-in-the-study-of-correlation.php weekly 0.7 /en/artkey/csf-201005-0002_studies-of-local-anaesthetics-part-191-utilization-of-artificial-neural-networks-in-the-study-of-correlation.php weekly 0.7 /artkey/csf-201005-0003_a-study-of-dissolution-profiles-of-tramadol-hydrochloride-from-the-dosage-forms-with-controlled-release-of-the.php weekly 0.7 /en/artkey/csf-201005-0003_a-study-of-dissolution-profiles-of-tramadol-hydrochloride-from-the-dosage-forms-with-controlled-release-of-the.php weekly 0.7 /artkey/csf-201005-0004_constituents-of-philadelphus-coronarius-l.php weekly 0.7 /en/artkey/csf-201005-0004_constituents-of-philadelphus-coronarius-l.php weekly 0.7 /artkey/csf-201005-0005_comparison-of-metoprolol-alpha-hydroxymetoprolol-metabolic-ratio-after-a-single-dose-and-in-steady-state.php weekly 0.7 /en/artkey/csf-201005-0005_comparison-of-metoprolol-alpha-hydroxymetoprolol-metabolic-ratio-after-a-single-dose-and-in-steady-state.php weekly 0.7 /artkey/csf-201005-0012_nove-knihy.php weekly 0.7 /en/artkey/csf-201005-0012_nove-knihy.php weekly 0.7 /artkey/csf-201005-0009_doc-rndr-magdalena-fulmekova-csc-jubiluje.php weekly 0.7 /en/artkey/csf-201005-0009_doc-rndr-magdalena-fulmekova-csc-jubiluje.php weekly 0.7 /artkey/csf-201005-0010_60-cesko-slovenske-farmakologicke-dny.php weekly 0.7 /en/artkey/csf-201005-0010_60-cesko-slovenske-farmakologicke-dny.php weekly 0.7 /artkey/csf-201005-0011_doc-rndr-marie-blesova-csc-in-memoriam.php weekly 0.7 /en/artkey/csf-201005-0011_doc-rndr-marie-blesova-csc-in-memoriam.php weekly 0.7 /artkey/csf-201005-0006_medicinal-preparations-in-the-renovated-prague-dispensatory-of-1750-part-i-introduction-and-the-first-nine-c.php weekly 0.7 /en/artkey/csf-201005-0006_medicinal-preparations-in-the-renovated-prague-dispensatory-of-1750-part-i-introduction-and-the-first-nine-c.php weekly 0.7 /artkey/csf-201005-0007_medicinal-preparations-in-the-restored-prague-dispensatory-of-1750-part-ii-the-examination-of-the-remaining.php weekly 0.7 /en/artkey/csf-201005-0007_medicinal-preparations-in-the-restored-prague-dispensatory-of-1750-part-ii-the-examination-of-the-remaining.php weekly 0.7 /artkey/csf-201005-0008_ze-zasedani-vyboru-ceske-farmaceuticke-spolecnosti.php weekly 0.7 /en/artkey/csf-201005-0008_ze-zasedani-vyboru-ceske-farmaceuticke-spolecnosti.php weekly 0.7 /magno/csf/2010/mn6.php weekly 0.7 /en/magno/csf/2010/mn6.php weekly 0.7 /artkey/csf-201006-0002_the-use-of-authorized-medicinal-products-for-human-use-in-veterinary-practice-in-the-czech-republic.php weekly 0.7 /en/artkey/csf-201006-0002_the-use-of-authorized-medicinal-products-for-human-use-in-veterinary-practice-in-the-czech-republic.php weekly 0.7 /artkey/csf-201006-0003_a-study-of-the-process-of-homogenization-of-powder-mixtures-using-nir-spectroscopy.php weekly 0.7 /en/artkey/csf-201006-0003_a-study-of-the-process-of-homogenization-of-powder-mixtures-using-nir-spectroscopy.php weekly 0.7 /artkey/csf-201006-0004_study-of-local-anesthetics-part-193-study-of-temperature-and-salt-induced-micellization-of-hepatacainium-perc.php weekly 0.7 /en/artkey/csf-201006-0004_study-of-local-anesthetics-part-193-study-of-temperature-and-salt-induced-micellization-of-hepatacainium-perc.php weekly 0.7 /artkey/csf-201006-0001_orodispersable-dosage-forms-and-technologies-used-in-their-production.php weekly 0.7 /en/artkey/csf-201006-0001_orodispersable-dosage-forms-and-technologies-used-in-their-production.php weekly 0.7 /artkey/csf-201006-0008_doc-rndr-maria-stankovicova-csc-ocenena-weberovou-cenou-sfs.php weekly 0.7 /en/artkey/csf-201006-0008_doc-rndr-maria-stankovicova-csc-ocenena-weberovou-cenou-sfs.php weekly 0.7 /artkey/csf-201006-0006_on-the-history-of-the-pharmacy-of-the-brothers-of-mercy-in-skalica-till-the-year-1919.php weekly 0.7 /en/artkey/csf-201006-0006_on-the-history-of-the-pharmacy-of-the-brothers-of-mercy-in-skalica-till-the-year-1919.php weekly 0.7 /artkey/csf-201006-0007_z-cinnosti-farmaceutickych-spolecnosti.php weekly 0.7 /en/artkey/csf-201006-0007_z-cinnosti-farmaceutickych-spolecnosti.php weekly 0.7 /artkey/csf-201006-0005_study-of-local-anaestetics-part-192-formulation-of-lidocaine-into-gels-with-anti-inflammatory-effect.php weekly 0.7 /en/artkey/csf-201006-0005_study-of-local-anaestetics-part-192-formulation-of-lidocaine-into-gels-with-anti-inflammatory-effect.php weekly 0.7 /artkey/csf-201006-0009_autorsky-a-vecny-rejstrik.php weekly 0.7 /en/artkey/csf-201006-0009_autorsky-a-vecny-rejstrik.php weekly 0.7 /magno/csf/2009/mn1.php weekly 0.7 /en/magno/csf/2009/mn1.php weekly 0.7 /artkey/csf-200901-0003_evaluation-of-pellet-friability.php weekly 0.7 /en/artkey/csf-200901-0003_evaluation-of-pellet-friability.php weekly 0.7 /artkey/csf-200901-0004_a-study-of-the-properties-of-compacts-from-directly-compressible-fructose.php weekly 0.7 /en/artkey/csf-200901-0004_a-study-of-the-properties-of-compacts-from-directly-compressible-fructose.php weekly 0.7 /artkey/csf-200901-0005_chitosan-pellets-produced-by-extrusion-spheronisation.php weekly 0.7 /en/artkey/csf-200901-0005_chitosan-pellets-produced-by-extrusion-spheronisation.php weekly 0.7 /artkey/csf-200901-0006_pharmacotherapy-of-cardiovascular-diseases-in-the-population-of-the-czech-republic.php weekly 0.7 /en/artkey/csf-200901-0006_pharmacotherapy-of-cardiovascular-diseases-in-the-population-of-the-czech-republic.php weekly 0.7 /artkey/csf-200901-0002_the-standard-prescriptions-for-the-preparation-of-pharmaceuticals-in-pharmacies-ii-proposals-for-innovation-an.php weekly 0.7 /en/artkey/csf-200901-0002_the-standard-prescriptions-for-the-preparation-of-pharmaceuticals-in-pharmacies-ii-proposals-for-innovation-an.php weekly 0.7 /artkey/csf-200901-0010_nove-knihy.php weekly 0.7 /en/artkey/csf-200901-0010_nove-knihy.php weekly 0.7 /artkey/csf-200901-0009_zivotni-vyroci-prof-rndr-phmr-karla-palata-csc.php weekly 0.7 /en/artkey/csf-200901-0009_zivotni-vyroci-prof-rndr-phmr-karla-palata-csc.php weekly 0.7 /artkey/csf-200901-0001_casopis-ceska-a-slovenska-farmacie-pri-vstupu-do-roku-2009.php weekly 0.7 /en/artkey/csf-200901-0001_casopis-ceska-a-slovenska-farmacie-pri-vstupu-do-roku-2009.php weekly 0.7 /artkey/csf-200901-0008_ze-zasedani-vyboru-ceske-farmaceuticke-spolecnosti.php weekly 0.7 /en/artkey/csf-200901-0008_ze-zasedani-vyboru-ceske-farmaceuticke-spolecnosti.php weekly 0.7 /artkey/csf-200901-0007_pokroky-v-lekovych-formach-pracovni-den-sekce-technologie-leku-ceske-farmaceuticke-spolecnosti-cls-jep.php weekly 0.7 /en/artkey/csf-200901-0007_pokroky-v-lekovych-formach-pracovni-den-sekce-technologie-leku-ceske-farmaceuticke-spolecnosti-cls-jep.php weekly 0.7 /magno/csf/2009/mn2.php weekly 0.7 /en/magno/csf/2009/mn2.php weekly 0.7 /artkey/csf-200902-0001_beneficial-effects-of-rutin-quercitrin-and-quercetin-on-inflammatory-bowel-disease.php weekly 0.7 /en/artkey/csf-200902-0001_beneficial-effects-of-rutin-quercitrin-and-quercetin-on-inflammatory-bowel-disease.php weekly 0.7 /artkey/csf-200902-0002_on-the-terms-pharmaceutical-care-pharmacy-care-and-good-pharmacy-practice.php weekly 0.7 /en/artkey/csf-200902-0002_on-the-terms-pharmaceutical-care-pharmacy-care-and-good-pharmacy-practice.php weekly 0.7 /artkey/csf-200902-0003_beta-blockers.php weekly 0.7 /en/artkey/csf-200902-0003_beta-blockers.php weekly 0.7 /artkey/csf-200902-0004_production-of-isoflavonoids-in-the-trifolium-pratense-l-suspension-culture.php weekly 0.7 /en/artkey/csf-200902-0004_production-of-isoflavonoids-in-the-trifolium-pratense-l-suspension-culture.php weekly 0.7 /artkey/csf-200902-0005_hplc-study-of-temperature-influence-on-some-enantiomer-separations-of-sulfoxides-determination-of-some-enantio.php weekly 0.7 /en/artkey/csf-200902-0005_hplc-study-of-temperature-influence-on-some-enantiomer-separations-of-sulfoxides-determination-of-some-enantio.php weekly 0.7 /artkey/csf-200902-0006_studies-of-local-anesthetics-part-187-extraction-of-1-methyl-2-piperidinoethylesters-of-alkoxyphenylcarbamic-a.php weekly 0.7 /en/artkey/csf-200902-0006_studies-of-local-anesthetics-part-187-extraction-of-1-methyl-2-piperidinoethylesters-of-alkoxyphenylcarbamic-a.php weekly 0.7 /artkey/csf-200902-0007_use-radionuclide-x-ray-fluorescence-analysis-for-determination-of-heavy-metals-content-in-dextrans-in-solid-and.php weekly 0.7 /en/artkey/csf-200902-0007_use-radionuclide-x-ray-fluorescence-analysis-for-determination-of-heavy-metals-content-in-dextrans-in-solid-and.php weekly 0.7 /artkey/csf-200902-0010_nove-knihy.php weekly 0.7 /en/artkey/csf-200902-0010_nove-knihy.php weekly 0.7 /artkey/csf-200902-0009_vyznamne-zivotni-jubileum-prof-rndr-evy-kvasnickove-csc.php weekly 0.7 /en/artkey/csf-200902-0009_vyznamne-zivotni-jubileum-prof-rndr-evy-kvasnickove-csc.php weekly 0.7 /artkey/csf-200902-0008_ze-zasedani-vyboru-ceske-farmaceuticke-spolecnosti.php weekly 0.7 /en/artkey/csf-200902-0008_ze-zasedani-vyboru-ceske-farmaceuticke-spolecnosti.php weekly 0.7 /magno/csf/2009/mn3.php weekly 0.7 /en/magno/csf/2009/mn3.php weekly 0.7 /artkey/csf-200903-0003_a-clinical-study-of-the-relationship-of-selenium-plasma-level-to-atopic-dermatitis-a-comparison-of-the-results.php weekly 0.7 /en/artkey/csf-200903-0003_a-clinical-study-of-the-relationship-of-selenium-plasma-level-to-atopic-dermatitis-a-comparison-of-the-results.php weekly 0.7 /artkey/csf-200903-0005_formulation-of-chlorhexidin-into-gels.php weekly 0.7 /en/artkey/csf-200903-0005_formulation-of-chlorhexidin-into-gels.php weekly 0.7 /artkey/csf-200903-0006_implementation-of-radio-frequency-identification-rfid-in-the-process-of-preparation-and-administration-of-dru.php weekly 0.7 /en/artkey/csf-200903-0006_implementation-of-radio-frequency-identification-rfid-in-the-process-of-preparation-and-administration-of-dru.php weekly 0.7 /artkey/csf-200903-0001_review-of-hydroxamic-matrix-metalloproteinase-inhibitors-and-their-therapeutic-potential.php weekly 0.7 /en/artkey/csf-200903-0001_review-of-hydroxamic-matrix-metalloproteinase-inhibitors-and-their-therapeutic-potential.php weekly 0.7 /artkey/csf-200903-0002_a-short-introduction-to-algal-and-cyanobacterial-constituents-the-occurrence-of-phenolic-metabolites.php weekly 0.7 /en/artkey/csf-200903-0002_a-short-introduction-to-algal-and-cyanobacterial-constituents-the-occurrence-of-phenolic-metabolites.php weekly 0.7 /artkey/csf-200903-0004_nove-knihy.php weekly 0.7 /en/artkey/csf-200903-0004_nove-knihy.php weekly 0.7 /artkey/csf-200903-0007_ointments-in-medieval-europe.php weekly 0.7 /en/artkey/csf-200903-0007_ointments-in-medieval-europe.php weekly 0.7 /artkey/csf-200903-0010_ze-zasedani-rady-eufeps-2009.php weekly 0.7 /en/artkey/csf-200903-0010_ze-zasedani-rady-eufeps-2009.php weekly 0.7 /artkey/csf-200903-0008_xxxi-pracovni-dny-sekce-radiofarmacie-ceske-spolecnosti-nuklearni-mediciny-cls-jep.php weekly 0.7 /en/artkey/csf-200903-0008_xxxi-pracovni-dny-sekce-radiofarmacie-ceske-spolecnosti-nuklearni-mediciny-cls-jep.php weekly 0.7 /artkey/csf-200903-0009_pracovni-den-sekce-prirodnich-leciv-ceske-farmaceuticke-spolecnosti-cls-jep.php weekly 0.7 /en/artkey/csf-200903-0009_pracovni-den-sekce-prirodnich-leciv-ceske-farmaceuticke-spolecnosti-cls-jep.php weekly 0.7 /magno/csf/2009/mn4.php weekly 0.7 /en/magno/csf/2009/mn4.php weekly 0.7 /artkey/csf-200904-0002_cardioprotective-effect-of-2-3-4-trihydroxychalcone-in-preclinical-experiment.php weekly 0.7 /en/artkey/csf-200904-0002_cardioprotective-effect-of-2-3-4-trihydroxychalcone-in-preclinical-experiment.php weekly 0.7 /artkey/csf-200904-0003_determination-of-the-coating-thickness-of-hpmc-hard-capsules-by-near-infrared-reflectance-spectroscopy.php weekly 0.7 /en/artkey/csf-200904-0003_determination-of-the-coating-thickness-of-hpmc-hard-capsules-by-near-infrared-reflectance-spectroscopy.php weekly 0.7 /artkey/csf-200904-0004_the-role-of-flavonoid-osajin-in-renal-ischemia-reperfusion-model.php weekly 0.7 /en/artkey/csf-200904-0004_the-role-of-flavonoid-osajin-in-renal-ischemia-reperfusion-model.php weekly 0.7 /artkey/csf-200904-0005_effects-of-combined-hormonal-deprivation-and-fungal-elicitation-on-the-production-of-coumarins-in-cell-suspensi.php weekly 0.7 /en/artkey/csf-200904-0005_effects-of-combined-hormonal-deprivation-and-fungal-elicitation-on-the-production-of-coumarins-in-cell-suspensi.php weekly 0.7 /artkey/csf-200904-0006_studies-of-the-properties-of-tablets-from-directly-compressible-isomalt.php weekly 0.7 /en/artkey/csf-200904-0006_studies-of-the-properties-of-tablets-from-directly-compressible-isomalt.php weekly 0.7 /artkey/csf-200904-0008_determination-of-the-constituents-of-propolis-of-different-geographical-origin.php weekly 0.7 /en/artkey/csf-200904-0008_determination-of-the-constituents-of-propolis-of-different-geographical-origin.php weekly 0.7 /artkey/csf-200904-0001_standard-prescriptions-for-the-formulation-of-medicinal-preparations-in-pharmacies-iii-some-possibilities-of-us.php weekly 0.7 /en/artkey/csf-200904-0001_standard-prescriptions-for-the-formulation-of-medicinal-preparations-in-pharmacies-iii-some-possibilities-of-us.php weekly 0.7 /artkey/csf-200904-0007_xlix-sympozium-z-historie-farmacie-a-veterinarni-mediciny.php weekly 0.7 /en/artkey/csf-200904-0007_xlix-sympozium-z-historie-farmacie-a-veterinarni-mediciny.php weekly 0.7 /artkey/csf-200904-0010_na-pamatku-prof-rndr-phmr-karla-palata-csc.php weekly 0.7 /en/artkey/csf-200904-0010_na-pamatku-prof-rndr-phmr-karla-palata-csc.php weekly 0.7 /artkey/csf-200904-0009_zasedani-vyboru-ceske-farmaceuticke-spolecnosti-v-obdobi-brezen-rijen-2009.php weekly 0.7 /en/artkey/csf-200904-0009_zasedani-vyboru-ceske-farmaceuticke-spolecnosti-v-obdobi-brezen-rijen-2009.php weekly 0.7 /magno/csf/2009/mn5.php weekly 0.7 /en/magno/csf/2009/mn5.php weekly 0.7 /artkey/csf-200905-0003_hypolipidemic-effect-of-amaranth-constituents.php weekly 0.7 /en/artkey/csf-200905-0003_hypolipidemic-effect-of-amaranth-constituents.php weekly 0.7 /artkey/csf-200905-0004_antimycobacterial-activity-of-novel-derivatives-of-arylcarbonyloxyaminopropanols.php weekly 0.7 /en/artkey/csf-200905-0004_antimycobacterial-activity-of-novel-derivatives-of-arylcarbonyloxyaminopropanols.php weekly 0.7 /artkey/csf-200905-0005_comparison-of-renal-accumulation-of-dota0-1-nal3-octreotide-labelled-with-selected-radiometals.php weekly 0.7 /en/artkey/csf-200905-0005_comparison-of-renal-accumulation-of-dota0-1-nal3-octreotide-labelled-with-selected-radiometals.php weekly 0.7 /artkey/csf-200905-0006_adhesivity-of-branched-plasticized-oligoesters.php weekly 0.7 /en/artkey/csf-200905-0006_adhesivity-of-branched-plasticized-oligoesters.php weekly 0.7 /artkey/csf-200905-0007_influence-of-formulation-technology-on-theophylline-release-from-chitosan-based-pellets.php weekly 0.7 /en/artkey/csf-200905-0007_influence-of-formulation-technology-on-theophylline-release-from-chitosan-based-pellets.php weekly 0.7 /artkey/csf-200905-0008_monitoring-of-surface-cytotoxic-drugs-in-the-environment-of-hospital-pharmacies-in-the-czech-republic.php weekly 0.7 /en/artkey/csf-200905-0008_monitoring-of-surface-cytotoxic-drugs-in-the-environment-of-hospital-pharmacies-in-the-czech-republic.php weekly 0.7 /artkey/csf-200905-0001_methods-of-preparation-of-microparticles-in-pharmaceutical-technology.php weekly 0.7 /en/artkey/csf-200905-0001_methods-of-preparation-of-microparticles-in-pharmaceutical-technology.php weekly 0.7 /artkey/csf-200905-0002_pandemic-h1n1-2009.php weekly 0.7 /en/artkey/csf-200905-0002_pandemic-h1n1-2009.php weekly 0.7 /artkey/csf-200905-0013_k-zivotnemu-jubileu-doc-rndr-zuzany-vitkovej-phd.php weekly 0.7 /en/artkey/csf-200905-0013_k-zivotnemu-jubileu-doc-rndr-zuzany-vitkovej-phd.php weekly 0.7 /artkey/csf-200905-0014_xxv-lekarnicke-dny-litomerice-3-5-rijna.php weekly 0.7 /en/artkey/csf-200905-0014_xxv-lekarnicke-dny-litomerice-3-5-rijna.php weekly 0.7 /artkey/csf-200905-0009_contributions-to-the-development-of-advertising-in-pharmacy-i.php weekly 0.7 /en/artkey/csf-200905-0009_contributions-to-the-development-of-advertising-in-pharmacy-i.php weekly 0.7 /artkey/csf-200905-0010_a-contribution-to-the-histories-of-the-pharmacies-of-the-brethren-of-mercy-in-the-territory-of-contemporary-slo.php weekly 0.7 /en/artkey/csf-200905-0010_a-contribution-to-the-histories-of-the-pharmacies-of-the-brethren-of-mercy-in-the-territory-of-contemporary-slo.php weekly 0.7 /artkey/csf-200905-0011_examination-of-selected-quality-parameters-of-the-parenteral-nutrition-aio-a-pilot-study.php weekly 0.7 /en/artkey/csf-200905-0011_examination-of-selected-quality-parameters-of-the-parenteral-nutrition-aio-a-pilot-study.php weekly 0.7 /artkey/csf-200905-0015_autorsky-rejstrik.php weekly 0.7 /en/artkey/csf-200905-0015_autorsky-rejstrik.php weekly 0.7 /artkey/csf-200905-0016_vecny-rejstrik.php weekly 0.7 /en/artkey/csf-200905-0016_vecny-rejstrik.php weekly 0.7 /artkey/csf-200905-0012_erratum.php weekly 0.7 /en/artkey/csf-200905-0012_erratum.php weekly 0.7 /magno/csf/2008/mn1.php weekly 0.7 /en/magno/csf/2008/mn1.php weekly 0.7 /artkey/csf-200801-0006_effects-of-auxins-on-growth-and-scopoletin-accumulation-in-cell-suspension-cultures-of-angelica-archangelica-l.php weekly 0.7 /en/artkey/csf-200801-0006_effects-of-auxins-on-growth-and-scopoletin-accumulation-in-cell-suspension-cultures-of-angelica-archangelica-l.php weekly 0.7 /artkey/csf-200801-0007_a-study-of-the-properties-of-tablets-made-of-directly-compressible-maltose.php weekly 0.7 /en/artkey/csf-200801-0007_a-study-of-the-properties-of-tablets-made-of-directly-compressible-maltose.php weekly 0.7 /artkey/csf-200801-0008_substances-modifying-the-activity-of-caspases.php weekly 0.7 /en/artkey/csf-200801-0008_substances-modifying-the-activity-of-caspases.php weekly 0.7 /artkey/csf-200801-0009_antioxidant-activity-of-tinctures-prepared-from-hawthorn-fruits-and-motherwort-herb.php weekly 0.7 /en/artkey/csf-200801-0009_antioxidant-activity-of-tinctures-prepared-from-hawthorn-fruits-and-motherwort-herb.php weekly 0.7 /artkey/csf-200801-0002_signal-pathways-of-cell-proliferation-and-death-as-targets-of-potential-chemotherapeutics.php weekly 0.7 /en/artkey/csf-200801-0002_signal-pathways-of-cell-proliferation-and-death-as-targets-of-potential-chemotherapeutics.php weekly 0.7 /artkey/csf-200801-0003_hemostatic-effects-of-oxidized-cellulose.php weekly 0.7 /en/artkey/csf-200801-0003_hemostatic-effects-of-oxidized-cellulose.php weekly 0.7 /artkey/csf-200801-0004_nove-knihy.php weekly 0.7 /en/artkey/csf-200801-0004_nove-knihy.php weekly 0.7 /artkey/csf-200801-0017_nove-knihy.php weekly 0.7 /en/artkey/csf-200801-0017_nove-knihy.php weekly 0.7 /artkey/csf-200801-0013_mezinarodni-kongres-historie-farmacie.php weekly 0.7 /en/artkey/csf-200801-0013_mezinarodni-kongres-historie-farmacie.php weekly 0.7 /artkey/csf-200801-0014_cena-pro-doc-rndr-phmr-vaclava-ruska-csc.php weekly 0.7 /en/artkey/csf-200801-0014_cena-pro-doc-rndr-phmr-vaclava-ruska-csc.php weekly 0.7 /artkey/csf-200801-0015_jubileum-doc-rndr-ruzeny-cizmarikovej-csc.php weekly 0.7 /en/artkey/csf-200801-0015_jubileum-doc-rndr-ruzeny-cizmarikovej-csc.php weekly 0.7 /artkey/csf-200801-0016_zivotne-jubileum-prof-rndr-vladimira-springera-csc.php weekly 0.7 /en/artkey/csf-200801-0016_zivotne-jubileum-prof-rndr-vladimira-springera-csc.php weekly 0.7 /artkey/csf-200801-0001_casopis-ceska-a-slovenska-farmacie-v-roce-2008.php weekly 0.7 /en/artkey/csf-200801-0001_casopis-ceska-a-slovenska-farmacie-v-roce-2008.php weekly 0.7 /artkey/csf-200801-0012_ze-zasedani-vyboru-ceske-farmaceuticke-spolecnosti.php weekly 0.7 /en/artkey/csf-200801-0012_ze-zasedani-vyboru-ceske-farmaceuticke-spolecnosti.php weekly 0.7 /artkey/csf-200801-0010_pokroky-v-lekovych-formach-pracovni-den-sekce-technologie-leku-cfs-jep.php weekly 0.7 /en/artkey/csf-200801-0010_pokroky-v-lekovych-formach-pracovni-den-sekce-technologie-leku-cfs-jep.php weekly 0.7 /artkey/csf-200801-0011_abstrakta-z-akci-cfs-v-casopisu-ceska-a-slovenska-farmacie.php weekly 0.7 /en/artkey/csf-200801-0011_abstrakta-z-akci-cfs-v-casopisu-ceska-a-slovenska-farmacie.php weekly 0.7 /artkey/csf-200801-0005_podvyziva-a-nevhodna-vyziva.php weekly 0.7 /en/artkey/csf-200801-0005_podvyziva-a-nevhodna-vyziva.php weekly 0.7 /magno/csf/2008/mn2.php weekly 0.7 /en/magno/csf/2008/mn2.php weekly 0.7 /artkey/csf-200802-0011_contribution-of-allergen-immunotherapy-using-phostal-in-the-treatment-of-seasonal-allergic-rhinitis-two-years.php weekly 0.7 /en/artkey/csf-200802-0011_contribution-of-allergen-immunotherapy-using-phostal-in-the-treatment-of-seasonal-allergic-rhinitis-two-years.php weekly 0.7 /artkey/csf-200802-0001_standard-prescriptions-for-the-formulation-of-medicinal-preparations-in-pharmacies-i-suspensions-for-dermal-ad.php weekly 0.7 /en/artkey/csf-200802-0001_standard-prescriptions-for-the-formulation-of-medicinal-preparations-in-pharmacies-i-suspensions-for-dermal-ad.php weekly 0.7 /artkey/csf-200802-0002_interaction-of-1-4-dihydropyridines-with-ion-channels.php weekly 0.7 /en/artkey/csf-200802-0002_interaction-of-1-4-dihydropyridines-with-ion-channels.php weekly 0.7 /artkey/csf-200802-0004_semisynthetic-cellulose-derivatives-as-the-base-of-hydrophilic-gel-systems.php weekly 0.7 /en/artkey/csf-200802-0004_semisynthetic-cellulose-derivatives-as-the-base-of-hydrophilic-gel-systems.php weekly 0.7 /artkey/csf-200802-0005_radiolabelled-peptides-in-the-diagnosis-and-therapy-of-tumours.php weekly 0.7 /en/artkey/csf-200802-0005_radiolabelled-peptides-in-the-diagnosis-and-therapy-of-tumours.php weekly 0.7 /artkey/csf-200802-0006_medicinal-plants-and-diabetes-mellitus.php weekly 0.7 /en/artkey/csf-200802-0006_medicinal-plants-and-diabetes-mellitus.php weekly 0.7 /artkey/csf-200802-0008_modern-instrumentation-for-the-studies-of-isoflavones.php weekly 0.7 /en/artkey/csf-200802-0008_modern-instrumentation-for-the-studies-of-isoflavones.php weekly 0.7 /artkey/csf-200802-0010_lactobacilli-and-their-probiotic-properties.php weekly 0.7 /en/artkey/csf-200802-0010_lactobacilli-and-their-probiotic-properties.php weekly 0.7 /artkey/csf-200802-0003_nove-knihy.php weekly 0.7 /en/artkey/csf-200802-0003_nove-knihy.php weekly 0.7 /artkey/csf-200802-0007_nove-knihy.php weekly 0.7 /en/artkey/csf-200802-0007_nove-knihy.php weekly 0.7 /artkey/csf-200802-0012_sedmdesatka-doc-rndr-jiriho-hartla-csc.php weekly 0.7 /en/artkey/csf-200802-0012_sedmdesatka-doc-rndr-jiriho-hartla-csc.php weekly 0.7 /artkey/csf-200802-0013_k-zivotnimu-jubileu-prof-rndr-rolfa-karlicka-drsc.php weekly 0.7 /en/artkey/csf-200802-0013_k-zivotnimu-jubileu-prof-rndr-rolfa-karlicka-drsc.php weekly 0.7 /artkey/csf-200802-0009_ze-zasedani-vyboru-ceske-farmaceuticke-spolecnosti.php weekly 0.7 /en/artkey/csf-200802-0009_ze-zasedani-vyboru-ceske-farmaceuticke-spolecnosti.php weekly 0.7 /magno/csf/2008/mn3.php weekly 0.7 /en/magno/csf/2008/mn3.php weekly 0.7 /artkey/csf-200803-0001_biotic-elicitation-of-the-l-suspension-culture.php weekly 0.7 /en/artkey/csf-200803-0001_biotic-elicitation-of-the-l-suspension-culture.php weekly 0.7 /artkey/csf-200803-0002_effects-of-mg-atp-on-the-flavonoid-production-in-the-scutellaria-baicalensis-georgii-suspension-cultures.php weekly 0.7 /en/artkey/csf-200803-0002_effects-of-mg-atp-on-the-flavonoid-production-in-the-scutellaria-baicalensis-georgii-suspension-cultures.php weekly 0.7 /artkey/csf-200803-0003_synthesis-of-2-3-4-4-fluorophenyl-1-piperazinyl-2-hydroxy-propoxy-phenylcarbamic-acid-alkylesters-and-in.php weekly 0.7 /en/artkey/csf-200803-0003_synthesis-of-2-3-4-4-fluorophenyl-1-piperazinyl-2-hydroxy-propoxy-phenylcarbamic-acid-alkylesters-and-in.php weekly 0.7 /artkey/csf-200803-0004_studies-on-local-anesthetics-part-183-micellization-and-thermodynamic-parameters-of-heptacainium-chloride-in-t.php weekly 0.7 /en/artkey/csf-200803-0004_studies-on-local-anesthetics-part-183-micellization-and-thermodynamic-parameters-of-heptacainium-chloride-in-t.php weekly 0.7 /artkey/csf-200803-0013_nove-knihy.php weekly 0.7 /en/artkey/csf-200803-0013_nove-knihy.php weekly 0.7 /artkey/csf-200803-0010_vyznacny-farmaceut-rndr-phmr-lumir-jindra-se-dozil-80-let.php weekly 0.7 /en/artkey/csf-200803-0010_vyznacny-farmaceut-rndr-phmr-lumir-jindra-se-dozil-80-let.php weekly 0.7 /artkey/csf-200803-0011_docent-ing-ivan-lacko-je-uz-sedemdesiatnikom.php weekly 0.7 /en/artkey/csf-200803-0011_docent-ing-ivan-lacko-je-uz-sedemdesiatnikom.php weekly 0.7 /artkey/csf-200803-0012_oslavy-zivotniho-jubilea-nestoru-ceske-farmacie.php weekly 0.7 /en/artkey/csf-200803-0012_oslavy-zivotniho-jubilea-nestoru-ceske-farmacie.php weekly 0.7 /artkey/csf-200803-0005_medicinal-preparations-in-mattioli-s-herbarium-of-1596.php weekly 0.7 /en/artkey/csf-200803-0005_medicinal-preparations-in-mattioli-s-herbarium-of-1596.php weekly 0.7 /artkey/csf-200803-0009_slovenska-farmaceuticka-spolocnost-55-rocna.php weekly 0.7 /en/artkey/csf-200803-0009_slovenska-farmaceuticka-spolocnost-55-rocna.php weekly 0.7 /artkey/csf-200803-0006_on-the-content-of-the-national-part-of-the-czech-pharmacopoeia-from-the-aspect-of-the-formulation-of-medicinal.php weekly 0.7 /en/artkey/csf-200803-0006_on-the-content-of-the-national-part-of-the-czech-pharmacopoeia-from-the-aspect-of-the-formulation-of-medicinal.php weekly 0.7 /artkey/csf-200803-0007_x-sjezd-ceske-farmaceuticke-spolecnosti-cls-jep.php weekly 0.7 /en/artkey/csf-200803-0007_x-sjezd-ceske-farmaceuticke-spolecnosti-cls-jep.php weekly 0.7 /artkey/csf-200803-0008_xxx-pracovni-dny-sekce-radiofarmacie-ceske-spolecnosti-nuklearni-mediciny-cls-jep.php weekly 0.7 /en/artkey/csf-200803-0008_xxx-pracovni-dny-sekce-radiofarmacie-ceske-spolecnosti-nuklearni-mediciny-cls-jep.php weekly 0.7 /magno/csf/2008/mn4.php weekly 0.7 /en/magno/csf/2008/mn4.php weekly 0.7 /artkey/csf-200804-0003_synthesis-identification-and-physicochemical-properties-of-novel-potential-ultrashort-acting-beta-adrenergic-b.php weekly 0.7 /en/artkey/csf-200804-0003_synthesis-identification-and-physicochemical-properties-of-novel-potential-ultrashort-acting-beta-adrenergic-b.php weekly 0.7 /artkey/csf-200804-0004_characterization-of-microcrystalline-celluloses-by-means-of-the-parameters-of-a-three-exponential-compression-e.php weekly 0.7 /en/artkey/csf-200804-0004_characterization-of-microcrystalline-celluloses-by-means-of-the-parameters-of-a-three-exponential-compression-e.php weekly 0.7 /artkey/csf-200804-0006_a-study-of-the-properties-of-tablets-from-two-types-of-directly-compressible-xylitol.php weekly 0.7 /en/artkey/csf-200804-0006_a-study-of-the-properties-of-tablets-from-two-types-of-directly-compressible-xylitol.php weekly 0.7 /artkey/csf-200804-0002_actual-acidity-of-the-environment-and-efficacy-of-auxiliary-substances-used-for-antimicrobial-stabilization-of.php weekly 0.7 /en/artkey/csf-200804-0002_actual-acidity-of-the-environment-and-efficacy-of-auxiliary-substances-used-for-antimicrobial-stabilization-of.php weekly 0.7 /artkey/csf-200804-0005_rada-vlady-cr-pro-vyzkum-a-vyvoj.php weekly 0.7 /en/artkey/csf-200804-0005_rada-vlady-cr-pro-vyzkum-a-vyvoj.php weekly 0.7 /artkey/csf-200804-0011_prof-mudr-jaroslav-drsata-csc-65-let.php weekly 0.7 /en/artkey/csf-200804-0011_prof-mudr-jaroslav-drsata-csc-65-let.php weekly 0.7 /artkey/csf-200804-0012_upozorneni.php weekly 0.7 /en/artkey/csf-200804-0012_upozorneni.php weekly 0.7 /artkey/csf-200804-0001_zprava-o-cinnosti-ceske-farmaceuticke-spolecnosti-cls-j-e-purkyne-za-obdobi-vii-2004-az-iv-2008-prednesena.php weekly 0.7 /en/artkey/csf-200804-0001_zprava-o-cinnosti-ceske-farmaceuticke-spolecnosti-cls-j-e-purkyne-za-obdobi-vii-2004-az-iv-2008-prednesena.php weekly 0.7 /artkey/csf-200804-0010_z-cinnosti-farmaceutickych-spolecnosti.php weekly 0.7 /en/artkey/csf-200804-0010_z-cinnosti-farmaceutickych-spolecnosti.php weekly 0.7 /artkey/csf-200804-0007_novy-zpusob-aplikace-ionsys-fentanylu-transdermalnim-systemem.php weekly 0.7 /en/artkey/csf-200804-0007_novy-zpusob-aplikace-ionsys-fentanylu-transdermalnim-systemem.php weekly 0.7 /artkey/csf-200804-0008_antiradical-activity-of-substances-with-a-potential-effect-on-the-cardiovascular-system.php weekly 0.7 /en/artkey/csf-200804-0008_antiradical-activity-of-substances-with-a-potential-effect-on-the-cardiovascular-system.php weekly 0.7 /artkey/csf-200804-0009_monitoring-of-pharmacotherapy-in-seniors-of-rest-homes-in-brno-region.php weekly 0.7 /en/artkey/csf-200804-0009_monitoring-of-pharmacotherapy-in-seniors-of-rest-homes-in-brno-region.php weekly 0.7 /magno/csf/2008/mn5.php weekly 0.7 /en/magno/csf/2008/mn5.php weekly 0.7 /artkey/csf-200805-0004_characterization-of-celluloses-by-means-of-viscoelastic-parameters.php weekly 0.7 /en/artkey/csf-200805-0004_characterization-of-celluloses-by-means-of-viscoelastic-parameters.php weekly 0.7 /artkey/csf-200805-0006_effect-of-montelukast-on-the-treatment-of-asthma-bronchiale-in-pediatric-patients-with-perennial-allergic-rhini.php weekly 0.7 /en/artkey/csf-200805-0006_effect-of-montelukast-on-the-treatment-of-asthma-bronchiale-in-pediatric-patients-with-perennial-allergic-rhini.php weekly 0.7 /artkey/csf-200805-0008_impact-of-demographic-factors-on-consumption-of-pharmaceuticals-in-the-czech-republic.php weekly 0.7 /en/artkey/csf-200805-0008_impact-of-demographic-factors-on-consumption-of-pharmaceuticals-in-the-czech-republic.php weekly 0.7 /artkey/csf-200805-0001_therapeutic-potential-of-phytocannabinoids-and-synthetic-derivatives-affecting-human-endocannabinoid-system.php weekly 0.7 /en/artkey/csf-200805-0001_therapeutic-potential-of-phytocannabinoids-and-synthetic-derivatives-affecting-human-endocannabinoid-system.php weekly 0.7 /artkey/csf-200805-0002_history-and-the-present-state-of-hypolipidaemic-therapy.php weekly 0.7 /en/artkey/csf-200805-0002_history-and-the-present-state-of-hypolipidaemic-therapy.php weekly 0.7 /artkey/csf-200805-0003_nove-knihy.php weekly 0.7 /en/artkey/csf-200805-0003_nove-knihy.php weekly 0.7 /artkey/csf-200805-0005_nove-knihy.php weekly 0.7 /en/artkey/csf-200805-0005_nove-knihy.php weekly 0.7 /artkey/csf-200805-0010_jubileum-doc-rndr-phmr-jaroslava-sovy-csc.php weekly 0.7 /en/artkey/csf-200805-0010_jubileum-doc-rndr-phmr-jaroslava-sovy-csc.php weekly 0.7 /artkey/csf-200805-0011_doc-dr-jan-baloun-osmdesatnikem.php weekly 0.7 /en/artkey/csf-200805-0011_doc-dr-jan-baloun-osmdesatnikem.php weekly 0.7 /artkey/csf-200805-0012_sympozium-farmaceuticke-technologie.php weekly 0.7 /en/artkey/csf-200805-0012_sympozium-farmaceuticke-technologie.php weekly 0.7 /artkey/csf-200805-0009_medicinal-preparations-in-prague-pharmacies-at-the-end-of-the-16th-century.php weekly 0.7 /en/artkey/csf-200805-0009_medicinal-preparations-in-prague-pharmacies-at-the-end-of-the-16th-century.php weekly 0.7 /artkey/csf-200805-0007_abstrakta-z-akci-cfs-v-casopisu-ceska-a-slovenska-farmacie.php weekly 0.7 /en/artkey/csf-200805-0007_abstrakta-z-akci-cfs-v-casopisu-ceska-a-slovenska-farmacie.php weekly 0.7 /magno/csf/2008/mn6.php weekly 0.7 /en/magno/csf/2008/mn6.php weekly 0.7 /artkey/csf-200806-0001_the-effect-of-crataegus-extract-on-heart-mitochondrial-function.php weekly 0.7 /en/artkey/csf-200806-0001_the-effect-of-crataegus-extract-on-heart-mitochondrial-function.php weekly 0.7 /artkey/csf-200806-0002_consumption-of-hipolipidemics-in-the-czech-republic-in-2000-2007.php weekly 0.7 /en/artkey/csf-200806-0002_consumption-of-hipolipidemics-in-the-czech-republic-in-2000-2007.php weekly 0.7 /artkey/csf-200806-0003_testing-the-effect-of-2-3-4-trihydroxychalcone-in-experimental-diabetes-mellitus-a-pilot-study.php weekly 0.7 /en/artkey/csf-200806-0003_testing-the-effect-of-2-3-4-trihydroxychalcone-in-experimental-diabetes-mellitus-a-pilot-study.php weekly 0.7 /artkey/csf-200806-0004_determination-of-metoprolol-and-its-metabolite-alpha-hydroxymetoprolol-in-serum-by-hplc-method-with-fluoresce.php weekly 0.7 /en/artkey/csf-200806-0004_determination-of-metoprolol-and-its-metabolite-alpha-hydroxymetoprolol-in-serum-by-hplc-method-with-fluoresce.php weekly 0.7 /artkey/csf-200806-0005_studies-of-local-anesthetics-part-185-thermodynamic-parameters-of-heptacainium-chloride-in-the-solution-of-nab.php weekly 0.7 /en/artkey/csf-200806-0005_studies-of-local-anesthetics-part-185-thermodynamic-parameters-of-heptacainium-chloride-in-the-solution-of-nab.php weekly 0.7 /artkey/csf-200806-0006_optimization-of-the-extraction-method-for-the-determination-of-methadone-and-its-metabolite-eddp-in-urine-by-ga.php weekly 0.7 /en/artkey/csf-200806-0006_optimization-of-the-extraction-method-for-the-determination-of-methadone-and-its-metabolite-eddp-in-urine-by-ga.php weekly 0.7 /artkey/csf-200806-0007_the-effect-of-lipophilic-carrier-concentration-on-hydrophilic-lipophilic-matrix-systems-characteristics.php weekly 0.7 /en/artkey/csf-200806-0007_the-effect-of-lipophilic-carrier-concentration-on-hydrophilic-lipophilic-matrix-systems-characteristics.php weekly 0.7 /artkey/csf-200806-0012_knihy.php weekly 0.7 /en/artkey/csf-200806-0012_knihy.php weekly 0.7 /artkey/csf-200806-0011_rndr-phmr-vaclav-mares-6-zari-1927-12-srpna-2008.php weekly 0.7 /en/artkey/csf-200806-0011_rndr-phmr-vaclav-mares-6-zari-1927-12-srpna-2008.php weekly 0.7 /artkey/csf-200806-0009_ze-zasedani-vyboru-ceske-farmaceuticke-spolecnosti.php weekly 0.7 /en/artkey/csf-200806-0009_ze-zasedani-vyboru-ceske-farmaceuticke-spolecnosti.php weekly 0.7 /artkey/csf-200806-0010_zasedani-rady-eufeps-2008.php weekly 0.7 /en/artkey/csf-200806-0010_zasedani-rady-eufeps-2008.php weekly 0.7 /artkey/csf-200806-0008_possible-effects-on-the-liberation-of-alaptid-from-dermal-semisolid-preparations.php weekly 0.7 /en/artkey/csf-200806-0008_possible-effects-on-the-liberation-of-alaptid-from-dermal-semisolid-preparations.php weekly 0.7 /artkey/csf-200806-0013_autorsky-rejstrik.php weekly 0.7 /en/artkey/csf-200806-0013_autorsky-rejstrik.php weekly 0.7 /artkey/csf-200806-0014_vecny-rejstrik.php weekly 0.7 /en/artkey/csf-200806-0014_vecny-rejstrik.php weekly 0.7 /magno/csf/2007/mn1.php weekly 0.7 /en/magno/csf/2007/mn1.php weekly 0.7 /artkey/csf-200701-0003_the-influence-of-the-extrusion-die-on-pellet-characteristics.php weekly 0.7 /en/artkey/csf-200701-0003_the-influence-of-the-extrusion-die-on-pellet-characteristics.php weekly 0.7 /artkey/csf-200701-0004_genista-tinctoria-in-vitro.php weekly 0.7 /en/artkey/csf-200701-0004_genista-tinctoria-in-vitro.php weekly 0.7 /artkey/csf-200701-0005_constituents-of-lilium-candidum-l-and-their-antioxidative-activity.php weekly 0.7 /en/artkey/csf-200701-0005_constituents-of-lilium-candidum-l-and-their-antioxidative-activity.php weekly 0.7 /artkey/csf-200701-0006_prescription-of-hypolipidemic-agents-in-2001-2004.php weekly 0.7 /en/artkey/csf-200701-0006_prescription-of-hypolipidemic-agents-in-2001-2004.php weekly 0.7 /artkey/csf-200701-0007_consumption-of-old-and-new-antiepileptic-drugs-in-the-czech-republic-in-1999-2004.php weekly 0.7 /en/artkey/csf-200701-0007_consumption-of-old-and-new-antiepileptic-drugs-in-the-czech-republic-in-1999-2004.php weekly 0.7 /artkey/csf-200701-0008_analysis-of-supplying-situation-in-pharmacies-i-supply-with-medicaments-and-health-appliances-from-the-viewpoi.php weekly 0.7 /en/artkey/csf-200701-0008_analysis-of-supplying-situation-in-pharmacies-i-supply-with-medicaments-and-health-appliances-from-the-viewpoi.php weekly 0.7 /artkey/csf-200701-0001_deep-vein-thromboembolism-in-malignant-diseases.php weekly 0.7 /en/artkey/csf-200701-0001_deep-vein-thromboembolism-in-malignant-diseases.php weekly 0.7 /artkey/csf-200701-0002_extrusion-spheronization-an-important-method-for-the-production-of-the-pellet-dosage-form.php weekly 0.7 /en/artkey/csf-200701-0002_extrusion-spheronization-an-important-method-for-the-production-of-the-pellet-dosage-form.php weekly 0.7 /magno/csf/2007/mn2.php weekly 0.7 /en/magno/csf/2007/mn2.php weekly 0.7 /artkey/csf-200702-0004_risk-of-drug-interactions-and-their-possible-solutions-in-the-population-of-patients-with-inflammatory-bowell-d.php weekly 0.7 /en/artkey/csf-200702-0004_risk-of-drug-interactions-and-their-possible-solutions-in-the-population-of-patients-with-inflammatory-bowell-d.php weekly 0.7 /artkey/csf-200702-0005_an-orientational-examination-of-the-effects-of-extracts-from-mixtures-of-herbal-drugs-on-selected-renal-functio.php weekly 0.7 /en/artkey/csf-200702-0005_an-orientational-examination-of-the-effects-of-extracts-from-mixtures-of-herbal-drugs-on-selected-renal-functio.php weekly 0.7 /artkey/csf-200702-0006_characterization-of-polyphenoloxidase-from-the-latex-of-greater-celandine-chelidonium-majus-l.php weekly 0.7 /en/artkey/csf-200702-0006_characterization-of-polyphenoloxidase-from-the-latex-of-greater-celandine-chelidonium-majus-l.php weekly 0.7 /artkey/csf-200702-0007_analysis-of-supplying-situation-in-pharmacies-ii-availability-of-medicaments-and-health-appliances-from-the-vi.php weekly 0.7 /en/artkey/csf-200702-0007_analysis-of-supplying-situation-in-pharmacies-ii-availability-of-medicaments-and-health-appliances-from-the-vi.php weekly 0.7 /artkey/csf-200702-0001_hypericin-and-hyperforin-bioactive-components-of-st-john-s-wort-hypericum-perforatum-their-isolation-analy.php weekly 0.7 /en/artkey/csf-200702-0001_hypericin-and-hyperforin-bioactive-components-of-st-john-s-wort-hypericum-perforatum-their-isolation-analy.php weekly 0.7 /artkey/csf-200702-0002_pellets-preparation-by-the-drug-layering-technique-in-a-rotary-processor.php weekly 0.7 /en/artkey/csf-200702-0002_pellets-preparation-by-the-drug-layering-technique-in-a-rotary-processor.php weekly 0.7 /artkey/csf-200702-0003_antioxidants-free-radicals-mechanism-of-action-and-application-in-the-therapy-of-the-sulfur-mustard-caused-in.php weekly 0.7 /en/artkey/csf-200702-0003_antioxidants-free-radicals-mechanism-of-action-and-application-in-the-therapy-of-the-sulfur-mustard-caused-in.php weekly 0.7 /magno/csf/2007/mn3.php weekly 0.7 /en/magno/csf/2007/mn3.php weekly 0.7 /artkey/csf-200703-0003_variability-of-the-essential-oil-from-three-sorts-of-echinacea-moench-genus-during-ontogenesis.php weekly 0.7 /en/artkey/csf-200703-0003_variability-of-the-essential-oil-from-three-sorts-of-echinacea-moench-genus-during-ontogenesis.php weekly 0.7 /artkey/csf-200703-0004_fagopyrum-esculentum-in-vitro.php weekly 0.7 /en/artkey/csf-200703-0004_fagopyrum-esculentum-in-vitro.php weekly 0.7 /artkey/csf-200703-0005_thermoplastic-granulation-as-an-alternative-method-for-the-preparation-of-hydrophiliclipophilic-oral-matrix-tab.php weekly 0.7 /en/artkey/csf-200703-0005_thermoplastic-granulation-as-an-alternative-method-for-the-preparation-of-hydrophiliclipophilic-oral-matrix-tab.php weekly 0.7 /artkey/csf-200703-0006_examination-of-the-antioxidative-and-antidiabetic-effect-of-pomiferin-in-alloxan-induced-diabetes-mellitus-in-a.php weekly 0.7 /en/artkey/csf-200703-0006_examination-of-the-antioxidative-and-antidiabetic-effect-of-pomiferin-in-alloxan-induced-diabetes-mellitus-in-a.php weekly 0.7 /artkey/csf-200703-0007_chitosan-in-topical-preparations.php weekly 0.7 /en/artkey/csf-200703-0007_chitosan-in-topical-preparations.php weekly 0.7 /artkey/csf-200703-0001_hplc-separation-of-enantiomers-using-chiral-stationary-phases.php weekly 0.7 /en/artkey/csf-200703-0001_hplc-separation-of-enantiomers-using-chiral-stationary-phases.php weekly 0.7 /artkey/csf-200703-0002_naphthoquinones-and-their-pharmacological-properties.php weekly 0.7 /en/artkey/csf-200703-0002_naphthoquinones-and-their-pharmacological-properties.php weekly 0.7 /artkey/csf-200703-0008_medicinal-preparations-in-a-manuscript-of-a-fifteen-century-franciscan-monk-in-brno.php weekly 0.7 /en/artkey/csf-200703-0008_medicinal-preparations-in-a-manuscript-of-a-fifteen-century-franciscan-monk-in-brno.php weekly 0.7 /magno/csf/2007/mn4.php weekly 0.7 /en/magno/csf/2007/mn4.php weekly 0.7 /artkey/csf-200704-0005_a-study-of-the-properties-of-tablets-from-the-mixtures-of-directly-compressible-starch-and-directly-compressibl.php weekly 0.7 /en/artkey/csf-200704-0005_a-study-of-the-properties-of-tablets-from-the-mixtures-of-directly-compressible-starch-and-directly-compressibl.php weekly 0.7 /artkey/csf-200704-0006_the-effect-of-polymeric-dispersion-type-on-the-release-of-diclofenac-sodium-from-coated-pellets.php weekly 0.7 /en/artkey/csf-200704-0006_the-effect-of-polymeric-dispersion-type-on-the-release-of-diclofenac-sodium-from-coated-pellets.php weekly 0.7 /artkey/csf-200704-0007_testing-of-antidiabetic-and-antioxidative-effect-of-the-flavonoid-osajin-in-an-experiment.php weekly 0.7 /en/artkey/csf-200704-0007_testing-of-antidiabetic-and-antioxidative-effect-of-the-flavonoid-osajin-in-an-experiment.php weekly 0.7 /artkey/csf-200704-0001_applications-of-molecularly-imprinted-polymers-in-analytical-and-pharmaceutical-chemistry.php weekly 0.7 /en/artkey/csf-200704-0001_applications-of-molecularly-imprinted-polymers-in-analytical-and-pharmaceutical-chemistry.php weekly 0.7 /artkey/csf-200704-0002_interactions-of-food-and-dietary-supplements-with-drug-metabolising-cytochrome-p450-enzymes.php weekly 0.7 /en/artkey/csf-200704-0002_interactions-of-food-and-dietary-supplements-with-drug-metabolising-cytochrome-p450-enzymes.php weekly 0.7 /artkey/csf-200704-0003_t-2-toxin-occurrence-and-detection.php weekly 0.7 /en/artkey/csf-200704-0003_t-2-toxin-occurrence-and-detection.php weekly 0.7 /artkey/csf-200704-0004_voltage-gated-calcium-channels-structure-characteristics-and-terminology.php weekly 0.7 /en/artkey/csf-200704-0004_voltage-gated-calcium-channels-structure-characteristics-and-terminology.php weekly 0.7 /magno/csf/2007/mn5.php weekly 0.7 /en/magno/csf/2007/mn5.php weekly 0.7 /artkey/csf-200705-0003_abiotic-elicitation-of-trifolium-pratense-l-suspension-culture.php weekly 0.7 /en/artkey/csf-200705-0003_abiotic-elicitation-of-trifolium-pratense-l-suspension-culture.php weekly 0.7 /artkey/csf-200705-0004_effect-of-vanadium-compounds-on-the-growth-and-production-of-coumarins-in-the-suspension-culture-of-angelica-ar.php weekly 0.7 /en/artkey/csf-200705-0004_effect-of-vanadium-compounds-on-the-growth-and-production-of-coumarins-in-the-suspension-culture-of-angelica-ar.php weekly 0.7 /artkey/csf-200705-0005_effect-of-thermal-curing-of-the-ethyl-cellulose-film-on-the-rapidity-of-release-of-diclofenac-sodium-from-pelle.php weekly 0.7 /en/artkey/csf-200705-0005_effect-of-thermal-curing-of-the-ethyl-cellulose-film-on-the-rapidity-of-release-of-diclofenac-sodium-from-pelle.php weekly 0.7 /artkey/csf-200705-0006_mucoadhesive-tablets-for-oral-administration-of-ciclopiroxolamine.php weekly 0.7 /en/artkey/csf-200705-0006_mucoadhesive-tablets-for-oral-administration-of-ciclopiroxolamine.php weekly 0.7 /artkey/csf-200705-0007_determination-of-valproic-acid-by-on-line-coupled-capillary-isotachophoresis-with-capillary-zone-electrophoresi.php weekly 0.7 /en/artkey/csf-200705-0007_determination-of-valproic-acid-by-on-line-coupled-capillary-isotachophoresis-with-capillary-zone-electrophoresi.php weekly 0.7 /artkey/csf-200705-0001_oxidative-stress-and-its-role-in-respiratory-diseases.php weekly 0.7 /en/artkey/csf-200705-0001_oxidative-stress-and-its-role-in-respiratory-diseases.php weekly 0.7 /artkey/csf-200705-0002_cytochrome-p450-3a-polymorphism-and-its-importance-in-cyclosporine-and-tacrolimus-therapy-in-transplanted-patie.php weekly 0.7 /en/artkey/csf-200705-0002_cytochrome-p450-3a-polymorphism-and-its-importance-in-cyclosporine-and-tacrolimus-therapy-in-transplanted-patie.php weekly 0.7 /magno/csf/2007/mn6.php weekly 0.7 /en/magno/csf/2007/mn6.php weekly 0.7 /artkey/csf-200706-0003_a-study-of-the-properties-of-tablets-from-coprocessed-dry-binders-composed-of-alpha-lactose-monohydrate-and-d.php weekly 0.7 /en/artkey/csf-200706-0003_a-study-of-the-properties-of-tablets-from-coprocessed-dry-binders-composed-of-alpha-lactose-monohydrate-and-d.php weekly 0.7 /artkey/csf-200706-0004_experience-with-ciclesonide-in-patients-with-mild-persistent-bronchial-asthma.php weekly 0.7 /en/artkey/csf-200706-0004_experience-with-ciclesonide-in-patients-with-mild-persistent-bronchial-asthma.php weekly 0.7 /artkey/csf-200706-0005_flavonoid-accumulation-in-scutellaria-baicalensis-georgii-in-vitro-cultures-upon-treatment-with-sodium-cinnamat.php weekly 0.7 /en/artkey/csf-200706-0005_flavonoid-accumulation-in-scutellaria-baicalensis-georgii-in-vitro-cultures-upon-treatment-with-sodium-cinnamat.php weekly 0.7 /artkey/csf-200706-0006_evaluation-of-mechanical-strength-of-tablets-from-microcrystalline-cellulose-by-means-of-energetic-parameters.php weekly 0.7 /en/artkey/csf-200706-0006_evaluation-of-mechanical-strength-of-tablets-from-microcrystalline-cellulose-by-means-of-energetic-parameters.php weekly 0.7 /artkey/csf-200706-0001_oxycellulose-a-cellulose-derivative-with-a-potential-to-become-an-active-pharmaceutical-substance-as-well-as.php weekly 0.7 /en/artkey/csf-200706-0001_oxycellulose-a-cellulose-derivative-with-a-potential-to-become-an-active-pharmaceutical-substance-as-well-as.php weekly 0.7 /artkey/csf-200706-0002_physiology-and-pharmacology-of-hyaluronic-acid.php weekly 0.7 /en/artkey/csf-200706-0002_physiology-and-pharmacology-of-hyaluronic-acid.php weekly 0.7 /artkey/csf-200706-0007_experta-the-first-company-specializing-in-scientific-evaluation-of-medicaments.php weekly 0.7 /en/artkey/csf-200706-0007_experta-the-first-company-specializing-in-scientific-evaluation-of-medicaments.php weekly 0.7 /magno/csf/2006/mn1.php weekly 0.7 /en/magno/csf/2006/mn1.php weekly 0.7 /artkey/csf-200601-0003_consumption-of-antiepileptics-in-1993-2004-using-various-methods.php weekly 0.7 /en/artkey/csf-200601-0003_consumption-of-antiepileptics-in-1993-2004-using-various-methods.php weekly 0.7 /artkey/csf-200601-0004_prophylactic-administration-of-homoisoflavonoid-in-ischemic-reperfusion-damage-of-the-renal-tissue-in-the-labor.php weekly 0.7 /en/artkey/csf-200601-0004_prophylactic-administration-of-homoisoflavonoid-in-ischemic-reperfusion-damage-of-the-renal-tissue-in-the-labor.php weekly 0.7 /artkey/csf-200601-0005_stabilization-of-colouring-of-castellani-s-solution-without-fuchsin-ph-b-mmii-and-control-of-its-efficacy.php weekly 0.7 /en/artkey/csf-200601-0005_stabilization-of-colouring-of-castellani-s-solution-without-fuchsin-ph-b-mmii-and-control-of-its-efficacy.php weekly 0.7 /artkey/csf-200601-0006_separation-of-dimetinden-enantiomers-in-drugs-by-means-of-capillary-isotachophoresis.php weekly 0.7 /en/artkey/csf-200601-0006_separation-of-dimetinden-enantiomers-in-drugs-by-means-of-capillary-isotachophoresis.php weekly 0.7 /artkey/csf-200601-0007_prescription-of-health-requisites-to-patients.php weekly 0.7 /en/artkey/csf-200601-0007_prescription-of-health-requisites-to-patients.php weekly 0.7 /artkey/csf-200601-0008_effect-of-ultrasound-on-the-production-of-flavonoids-by-the-culture-of-ononis-arvensis-l-in-vitro.php weekly 0.7 /en/artkey/csf-200601-0008_effect-of-ultrasound-on-the-production-of-flavonoids-by-the-culture-of-ononis-arvensis-l-in-vitro.php weekly 0.7 /artkey/csf-200601-0009_explant-culture-of-trifolium-pratense-l.php weekly 0.7 /en/artkey/csf-200601-0009_explant-culture-of-trifolium-pratense-l.php weekly 0.7 /artkey/csf-200601-0001_natural-polymers-in-the-formulation-of-hydrophilic-matrix-tablets.php weekly 0.7 /en/artkey/csf-200601-0001_natural-polymers-in-the-formulation-of-hydrophilic-matrix-tablets.php weekly 0.7 /artkey/csf-200601-0002_interconversion-of-stereochemically-unstable-chiral-drugs-utilization-of-chromatographic-techniques-for-the-st.php weekly 0.7 /en/artkey/csf-200601-0002_interconversion-of-stereochemically-unstable-chiral-drugs-utilization-of-chromatographic-techniques-for-the-st.php weekly 0.7 /magno/csf/2006/mn2.php weekly 0.7 /en/magno/csf/2006/mn2.php weekly 0.7 /artkey/csf-200602-0003_preparation-of-pharmaceuticals-in-pharmacies-i-contemporary-situation-from-the-viewpoint-of-computer-records.php weekly 0.7 /en/artkey/csf-200602-0003_preparation-of-pharmaceuticals-in-pharmacies-i-contemporary-situation-from-the-viewpoint-of-computer-records.php weekly 0.7 /artkey/csf-200602-0004_effect-of-dissolution-medium-on-the-release-of-diltiazem-hydrochloride-from-carbomeric-matrices.php weekly 0.7 /en/artkey/csf-200602-0004_effect-of-dissolution-medium-on-the-release-of-diltiazem-hydrochloride-from-carbomeric-matrices.php weekly 0.7 /artkey/csf-200602-0005_a-study-of-the-properties-of-tablets-from-mixtures-of-two-size-degrees-of-alpha-lactose-monohydrate-and-micro.php weekly 0.7 /en/artkey/csf-200602-0005_a-study-of-the-properties-of-tablets-from-mixtures-of-two-size-degrees-of-alpha-lactose-monohydrate-and-micro.php weekly 0.7 /artkey/csf-200602-0006_morin-in-the-therapy-of-the-ischemia-reperfusion-damage-model-of-the-rat-kidney.php weekly 0.7 /en/artkey/csf-200602-0006_morin-in-the-therapy-of-the-ischemia-reperfusion-damage-model-of-the-rat-kidney.php weekly 0.7 /artkey/csf-200602-0001_drugs-and-preparations-for-the-treatment-of-burns.php weekly 0.7 /en/artkey/csf-200602-0001_drugs-and-preparations-for-the-treatment-of-burns.php weekly 0.7 /artkey/csf-200602-0002_natural-derivatives-of-4h-pyran-4-one.php weekly 0.7 /en/artkey/csf-200602-0002_natural-derivatives-of-4h-pyran-4-one.php weekly 0.7 /artkey/csf-200602-0007_medicinal-preparations-in-the-czech-translation-of-saliceto-s-treatise-on-surgery.php weekly 0.7 /en/artkey/csf-200602-0007_medicinal-preparations-in-the-czech-translation-of-saliceto-s-treatise-on-surgery.php weekly 0.7 /magno/csf/2006/mn3.php weekly 0.7 /en/magno/csf/2006/mn3.php weekly 0.7 /artkey/csf-200603-0003_synthesis-of-reactivators-of-phosphorylated-acetylcholinesterase-of-bis-pyridiniumdialdoxime-type-with-a-3-oxap.php weekly 0.7 /en/artkey/csf-200603-0003_synthesis-of-reactivators-of-phosphorylated-acetylcholinesterase-of-bis-pyridiniumdialdoxime-type-with-a-3-oxap.php weekly 0.7 /artkey/csf-200603-0004_study-of-a-newly-synthesized-substance-with-a-potential-to-stimulate-3-adrenergic-receptors.php weekly 0.7 /en/artkey/csf-200603-0004_study-of-a-newly-synthesized-substance-with-a-potential-to-stimulate-3-adrenergic-receptors.php weekly 0.7 /artkey/csf-200603-0005_interconversion-of-stereochemically-unstable-chiral-drugs-part-iii-using-cyclodextrin-as-a-chiral-stationary.php weekly 0.7 /en/artkey/csf-200603-0005_interconversion-of-stereochemically-unstable-chiral-drugs-part-iii-using-cyclodextrin-as-a-chiral-stationary.php weekly 0.7 /artkey/csf-200603-0006_analysis-of-zinc-and-copper-containing-tablets-in-multicomponent-mineral-nutritional-preparations.php weekly 0.7 /en/artkey/csf-200603-0006_analysis-of-zinc-and-copper-containing-tablets-in-multicomponent-mineral-nutritional-preparations.php weekly 0.7 /artkey/csf-200603-0001_cytotoxicity-screening-and-mode-of-action-of-natural-and-synthetically-prepared-compounds-usable-in-tumour-chem.php weekly 0.7 /en/artkey/csf-200603-0001_cytotoxicity-screening-and-mode-of-action-of-natural-and-synthetically-prepared-compounds-usable-in-tumour-chem.php weekly 0.7 /artkey/csf-200603-0002_present-day-legislation-and-the-handling-of-chemical-substances-and-preparations-at-the-workplaces-performing-d.php weekly 0.7 /en/artkey/csf-200603-0002_present-day-legislation-and-the-handling-of-chemical-substances-and-preparations-at-the-workplaces-performing-d.php weekly 0.7 /magno/csf/2006/mn4.php weekly 0.7 /en/magno/csf/2006/mn4.php weekly 0.7 /artkey/csf-200604-0003_protective-effects-of-the-flavonoids-osajin-and-pomiferin-on-heart-ischemia-reperfusion.php weekly 0.7 /en/artkey/csf-200604-0003_protective-effects-of-the-flavonoids-osajin-and-pomiferin-on-heart-ischemia-reperfusion.php weekly 0.7 /artkey/csf-200604-0004_properties-of-benzethonium-chloride-in-micellar-solutions-and-the-effect-of-added-sodium-chloride.php weekly 0.7 /en/artkey/csf-200604-0004_properties-of-benzethonium-chloride-in-micellar-solutions-and-the-effect-of-added-sodium-chloride.php weekly 0.7 /artkey/csf-200604-0005_a-study-of-qualitative-properties-of-the-essential-oil-of-tanacetum-vulgare-l.php weekly 0.7 /en/artkey/csf-200604-0005_a-study-of-qualitative-properties-of-the-essential-oil-of-tanacetum-vulgare-l.php weekly 0.7 /artkey/csf-200604-0006_effect-of-agno3-on-the-production-of-flavonoids-by-the-culture-of-ononis-arvensis-l-in-vitro.php weekly 0.7 /en/artkey/csf-200604-0006_effect-of-agno3-on-the-production-of-flavonoids-by-the-culture-of-ononis-arvensis-l-in-vitro.php weekly 0.7 /artkey/csf-200604-0007_theory-and-practice-of-pharmacopoeial-control-of-the-quality-of-drugs-and-auxiliary-substances-vi-stability-of.php weekly 0.7 /en/artkey/csf-200604-0007_theory-and-practice-of-pharmacopoeial-control-of-the-quality-of-drugs-and-auxiliary-substances-vi-stability-of.php weekly 0.7 /artkey/csf-200604-0001_naphthoquinones-biosynthesis-occurrence-and-metabolism-in-plants.php weekly 0.7 /en/artkey/csf-200604-0001_naphthoquinones-biosynthesis-occurrence-and-metabolism-in-plants.php weekly 0.7 /artkey/csf-200604-0002_angiotensin-converting-enzyme-inhibitors.php weekly 0.7 /en/artkey/csf-200604-0002_angiotensin-converting-enzyme-inhibitors.php weekly 0.7 /magno/csf/2006/mn5.php weekly 0.7 /en/magno/csf/2006/mn5.php weekly 0.7 /artkey/csf-200605-0006_studies-of-the-properties-of-tablets-made-from-directly-compressible-starch-and-its-mixtures-with-directly-comp.php weekly 0.7 /en/artkey/csf-200605-0006_studies-of-the-properties-of-tablets-made-from-directly-compressible-starch-and-its-mixtures-with-directly-comp.php weekly 0.7 /artkey/csf-200605-0007_flavonoids-main-constituents-of-the-leaves-of-holodiscus-discolor-pursh-maxim.php weekly 0.7 /en/artkey/csf-200605-0007_flavonoids-main-constituents-of-the-leaves-of-holodiscus-discolor-pursh-maxim.php weekly 0.7 /artkey/csf-200605-0001_new-systems-for-colonic-drug-targeting.php weekly 0.7 /en/artkey/csf-200605-0001_new-systems-for-colonic-drug-targeting.php weekly 0.7 /artkey/csf-200605-0002_some-possibilities-of-using-spectrometry-in-the-near-infrared-region-in-drug-quality-control.php weekly 0.7 /en/artkey/csf-200605-0002_some-possibilities-of-using-spectrometry-in-the-near-infrared-region-in-drug-quality-control.php weekly 0.7 /artkey/csf-200605-0003_radionuclide-x-ray-fluorescence-as-an-alternative-method-to-pharmacopeial-tests-for-heavy-metals.php weekly 0.7 /en/artkey/csf-200605-0003_radionuclide-x-ray-fluorescence-as-an-alternative-method-to-pharmacopeial-tests-for-heavy-metals.php weekly 0.7 /artkey/csf-200605-0004_plant-metabolites-as-nootropics-and-cognitives.php weekly 0.7 /en/artkey/csf-200605-0004_plant-metabolites-as-nootropics-and-cognitives.php weekly 0.7 /artkey/csf-200605-0005_a-comparison-of-inhalatory-beta2-mimetics-with-long-term-action-formoterol-vs-salmeterol.php weekly 0.7 /en/artkey/csf-200605-0005_a-comparison-of-inhalatory-beta2-mimetics-with-long-term-action-formoterol-vs-salmeterol.php weekly 0.7 /magno/csf/2006/mn6.php weekly 0.7 /en/magno/csf/2006/mn6.php weekly 0.7 /artkey/csf-200606-0002_measurement-of-adhesive-properties-of-polymers-in-vitro.php weekly 0.7 /en/artkey/csf-200606-0002_measurement-of-adhesive-properties-of-polymers-in-vitro.php weekly 0.7 /artkey/csf-200606-0003_liquid-ginger-extract-technology-of-production-and-quality-evaluation.php weekly 0.7 /en/artkey/csf-200606-0003_liquid-ginger-extract-technology-of-production-and-quality-evaluation.php weekly 0.7 /artkey/csf-200606-0004_potentiometric-determination-of-aqueous-dissociation-constants-of-2-3-4-3-4-benzhydryl-piperazine-1-yl-2-h.php weekly 0.7 /en/artkey/csf-200606-0004_potentiometric-determination-of-aqueous-dissociation-constants-of-2-3-4-3-4-benzhydryl-piperazine-1-yl-2-h.php weekly 0.7 /artkey/csf-200606-0005_continuous-education-of-pharmacists-in-the-czech-republic-2nd-cycle-2002-2005.php weekly 0.7 /en/artkey/csf-200606-0005_continuous-education-of-pharmacists-in-the-czech-republic-2nd-cycle-2002-2005.php weekly 0.7 /artkey/csf-200606-0001_university-courses-in-pharmacy-in-the-czech-republic.php weekly 0.7 /en/artkey/csf-200606-0001_university-courses-in-pharmacy-in-the-czech-republic.php weekly 0.7 /magno/csf/2005/mn1.php weekly 0.7 /en/magno/csf/2005/mn1.php weekly 0.7 /artkey/csf-200501-0004_adsorption-of-substances-on-active-charcoal-part-2-basic-esters-of-phenylcarbamic-acid-with-beta-adrenolytic-e.php weekly 0.7 /en/artkey/csf-200501-0004_adsorption-of-substances-on-active-charcoal-part-2-basic-esters-of-phenylcarbamic-acid-with-beta-adrenolytic-e.php weekly 0.7 /artkey/csf-200501-0005_prescription-and-structure-of-formulation-of-medicinal-preparations-in-a-pharmacy-ii.php weekly 0.7 /en/artkey/csf-200501-0005_prescription-and-structure-of-formulation-of-medicinal-preparations-in-a-pharmacy-ii.php weekly 0.7 /artkey/csf-200501-0006_analysis-of-drugs-used-in-out-patient-practice-of-veterinary-surgeons.php weekly 0.7 /en/artkey/csf-200501-0006_analysis-of-drugs-used-in-out-patient-practice-of-veterinary-surgeons.php weekly 0.7 /artkey/csf-200501-0007_power-law-equation-and-liberation-kinetics.php weekly 0.7 /en/artkey/csf-200501-0007_power-law-equation-and-liberation-kinetics.php weekly 0.7 /artkey/csf-200501-0008_antilipoxygenase-activity-and-the-trace-elements-content-of-aloe-vera-in-relation-to-the-therapeutical-effect.php weekly 0.7 /en/artkey/csf-200501-0008_antilipoxygenase-activity-and-the-trace-elements-content-of-aloe-vera-in-relation-to-the-therapeutical-effect.php weekly 0.7 /artkey/csf-200501-0009_effect-of-manganese-ii-cobalt-ii-and-nickel-ii-ions-on-the-growth-and-production-of-coumarins-in-the-su.php weekly 0.7 /en/artkey/csf-200501-0009_effect-of-manganese-ii-cobalt-ii-and-nickel-ii-ions-on-the-growth-and-production-of-coumarins-in-the-su.php weekly 0.7 /artkey/csf-200501-0001_in-situ-gelling-polymers-for-ophthalmic-drops.php weekly 0.7 /en/artkey/csf-200501-0001_in-situ-gelling-polymers-for-ophthalmic-drops.php weekly 0.7 /artkey/csf-200501-0002_the-present-and-future-of-controlled-transport-of-the-drug-into-the-organism.php weekly 0.7 /en/artkey/csf-200501-0002_the-present-and-future-of-controlled-transport-of-the-drug-into-the-organism.php weekly 0.7 /artkey/csf-200501-0003_enzymology-of-production-of-benzylisoquinoline-alkaloids.php weekly 0.7 /en/artkey/csf-200501-0003_enzymology-of-production-of-benzylisoquinoline-alkaloids.php weekly 0.7 /magno/csf/2005/mn2.php weekly 0.7 /en/magno/csf/2005/mn2.php weekly 0.7 /artkey/csf-200502-0002_adsorption-of-substances-on-active-charcoal-part-3-stobadin-acylderivatives.php weekly 0.7 /en/artkey/csf-200502-0002_adsorption-of-substances-on-active-charcoal-part-3-stobadin-acylderivatives.php weekly 0.7 /artkey/csf-200502-0003_dispensation-during-pharmaceutical-stand-by-duty-service.php weekly 0.7 /en/artkey/csf-200502-0003_dispensation-during-pharmaceutical-stand-by-duty-service.php weekly 0.7 /artkey/csf-200502-0004_dispensing-care-at-the-dispensing-counter-in-the-conditions-of-a-czech-pharmacy.php weekly 0.7 /en/artkey/csf-200502-0004_dispensing-care-at-the-dispensing-counter-in-the-conditions-of-a-czech-pharmacy.php weekly 0.7 /artkey/csf-200502-0005_preformulation-studies-of-potential-drug-xix-m-partition-coefficient.php weekly 0.7 /en/artkey/csf-200502-0005_preformulation-studies-of-potential-drug-xix-m-partition-coefficient.php weekly 0.7 /artkey/csf-200502-0006_arbutin-salicin-the-possibilities-of-their-biotechnological-production.php weekly 0.7 /en/artkey/csf-200502-0006_arbutin-salicin-the-possibilities-of-their-biotechnological-production.php weekly 0.7 /artkey/csf-200502-0007_use-of-dinitrophenols-in-ion-pair-extraction-spectrophotometry-of-cationic-tensides.php weekly 0.7 /en/artkey/csf-200502-0007_use-of-dinitrophenols-in-ion-pair-extraction-spectrophotometry-of-cationic-tensides.php weekly 0.7 /artkey/csf-200502-0008_use-of-capillary-isotachophoresis-for-the-determination-o-pheniramine-in-granulated-powders.php weekly 0.7 /en/artkey/csf-200502-0008_use-of-capillary-isotachophoresis-for-the-determination-o-pheniramine-in-granulated-powders.php weekly 0.7 /artkey/csf-200502-0009_pharmacoeconomic-profile-of-antibiotics-used-in-the-treatment-of-lower-respiratory-tract-infections-in-geriatri.php weekly 0.7 /en/artkey/csf-200502-0009_pharmacoeconomic-profile-of-antibiotics-used-in-the-treatment-of-lower-respiratory-tract-infections-in-geriatri.php weekly 0.7 /artkey/csf-200502-0010_effect-of-polymer-concentration-on-rheological-properties-of-carbopol-reg-980-hydrogels-containing-trimecainiu.php weekly 0.7 /en/artkey/csf-200502-0010_effect-of-polymer-concentration-on-rheological-properties-of-carbopol-reg-980-hydrogels-containing-trimecainiu.php weekly 0.7 /artkey/csf-200502-0001_pharmaceutical-hydrophilic-gels.php weekly 0.7 /en/artkey/csf-200502-0001_pharmaceutical-hydrophilic-gels.php weekly 0.7 /magno/csf/2005/mn3.php weekly 0.7 /en/magno/csf/2005/mn3.php weekly 0.7 /artkey/csf-200503-0002_pre-formulation-studies-of-the-h1-antihistamine-loratadine-for-a-topical-dosage-form.php weekly 0.7 /en/artkey/csf-200503-0002_pre-formulation-studies-of-the-h1-antihistamine-loratadine-for-a-topical-dosage-form.php weekly 0.7 /artkey/csf-200503-0003_antioxidative-activity-of-some-over-the-counter-plant-extracts.php weekly 0.7 /en/artkey/csf-200503-0003_antioxidative-activity-of-some-over-the-counter-plant-extracts.php weekly 0.7 /artkey/csf-200503-0004_a-study-of-the-properties-of-compacts-from-a-mixed-dry-binder-on-the-base-of-alpha-lactose-monohydrate-and-mi.php weekly 0.7 /en/artkey/csf-200503-0004_a-study-of-the-properties-of-compacts-from-a-mixed-dry-binder-on-the-base-of-alpha-lactose-monohydrate-and-mi.php weekly 0.7 /artkey/csf-200503-0005_knowledge-attitudes-and-behaviour-of-the-population-of-the-czech-republic-to-self-medication-i-knowledge-of.php weekly 0.7 /en/artkey/csf-200503-0005_knowledge-attitudes-and-behaviour-of-the-population-of-the-czech-republic-to-self-medication-i-knowledge-of.php weekly 0.7 /artkey/csf-200503-0006_comparison-of-the-consumption-of-antiepileptic-drugs-in-the-czech-republic-scandinavia-and-australia.php weekly 0.7 /en/artkey/csf-200503-0006_comparison-of-the-consumption-of-antiepileptic-drugs-in-the-czech-republic-scandinavia-and-australia.php weekly 0.7 /artkey/csf-200503-0007_solubilization-and-complexation-of-the-antileukotrienic-drug-quinlukast-in-aqueous-solutions-of-cyclodextrins.php weekly 0.7 /en/artkey/csf-200503-0007_solubilization-and-complexation-of-the-antileukotrienic-drug-quinlukast-in-aqueous-solutions-of-cyclodextrins.php weekly 0.7 /artkey/csf-200503-0008_xanthium-spinosum-l-a-phytochemical-study.php weekly 0.7 /en/artkey/csf-200503-0008_xanthium-spinosum-l-a-phytochemical-study.php weekly 0.7 /artkey/csf-200503-0009_optimization-of-isolation-of-inulin-from-cichorium-intybus-l-and-some-of-its-uses-in-social-practice.php weekly 0.7 /en/artkey/csf-200503-0009_optimization-of-isolation-of-inulin-from-cichorium-intybus-l-and-some-of-its-uses-in-social-practice.php weekly 0.7 /artkey/csf-200503-0010_effect-of-vanadyl-iv-sulfate-voso4-on-the-production-of-flavonoids-by-the-culture-ononis-arvensis-l-in-vit.php weekly 0.7 /en/artkey/csf-200503-0010_effect-of-vanadyl-iv-sulfate-voso4-on-the-production-of-flavonoids-by-the-culture-ononis-arvensis-l-in-vit.php weekly 0.7 /artkey/csf-200503-0001_novel-perspective-approaches-to-the-therapy-of-dyslipidaemias.php weekly 0.7 /en/artkey/csf-200503-0001_novel-perspective-approaches-to-the-therapy-of-dyslipidaemias.php weekly 0.7 /magno/csf/2005/mn4.php weekly 0.7 /en/magno/csf/2005/mn4.php weekly 0.7 /artkey/csf-200504-0003_knowledge-attitudes-and-behaviour-of-the-population-of-the-czech-republic-to-self-medication-ii-knowledge-of.php weekly 0.7 /en/artkey/csf-200504-0003_knowledge-attitudes-and-behaviour-of-the-population-of-the-czech-republic-to-self-medication-ii-knowledge-of.php weekly 0.7 /artkey/csf-200504-0004_hplc-separation-of-racemic-basic-esters-of-alkoxyphenylcarbamic-acid-using-two-teicoplanin-chiral-stationary-ph.php weekly 0.7 /en/artkey/csf-200504-0004_hplc-separation-of-racemic-basic-esters-of-alkoxyphenylcarbamic-acid-using-two-teicoplanin-chiral-stationary-ph.php weekly 0.7 /artkey/csf-200504-0005_a-survey-into-smokers-interest-in-quitting-smoking-and-in-the-provision-of-smoking-cessation-counselling-in-co.php weekly 0.7 /en/artkey/csf-200504-0005_a-survey-into-smokers-interest-in-quitting-smoking-and-in-the-provision-of-smoking-cessation-counselling-in-co.php weekly 0.7 /artkey/csf-200504-0006_penetrometry-used-for-the-estimation-of-flow-rate.php weekly 0.7 /en/artkey/csf-200504-0006_penetrometry-used-for-the-estimation-of-flow-rate.php weekly 0.7 /artkey/csf-200504-0007_effect-of-humectants-on-pharmaceutical-availability-and-rheological-properties-of-loratadin-containing-hydrogel.php weekly 0.7 /en/artkey/csf-200504-0007_effect-of-humectants-on-pharmaceutical-availability-and-rheological-properties-of-loratadin-containing-hydrogel.php weekly 0.7 /artkey/csf-200504-0008_a-comparison-of-the-efficacy-of-the-reactivators-of-acetylcholinesterase-inhibited-with-tabun.php weekly 0.7 /en/artkey/csf-200504-0008_a-comparison-of-the-efficacy-of-the-reactivators-of-acetylcholinesterase-inhibited-with-tabun.php weekly 0.7 /artkey/csf-200504-0001_advances-in-enantioselective-tlc-of-therapeutic-agents.php weekly 0.7 /en/artkey/csf-200504-0001_advances-in-enantioselective-tlc-of-therapeutic-agents.php weekly 0.7 /artkey/csf-200504-0002_methods-of-artificial-intelligence-a-new-trend-in-pharmacy.php weekly 0.7 /en/artkey/csf-200504-0002_methods-of-artificial-intelligence-a-new-trend-in-pharmacy.php weekly 0.7 /magno/csf/2005/mn5.php weekly 0.7 /en/magno/csf/2005/mn5.php weekly 0.7 /artkey/csf-200505-0004_knowledge-attitudes-and-behaviour-of-the-population-of-the-czech-republic-to-self-medication-iii-behaviour-i.php weekly 0.7 /en/artkey/csf-200505-0004_knowledge-attitudes-and-behaviour-of-the-population-of-the-czech-republic-to-self-medication-iii-behaviour-i.php weekly 0.7 /artkey/csf-200505-0005_price-development-of-oral-contraceptives.php weekly 0.7 /en/artkey/csf-200505-0005_price-development-of-oral-contraceptives.php weekly 0.7 /artkey/csf-200505-0006_effect-of-humectants-on-pharmaceutical-availability-and-rheological-properties-of-cetirizine-containing-hydroge.php weekly 0.7 /en/artkey/csf-200505-0006_effect-of-humectants-on-pharmaceutical-availability-and-rheological-properties-of-cetirizine-containing-hydroge.php weekly 0.7 /artkey/csf-200505-0007_dimethindene-determination-in-various-dosage-forms-by-means-of-capillary-isotachophoresis.php weekly 0.7 /en/artkey/csf-200505-0007_dimethindene-determination-in-various-dosage-forms-by-means-of-capillary-isotachophoresis.php weekly 0.7 /artkey/csf-200505-0008_a-study-of-physicochemical-properties-of-2-3-4-alkoxyphenylcarbamic-acid-derivatives-with-a-substituted-n-p.php weekly 0.7 /en/artkey/csf-200505-0008_a-study-of-physicochemical-properties-of-2-3-4-alkoxyphenylcarbamic-acid-derivatives-with-a-substituted-n-p.php weekly 0.7 /artkey/csf-200505-0001_the-development-of-the-composition-of-castellan-s-solution.php weekly 0.7 /en/artkey/csf-200505-0001_the-development-of-the-composition-of-castellan-s-solution.php weekly 0.7 /artkey/csf-200505-0002_blockers-of-beta-adrenergic-receptors-a-group-of-chiral-agents-stereoselective-synthesis-of-beta-blockers.php weekly 0.7 /en/artkey/csf-200505-0002_blockers-of-beta-adrenergic-receptors-a-group-of-chiral-agents-stereoselective-synthesis-of-beta-blockers.php weekly 0.7 /artkey/csf-200505-0003_ouabain-from-an-arrow-poison-to-a-new-steroidal-hormone.php weekly 0.7 /en/artkey/csf-200505-0003_ouabain-from-an-arrow-poison-to-a-new-steroidal-hormone.php weekly 0.7 /magno/csf/2005/mn6.php weekly 0.7 /en/magno/csf/2005/mn6.php weekly 0.7 /artkey/csf-200506-0004_composite-tincture-from-the-tops-of-the-purple-coneflower-echinacea-purpurea-and-the-fruits-of-the-dog-rose.php weekly 0.7 /en/artkey/csf-200506-0004_composite-tincture-from-the-tops-of-the-purple-coneflower-echinacea-purpurea-and-the-fruits-of-the-dog-rose.php weekly 0.7 /artkey/csf-200506-0005_isotachophoretic-determination-of-desloratadine-in-tablets-and-syrup.php weekly 0.7 /en/artkey/csf-200506-0005_isotachophoretic-determination-of-desloratadine-in-tablets-and-syrup.php weekly 0.7 /artkey/csf-200506-0006_analytical-profile-of-1-4-fluorophenyl-4-3-3-propoxyphenylcarbamoyloxy-2-hydroxypropyl-piperazinium-chlori.php weekly 0.7 /en/artkey/csf-200506-0006_analytical-profile-of-1-4-fluorophenyl-4-3-3-propoxyphenylcarbamoyloxy-2-hydroxypropyl-piperazinium-chlori.php weekly 0.7 /artkey/csf-200506-0001_contemporary-programme-of-pharmaceutical-studies-in-germany.php weekly 0.7 /en/artkey/csf-200506-0001_contemporary-programme-of-pharmaceutical-studies-in-germany.php weekly 0.7 /artkey/csf-200506-0002_logistics-in-the-pharmaceutical-service.php weekly 0.7 /en/artkey/csf-200506-0002_logistics-in-the-pharmaceutical-service.php weekly 0.7 /artkey/csf-200506-0003_interconversion-of-stereochemically-unstable-chiral-drugs-utilization-of-chromatographic-techniques-for-the-st.php weekly 0.7 /en/artkey/csf-200506-0003_interconversion-of-stereochemically-unstable-chiral-drugs-utilization-of-chromatographic-techniques-for-the-st.php weekly 0.7 /artkey/csf-200506-0007_pharmaceutical-literature-in-the-library-of-the-kuks-hospice-i-a-contribution-to-the-history-of-the-hospital-p.php weekly 0.7 /en/artkey/csf-200506-0007_pharmaceutical-literature-in-the-library-of-the-kuks-hospice-i-a-contribution-to-the-history-of-the-hospital-p.php weekly 0.7 /magno/csf/2004/mn1.php weekly 0.7 /en/magno/csf/2004/mn1.php weekly 0.7 /artkey/csf-200401-0001_beta-adrenergic-receptor-blockers-a-group-of-chiral-drugs-enantioseparation-in-thegroup-of-beta-blockers.php weekly 0.7 /en/artkey/csf-200401-0001_beta-adrenergic-receptor-blockers-a-group-of-chiral-drugs-enantioseparation-in-thegroup-of-beta-blockers.php weekly 0.7 /artkey/csf-200401-0002_caspases-a-target-of-intervention-in-the-diseases-that-are-still-difficult-to-treat.php weekly 0.7 /en/artkey/csf-200401-0002_caspases-a-target-of-intervention-in-the-diseases-that-are-still-difficult-to-treat.php weekly 0.7 /artkey/csf-200401-0003_effect-of-plasticizers-of-the-triester-glycerol-type-on-the-release-of-albumin-from-biodegradable-polymer-matri.php weekly 0.7 /en/artkey/csf-200401-0003_effect-of-plasticizers-of-the-triester-glycerol-type-on-the-release-of-albumin-from-biodegradable-polymer-matri.php weekly 0.7 /artkey/csf-200401-0004_effect-of-a-dose-of-acetylcholinesterase-reactivators-on-their-efficiency-in-the-therapy-of-tabun-poisoning-in.php weekly 0.7 /en/artkey/csf-200401-0004_effect-of-a-dose-of-acetylcholinesterase-reactivators-on-their-efficiency-in-the-therapy-of-tabun-poisoning-in.php weekly 0.7 /artkey/csf-200401-0005_selection-of-the-extraction-agent-and-the-elaboration-of-the-technology-of-the-production-of-an-extract-with-a.php weekly 0.7 /en/artkey/csf-200401-0005_selection-of-the-extraction-agent-and-the-elaboration-of-the-technology-of-the-production-of-an-extract-with-a.php weekly 0.7 /artkey/csf-200401-0006_leonurus-cardiaca-in-vitro.php weekly 0.7 /en/artkey/csf-200401-0006_leonurus-cardiaca-in-vitro.php weekly 0.7 /artkey/csf-200401-0007_analytical-evaluation-of-potential-nootropic-agents.php weekly 0.7 /en/artkey/csf-200401-0007_analytical-evaluation-of-potential-nootropic-agents.php weekly 0.7 /artkey/csf-200401-0008_s-k-zeidler-1620-1989-on-drugs.php weekly 0.7 /en/artkey/csf-200401-0008_s-k-zeidler-1620-1989-on-drugs.php weekly 0.7 /magno/csf/2004/mn2.php weekly 0.7 /en/magno/csf/2004/mn2.php weekly 0.7 /artkey/csf-200402-0001_ace-inhibitors-in-the-therapy-of-ventricular-dysfunction-after-cardiotoxic-cytostatics.php weekly 0.7 /en/artkey/csf-200402-0001_ace-inhibitors-in-the-therapy-of-ventricular-dysfunction-after-cardiotoxic-cytostatics.php weekly 0.7 /artkey/csf-200402-0002_electromigration-analytical-methods-in-the-quality-control-of-pharmacopoeial-herbaldrugs.php weekly 0.7 /en/artkey/csf-200402-0002_electromigration-analytical-methods-in-the-quality-control-of-pharmacopoeial-herbaldrugs.php weekly 0.7 /artkey/csf-200402-0003_statistical-aspects-of-drug-dosing-in-random-powder-mixtures.php weekly 0.7 /en/artkey/csf-200402-0003_statistical-aspects-of-drug-dosing-in-random-powder-mixtures.php weekly 0.7 /artkey/csf-200402-0004_biological-availability-of-ophthalmic-preparations-i-increased-penetrability-of-theactive-ingredient-through.php weekly 0.7 /en/artkey/csf-200402-0004_biological-availability-of-ophthalmic-preparations-i-increased-penetrability-of-theactive-ingredient-through.php weekly 0.7 /artkey/csf-200402-0005_testing-the-bradycardiac-effect-of-newly-synthesized-potential-ultrashort-beta-blockers-on-the-laboratory-rat.php weekly 0.7 /en/artkey/csf-200402-0005_testing-the-bradycardiac-effect-of-newly-synthesized-potential-ultrashort-beta-blockers-on-the-laboratory-rat.php weekly 0.7 /artkey/csf-200402-0006_catalytic-activity-of-butyrylcholinesterase-in-biodegradation-of-organic-ammoniumsalts-in-vitro.php weekly 0.7 /en/artkey/csf-200402-0006_catalytic-activity-of-butyrylcholinesterase-in-biodegradation-of-organic-ammoniumsalts-in-vitro.php weekly 0.7 /artkey/csf-200402-0007_simultaneous-determination-of-dioxopromethazine-and-phenylephrine-in-eye-drops-using-capillary-isotachophoresis.php weekly 0.7 /en/artkey/csf-200402-0007_simultaneous-determination-of-dioxopromethazine-and-phenylephrine-in-eye-drops-using-capillary-isotachophoresis.php weekly 0.7 /artkey/csf-200402-0008_the-in-vitro-reactivation-of-o-isopropylmethylfluorophosphonate-inhibited-acetylcholinesteraseby-bisquaternar.php weekly 0.7 /en/artkey/csf-200402-0008_the-in-vitro-reactivation-of-o-isopropylmethylfluorophosphonate-inhibited-acetylcholinesteraseby-bisquaternar.php weekly 0.7 /artkey/csf-200402-0009_effect-of-auxiliary-substances-on-the-physicochemical-indices-of-the-solutions-of-substance-xxii-b.php weekly 0.7 /en/artkey/csf-200402-0009_effect-of-auxiliary-substances-on-the-physicochemical-indices-of-the-solutions-of-substance-xxii-b.php weekly 0.7 /artkey/csf-200402-0010_slovak-nomenclature-of-organic-chemistry.php weekly 0.7 /en/artkey/csf-200402-0010_slovak-nomenclature-of-organic-chemistry.php weekly 0.7 /magno/csf/2004/mn3.php weekly 0.7 /en/magno/csf/2004/mn3.php weekly 0.7 /artkey/csf-200403-0001_antimicrobial-substances-in-ophthalmic-drops.php weekly 0.7 /en/artkey/csf-200403-0001_antimicrobial-substances-in-ophthalmic-drops.php weekly 0.7 /artkey/csf-200403-0002_pharmaceutical-importance-of-allium-sativum-l-5-hypolipidemic-effect-in-vitro-and-in-vivo.php weekly 0.7 /en/artkey/csf-200403-0002_pharmaceutical-importance-of-allium-sativum-l-5-hypolipidemic-effect-in-vitro-and-in-vivo.php weekly 0.7 /artkey/csf-200403-0003_advances-in-the-development-of-antituberculotics-containing-no-heterocycles-in-thepharmacophore-part-2-other-d.php weekly 0.7 /en/artkey/csf-200403-0003_advances-in-the-development-of-antituberculotics-containing-no-heterocycles-in-thepharmacophore-part-2-other-d.php weekly 0.7 /artkey/csf-200403-0004_ricin-a-plant-toxin-with-possible-therapeutic-use.php weekly 0.7 /en/artkey/csf-200403-0004_ricin-a-plant-toxin-with-possible-therapeutic-use.php weekly 0.7 /artkey/csf-200403-0005_silybum-marianum-in-vitro.php weekly 0.7 /en/artkey/csf-200403-0005_silybum-marianum-in-vitro.php weekly 0.7 /artkey/csf-200403-0006_use-of-phenylglyoxylic-ketyl-radicals-on-the-testing-of-the-antioxidant-effect-of-variouscompounds.php weekly 0.7 /en/artkey/csf-200403-0006_use-of-phenylglyoxylic-ketyl-radicals-on-the-testing-of-the-antioxidant-effect-of-variouscompounds.php weekly 0.7 /artkey/csf-200403-0007_oxidative-determination-of-rutine-in-tablets-by-the-method-of-flow-injection-analysiswith-chemiluminescence-det.php weekly 0.7 /en/artkey/csf-200403-0007_oxidative-determination-of-rutine-in-tablets-by-the-method-of-flow-injection-analysiswith-chemiluminescence-det.php weekly 0.7 /artkey/csf-200403-0008_contact-sensitization-to-auxiliary-substances-in-dermatological-external-and-cosmeticpreparations.php weekly 0.7 /en/artkey/csf-200403-0008_contact-sensitization-to-auxiliary-substances-in-dermatological-external-and-cosmeticpreparations.php weekly 0.7 /magno/csf/2004/mn4.php weekly 0.7 /en/magno/csf/2004/mn4.php weekly 0.7 /artkey/csf-200404-0001_pharmacological-aspects-of-lyme-borreliosis.php weekly 0.7 /en/artkey/csf-200404-0001_pharmacological-aspects-of-lyme-borreliosis.php weekly 0.7 /artkey/csf-200404-0002_interactive-powder-mixtures.php weekly 0.7 /en/artkey/csf-200404-0002_interactive-powder-mixtures.php weekly 0.7 /artkey/csf-200404-0003_over-the-counter-drugs-in-the-inquiries-to-the-poison-information-centre.php weekly 0.7 /en/artkey/csf-200404-0003_over-the-counter-drugs-in-the-inquiries-to-the-poison-information-centre.php weekly 0.7 /artkey/csf-200404-0004_liberation-of-folic-acids-from-composite-chitosan-films.php weekly 0.7 /en/artkey/csf-200404-0004_liberation-of-folic-acids-from-composite-chitosan-films.php weekly 0.7 /artkey/csf-200404-0005_study-of-the-strenght-of-compacts-of-mixed-dry-binders-consisting-of-powdered-celluloseand-directly-compressibl.php weekly 0.7 /en/artkey/csf-200404-0005_study-of-the-strenght-of-compacts-of-mixed-dry-binders-consisting-of-powdered-celluloseand-directly-compressibl.php weekly 0.7 /artkey/csf-200404-0006_a-study-of-the-stability-of-dioxopromethazine-by-hplc-method.php weekly 0.7 /en/artkey/csf-200404-0006_a-study-of-the-stability-of-dioxopromethazine-by-hplc-method.php weekly 0.7 /artkey/csf-200404-0007_analysis-of-tablets-containing-the-antihistamine-loratadine-a-contribution-to-theidentification-of-impurities.php weekly 0.7 /en/artkey/csf-200404-0007_analysis-of-tablets-containing-the-antihistamine-loratadine-a-contribution-to-theidentification-of-impurities.php weekly 0.7 /artkey/csf-200404-0008_separation-of-enantiomers-of-phenylcarbamic-acid-derivatives-by-hplc-method.php weekly 0.7 /en/artkey/csf-200404-0008_separation-of-enantiomers-of-phenylcarbamic-acid-derivatives-by-hplc-method.php weekly 0.7 /magno/csf/2004/mn5.php weekly 0.7 /en/magno/csf/2004/mn5.php weekly 0.7 /artkey/csf-200405-0001_biological-availability-of-ophthalmic-preparations-2-ophthalmic-therapeutic-systems.php weekly 0.7 /en/artkey/csf-200405-0001_biological-availability-of-ophthalmic-preparations-2-ophthalmic-therapeutic-systems.php weekly 0.7 /artkey/csf-200405-0002_photodynamic-therapy-as-a-new-prospective-method-for-cancer-treatment-i-history-basic-principles.php weekly 0.7 /en/artkey/csf-200405-0002_photodynamic-therapy-as-a-new-prospective-method-for-cancer-treatment-i-history-basic-principles.php weekly 0.7 /artkey/csf-200405-0003_hplc-determination-of-diperodon-enantiomers-in-blood-serum-by-using-teicoplanin-chiral-stationary-phase.php weekly 0.7 /en/artkey/csf-200405-0003_hplc-determination-of-diperodon-enantiomers-in-blood-serum-by-using-teicoplanin-chiral-stationary-phase.php weekly 0.7 /artkey/csf-200405-0004_validation-of-a-hplc-method-for-the-analysis-of-decomposition-products-of-diazepamin-injections.php weekly 0.7 /en/artkey/csf-200405-0004_validation-of-a-hplc-method-for-the-analysis-of-decomposition-products-of-diazepamin-injections.php weekly 0.7 /artkey/csf-200405-0005_patient-oriented-advice-on-pharmaceuticals-and-its-position-in-pregraduate-education-of-pharmacists.php weekly 0.7 /en/artkey/csf-200405-0005_patient-oriented-advice-on-pharmaceuticals-and-its-position-in-pregraduate-education-of-pharmacists.php weekly 0.7 /artkey/csf-200405-0006_unit-dose-systems-prepared-for-geriatric-patiens-i.php weekly 0.7 /en/artkey/csf-200405-0006_unit-dose-systems-prepared-for-geriatric-patiens-i.php weekly 0.7 /artkey/csf-200405-0007_isolation-and-characterization-of-active-compounds-from-aloe-vera-with-possible-rolein-skin-protection.php weekly 0.7 /en/artkey/csf-200405-0007_isolation-and-characterization-of-active-compounds-from-aloe-vera-with-possible-rolein-skin-protection.php weekly 0.7 /artkey/csf-200405-0008_abiotic-elicitation-of-the-explant-culture-of-rheum-palmatum-l-by-heavy-metals.php weekly 0.7 /en/artkey/csf-200405-0008_abiotic-elicitation-of-the-explant-culture-of-rheum-palmatum-l-by-heavy-metals.php weekly 0.7 /artkey/csf-200405-0009_analytical-evaluation-of-1-dipropalamino-3-piperidine-propane-1-yl-3-pentyloxyphenylcarbamate-ck-3635.php weekly 0.7 /en/artkey/csf-200405-0009_analytical-evaluation-of-1-dipropalamino-3-piperidine-propane-1-yl-3-pentyloxyphenylcarbamate-ck-3635.php weekly 0.7 /artkey/csf-200405-0010_examination-of-stability-of-hydrogen-peroxide-solutions.php weekly 0.7 /en/artkey/csf-200405-0010_examination-of-stability-of-hydrogen-peroxide-solutions.php weekly 0.7 /artkey/csf-200405-0011_study-of-mixed-dry-binders-from-directly-compressible-lactoses-and-microcrystallinecellulose.php weekly 0.7 /en/artkey/csf-200405-0011_study-of-mixed-dry-binders-from-directly-compressible-lactoses-and-microcrystallinecellulose.php weekly 0.7 /magno/csf/2004/mn6.php weekly 0.7 /en/magno/csf/2004/mn6.php weekly 0.7 /artkey/csf-200406-0001_photodynamic-therapy-as-a-new-prospective-method-for-cancer-treatment-ii-overview-of-photosensitizers.php weekly 0.7 /en/artkey/csf-200406-0001_photodynamic-therapy-as-a-new-prospective-method-for-cancer-treatment-ii-overview-of-photosensitizers.php weekly 0.7 /artkey/csf-200406-0002_isolation-of-immunoglobulins-by-thiophilic-adsorption-chromatography.php weekly 0.7 /en/artkey/csf-200406-0002_isolation-of-immunoglobulins-by-thiophilic-adsorption-chromatography.php weekly 0.7 /artkey/csf-200406-0003_chiral-switch-pure-enantiomers-of-drugs-instead-of-racemic-mixtures.php weekly 0.7 /en/artkey/csf-200406-0003_chiral-switch-pure-enantiomers-of-drugs-instead-of-racemic-mixtures.php weekly 0.7 /artkey/csf-200406-0004_salicylanilides-still-a-topical-potential-antibacterially-active-group.php weekly 0.7 /en/artkey/csf-200406-0004_salicylanilides-still-a-topical-potential-antibacterially-active-group.php weekly 0.7 /artkey/csf-200406-0005_carbomers-and-their-use-in-pharmaceutical-technology.php weekly 0.7 /en/artkey/csf-200406-0005_carbomers-and-their-use-in-pharmaceutical-technology.php weekly 0.7 /artkey/csf-200406-0006_adsorption-of-substances-on-active-charcoal-part-1-basic-esters-of-phenylcarbamic-acid-with-local-anaesthetic.php weekly 0.7 /en/artkey/csf-200406-0006_adsorption-of-substances-on-active-charcoal-part-1-basic-esters-of-phenylcarbamic-acid-with-local-anaesthetic.php weekly 0.7 /artkey/csf-200406-0007_determination-of-the-antioxidant-activity-of-potential-scavengers-of-nitrogen-oxide.php weekly 0.7 /en/artkey/csf-200406-0007_determination-of-the-antioxidant-activity-of-potential-scavengers-of-nitrogen-oxide.php weekly 0.7 /artkey/csf-200406-0008_unit-dose-systems-prepared-for-geriatric-patients-ii.php weekly 0.7 /en/artkey/csf-200406-0008_unit-dose-systems-prepared-for-geriatric-patients-ii.php weekly 0.7 /artkey/csf-200406-0009_prescription-and-structure-of-formulation-of-medicinal-preparations-in-a-pharmacy-i.php weekly 0.7 /en/artkey/csf-200406-0009_prescription-and-structure-of-formulation-of-medicinal-preparations-in-a-pharmacy-i.php weekly 0.7 /artkey/csf-200406-0010_use-of-chelating-extraction-membranes-for-the-identification-and-determination-of-heavy-metals-by-the-method-of.php weekly 0.7 /en/artkey/csf-200406-0010_use-of-chelating-extraction-membranes-for-the-identification-and-determination-of-heavy-metals-by-the-method-of.php weekly 0.7 /artkey/csf-200406-0011_pindolol-determination-in-pharmaceuticals-by-the-method-of-capillary-isotachophoresis.php weekly 0.7 /en/artkey/csf-200406-0011_pindolol-determination-in-pharmaceuticals-by-the-method-of-capillary-isotachophoresis.php weekly 0.7 /artkey/csf-200406-0012_weibull-equation-and-dissolution-kinetics.php weekly 0.7 /en/artkey/csf-200406-0012_weibull-equation-and-dissolution-kinetics.php weekly 0.7 /artkey/csf-200406-0013_the-content-of-zn-and-cd-in-medicinal-plants-and-the-dynamics-of-their-transport-into-the-dosage-forms.php weekly 0.7 /en/artkey/csf-200406-0013_the-content-of-zn-and-cd-in-medicinal-plants-and-the-dynamics-of-their-transport-into-the-dosage-forms.php weekly 0.7 /magno/csf/2003/mn1.php weekly 0.7 /en/magno/csf/2003/mn1.php weekly 0.7 /artkey/csf-200301-0001_soft-gelatin-capsules-their-manufacture-and-evaluation.php weekly 0.7 /en/artkey/csf-200301-0001_soft-gelatin-capsules-their-manufacture-and-evaluation.php weekly 0.7 /artkey/csf-200301-0002_chalcones-1-3-diarylpropen-1-ones-and-their-analogues-as-potential-therapeuticagents-of-diseases-of-the-cardi.php weekly 0.7 /en/artkey/csf-200301-0002_chalcones-1-3-diarylpropen-1-ones-and-their-analogues-as-potential-therapeuticagents-of-diseases-of-the-cardi.php weekly 0.7 /artkey/csf-200301-0003_therapeutic-and-toxicological-aspects-of-biological-activity-of-saint-john-s-wort-hypericum-perforatum.php weekly 0.7 /en/artkey/csf-200301-0003_therapeutic-and-toxicological-aspects-of-biological-activity-of-saint-john-s-wort-hypericum-perforatum.php weekly 0.7 /artkey/csf-200301-0004_kinetics-of-release-of-scopolamine-bromide-from-hydrogel-by-a-filtering-membrane.php weekly 0.7 /en/artkey/csf-200301-0004_kinetics-of-release-of-scopolamine-bromide-from-hydrogel-by-a-filtering-membrane.php weekly 0.7 /artkey/csf-200301-0005_dissolution-of-nimodipine-in-aqueous-solutions-of-hydroxyethyl-beta-cyclodextrin-and-thesurvey-of-nimodipine.php weekly 0.7 /en/artkey/csf-200301-0005_dissolution-of-nimodipine-in-aqueous-solutions-of-hydroxyethyl-beta-cyclodextrin-and-thesurvey-of-nimodipine.php weekly 0.7 /artkey/csf-200301-0006_seasonal-variation-in-the-haemolytic-activity-of-the-capitula-of-bellis-perennis-l.php weekly 0.7 /en/artkey/csf-200301-0006_seasonal-variation-in-the-haemolytic-activity-of-the-capitula-of-bellis-perennis-l.php weekly 0.7 /artkey/csf-200301-0007_new-groups-of-potential-antituberculotics-3-4-ethoxythiocarbonylphenyl-2h-benzoxazin-2-4-3h-dithiones-and-3.php weekly 0.7 /en/artkey/csf-200301-0007_new-groups-of-potential-antituberculotics-3-4-ethoxythiocarbonylphenyl-2h-benzoxazin-2-4-3h-dithiones-and-3.php weekly 0.7 /magno/csf/2003/mn2.php weekly 0.7 /en/magno/csf/2003/mn2.php weekly 0.7 /artkey/csf-200302-0001_modern-hplc-in-the-analysis-of-drugs.php weekly 0.7 /en/artkey/csf-200302-0001_modern-hplc-in-the-analysis-of-drugs.php weekly 0.7 /artkey/csf-200302-0002_information-system-beilstein-crossfire-and-its-versatility-in-medicinal-chemistry.php weekly 0.7 /en/artkey/csf-200302-0002_information-system-beilstein-crossfire-and-its-versatility-in-medicinal-chemistry.php weekly 0.7 /artkey/csf-200302-0003_advances-in-the-development-of-antituberculotics-containing-no-heterocycles-in-thepharmacophorepart-1-carboxyl.php weekly 0.7 /en/artkey/csf-200302-0003_advances-in-the-development-of-antituberculotics-containing-no-heterocycles-in-thepharmacophorepart-1-carboxyl.php weekly 0.7 /artkey/csf-200302-0004_pharmaceutical-importance-of-alium-sativum-l-4-antifungal-effect.php weekly 0.7 /en/artkey/csf-200302-0004_pharmaceutical-importance-of-alium-sativum-l-4-antifungal-effect.php weekly 0.7 /artkey/csf-200302-0005_use-of-penetrometry-in-the-evaluation-of-flowability-and-structure-of-powdered-substances.php weekly 0.7 /en/artkey/csf-200302-0005_use-of-penetrometry-in-the-evaluation-of-flowability-and-structure-of-powdered-substances.php weekly 0.7 /artkey/csf-200302-0006_a-study-of-the-rheological-properties-of-vivastar-reg-p-5000-hydrogels.php weekly 0.7 /en/artkey/csf-200302-0006_a-study-of-the-rheological-properties-of-vivastar-reg-p-5000-hydrogels.php weekly 0.7 /artkey/csf-200302-0007_effect-of-the-saccharide-parts-in-the-teikoplanin-stationary-phase-on-the-separation-ofsome-enantiomers-of-the.php weekly 0.7 /en/artkey/csf-200302-0007_effect-of-the-saccharide-parts-in-the-teikoplanin-stationary-phase-on-the-separation-ofsome-enantiomers-of-the.php weekly 0.7 /magno/csf/2003/mn3.php weekly 0.7 /en/magno/csf/2003/mn3.php weekly 0.7 /artkey/csf-200303-0001_fifty-years-of-the-research-institute-for-pharmacy-and-biochemistry.php weekly 0.7 /en/artkey/csf-200303-0001_fifty-years-of-the-research-institute-for-pharmacy-and-biochemistry.php weekly 0.7 /artkey/csf-200303-0002_two-phase-semisolid-hydrophilic-systems-hydrocreams.php weekly 0.7 /en/artkey/csf-200303-0002_two-phase-semisolid-hydrophilic-systems-hydrocreams.php weekly 0.7 /artkey/csf-200303-0003_chiral-separations-of-some-drugs-on-the-basis-of-macrocyclic-antibiotics-in-hplc-sfcand-cec.php weekly 0.7 /en/artkey/csf-200303-0003_chiral-separations-of-some-drugs-on-the-basis-of-macrocyclic-antibiotics-in-hplc-sfcand-cec.php weekly 0.7 /artkey/csf-200303-0004_chemoprotective-agents-of-natural-origin.php weekly 0.7 /en/artkey/csf-200303-0004_chemoprotective-agents-of-natural-origin.php weekly 0.7 /artkey/csf-200303-0005_influencing-pseudoplastic-hydrogel-by-an-addition-of-pilocarpinium-chloride.php weekly 0.7 /en/artkey/csf-200303-0005_influencing-pseudoplastic-hydrogel-by-an-addition-of-pilocarpinium-chloride.php weekly 0.7 /artkey/csf-200303-0006_tlc-and-hplc-separation-of-positional-isomers-of-alkylesters-of-2-3-4-2-hydroxy-3-4-diphenylmethyl-pip.php weekly 0.7 /en/artkey/csf-200303-0006_tlc-and-hplc-separation-of-positional-isomers-of-alkylesters-of-2-3-4-2-hydroxy-3-4-diphenylmethyl-pip.php weekly 0.7 /artkey/csf-200303-0007_effect-of-disinfectants-on-surface-hydrophobicity-and-motility-of-salmonella-entericaserovar-typhimurium-dt104.php weekly 0.7 /en/artkey/csf-200303-0007_effect-of-disinfectants-on-surface-hydrophobicity-and-motility-of-salmonella-entericaserovar-typhimurium-dt104.php weekly 0.7 /artkey/csf-200303-0008_the-effect-of-jasminic-acid-on-the-production-of-anthracene-derivatives-in-the-culture-of-rheum-palmatum-l-in.php weekly 0.7 /en/artkey/csf-200303-0008_the-effect-of-jasminic-acid-on-the-production-of-anthracene-derivatives-in-the-culture-of-rheum-palmatum-l-in.php weekly 0.7 /artkey/csf-200303-0009_jaroslav-hladik-a-czech-pharmaceutic-historian-in-jubilee-appraisal.php weekly 0.7 /en/artkey/csf-200303-0009_jaroslav-hladik-a-czech-pharmaceutic-historian-in-jubilee-appraisal.php weekly 0.7 /magno/csf/2003/mn4.php weekly 0.7 /en/magno/csf/2003/mn4.php weekly 0.7 /artkey/csf-200304-0001_opinions-of-physicians-and-pharmacists-on-drugs.php weekly 0.7 /en/artkey/csf-200304-0001_opinions-of-physicians-and-pharmacists-on-drugs.php weekly 0.7 /artkey/csf-200304-0002_antibiotika-v-ambulantnej-praxi-na-slovensku-v-rokoch-1999-2001.php weekly 0.7 /en/artkey/csf-200304-0002_antibiotika-v-ambulantnej-praxi-na-slovensku-v-rokoch-1999-2001.php weekly 0.7 /artkey/csf-200304-0003_antioxidacni-aktivita-pyridoindolu-a-n-alkoxyfenyl-2-2-oxo-1-aza-1-cykloalkyl-acetamiduv-biologickem-enzym.php weekly 0.7 /en/artkey/csf-200304-0003_antioxidacni-aktivita-pyridoindolu-a-n-alkoxyfenyl-2-2-oxo-1-aza-1-cykloalkyl-acetamiduv-biologickem-enzym.php weekly 0.7 /artkey/csf-200304-0004_sucha-pojiva-vivapur-102-vivapur-12-a-vliv-stearanu-horecnateho-na-pevnost-tablet-z-techto-latek.php weekly 0.7 /en/artkey/csf-200304-0004_sucha-pojiva-vivapur-102-vivapur-12-a-vliv-stearanu-horecnateho-na-pevnost-tablet-z-techto-latek.php weekly 0.7 /artkey/csf-200304-0005_migrace-vody-v-mekkych-zelatinovych-tobolkach.php weekly 0.7 /en/artkey/csf-200304-0005_migrace-vody-v-mekkych-zelatinovych-tobolkach.php weekly 0.7 /artkey/csf-200304-0006_vliv-auxinu-na-produkci-kumarinu-v-suspenzni-kulture-angelica-archangelica-l.php weekly 0.7 /en/artkey/csf-200304-0006_vliv-auxinu-na-produkci-kumarinu-v-suspenzni-kulture-angelica-archangelica-l.php weekly 0.7 /artkey/csf-200304-0007_kyselina-jodoctova-jako-potencialni-elicitor-zvysene-tvorby-flavonoidu-v-kulture-ononisarvensis-l-in-vitro.php weekly 0.7 /en/artkey/csf-200304-0007_kyselina-jodoctova-jako-potencialni-elicitor-zvysene-tvorby-flavonoidu-v-kulture-ononisarvensis-l-in-vitro.php weekly 0.7 /artkey/csf-200304-0008_vplyv-tobramycinu-na-niektore-charakteristiky-kmenov-acinetobacter-species.php weekly 0.7 /en/artkey/csf-200304-0008_vplyv-tobramycinu-na-niektore-charakteristiky-kmenov-acinetobacter-species.php weekly 0.7 /artkey/csf-200304-0009_zdravotnicke-prostredky-v-sortimentu-lekaren-zakladniho-typu.php weekly 0.7 /en/artkey/csf-200304-0009_zdravotnicke-prostredky-v-sortimentu-lekaren-zakladniho-typu.php weekly 0.7 /artkey/csf-200304-0010_vyuzite-radionuklidovej-r-ntgenofluorescencnej-analyzy-vo-farmacii-stanovenie-obsahu-prvkov-vo-farmaceutickyc.php weekly 0.7 /en/artkey/csf-200304-0010_vyuzite-radionuklidovej-r-ntgenofluorescencnej-analyzy-vo-farmacii-stanovenie-obsahu-prvkov-vo-farmaceutickyc.php weekly 0.7 /magno/csf/2003/mn5.php weekly 0.7 /en/magno/csf/2003/mn5.php weekly 0.7 /artkey/csf-200305-0001_hydrophilic-gel-matrix-tablets-for-oral-administration-of-drugs.php weekly 0.7 /en/artkey/csf-200305-0001_hydrophilic-gel-matrix-tablets-for-oral-administration-of-drugs.php weekly 0.7 /artkey/csf-200305-0002_derivation-absorption-spectrophotometry-in-the-ultraviolet-region-as-an-alternative-tohplc-and-other-instrument.php weekly 0.7 /en/artkey/csf-200305-0002_derivation-absorption-spectrophotometry-in-the-ultraviolet-region-as-an-alternative-tohplc-and-other-instrument.php weekly 0.7 /artkey/csf-200305-0003_novel-antifungal-substances-from-the-group-of-guanidine-derivatives.php weekly 0.7 /en/artkey/csf-200305-0003_novel-antifungal-substances-from-the-group-of-guanidine-derivatives.php weekly 0.7 /artkey/csf-200305-0004_availability-of-antidotes-in-hospital-pharmacies-in-the-czech-republic.php weekly 0.7 /en/artkey/csf-200305-0004_availability-of-antidotes-in-hospital-pharmacies-in-the-czech-republic.php weekly 0.7 /artkey/csf-200305-0005_a-study-of-compressibility-of-the-directly-compacting-form-of-lactitol.php weekly 0.7 /en/artkey/csf-200305-0005_a-study-of-compressibility-of-the-directly-compacting-form-of-lactitol.php weekly 0.7 /artkey/csf-200305-0006_granulometry-and-fractal-dimension.php weekly 0.7 /en/artkey/csf-200305-0006_granulometry-and-fractal-dimension.php weekly 0.7 /artkey/csf-200305-0007_effect-of-abiotic-elicitation-and-calcium-ions-on-the-production-of-the-explant-culturesof-rheum-palmatum-l.php weekly 0.7 /en/artkey/csf-200305-0007_effect-of-abiotic-elicitation-and-calcium-ions-on-the-production-of-the-explant-culturesof-rheum-palmatum-l.php weekly 0.7 /artkey/csf-200305-0008_extraction-spectrophotometric-determination-of-carbethopendecinium-bromide-inselected-medicinal-preparations.php weekly 0.7 /en/artkey/csf-200305-0008_extraction-spectrophotometric-determination-of-carbethopendecinium-bromide-inselected-medicinal-preparations.php weekly 0.7 /artkey/csf-200305-0009_long-term-pharmacological-treatment-of-obesity-in-2002-a-pharmacoeconomic-view.php weekly 0.7 /en/artkey/csf-200305-0009_long-term-pharmacological-treatment-of-obesity-in-2002-a-pharmacoeconomic-view.php weekly 0.7 /magno/csf/2003/mn6.php weekly 0.7 /en/magno/csf/2003/mn6.php weekly 0.7 /artkey/csf-200306-0001_a-new-strategy-of-therapeutic-drug-monitorining-of-cyclosporine-a-blood-levels-inpatients-after-renal-transplan.php weekly 0.7 /en/artkey/csf-200306-0001_a-new-strategy-of-therapeutic-drug-monitorining-of-cyclosporine-a-blood-levels-inpatients-after-renal-transplan.php weekly 0.7 /artkey/csf-200306-0002_biological-effects-of-resveratrol-and-other-constituents-of-wine.php weekly 0.7 /en/artkey/csf-200306-0002_biological-effects-of-resveratrol-and-other-constituents-of-wine.php weekly 0.7 /artkey/csf-200306-0003_biologically-active-benzoxazoles.php weekly 0.7 /en/artkey/csf-200306-0003_biologically-active-benzoxazoles.php weekly 0.7 /artkey/csf-200306-0004_the-release-of-diltiazemiumchloride-and-ibuprofen-from-hydrophilic-matrix-tablets.php weekly 0.7 /en/artkey/csf-200306-0004_the-release-of-diltiazemiumchloride-and-ibuprofen-from-hydrophilic-matrix-tablets.php weekly 0.7 /artkey/csf-200306-0005_solubilization-of-unilamellar-egg-yolk-phosphatidylcholine-liposomes-by-n-alkyl-n-ndimethylaminen-oxides.php weekly 0.7 /en/artkey/csf-200306-0005_solubilization-of-unilamellar-egg-yolk-phosphatidylcholine-liposomes-by-n-alkyl-n-ndimethylaminen-oxides.php weekly 0.7 /artkey/csf-200306-0006_anticomplementary-activity-of-saponins-from-cynara-cardunculus-l.php weekly 0.7 /en/artkey/csf-200306-0006_anticomplementary-activity-of-saponins-from-cynara-cardunculus-l.php weekly 0.7 /artkey/csf-200306-0007_a-novel-group-of-potential-antituberculotic-agents-antimycobacterial-n-benzylsalicylamides.php weekly 0.7 /en/artkey/csf-200306-0007_a-novel-group-of-potential-antituberculotic-agents-antimycobacterial-n-benzylsalicylamides.php weekly 0.7 /magno/csf/2002/mn1.php weekly 0.7 /en/magno/csf/2002/mn1.php weekly 0.7 /artkey/csf-200201-0001_penicillin-g-acylase-its-synthesis-regulation-and-production.php weekly 0.7 /en/artkey/csf-200201-0001_penicillin-g-acylase-its-synthesis-regulation-and-production.php weekly 0.7 /artkey/csf-200201-0002_farmaceuticky-vyznam-allium-sativum-l-2-antibakterialni-ucinek.php weekly 0.7 /en/artkey/csf-200201-0002_farmaceuticky-vyznam-allium-sativum-l-2-antibakterialni-ucinek.php weekly 0.7 /artkey/csf-200201-0003_chiralita-leciv.php weekly 0.7 /en/artkey/csf-200201-0003_chiralita-leciv.php weekly 0.7 /artkey/csf-200201-0004_pokroky-ve-vyvoji-novych-antimykobakterialnich-latek-alkylsulfanyl-skupina-farmakofor-antimykobakterialni-akt.php weekly 0.7 /en/artkey/csf-200201-0004_pokroky-ve-vyvoji-novych-antimykobakterialnich-latek-alkylsulfanyl-skupina-farmakofor-antimykobakterialni-akt.php weekly 0.7 /artkey/csf-200201-0005_uvolnovanie-potencialnych-lokalnych-anestetik-z-koloidnych-disperzii.php weekly 0.7 /en/artkey/csf-200201-0005_uvolnovanie-potencialnych-lokalnych-anestetik-z-koloidnych-disperzii.php weekly 0.7 /artkey/csf-200201-0006_vliv-stearanu-horecnateho-na-pevnost-tablet-v-tahu-ze-sucheho-pojiva-prosolv-smcc-90.php weekly 0.7 /en/artkey/csf-200201-0006_vliv-stearanu-horecnateho-na-pevnost-tablet-v-tahu-ze-sucheho-pojiva-prosolv-smcc-90.php weekly 0.7 /artkey/csf-200201-0007_vliv-tvorby-flavonoidu-v-kulture-ononis-arvensis-l-in-vitro-pusobenim-crcl3.php weekly 0.7 /en/artkey/csf-200201-0007_vliv-tvorby-flavonoidu-v-kulture-ononis-arvensis-l-in-vitro-pusobenim-crcl3.php weekly 0.7 /artkey/csf-200201-0008_vliv-prekurzoru-na-produkci-kumarinu-v-suspenzni-kulture-angelica-archangelica-l.php weekly 0.7 /en/artkey/csf-200201-0008_vliv-prekurzoru-na-produkci-kumarinu-v-suspenzni-kulture-angelica-archangelica-l.php weekly 0.7 /magno/csf/2002/mn2.php weekly 0.7 /en/magno/csf/2002/mn2.php weekly 0.7 /artkey/csf-200202-0001_inhibitors-of-5-lipoxygenase.php weekly 0.7 /en/artkey/csf-200202-0001_inhibitors-of-5-lipoxygenase.php weekly 0.7 /artkey/csf-200202-0002_the-ace-inhibitor-captopril-in-the-light-of-recent-clinical-studies.php weekly 0.7 /en/artkey/csf-200202-0002_the-ace-inhibitor-captopril-in-the-light-of-recent-clinical-studies.php weekly 0.7 /artkey/csf-200202-0003_dried-milk-based-infant-formula-and-its-possible-contamination-with-pesticide-rssidues.php weekly 0.7 /en/artkey/csf-200202-0003_dried-milk-based-infant-formula-and-its-possible-contamination-with-pesticide-rssidues.php weekly 0.7 /artkey/csf-200202-0004_effects-of-consupren-carvedilol-and-bl-443-on-lactate-dehydrogenase-pattern-in-tissues-of-rats-with-cyclospori.php weekly 0.7 /en/artkey/csf-200202-0004_effects-of-consupren-carvedilol-and-bl-443-on-lactate-dehydrogenase-pattern-in-tissues-of-rats-with-cyclospori.php weekly 0.7 /artkey/csf-200202-0005_pharmacoeconomics-in-the-therapy-of-peptic-ulcers.php weekly 0.7 /en/artkey/csf-200202-0005_pharmacoeconomics-in-the-therapy-of-peptic-ulcers.php weekly 0.7 /artkey/csf-200202-0006_reperfusion-injury-of-cold-preserved-rat-liver.php weekly 0.7 /en/artkey/csf-200202-0006_reperfusion-injury-of-cold-preserved-rat-liver.php weekly 0.7 /artkey/csf-200202-0007_validation-of-a-hplc-method-for-the-determination-of-dioxopromethazine-and-phenylephrine-in-eye-drops.php weekly 0.7 /en/artkey/csf-200202-0007_validation-of-a-hplc-method-for-the-determination-of-dioxopromethazine-and-phenylephrine-in-eye-drops.php weekly 0.7 /artkey/csf-200202-0008_the-effect-of-jasminic-acid-on-the-production-of-flavonoids-by-the-culture-ononis-arvensis-l-in-vitro.php weekly 0.7 /en/artkey/csf-200202-0008_the-effect-of-jasminic-acid-on-the-production-of-flavonoids-by-the-culture-ononis-arvensis-l-in-vitro.php weekly 0.7 /artkey/csf-200202-0009_pre-formulation-studies-of-a-potential-local-anaesthetic-from-the-group-of-phenylcarbamic-acid-derivatives.php weekly 0.7 /en/artkey/csf-200202-0009_pre-formulation-studies-of-a-potential-local-anaesthetic-from-the-group-of-phenylcarbamic-acid-derivatives.php weekly 0.7 /magno/csf/2002/mn3.php weekly 0.7 /en/magno/csf/2002/mn3.php weekly 0.7 /artkey/csf-200203-0001_analysis-of-cyclosporine-a-by-high-performance-liquid-chromatography-hplc.php weekly 0.7 /en/artkey/csf-200203-0001_analysis-of-cyclosporine-a-by-high-performance-liquid-chromatography-hplc.php weekly 0.7 /artkey/csf-200203-0002_immunoanalytical-methods-of-analysis-of-cyclosporine-a.php weekly 0.7 /en/artkey/csf-200203-0002_immunoanalytical-methods-of-analysis-of-cyclosporine-a.php weekly 0.7 /artkey/csf-200203-0003_r-adrenergic-receptor-blockers-the-group-of-chiral-drugs-different-effects-of-individual-enantiomers.php weekly 0.7 /en/artkey/csf-200203-0003_r-adrenergic-receptor-blockers-the-group-of-chiral-drugs-different-effects-of-individual-enantiomers.php weekly 0.7 /artkey/csf-200203-0004_drug-policy-in-slovakia-and-its-reflection-in-prescription1-prescription-of-mass-produced-drugs-according-to-t.php weekly 0.7 /en/artkey/csf-200203-0004_drug-policy-in-slovakia-and-its-reflection-in-prescription1-prescription-of-mass-produced-drugs-according-to-t.php weekly 0.7 /artkey/csf-200203-0005_characteristics-of-chitosan-and-the-sorption-of-copper-ii-ions-from-copper-sulfate-solutions-on-chitosan.php weekly 0.7 /en/artkey/csf-200203-0005_characteristics-of-chitosan-and-the-sorption-of-copper-ii-ions-from-copper-sulfate-solutions-on-chitosan.php weekly 0.7 /artkey/csf-200203-0006_antimycobacterial-effects-of-pyrrolidinoethylesters-of-alkoxysubstituted-phenylcarbamic-acids.php weekly 0.7 /en/artkey/csf-200203-0006_antimycobacterial-effects-of-pyrrolidinoethylesters-of-alkoxysubstituted-phenylcarbamic-acids.php weekly 0.7 /artkey/csf-200203-0007_the-relationship-of-the-structure-and-effect-of-propaphenone-and-alkylesters-of-2-and-4-3-propylamino-2-hydr.php weekly 0.7 /en/artkey/csf-200203-0007_the-relationship-of-the-structure-and-effect-of-propaphenone-and-alkylesters-of-2-and-4-3-propylamino-2-hydr.php weekly 0.7 /artkey/csf-200203-0008_studies-of-local-anaestheticsclix-hplc-separation-of-1-methyl-2-piperidinoethylesters-of-alkoxyphenylcarbamic.php weekly 0.7 /en/artkey/csf-200203-0008_studies-of-local-anaestheticsclix-hplc-separation-of-1-methyl-2-piperidinoethylesters-of-alkoxyphenylcarbamic.php weekly 0.7 /artkey/csf-200203-0009_study-of-local-anesthetics-clx-determination-of-the-critical-micellar-concentration-c-m-c-in-series-of-the.php weekly 0.7 /en/artkey/csf-200203-0009_study-of-local-anesthetics-clx-determination-of-the-critical-micellar-concentration-c-m-c-in-series-of-the.php weekly 0.7 /magno/csf/2002/mn4.php weekly 0.7 /en/magno/csf/2002/mn4.php weekly 0.7 /artkey/csf-200204-0001_therapeutic-drug-monitoring-of-cyclosporine-a.php weekly 0.7 /en/artkey/csf-200204-0001_therapeutic-drug-monitoring-of-cyclosporine-a.php weekly 0.7 /artkey/csf-200204-0002_pharmaceutical-importance-of-allium-sativum-l-3-antibacterial-effect-against-helicobacter-pylori.php weekly 0.7 /en/artkey/csf-200204-0002_pharmaceutical-importance-of-allium-sativum-l-3-antibacterial-effect-against-helicobacter-pylori.php weekly 0.7 /artkey/csf-200204-0003_ononis-arvensis-in-vitro-abiotic-elicitation.php weekly 0.7 /en/artkey/csf-200204-0003_ononis-arvensis-in-vitro-abiotic-elicitation.php weekly 0.7 /artkey/csf-200204-0004_effect-of-salicylic-acid-on-the-production-of-anthracene-derivatives-in-the-culture-ofrheum-palmatum-l-in-vitro.php weekly 0.7 /en/artkey/csf-200204-0004_effect-of-salicylic-acid-on-the-production-of-anthracene-derivatives-in-the-culture-ofrheum-palmatum-l-in-vitro.php weekly 0.7 /artkey/csf-200204-0005_changes-in-sanguinarine-content-and-polyphenoloxidase-activity-due-to-a-fungalelicitor-in-suspension-cultures-o.php weekly 0.7 /en/artkey/csf-200204-0005_changes-in-sanguinarine-content-and-polyphenoloxidase-activity-due-to-a-fungalelicitor-in-suspension-cultures-o.php weekly 0.7 /artkey/csf-200204-0006_drug-policy-in-slovakia-and-its-reflection-in-prescription-2-prescription-of-extemporaneously-prepared-drugs-a.php weekly 0.7 /en/artkey/csf-200204-0006_drug-policy-in-slovakia-and-its-reflection-in-prescription-2-prescription-of-extemporaneously-prepared-drugs-a.php weekly 0.7 /artkey/csf-200204-0007_state-of-treatment-of-allergic-rhinitis-in-field-practice-and-its-pharmacoeconomic-aspects.php weekly 0.7 /en/artkey/csf-200204-0007_state-of-treatment-of-allergic-rhinitis-in-field-practice-and-its-pharmacoeconomic-aspects.php weekly 0.7 /artkey/csf-200204-0008_conformational-study-of-drugs-with-effect-on-i1-imidazoline-receptors.php weekly 0.7 /en/artkey/csf-200204-0008_conformational-study-of-drugs-with-effect-on-i1-imidazoline-receptors.php weekly 0.7 /artkey/csf-200204-0009_anti-inflammatory-activities-of-o-cresotato-copper-ii-and-zinc-ii-aquacomplexes.php weekly 0.7 /en/artkey/csf-200204-0009_anti-inflammatory-activities-of-o-cresotato-copper-ii-and-zinc-ii-aquacomplexes.php weekly 0.7 /magno/csf/2002/mn5.php weekly 0.7 /en/magno/csf/2002/mn5.php weekly 0.7 /artkey/csf-200205-0001_immunopathogenesis-of-psoriasis-and-its-current-therapy-possibilities.php weekly 0.7 /en/artkey/csf-200205-0001_immunopathogenesis-of-psoriasis-and-its-current-therapy-possibilities.php weekly 0.7 /artkey/csf-200205-0002_mycophenolate-mofetil-a-new-prospective-immunosuppressant.php weekly 0.7 /en/artkey/csf-200205-0002_mycophenolate-mofetil-a-new-prospective-immunosuppressant.php weekly 0.7 /artkey/csf-200205-0003_progress-in-antifungal-drugs-development.php weekly 0.7 /en/artkey/csf-200205-0003_progress-in-antifungal-drugs-development.php weekly 0.7 /artkey/csf-200205-0004_influence-of-fractal-dimension-on-the-flow-rate-of-powdered-auxiliary-substances.php weekly 0.7 /en/artkey/csf-200205-0004_influence-of-fractal-dimension-on-the-flow-rate-of-powdered-auxiliary-substances.php weekly 0.7 /artkey/csf-200205-0005_cholesterol-inhibits-peroxidation-of-egg-phosphatidylcholine-in-multilamellarliposomes.php weekly 0.7 /en/artkey/csf-200205-0005_cholesterol-inhibits-peroxidation-of-egg-phosphatidylcholine-in-multilamellarliposomes.php weekly 0.7 /artkey/csf-200205-0006_the-role-of-the-moistening-agent-in-the-process-of-extrusion-and-spheronization.php weekly 0.7 /en/artkey/csf-200205-0006_the-role-of-the-moistening-agent-in-the-process-of-extrusion-and-spheronization.php weekly 0.7 /artkey/csf-200205-0007_effect-of-sodium-chloride-on-elastic-behaviour-of-silicone-matrices.php weekly 0.7 /en/artkey/csf-200205-0007_effect-of-sodium-chloride-on-elastic-behaviour-of-silicone-matrices.php weekly 0.7 /artkey/csf-200205-0008_biodistribution-of-99mtc-labelled-low-molecular-peptides-and-proteins-in-an-animalmodel-of-inflammation.php weekly 0.7 /en/artkey/csf-200205-0008_biodistribution-of-99mtc-labelled-low-molecular-peptides-and-proteins-in-an-animalmodel-of-inflammation.php weekly 0.7 /artkey/csf-200205-0009_optimization-of-conditions-for-determination-of-l-cystine-using-capillaryisotachophoresis.php weekly 0.7 /en/artkey/csf-200205-0009_optimization-of-conditions-for-determination-of-l-cystine-using-capillaryisotachophoresis.php weekly 0.7 /magno/csf/2002/mn6.php weekly 0.7 /en/magno/csf/2002/mn6.php weekly 0.7 /artkey/csf-200206-0001_immunosuppressives-retinoids-and-new-trends-in-psoriasis-therapy.php weekly 0.7 /en/artkey/csf-200206-0001_immunosuppressives-retinoids-and-new-trends-in-psoriasis-therapy.php weekly 0.7 /artkey/csf-200206-0002_what-every-worker-in-the-synthesis-and-analysis-of-drugs-could-learn-from-the-law-concerning-chemical-substance.php weekly 0.7 /en/artkey/csf-200206-0002_what-every-worker-in-the-synthesis-and-analysis-of-drugs-could-learn-from-the-law-concerning-chemical-substance.php weekly 0.7 /artkey/csf-200206-0003_the-scullcap-plant-scutellaria-baicalensis-georgi-a-potential-resource-of-new-drugs.php weekly 0.7 /en/artkey/csf-200206-0003_the-scullcap-plant-scutellaria-baicalensis-georgi-a-potential-resource-of-new-drugs.php weekly 0.7 /artkey/csf-200206-0004_reactive-fractal-dimension-of-scopolamine-bromide-release-from-hydrogel.php weekly 0.7 /en/artkey/csf-200206-0004_reactive-fractal-dimension-of-scopolamine-bromide-release-from-hydrogel.php weekly 0.7 /artkey/csf-200206-0005_analysis-of-current-conservative-treatment-of-nephropathies.php weekly 0.7 /en/artkey/csf-200206-0005_analysis-of-current-conservative-treatment-of-nephropathies.php weekly 0.7 /artkey/csf-200206-0006_knowledge-of-patients-about-the-otc-preparation-as-the-result-of-pharmacist-patient-consultations.php weekly 0.7 /en/artkey/csf-200206-0006_knowledge-of-patients-about-the-otc-preparation-as-the-result-of-pharmacist-patient-consultations.php weekly 0.7 /artkey/csf-200206-0007_anti-yeast-activity-of-the-ethanolic-extracts-of-lilium-candidum-l.php weekly 0.7 /en/artkey/csf-200206-0007_anti-yeast-activity-of-the-ethanolic-extracts-of-lilium-candidum-l.php weekly 0.7 /artkey/csf-200206-0008_the-construction-of-a-baculovirus-expression-system-for-in-vitro-production-of-isoenzymes-p4501a1-and-p4503a4.php weekly 0.7 /en/artkey/csf-200206-0008_the-construction-of-a-baculovirus-expression-system-for-in-vitro-production-of-isoenzymes-p4501a1-and-p4503a4.php weekly 0.7 /artkey/csf-200206-0009_preparation-and-physico-chemical-properties-of-alkyl-esters-of-2-hydroxy-3-diphenyl-methylpiperazinyl-propoxy.php weekly 0.7 /en/artkey/csf-200206-0009_preparation-and-physico-chemical-properties-of-alkyl-esters-of-2-hydroxy-3-diphenyl-methylpiperazinyl-propoxy.php weekly 0.7 /artkey/csf-200206-0010_therapy-of-hyperhomocysteinemia-by-vitamin-b12.php weekly 0.7 /en/artkey/csf-200206-0010_therapy-of-hyperhomocysteinemia-by-vitamin-b12.php weekly 0.7 /magno/csf/2001/mn1.php weekly 0.7 /en/magno/csf/2001/mn1.php weekly 0.7 /artkey/csf-200101-0001_development-of-tuberculosis-chemotherapy.php weekly 0.7 /en/artkey/csf-200101-0001_development-of-tuberculosis-chemotherapy.php weekly 0.7 /artkey/csf-200101-0002_pharmaceutical-importance-of-allium-sativum-l.php weekly 0.7 /en/artkey/csf-200101-0002_pharmaceutical-importance-of-allium-sativum-l.php weekly 0.7 /artkey/csf-200101-0003_a-review-of-radiodiagnostics-of-inflammation.php weekly 0.7 /en/artkey/csf-200101-0003_a-review-of-radiodiagnostics-of-inflammation.php weekly 0.7 /artkey/csf-200101-0004_use-of-synthetic-biodegradable-polymers-in-medicine.php weekly 0.7 /en/artkey/csf-200101-0004_use-of-synthetic-biodegradable-polymers-in-medicine.php weekly 0.7 /artkey/csf-200101-0005_calorimetric-evaluation-of-directly-compressed-tablets.php weekly 0.7 /en/artkey/csf-200101-0005_calorimetric-evaluation-of-directly-compressed-tablets.php weekly 0.7 /artkey/csf-200101-0006_prednicarbat-and-cetirizin-dihydrochloride-in-the-treatment-of-acute-stage-of-atopic-eczema-in-children.php weekly 0.7 /en/artkey/csf-200101-0006_prednicarbat-and-cetirizin-dihydrochloride-in-the-treatment-of-acute-stage-of-atopic-eczema-in-children.php weekly 0.7 /artkey/csf-200101-0007_effect-of-the-biotic-elicitor-candida-utilis-on-the-production-of-anthracene-derivativesby-the-tissue-culture-o.php weekly 0.7 /en/artkey/csf-200101-0007_effect-of-the-biotic-elicitor-candida-utilis-on-the-production-of-anthracene-derivativesby-the-tissue-culture-o.php weekly 0.7 /artkey/csf-200101-0008_content-and-quality-of-the-essential-oil-of-melissa-officinalis-after-the-administrationof-rastin-30-dkv.php weekly 0.7 /en/artkey/csf-200101-0008_content-and-quality-of-the-essential-oil-of-melissa-officinalis-after-the-administrationof-rastin-30-dkv.php weekly 0.7 /artkey/csf-200101-0009_polyphenolic-compounds-from-hamamelis-virginiana-l.php weekly 0.7 /en/artkey/csf-200101-0009_polyphenolic-compounds-from-hamamelis-virginiana-l.php weekly 0.7 /magno/csf/2001/mn2.php weekly 0.7 /en/magno/csf/2001/mn2.php weekly 0.7 /artkey/csf-200102-0001_orphan-drugs.php weekly 0.7 /en/artkey/csf-200102-0001_orphan-drugs.php weekly 0.7 /artkey/csf-200102-0002_silymarin-an-extract-from-silybum-marianum-a-drug-or-a-nutritional-supplement.php weekly 0.7 /en/artkey/csf-200102-0002_silymarin-an-extract-from-silybum-marianum-a-drug-or-a-nutritional-supplement.php weekly 0.7 /artkey/csf-200102-0003_viral-liver-diseases-current-status-of-therapy.php weekly 0.7 /en/artkey/csf-200102-0003_viral-liver-diseases-current-status-of-therapy.php weekly 0.7 /artkey/csf-200102-0004_coenzyme-q-and-its-medical-implications.php weekly 0.7 /en/artkey/csf-200102-0004_coenzyme-q-and-its-medical-implications.php weekly 0.7 /artkey/csf-200102-0005_bergenia-crassifolia-l-fritsch-in-vitro.php weekly 0.7 /en/artkey/csf-200102-0005_bergenia-crassifolia-l-fritsch-in-vitro.php weekly 0.7 /artkey/csf-200102-0006_study-of-the-kinetics-of-hydrolysis-of-stobadine-acyl-derivatives-the-prodrug-forms-of-extinguishers-of-free-o.php weekly 0.7 /en/artkey/csf-200102-0006_study-of-the-kinetics-of-hydrolysis-of-stobadine-acyl-derivatives-the-prodrug-forms-of-extinguishers-of-free-o.php weekly 0.7 /artkey/csf-200102-0007_strength-of-the-compacts-from-avicel-ph-102-and-avicel-ph-301-and-the-influence-on-it-exerted-by-magnesium-stea.php weekly 0.7 /en/artkey/csf-200102-0007_strength-of-the-compacts-from-avicel-ph-102-and-avicel-ph-301-and-the-influence-on-it-exerted-by-magnesium-stea.php weekly 0.7 /artkey/csf-200102-0008_study-of-relation-pharmaceutical-store-and-chemistis-schops-in-the-first-year-s-in-the-independent-czechoslovak.php weekly 0.7 /en/artkey/csf-200102-0008_study-of-relation-pharmaceutical-store-and-chemistis-schops-in-the-first-year-s-in-the-independent-czechoslovak.php weekly 0.7 /magno/csf/2001/mn3.php weekly 0.7 /en/magno/csf/2001/mn3.php weekly 0.7 /artkey/csf-200103-0001_improvement-of-amperometric-detection-ad-by-determination-of-drugs-by-flow-injection-methods-flow-injection.php weekly 0.7 /en/artkey/csf-200103-0001_improvement-of-amperometric-detection-ad-by-determination-of-drugs-by-flow-injection-methods-flow-injection.php weekly 0.7 /artkey/csf-200103-0002_sorbents-used-for-the-extraction-on-the-solid-phase-and-their-use.php weekly 0.7 /en/artkey/csf-200103-0002_sorbents-used-for-the-extraction-on-the-solid-phase-and-their-use.php weekly 0.7 /artkey/csf-200103-0003_situation-of-yemeni-public-health-service-and-possible-cooperation-with-the-czech-republic-in-the-field-of-phar.php weekly 0.7 /en/artkey/csf-200103-0003_situation-of-yemeni-public-health-service-and-possible-cooperation-with-the-czech-republic-in-the-field-of-phar.php weekly 0.7 /artkey/csf-200103-0004_effect-of-n-decane-and-n-octadecane-on-the-autoperoxidation-of-egg-yolk-phosphatidylcholine-in-multilamellar-li.php weekly 0.7 /en/artkey/csf-200103-0004_effect-of-n-decane-and-n-octadecane-on-the-autoperoxidation-of-egg-yolk-phosphatidylcholine-in-multilamellar-li.php weekly 0.7 /artkey/csf-200103-0005_use-of-otc-preparations-containing-ibuprofen-in-self-medication.php weekly 0.7 /en/artkey/csf-200103-0005_use-of-otc-preparations-containing-ibuprofen-in-self-medication.php weekly 0.7 /artkey/csf-200103-0006_the-opinions-and-attitudes-of-patients-visiting-pharmacies.php weekly 0.7 /en/artkey/csf-200103-0006_the-opinions-and-attitudes-of-patients-visiting-pharmacies.php weekly 0.7 /artkey/csf-200103-0007_antimycobacterial-salicylanilides-and-3-phenyl-2h-1-3-benzoxazine-2-4-3h-diones.php weekly 0.7 /en/artkey/csf-200103-0007_antimycobacterial-salicylanilides-and-3-phenyl-2h-1-3-benzoxazine-2-4-3h-diones.php weekly 0.7 /artkey/csf-200103-0008_study-of-local-anesthetics-part-154-study-of-micelization-of-the-homologs-of-heptacainium-chloride.php weekly 0.7 /en/artkey/csf-200103-0008_study-of-local-anesthetics-part-154-study-of-micelization-of-the-homologs-of-heptacainium-chloride.php weekly 0.7 /magno/csf/2001/mn4.php weekly 0.7 /en/magno/csf/2001/mn4.php weekly 0.7 /artkey/csf-200104-0001_advances-in-the-development-of-new-antituberculotics-from-the-group-of-ortho-condensed-heterocyclic-compounds.php weekly 0.7 /en/artkey/csf-200104-0001_advances-in-the-development-of-new-antituberculotics-from-the-group-of-ortho-condensed-heterocyclic-compounds.php weekly 0.7 /artkey/csf-200104-0002_enantiomeric-separations-of-drugs-on-the-basis-of-macrocyclic-antibiotics.php weekly 0.7 /en/artkey/csf-200104-0002_enantiomeric-separations-of-drugs-on-the-basis-of-macrocyclic-antibiotics.php weekly 0.7 /artkey/csf-200104-0003_phytotherapeutic-aspects-of-the-diseases-of-the-circulatory-system7-schisandra-chinensis-turcz-baill-its.php weekly 0.7 /en/artkey/csf-200104-0003_phytotherapeutic-aspects-of-the-diseases-of-the-circulatory-system7-schisandra-chinensis-turcz-baill-its.php weekly 0.7 /artkey/csf-200104-0004_unused-drugs-returned-to-pharmacies-i.php weekly 0.7 /en/artkey/csf-200104-0004_unused-drugs-returned-to-pharmacies-i.php weekly 0.7 /artkey/csf-200104-0005_pharmacotherapy-of-osteoporosis-in-out-patient-practice-and-its-pharmaceutical-aspects.php weekly 0.7 /en/artkey/csf-200104-0005_pharmacotherapy-of-osteoporosis-in-out-patient-practice-and-its-pharmaceutical-aspects.php weekly 0.7 /artkey/csf-200104-0006_effect-of-losartan-on-the-antioxidant-status-of-rats-with-diabetes-mellitus.php weekly 0.7 /en/artkey/csf-200104-0006_effect-of-losartan-on-the-antioxidant-status-of-rats-with-diabetes-mellitus.php weekly 0.7 /artkey/csf-200104-0007_analytical-evaluation-of-the-substance-bl-443-pivalate.php weekly 0.7 /en/artkey/csf-200104-0007_analytical-evaluation-of-the-substance-bl-443-pivalate.php weekly 0.7 /artkey/csf-200104-0008_antiradical-activity-of-some-antiulcer-and-local-anaesthetic-active-substances.php weekly 0.7 /en/artkey/csf-200104-0008_antiradical-activity-of-some-antiulcer-and-local-anaesthetic-active-substances.php weekly 0.7 /magno/csf/2001/mn5.php weekly 0.7 /en/magno/csf/2001/mn5.php weekly 0.7 /artkey/csf-200105-0001_advances-in-the-development-of-new-antituberculotics-from-the-group-of-orthocondensed-heterocyclic-compoundspar.php weekly 0.7 /en/artkey/csf-200105-0001_advances-in-the-development-of-new-antituberculotics-from-the-group-of-orthocondensed-heterocyclic-compoundspar.php weekly 0.7 /artkey/csf-200105-0002_phytotherapeutic-aspects-of-the-diseases-of-the-circulatory-systems-schisandra-chinensis-turcz-baill-prod.php weekly 0.7 /en/artkey/csf-200105-0002_phytotherapeutic-aspects-of-the-diseases-of-the-circulatory-systems-schisandra-chinensis-turcz-baill-prod.php weekly 0.7 /artkey/csf-200105-0003_biochemical-and-molecular-biological-aspects-of-plant-phospholipase-d.php weekly 0.7 /en/artkey/csf-200105-0003_biochemical-and-molecular-biological-aspects-of-plant-phospholipase-d.php weekly 0.7 /artkey/csf-200105-0004_studies-on-local-anaesthetics-clvii-chromatographic-properties-of-pentacaine-carbisocaine-heptacaine-and-it.php weekly 0.7 /en/artkey/csf-200105-0004_studies-on-local-anaesthetics-clvii-chromatographic-properties-of-pentacaine-carbisocaine-heptacaine-and-it.php weekly 0.7 /artkey/csf-200105-0005_cytotoxic-and-genotoxic-activity-of-selected-preservative-compounds-for-cosmetics.php weekly 0.7 /en/artkey/csf-200105-0005_cytotoxic-and-genotoxic-activity-of-selected-preservative-compounds-for-cosmetics.php weekly 0.7 /artkey/csf-200105-0006_unused-drugs-returned-to-pharmacies-ii.php weekly 0.7 /en/artkey/csf-200105-0006_unused-drugs-returned-to-pharmacies-ii.php weekly 0.7 /artkey/csf-200105-0007_effect-of-chitosan-on-the-production-of-anthracene-derivatives-in-the-tissue-culture-of-rheum-palmatum-l.php weekly 0.7 /en/artkey/csf-200105-0007_effect-of-chitosan-on-the-production-of-anthracene-derivatives-in-the-tissue-culture-of-rheum-palmatum-l.php weekly 0.7 /artkey/csf-200105-0008_effect-of-diazepam-on-antidotal-therapy-of-lethal-toxic-effects-of-soman-in-the-rat.php weekly 0.7 /en/artkey/csf-200105-0008_effect-of-diazepam-on-antidotal-therapy-of-lethal-toxic-effects-of-soman-in-the-rat.php weekly 0.7 /magno/csf/2001/mn6.php weekly 0.7 /en/magno/csf/2001/mn6.php weekly 0.7 /artkey/csf-200106-0001_nanobiotechnologie-ve-farmacii-a-medicine.php weekly 0.7 /en/artkey/csf-200106-0001_nanobiotechnologie-ve-farmacii-a-medicine.php weekly 0.7 /artkey/csf-200106-0002_advances-in-the-development-of-new-antituberculotics-from-the-group-of-ortho-condensed-heterocyclic-compounds.php weekly 0.7 /en/artkey/csf-200106-0002_advances-in-the-development-of-new-antituberculotics-from-the-group-of-ortho-condensed-heterocyclic-compounds.php weekly 0.7 /artkey/csf-200106-0003_nonpolar-constituents-of-the-leaves-of-philadelphus-coronarius-l.php weekly 0.7 /en/artkey/csf-200106-0003_nonpolar-constituents-of-the-leaves-of-philadelphus-coronarius-l.php weekly 0.7 /artkey/csf-200106-0004_monodesmosidic-saponins-from-cynara-cardunculus-l.php weekly 0.7 /en/artkey/csf-200106-0004_monodesmosidic-saponins-from-cynara-cardunculus-l.php weekly 0.7 /artkey/csf-200106-0005_constituents-of-holodiscus-discolor-pursh-maxim.php weekly 0.7 /en/artkey/csf-200106-0005_constituents-of-holodiscus-discolor-pursh-maxim.php weekly 0.7 /artkey/csf-200106-0006_constituents-of-ligustrum-delavayanum-hariot.php weekly 0.7 /en/artkey/csf-200106-0006_constituents-of-ligustrum-delavayanum-hariot.php weekly 0.7 /artkey/csf-200106-0007_a-study-of-the-anticomplementary-activity-of-mahonia-aquifolium-crude-extract-bisbenzylisoquinoline-alkaloids.php weekly 0.7 /en/artkey/csf-200106-0007_a-study-of-the-anticomplementary-activity-of-mahonia-aquifolium-crude-extract-bisbenzylisoquinoline-alkaloids.php weekly 0.7 /artkey/csf-200106-0008_a-study-of-qualitative-properties-of-selected-species-of-the-genus-echinacea-moench.php weekly 0.7 /en/artkey/csf-200106-0008_a-study-of-qualitative-properties-of-selected-species-of-the-genus-echinacea-moench.php weekly 0.7 /artkey/csf-200106-0009_experiments-with-the-cultivation-of-hypericum-perforatum-l-in-bratislava.php weekly 0.7 /en/artkey/csf-200106-0009_experiments-with-the-cultivation-of-hypericum-perforatum-l-in-bratislava.php weekly 0.7 /artkey/csf-200106-0010_comparison-of-the-quality-of-melissa-officinalis-l-cv-citra-with-melissas-of-european-origin.php weekly 0.7 /en/artkey/csf-200106-0010_comparison-of-the-quality-of-melissa-officinalis-l-cv-citra-with-melissas-of-european-origin.php weekly 0.7 /artkey/csf-200106-0011_hplc-analysis-of-non-steroidal-antirheumatics-in-biological-material-v-fenamates.php weekly 0.7 /en/artkey/csf-200106-0011_hplc-analysis-of-non-steroidal-antirheumatics-in-biological-material-v-fenamates.php weekly 0.7 /magno/csf/2000/mn1.php weekly 0.7 /en/magno/csf/2000/mn1.php weekly 0.7 /artkey/csf-200001-0001_nomenclature-of-dosage-forms-an-outline-of-its-development-and-contemporary-state.php weekly 0.7 /en/artkey/csf-200001-0001_nomenclature-of-dosage-forms-an-outline-of-its-development-and-contemporary-state.php weekly 0.7 /artkey/csf-200001-0002_on-the-problems-of-good-pharmacotherapy.php weekly 0.7 /en/artkey/csf-200001-0002_on-the-problems-of-good-pharmacotherapy.php weekly 0.7 /artkey/csf-200001-0003_human-hepatocyte-ii-cryopreservation.php weekly 0.7 /en/artkey/csf-200001-0003_human-hepatocyte-ii-cryopreservation.php weekly 0.7 /artkey/csf-200001-0004_some-aspects-of-the-occurrence-and-use-of-anthracenons.php weekly 0.7 /en/artkey/csf-200001-0004_some-aspects-of-the-occurrence-and-use-of-anthracenons.php weekly 0.7 /artkey/csf-200001-0005_sterols-in-lilium-candidum-l.php weekly 0.7 /en/artkey/csf-200001-0005_sterols-in-lilium-candidum-l.php weekly 0.7 /artkey/csf-200001-0006_antibacterial-and-anticancer-activity-of-2-4-disubstituted-6h-5-1-3-benzothiadiazocines.php weekly 0.7 /en/artkey/csf-200001-0006_antibacterial-and-anticancer-activity-of-2-4-disubstituted-6h-5-1-3-benzothiadiazocines.php weekly 0.7 /artkey/csf-200001-0007_effect-of-panpal-prophylaxis-on-the-activity-of-acetylcholinesterase-in-the-blood-diaphragm-and-various-parts.php weekly 0.7 /en/artkey/csf-200001-0007_effect-of-panpal-prophylaxis-on-the-activity-of-acetylcholinesterase-in-the-blood-diaphragm-and-various-parts.php weekly 0.7 /artkey/csf-200001-0008_pharmacodynamic-parameters-of-gentamicin-and-their-influence-on-surface-hyd-rophobicity-of-acinetobacter-bauman.php weekly 0.7 /en/artkey/csf-200001-0008_pharmacodynamic-parameters-of-gentamicin-and-their-influence-on-surface-hyd-rophobicity-of-acinetobacter-bauman.php weekly 0.7 /artkey/csf-200001-0009_effect-of-compounds-of-aryloxyaminopropanol-type-on-the-photosynthetic-activity-ofspinach-chloroplasts.php weekly 0.7 /en/artkey/csf-200001-0009_effect-of-compounds-of-aryloxyaminopropanol-type-on-the-photosynthetic-activity-ofspinach-chloroplasts.php weekly 0.7 /magno/csf/2000/mn2.php weekly 0.7 /en/magno/csf/2000/mn2.php weekly 0.7 /artkey/csf-200002-0001_mucoadhesive-oral-tablets-a-modern-dosage-form-with-controlled-release-of-the-active-ingredient.php weekly 0.7 /en/artkey/csf-200002-0001_mucoadhesive-oral-tablets-a-modern-dosage-form-with-controlled-release-of-the-active-ingredient.php weekly 0.7 /artkey/csf-200002-0002_effective-and-safe-pharmacotherapy-of-acne-vulgaris-and-the-treatment-of-solarimpairment-of-the-skin.php weekly 0.7 /en/artkey/csf-200002-0002_effective-and-safe-pharmacotherapy-of-acne-vulgaris-and-the-treatment-of-solarimpairment-of-the-skin.php weekly 0.7 /artkey/csf-200002-0003_chemical-structure-of-new-quinolones-and-their-antibacterial-activityii-4-quinolones-their-natural-occurrence.php weekly 0.7 /en/artkey/csf-200002-0003_chemical-structure-of-new-quinolones-and-their-antibacterial-activityii-4-quinolones-their-natural-occurrence.php weekly 0.7 /artkey/csf-200002-0004_apigenin-7-methylglucuronide-from-cynara-cardunculus-l.php weekly 0.7 /en/artkey/csf-200002-0004_apigenin-7-methylglucuronide-from-cynara-cardunculus-l.php weekly 0.7 /artkey/csf-200002-0005_effect-of-linoleic-acid-on-the-production-of-secondary-metabolites.php weekly 0.7 /en/artkey/csf-200002-0005_effect-of-linoleic-acid-on-the-production-of-secondary-metabolites.php weekly 0.7 /artkey/csf-200002-0006_hplc-analysis-of-non-steroidal-antirheumatics-in-biological-material-iv-acetic-acid-derivatives.php weekly 0.7 /en/artkey/csf-200002-0006_hplc-analysis-of-non-steroidal-antirheumatics-in-biological-material-iv-acetic-acid-derivatives.php weekly 0.7 /artkey/csf-200002-0007_determination-of-xanthinol-nicotinate-in-dosage-forms-by-capillary-isotachophoresis.php weekly 0.7 /en/artkey/csf-200002-0007_determination-of-xanthinol-nicotinate-in-dosage-forms-by-capillary-isotachophoresis.php weekly 0.7 /artkey/csf-200002-0008_99mtc-labelled-product-of-photochemical-degradation-of-insulin.php weekly 0.7 /en/artkey/csf-200002-0008_99mtc-labelled-product-of-photochemical-degradation-of-insulin.php weekly 0.7 /artkey/csf-200002-0009_pharmaceutical-dosage-forms-as-the-subject-of-a-dissertation-in-the-historic-past-of-charles-university.php weekly 0.7 /en/artkey/csf-200002-0009_pharmaceutical-dosage-forms-as-the-subject-of-a-dissertation-in-the-historic-past-of-charles-university.php weekly 0.7 /magno/csf/2000/mn3.php weekly 0.7 /en/magno/csf/2000/mn3.php weekly 0.7 /artkey/csf-200003-0001_coffea-arabica-production-classification-new-constituents-and-active-principles-andsome-of-their-pharmacolog.php weekly 0.7 /en/artkey/csf-200003-0001_coffea-arabica-production-classification-new-constituents-and-active-principles-andsome-of-their-pharmacolog.php weekly 0.7 /artkey/csf-200003-0002_protituberkulozni-derivaty-chinazolinu.php weekly 0.7 /en/artkey/csf-200003-0002_protituberkulozni-derivaty-chinazolinu.php weekly 0.7 /artkey/csf-200003-0003_koenzym-q10-vyznam-vlastnosti-a-vyuzitie-vo-vyzive-a-kozmetike.php weekly 0.7 /en/artkey/csf-200003-0003_koenzym-q10-vyznam-vlastnosti-a-vyuzitie-vo-vyzive-a-kozmetike.php weekly 0.7 /artkey/csf-200003-0004_reologicke-vlastnosti-viskoelastickych-teles-identifikace-modelu-a-odhad-parametru.php weekly 0.7 /en/artkey/csf-200003-0004_reologicke-vlastnosti-viskoelastickych-teles-identifikace-modelu-a-odhad-parametru.php weekly 0.7 /artkey/csf-200003-0005_obsah-mn-a-zn-v-droge-folium-betulae-folium-betulaez-r-znych-lokalit.php weekly 0.7 /en/artkey/csf-200003-0005_obsah-mn-a-zn-v-droge-folium-betulae-folium-betulaez-r-znych-lokalit.php weekly 0.7 /artkey/csf-200003-0006_vplyv-kyseliny-askorbovej-na-antibakterialnu-aktivitu-vybranych-antibiotik-a-syntetickych-chemoterapeutik-v-pod.php weekly 0.7 /en/artkey/csf-200003-0006_vplyv-kyseliny-askorbovej-na-antibakterialnu-aktivitu-vybranych-antibiotik-a-syntetickych-chemoterapeutik-v-pod.php weekly 0.7 /artkey/csf-200003-0007_prezentacia-sekrecie-b-galaktozidazy-rastlinnymi-bunkami.php weekly 0.7 /en/artkey/csf-200003-0007_prezentacia-sekrecie-b-galaktozidazy-rastlinnymi-bunkami.php weekly 0.7 /artkey/csf-200003-0008_vliv-makromolekularnich-latek-na-farmaceutickou-dostupnost-potencialniho-lokalniho-anestetika.php weekly 0.7 /en/artkey/csf-200003-0008_vliv-makromolekularnich-latek-na-farmaceutickou-dostupnost-potencialniho-lokalniho-anestetika.php weekly 0.7 /artkey/csf-200003-0009_vliv-stearanu-horecnateho-na-vnitrni-poruchovost-tablet-z-avicelu-ph-101.php weekly 0.7 /en/artkey/csf-200003-0009_vliv-stearanu-horecnateho-na-vnitrni-poruchovost-tablet-z-avicelu-ph-101.php weekly 0.7 /artkey/csf-200003-0010_ucinok-potencialnych-beta-adrenolytik-na-enzymove-aktivity-markerov-subcelularnych-frakcii-srdcoveho-svalu.php weekly 0.7 /en/artkey/csf-200003-0010_ucinok-potencialnych-beta-adrenolytik-na-enzymove-aktivity-markerov-subcelularnych-frakcii-srdcoveho-svalu.php weekly 0.7 /magno/csf/2000/mn4.php weekly 0.7 /en/magno/csf/2000/mn4.php weekly 0.7 /artkey/csf-200004-0001_interactions-between-medicinal-plants-and-drugs.php weekly 0.7 /en/artkey/csf-200004-0001_interactions-between-medicinal-plants-and-drugs.php weekly 0.7 /artkey/csf-200004-0002_curcumin-as-a-potential-antioxidant-agent.php weekly 0.7 /en/artkey/csf-200004-0002_curcumin-as-a-potential-antioxidant-agent.php weekly 0.7 /artkey/csf-200004-0003_role-of-aminooxidase-in-alkaloid-biosynthesis.php weekly 0.7 /en/artkey/csf-200004-0003_role-of-aminooxidase-in-alkaloid-biosynthesis.php weekly 0.7 /artkey/csf-200004-0004_effects-of-a-4-fluorophenyl-piperazine-derivative-substance-iiiv-on-the-cardiovascular-functions.php weekly 0.7 /en/artkey/csf-200004-0004_effects-of-a-4-fluorophenyl-piperazine-derivative-substance-iiiv-on-the-cardiovascular-functions.php weekly 0.7 /artkey/csf-200004-0005_fractal-dimension-of-powders-for-pharmaceutical-dusting-powders.php weekly 0.7 /en/artkey/csf-200004-0005_fractal-dimension-of-powders-for-pharmaceutical-dusting-powders.php weekly 0.7 /artkey/csf-200004-0006_physicochemical-in-vitro-and-in-vivo-investigation-of-the-depot-formation-of-cinchocaine-in-atelocollagen-felt.php weekly 0.7 /en/artkey/csf-200004-0006_physicochemical-in-vitro-and-in-vivo-investigation-of-the-depot-formation-of-cinchocaine-in-atelocollagen-felt.php weekly 0.7 /artkey/csf-200004-0007_analysis-of-a-cardioplegic-solution-using-capillary-isotachophoresis.php weekly 0.7 /en/artkey/csf-200004-0007_analysis-of-a-cardioplegic-solution-using-capillary-isotachophoresis.php weekly 0.7 /artkey/csf-200004-0008_evaluation-of-the-quality-of-mexiletine-hydrochloride-by-means-of-capillaryelectrophoresis.php weekly 0.7 /en/artkey/csf-200004-0008_evaluation-of-the-quality-of-mexiletine-hydrochloride-by-means-of-capillaryelectrophoresis.php weekly 0.7 /artkey/csf-200004-0009_oxidative-determination-of-hydroxyamphetamine-in-drops-by-the-method-of-flowinjection-analysis.php weekly 0.7 /en/artkey/csf-200004-0009_oxidative-determination-of-hydroxyamphetamine-in-drops-by-the-method-of-flowinjection-analysis.php weekly 0.7 /artkey/csf-200004-0010_anti-inflammatory-activities-of-copper-ii-and-zinc-ii-p-cresotates-dihydrates.php weekly 0.7 /en/artkey/csf-200004-0010_anti-inflammatory-activities-of-copper-ii-and-zinc-ii-p-cresotates-dihydrates.php weekly 0.7 /magno/csf/2000/mn6.php weekly 0.7 /en/magno/csf/2000/mn6.php weekly 0.7 /artkey/csf-200006-0001_advances-in-the-development-of-new-antituberculotic-agents-in-the-group-of-monocyclic-six-membered-heterocyclic.php weekly 0.7 /en/artkey/csf-200006-0001_advances-in-the-development-of-new-antituberculotic-agents-in-the-group-of-monocyclic-six-membered-heterocyclic.php weekly 0.7 /artkey/csf-200006-0002_chalcones-and-their-heterocyclic-analogues-as-potential-therapeutic-agents-of-bacterial-diseases.php weekly 0.7 /en/artkey/csf-200006-0002_chalcones-and-their-heterocyclic-analogues-as-potential-therapeutic-agents-of-bacterial-diseases.php weekly 0.7 /artkey/csf-200006-0003_allergic-contact-dermatitis-due-to-propolis.php weekly 0.7 /en/artkey/csf-200006-0003_allergic-contact-dermatitis-due-to-propolis.php weekly 0.7 /artkey/csf-200006-0004_kojic-acid-and-its-derivatives-as-potential-drugs.php weekly 0.7 /en/artkey/csf-200006-0004_kojic-acid-and-its-derivatives-as-potential-drugs.php weekly 0.7 /artkey/csf-200006-0005_examination-of-the-consumption-of-hypolipidemic-agents-by-means-of-the-databases-of-health-insurance-companies.php weekly 0.7 /en/artkey/csf-200006-0005_examination-of-the-consumption-of-hypolipidemic-agents-by-means-of-the-databases-of-health-insurance-companies.php weekly 0.7 /artkey/csf-200006-0006_studies-of-local-anaesthetics-part-153-the-relationship-between-the-chemical-structure-physical-chemical-pro.php weekly 0.7 /en/artkey/csf-200006-0006_studies-of-local-anaesthetics-part-153-the-relationship-between-the-chemical-structure-physical-chemical-pro.php weekly 0.7 /magno/csf/1999/mn1.php weekly 0.7 /en/magno/csf/1999/mn1.php weekly 0.7 /artkey/csf-199901-0001_antioxidants-of-biogenic-origin.php weekly 0.7 /en/artkey/csf-199901-0001_antioxidants-of-biogenic-origin.php weekly 0.7 /artkey/csf-199901-0002_kinetics-of-hydration-of-lyophilised-xerogel-of-hydroxypropylmethylcellulose.php weekly 0.7 /en/artkey/csf-199901-0002_kinetics-of-hydration-of-lyophilised-xerogel-of-hydroxypropylmethylcellulose.php weekly 0.7 /artkey/csf-199901-0003_calorimetric-determination-of-silicone-matrices.php weekly 0.7 /en/artkey/csf-199901-0003_calorimetric-determination-of-silicone-matrices.php weekly 0.7 /artkey/csf-199901-0004_a-study-of-labeling-conditions-of-derivatives-of-2rs-4r-1-3-carboxylic-acid-with-technetium-99m.php weekly 0.7 /en/artkey/csf-199901-0004_a-study-of-labeling-conditions-of-derivatives-of-2rs-4r-1-3-carboxylic-acid-with-technetium-99m.php weekly 0.7 /artkey/csf-199901-0005_targeting-and-controlled-release-of-drugs-using-magnetoliposomes.php weekly 0.7 /en/artkey/csf-199901-0005_targeting-and-controlled-release-of-drugs-using-magnetoliposomes.php weekly 0.7 /artkey/csf-199901-0006_invertase-in-immobilized-poppy-cells.php weekly 0.7 /en/artkey/csf-199901-0006_invertase-in-immobilized-poppy-cells.php weekly 0.7 /artkey/csf-199901-0007_microscopic-description-of-the-stem-and-leaves-of-stevia-rebaudiana-bertoni-hemsley-asteraceae.php weekly 0.7 /en/artkey/csf-199901-0007_microscopic-description-of-the-stem-and-leaves-of-stevia-rebaudiana-bertoni-hemsley-asteraceae.php weekly 0.7 /artkey/csf-199901-0008_effect-of-the-elicitor-from-rhodotorula-rubra-on-the-production-of-flavonoids-in-the-culture-of-ononis-arvensis.php weekly 0.7 /en/artkey/csf-199901-0008_effect-of-the-elicitor-from-rhodotorula-rubra-on-the-production-of-flavonoids-in-the-culture-of-ononis-arvensis.php weekly 0.7 /artkey/csf-199901-0009_inter-organ-variability-of-enzymatic-hydrolysis-of-organic-ammonium-salts-in-the-rat-in-vitro.php weekly 0.7 /en/artkey/csf-199901-0009_inter-organ-variability-of-enzymatic-hydrolysis-of-organic-ammonium-salts-in-the-rat-in-vitro.php weekly 0.7 /artkey/csf-199901-0010_a-comparison-of-the-effect-of-the-new-asymmetric-bispyridinium-oxime-bi-6-with-oxime-hi-6-and-obidoxime-in-comb.php weekly 0.7 /en/artkey/csf-199901-0010_a-comparison-of-the-effect-of-the-new-asymmetric-bispyridinium-oxime-bi-6-with-oxime-hi-6-and-obidoxime-in-comb.php weekly 0.7 /magno/csf/1999/mn2.php weekly 0.7 /en/magno/csf/1999/mn2.php weekly 0.7 /artkey/csf-199902-0001_generics-alternatives-substitution-interchange.php weekly 0.7 /en/artkey/csf-199902-0001_generics-alternatives-substitution-interchange.php weekly 0.7 /artkey/csf-199902-0002_human-hepatocyt-i-model-for-the-study-of-xenobiotic-metabolism-and-toxicity.php weekly 0.7 /en/artkey/csf-199902-0002_human-hepatocyt-i-model-for-the-study-of-xenobiotic-metabolism-and-toxicity.php weekly 0.7 /artkey/csf-199902-0003_density-of-lyophilised-ophthalmic-lamellae2-use-of-the-correlogram-of-xerogel-density.php weekly 0.7 /en/artkey/csf-199902-0003_density-of-lyophilised-ophthalmic-lamellae2-use-of-the-correlogram-of-xerogel-density.php weekly 0.7 /artkey/csf-199902-0004_a-study-of-manufacturing-defects-of-hard-gelatine-capsules-etalock.php weekly 0.7 /en/artkey/csf-199902-0004_a-study-of-manufacturing-defects-of-hard-gelatine-capsules-etalock.php weekly 0.7 /artkey/csf-199902-0005_evaluation-of-preparations-of-natural-medicine-by-means-of-a-special-fluorescenttechnique.php weekly 0.7 /en/artkey/csf-199902-0005_evaluation-of-preparations-of-natural-medicine-by-means-of-a-special-fluorescenttechnique.php weekly 0.7 /artkey/csf-199902-0006_the-relationship-of-the-structure-physico-chemical-properties-and-local-anaesthetic-activity-in-a-group-of-1-m.php weekly 0.7 /en/artkey/csf-199902-0006_the-relationship-of-the-structure-physico-chemical-properties-and-local-anaesthetic-activity-in-a-group-of-1-m.php weekly 0.7 /artkey/csf-199902-0007_preparation-aggregative-properties-and-antimicrobial-activity-of-n-alkyl-n-2-hydro-xydodecyl-n-n-dimethylamm.php weekly 0.7 /en/artkey/csf-199902-0007_preparation-aggregative-properties-and-antimicrobial-activity-of-n-alkyl-n-2-hydro-xydodecyl-n-n-dimethylamm.php weekly 0.7 /artkey/csf-199902-0008_theory-and-practice-of-pharmacopoeial-control-of-the-quality-of-drugs-and-auxiliarysubstancesv-rapae-oleum-hyd.php weekly 0.7 /en/artkey/csf-199902-0008_theory-and-practice-of-pharmacopoeial-control-of-the-quality-of-drugs-and-auxiliarysubstancesv-rapae-oleum-hyd.php weekly 0.7 /artkey/csf-199902-0009_a-contribution-to-the-analytical-profile-of-n-isopropyl-3-2-acetyl-4-propoxycarbonyl-amino-phenoxy-2-hydroxy.php weekly 0.7 /en/artkey/csf-199902-0009_a-contribution-to-the-analytical-profile-of-n-isopropyl-3-2-acetyl-4-propoxycarbonyl-amino-phenoxy-2-hydroxy.php weekly 0.7 /magno/csf/1999/mn3.php weekly 0.7 /en/magno/csf/1999/mn3.php weekly 0.7 /artkey/csf-199903-0001_chiral-compounds-and-their-pharmacological-effects.php weekly 0.7 /en/artkey/csf-199903-0001_chiral-compounds-and-their-pharmacological-effects.php weekly 0.7 /artkey/csf-199903-0002_pharmaceutical-significance-of-the-species-of-the-genus-solidago-2-the-saponins-of-the-species-solidago-canade.php weekly 0.7 /en/artkey/csf-199903-0002_pharmaceutical-significance-of-the-species-of-the-genus-solidago-2-the-saponins-of-the-species-solidago-canade.php weekly 0.7 /artkey/csf-199903-0003_several-common-gastrointestinal-symptoms-and-their-effective-and-safe-treatment.php weekly 0.7 /en/artkey/csf-199903-0003_several-common-gastrointestinal-symptoms-and-their-effective-and-safe-treatment.php weekly 0.7 /artkey/csf-199903-0004_density-of-lyophilised-ophthalmic-lamellae-3-effects-on-the-density-due-to-addition-of-pilocarpinium-chloride.php weekly 0.7 /en/artkey/csf-199903-0004_density-of-lyophilised-ophthalmic-lamellae-3-effects-on-the-density-due-to-addition-of-pilocarpinium-chloride.php weekly 0.7 /artkey/csf-199903-0005_a-contribution-to-the-estimation-of-particle-size-in-semisolid-emulsion-systems.php weekly 0.7 /en/artkey/csf-199903-0005_a-contribution-to-the-estimation-of-particle-size-in-semisolid-emulsion-systems.php weekly 0.7 /artkey/csf-199903-0006_investigation-of-the-effects-of-ecological-aspects-on-the-content-of-toxic-metals-pb-and-cd-in-the-drugs-fl.php weekly 0.7 /en/artkey/csf-199903-0006_investigation-of-the-effects-of-ecological-aspects-on-the-content-of-toxic-metals-pb-and-cd-in-the-drugs-fl.php weekly 0.7 /artkey/csf-199903-0007_effect-of-biotic-elicitation-on-the-production-of-anthraglycosides-by-the-tissue-cultureof-rheum-palmatum-l.php weekly 0.7 /en/artkey/csf-199903-0007_effect-of-biotic-elicitation-on-the-production-of-anthraglycosides-by-the-tissue-cultureof-rheum-palmatum-l.php weekly 0.7 /artkey/csf-199903-0008_examination-of-the-activity-of-some-aminopeptidases-in-immobilized-cells-of-the-poppy-plant.php weekly 0.7 /en/artkey/csf-199903-0008_examination-of-the-activity-of-some-aminopeptidases-in-immobilized-cells-of-the-poppy-plant.php weekly 0.7 /magno/csf/1999/mn4.php weekly 0.7 /en/magno/csf/1999/mn4.php weekly 0.7 /artkey/csf-199904-0001_advances-in-the-development-of-new-antituberculotics-of-the-group-of-five-membered-heterocyclic-compounds-conta.php weekly 0.7 /en/artkey/csf-199904-0001_advances-in-the-development-of-new-antituberculotics-of-the-group-of-five-membered-heterocyclic-compounds-conta.php weekly 0.7 /artkey/csf-199904-0002_opinions-on-the-provision-of-pharmaceutical-care-in-the-czech-republic.php weekly 0.7 /en/artkey/csf-199904-0002_opinions-on-the-provision-of-pharmaceutical-care-in-the-czech-republic.php weekly 0.7 /artkey/csf-199904-0003_kinetics-of-the-liberation-of-active-ingredients-from-lyophilised-xerogel.php weekly 0.7 /en/artkey/csf-199904-0003_kinetics-of-the-liberation-of-active-ingredients-from-lyophilised-xerogel.php weekly 0.7 /artkey/csf-199904-0004_use-of-stomatal-index-determination-to-distinguish-the-leaves-of-the-mentha-l.php weekly 0.7 /en/artkey/csf-199904-0004_use-of-stomatal-index-determination-to-distinguish-the-leaves-of-the-mentha-l.php weekly 0.7 /artkey/csf-199904-0005_studies-of-physico-chemical-properties-of-compounds-from-the-group-of-1-4-phenyl-1-piperazinyl-3-methoxy-2-p.php weekly 0.7 /en/artkey/csf-199904-0005_studies-of-physico-chemical-properties-of-compounds-from-the-group-of-1-4-phenyl-1-piperazinyl-3-methoxy-2-p.php weekly 0.7 /artkey/csf-199904-0006_preparation-and-anti-inflammatory-activity-of-selected-aqua-aryloxyacetato-zinc-ii-complexes.php weekly 0.7 /en/artkey/csf-199904-0006_preparation-and-anti-inflammatory-activity-of-selected-aqua-aryloxyacetato-zinc-ii-complexes.php weekly 0.7 /artkey/csf-199904-0007_isotachophoretic-analysis-of-ophthalmic-drops.php weekly 0.7 /en/artkey/csf-199904-0007_isotachophoretic-analysis-of-ophthalmic-drops.php weekly 0.7 /artkey/csf-199904-0008_comparative-study-of-the-application-of-sulfo-and-carboxy-azo-dyes-as-reagents-in-theion-pair-extraction-spectr.php weekly 0.7 /en/artkey/csf-199904-0008_comparative-study-of-the-application-of-sulfo-and-carboxy-azo-dyes-as-reagents-in-theion-pair-extraction-spectr.php weekly 0.7 /magno/csf/1999/mn5.php weekly 0.7 /en/magno/csf/1999/mn5.php weekly 0.7 /artkey/csf-199905-0001_advances-in-the-development-of-new-antituberculotics-from-the-group-of-five-membe-red-heterocyclic-substances-c.php weekly 0.7 /en/artkey/csf-199905-0001_advances-in-the-development-of-new-antituberculotics-from-the-group-of-five-membe-red-heterocyclic-substances-c.php weekly 0.7 /artkey/csf-199905-0002_new-isoprenoid-biosynthetic-pathway.php weekly 0.7 /en/artkey/csf-199905-0002_new-isoprenoid-biosynthetic-pathway.php weekly 0.7 /artkey/csf-199905-0003_influence-of-the-health-service-reform-in-germany-on-the-pharmacist-s-role-in-pharmacotherapy.php weekly 0.7 /en/artkey/csf-199905-0003_influence-of-the-health-service-reform-in-germany-on-the-pharmacist-s-role-in-pharmacotherapy.php weekly 0.7 /artkey/csf-199905-0004_in-vitro-determination-of-verapamil-hydrochloride-tablet-dissolution.php weekly 0.7 /en/artkey/csf-199905-0004_in-vitro-determination-of-verapamil-hydrochloride-tablet-dissolution.php weekly 0.7 /artkey/csf-199905-0005_use-of-a-redox-polymers-for-insulin-labelling-with-technetium-99mtc.php weekly 0.7 /en/artkey/csf-199905-0005_use-of-a-redox-polymers-for-insulin-labelling-with-technetium-99mtc.php weekly 0.7 /artkey/csf-199905-0006_liberation-of-drugs-from-impregnated-wound-covers.php weekly 0.7 /en/artkey/csf-199905-0006_liberation-of-drugs-from-impregnated-wound-covers.php weekly 0.7 /artkey/csf-199905-0007_the-oyster-mushroom-pleurotus-ostreatus-effectivelly-prevents-development-of-atherosclerosis-in-the-rabbit.php weekly 0.7 /en/artkey/csf-199905-0007_the-oyster-mushroom-pleurotus-ostreatus-effectivelly-prevents-development-of-atherosclerosis-in-the-rabbit.php weekly 0.7 /artkey/csf-199905-0008_determination-of-the-stomatal-index-of-betulae-folium.php weekly 0.7 /en/artkey/csf-199905-0008_determination-of-the-stomatal-index-of-betulae-folium.php weekly 0.7 /artkey/csf-199905-0009_preparation-of-hydrazones-of-r-and-s-usnic-acid-their-antitumor-activity.php weekly 0.7 /en/artkey/csf-199905-0009_preparation-of-hydrazones-of-r-and-s-usnic-acid-their-antitumor-activity.php weekly 0.7 /artkey/csf-199905-0010_contributions-to-drug-analysis-xxi-determination-of-methylrosanilinium-chloride-content-by-differential-titrat.php weekly 0.7 /en/artkey/csf-199905-0010_contributions-to-drug-analysis-xxi-determination-of-methylrosanilinium-chloride-content-by-differential-titrat.php weekly 0.7 /magno/csf/1999/mn6.php weekly 0.7 /en/magno/csf/1999/mn6.php weekly 0.7 /artkey/csf-199906-0001_the-use-of-the-concept-of-the-pharmacophore-in-drug-design.php weekly 0.7 /en/artkey/csf-199906-0001_the-use-of-the-concept-of-the-pharmacophore-in-drug-design.php weekly 0.7 /artkey/csf-199906-0002_chalcones-and-their-heterocyclic-analogues-as-potential-antifungal-chemotherapeutics.php weekly 0.7 /en/artkey/csf-199906-0002_chalcones-and-their-heterocyclic-analogues-as-potential-antifungal-chemotherapeutics.php weekly 0.7 /artkey/csf-199906-0003_production-of-anthracene-derivatives-by-the-elicited-tissue-culture-of-rheumpalmatum-l.php weekly 0.7 /en/artkey/csf-199906-0003_production-of-anthracene-derivatives-by-the-elicited-tissue-culture-of-rheumpalmatum-l.php weekly 0.7 /artkey/csf-199906-0004_the-use-of-the-elicitor-from-pseudomonas-aeruginosa-on-the-production-of-flavonoids-by-the-culture-of-ononis-ar.php weekly 0.7 /en/artkey/csf-199906-0004_the-use-of-the-elicitor-from-pseudomonas-aeruginosa-on-the-production-of-flavonoids-by-the-culture-of-ononis-ar.php weekly 0.7 /artkey/csf-199906-0005_determination-of-selected-secondary-metabolites-and-extractive-substances-in-phila-delphus-coronarius-l.php weekly 0.7 /en/artkey/csf-199906-0005_determination-of-selected-secondary-metabolites-and-extractive-substances-in-phila-delphus-coronarius-l.php weekly 0.7 /artkey/csf-199906-0006_effect-of-biotic-elicitors-on-the-production-of-flavonoids-in-suspension-culture-of-bellisperennis-l.php weekly 0.7 /en/artkey/csf-199906-0006_effect-of-biotic-elicitors-on-the-production-of-flavonoids-in-suspension-culture-of-bellisperennis-l.php weekly 0.7 /artkey/csf-199906-0007_in-vitro-effect-of-quinolones-on-hydrophobicity-of-acinetobacter-baumannii.php weekly 0.7 /en/artkey/csf-199906-0007_in-vitro-effect-of-quinolones-on-hydrophobicity-of-acinetobacter-baumannii.php weekly 0.7 /artkey/csf-199906-0008_studies-of-local-anaesthetics-cl-models-of-dependence-of-local-anaesthetic-effectiveness-of-basic-esters-of-al.php weekly 0.7 /en/artkey/csf-199906-0008_studies-of-local-anaesthetics-cl-models-of-dependence-of-local-anaesthetic-effectiveness-of-basic-esters-of-al.php weekly 0.7 /artkey/csf-199906-0009_substituted-benzo-b-thiophenes-with-antileucotriene-activity.php weekly 0.7 /en/artkey/csf-199906-0009_substituted-benzo-b-thiophenes-with-antileucotriene-activity.php weekly 0.7 /artkey/csf-199906-0010_dissolution-and-supersaturation-episodes-of-nimodipine-in-the-aqueous-solutions-of-the-cyclodextrins-a-cd-hp-a.php weekly 0.7 /en/artkey/csf-199906-0010_dissolution-and-supersaturation-episodes-of-nimodipine-in-the-aqueous-solutions-of-the-cyclodextrins-a-cd-hp-a.php weekly 0.7 /artkey/csf-199906-0011_czech-pharmaceutical-education-under-german-occupation-in-1939-1945.php weekly 0.7 /en/artkey/csf-199906-0011_czech-pharmaceutical-education-under-german-occupation-in-1939-1945.php weekly 0.7 /magno/csf/1998/mn6.php weekly 0.7 /en/magno/csf/1998/mn6.php weekly 0.7 /artkey/csf-199806-0001_are-the-present-names-and-definitions-of-principal-pharmaceutical-categories-correct.php weekly 0.7 /en/artkey/csf-199806-0001_are-the-present-names-and-definitions-of-principal-pharmaceutical-categories-correct.php weekly 0.7 /artkey/csf-199806-0002_contemporary-knowledge-of-postantibiotic-effects-of-antimicrobial-agents.php weekly 0.7 /en/artkey/csf-199806-0002_contemporary-knowledge-of-postantibiotic-effects-of-antimicrobial-agents.php weekly 0.7 /artkey/csf-199806-0003_excerpta.php weekly 0.7 /en/artkey/csf-199806-0003_excerpta.php weekly 0.7 /artkey/csf-199806-0004_effect-of-cdcl2-and-cuso4-on-the-production-of-flavonoids-by-the-culture-of-ononis-arvensis-l-in-vitro.php weekly 0.7 /en/artkey/csf-199806-0004_effect-of-cdcl2-and-cuso4-on-the-production-of-flavonoids-by-the-culture-of-ononis-arvensis-l-in-vitro.php weekly 0.7 /artkey/csf-199806-0005_brassica-oleracea-in-vitro.php weekly 0.7 /en/artkey/csf-199806-0005_brassica-oleracea-in-vitro.php weekly 0.7 /artkey/csf-199806-0006_constituents-of-iresine-herbstii.php weekly 0.7 /en/artkey/csf-199806-0006_constituents-of-iresine-herbstii.php weekly 0.7 /artkey/csf-199806-0007_a-new-method-of-detection-of-plant-extracellular-proteolytic-enzymes.php weekly 0.7 /en/artkey/csf-199806-0007_a-new-method-of-detection-of-plant-extracellular-proteolytic-enzymes.php weekly 0.7 /artkey/csf-199806-0008_effect-of-auxins-on-the-growth-of-the-callus-culture-of-bellis-perennis-l-and-the-production-of-flavonoids.php weekly 0.7 /en/artkey/csf-199806-0008_effect-of-auxins-on-the-growth-of-the-callus-culture-of-bellis-perennis-l-and-the-production-of-flavonoids.php weekly 0.7 /artkey/csf-199806-0009_density-of-lyophilised-ophthalmic-lamellae.php weekly 0.7 /en/artkey/csf-199806-0009_density-of-lyophilised-ophthalmic-lamellae.php weekly 0.7 /artkey/csf-199806-0010_formation-of-the-scientific-basis-of-czech-pharmacy-in-1939-1945.php weekly 0.7 /en/artkey/csf-199806-0010_formation-of-the-scientific-basis-of-czech-pharmacy-in-1939-1945.php weekly 0.7 /artkey/csf-199806-0011_from-purkynje-s-pharmacological-observations-to-molecular-drug-interactions.php weekly 0.7 /en/artkey/csf-199806-0011_from-purkynje-s-pharmacological-observations-to-molecular-drug-interactions.php weekly 0.7 /artkey/csf-199806-0012_nove-knihy.php weekly 0.7 /en/artkey/csf-199806-0012_nove-knihy.php weekly 0.7 /artkey/csf-199806-0013_z-cinnosti-farmaceutickych-spolecnosti.php weekly 0.7 /en/artkey/csf-199806-0013_z-cinnosti-farmaceutickych-spolecnosti.php weekly 0.7